SUSMP Nov 2016 PDF
SUSMP Nov 2016 PDF
SUSMP Nov 2016 PDF
I, ANTHONY GILL, a delegate of the Secretary to the Department of Health for the purposes of
paragraph 52D(2)(b) of the Therapeutic Goods Act 1989 (the Act) and acting in accordance with
the Secretarys power under that paragraph of the Act, prepare this new Poisons Standard, in
substitution for the current Poisons Standard.
(Signed by)
ANTHONY GILL
Delegate of the Secretary to the Department of Health
1.
Citation
This instrument is the Poisons Standard November 2016.
2.
3.
Commencement
The Poisons Standard November 2016 commences on 1 November 2016.
Reasons for scheduling delegates final decisions can be accessed from the TGA website, at
https://www.tga.gov.au/reasons-scheduling-delegates-final-decisions
Further inquiries in relation to this document should be directed to:
The Secretary
Chemicals Scheduling Secretariat (MD122)
Scheduling and Committee Governance
Therapeutic Goods Administration
PO Box 100
WODEN ACT 2606
The Secretary
Medicines Scheduling Secretariat (MD122)
Scheduling and Committee Governance
Therapeutic Goods Administration
PO Box 100
WODEN ACT 2606
or by email to
Chemicals.Scheduling@tga.gov.au
or by email to
Medicines.Scheduling@tga.gov.au
Table of Contents
Table of Contents
INTRODUCTION
iii
CLASSIFICATION
iv
PRINCIPLES OF SCHEDULING
AVAILABILITY OF POISONS
vii
vii
PART 1
INTERPRETATION ___________________________________________ 1
PART 2
10
LABELS __________________________________________ 10
SECTION TWO
CONTAINERS _____________________________________ 21
SECTION THREE
STORAGE ______________________________________ 26
SECTION SEVEN/Appendix I
PART 3
30
ADVERTISING ____________________________________ 30
SECTION TWO
SECTION THREE
STORAGE ______________________________________ 31
PART 4
32
Poisons Standard November 2016
PART 5
244
ii
INDEX
353
INTRODUCTION
The Poisons Standard November 2016, which, under section 2 above consists of the Standard
for the Uniform Scheduling of Medicines and Poisons (the Standard, or the SUSMP), is made
under paragraph 52D(2)(b) of the Therapeutic Goods Act 1989, and is a compilation of
decisions made under section 52D of the same Act. The SUSMP should be read in conjunction
with the Scheduling Policy Framework (SPF) of the Australian Health Ministers' Advisory
Council. Further information on the scheduling amendments and the SPF can be accessed at
www.tga.gov.au. Refer to Part 1, Interpretation, on page 2 below for definitions of specific
terms used in this document including medicine and poison (noting that the definition of
poison includes medicine).
The SUSMP serves two key purposes.
Firstly, the SUSMP contains the decisions of the Secretary of the Department of Health or the
Secretary's delegates regarding the classification of poisons into Schedules, as recommendations
to Australian States and Territories. The scheduling classification sets the level of control on
the availability of poisons. The scheduling of poisons is implemented through relevant State
and Territory legislation. Certain advertising, labelling and packaging requirements may also
be a consequence of scheduling, but are the subject of other Commonwealth registration
schemes.
Secondly, the SUSMP includes provisions for labelling, containers, storage, disposal, recordkeeping, sale, supply and possession of poisons in general which are intended to be adopted for
use in each jurisdiction of Australia. Other government agencies may also impose controls on
certain products, for example cosmetics.
The requirements for labelling and containers in the SUSMP are intended to integrate with
existing legislative instruments for labelling and containers. Advertising, labelling and
packaging of therapeutic goods and agricultural and veterinary chemicals are also dealt with
through the respective product registration schemes provided for in Commonwealth legislation.
Poisons which are packed and sold solely for industrial, manufacturing, laboratory or dispensary
use are exempt from all labelling requirements included in the SUSMP as they are covered by
labelling requirements under applicable jurisdictional Work Health and Safety laws, as amended
from time to time. Note, however that this exemption does not extend to controls on supply of
these poisons.
The SUSMP is presented with a view to promoting uniform:
scheduling of poisons throughout Australia;
signal headings on labels for poisons throughout Australia;
labelling and packaging requirements for poisons throughout Australia;
additional controls on the availability and use of poisons in Australia.
iii
The various Commonwealth Acts, legislative instruments and other documents which integrate
with the SUSMP include:
the Agricultural and Veterinary Chemicals Code Act 1994
the Agricultural and Veterinary Chemicals Code Regulations 1995
the Therapeutic Goods Act 1989
Therapeutic Goods Order 69 General requirements for labels for medicines
Therapeutic Goods Order 80 Child-Resistant Packaging Requirements for Medicines
the Required Advisory Statements for Medicine Labels (RASML).
CLASSIFICATION
Poisons are classified according to the Schedules in which they are included. The following is a
general description of the Schedules. For the legal definitions, however, it is necessary to check
with each relevant State or Territory authority.
Schedule 1.
Schedule 2.
Pharmacy Medicine Substances, the safe use of which may require advice
from a pharmacist and which should be available from a pharmacy or, where a
pharmacy service is not available, from a licensed person.
Schedule 3.
Schedule 4.
Schedule 5.
Caution Substances with a low potential for causing harm, the extent of which
can be reduced through the use of appropriate packaging with simple warnings
and safety directions on the label.
Schedule 6.
Poison Substances with a moderate potential for causing harm, the extent of
which can be reduced through the use of distinctive packaging with strong
warnings and safety directions on the label.
Schedule 7.
Dangerous Poison Substances with a high potential for causing harm at low
exposure and which require special precautions during manufacture, handling or
use. These poisons should be available only to specialised or authorised users
who have the skills necessary to handle them safely. Special regulations
Poisons Standard November 2016
iv
Controlled Drug Substances which should be available for use but require
restriction of manufacture, supply, distribution, possession and use to reduce
abuse, misuse and physical or psychological dependence.
Schedule 9.
Schedule 10
(previously
Appendix C).
PRINCIPLES OF SCHEDULING
Poisons are not scheduled on the basis of a universal scale of toxicity. Although toxicity is one
of the factors considered, and is itself a complex of factors, the decision to include a substance
in a particular Schedule also takes into account many other criteria such as the purpose of use,
potential for abuse, safety in use and the need for the substance.
This Standard lists poisons in ten Schedules according to the degree of control recommended to
be exercised over their availability to the public.
Poisons for therapeutic use (medicines) are mostly included in Schedules 2, 3, 4 and 8 with
progression through these Schedules signifying increasingly restrictive regulatory controls.
For some medicines and agricultural, domestic and industrial poisons, Schedules 5, 6 and 7
represent increasingly stricter container and labelling requirements with special regulatory
controls over the availability of the poisons listed in Schedule 7. Products for domestic use
must not include poisons listed in Schedule 7.
Schedule 9 contains substances that should be available only for teaching, training, medical or
scientific research including clinical trials conducted with the approval of Commonwealth
and/or State and Territory health authorities. Although appearing as a Schedule in this
Standard, the method by which it is implemented in the States and Territories may vary.
Schedule 10 (previously Appendix C) contains a list of substances or preparations, the sale,
supply or use of which should be prohibited because of their known dangerous properties.
Substances in products which have been considered for scheduling, but have been exempted
from this Standard, may be listed in either Appendix A (general exemptions) or Appendix B
(substances considered not to require control by scheduling).
necessary to keep this variety of expression in mind when searching or interpreting Schedule
entries.
Firstly, poisons are scheduled individually using their approved names wherever practicable
although exceptions are necessary in some cases. Some of those are mentioned overleaf. Older
group entries are revised and replaced by individual entries as time permits, although in some of
these cases a group term has also been retained to deal with any members of the group or class
that may have escaped attention but should be scheduled.
Secondly, Schedule entries have been expressed in either positive or negative terms and care
must be taken to distinguish between the two different forms of expression. Thus, selenium is
in Schedule 6 only when one of the clauses in this Schedule entry applies, while fluorides are in
Schedule 6 unless one of the exempting clauses applies.
Where exceptions are included in an entry, these have been emphasised by printing the word
except in bold type.
Where the Schedule entries for a poison make a specific exclusion or exemption, the
requirements of this Standard do not apply to that poison within the constraints of that exclusion
or exemption although controls under other legislation, such as pesticide registration, may
apply.
Where a Schedule entry for a poison requires a specific statement to be included on a label as a
condition for a product to qualify for an exemption (reverse scheduling), then in cases where it
is impracticable for a supplier to use the exact wording of such a statement, its wording may be
varied provided that the full intent and meaning of the statement is not changed.
Where a poison has been included in more than one Schedule, the principal entry, where
practicable, has been included in the most restrictive Schedule with references to the other
Schedule(s) involved.
It is important to remember that a Schedule entry includes preparations containing the poison in
any concentration and all salts and derivatives of the poison unless it specifically states
otherwise. (See Part 1, Interpretation, subparagraph 1(2)).
It is important to note that a substance is not classed as a derivative on the basis of a single,
prescriptive set of criteria. Classification of a substance as a derivative of a scheduled poison
relies on a balanced consideration of factors to decide if a substance has a similar nature (e.g.
structurally, pharmacologically, and toxicologically) to a scheduled poison or is readily
converted (either physically or chemically) to a scheduled poison. However, a substance is only
considered a derivative of a scheduled poison if it is not individually listed elsewhere in the
Schedules, or captured by a more restrictive group or class entry. Additionally, some entries
specifically exclude derivatives. Once a substance is determined to be a derivative of a
scheduled poison, the same scheduling requirements as the scheduled poison, including limits
on access, supply and availability, will apply.
Finally, when using this Standard to determine the scheduling status of a poison, it may be
necessary to search each relevant Schedule as well as Appendices A, B and the Index. In this
process, if the poison is not found under its approved name it may be shown under a group
term such as:
Group
Example
vi
the element
a pharmacological group
AVAILABILITY OF POISONS
The purpose of classification is to group substances into Schedules that require similar
regulatory controls over their availability.
These Schedules have been developed over a long period and contain poisons that may be
obsolete for various reasons. Also, as part of the move to harmonise the Australian and New
Zealand classifications, many substances have been added to the Schedules for that purpose,
irrespective of their availability in either country.
Inclusion of a poison in a Schedule indicates the degree of control required if it is marketed. It
does not indicate:
that the poison is available; nor
that is has been approved or is efficacious for any use that may be specified in a Schedule;
nor
does it negate any obligation for registration of a therapeutic good, or agricultural or
veterinary chemical product containing that poison.
vii
Appendix
Title
Appendix A
General exemptions
Appendix B
Substances considered
not to require control by
scheduling
Appendix C
Appendix is
intentionally left blank
Appendix D
Additional controls on
possession or supply of
poisons included in
Schedule 4 or 8
Appendix E
Appendix F
Appendix G
Dilute preparations
Appendix H
Schedule 3 medicines
permitted to be
advertised
Appendix I
Appendix is
intentionally left blank
viii
Appendix J
Conditions for
availability and use of
Schedule 7 poisons
Appendix K
Human medicines
required to be labelled
with a sedation warning
Appendix L
Requirements for
dispensing labels for
medicines
ix
PART 1 - INTERPRETATION
PART 1
INTERPRETATION
1.
PART 1 - INTERPRETATION
h) for the purpose of providing an exemption from all or part of Section 1.1 to Section
1.5.3 of this Standard by the Therapeutic Goods Administration, the National
Manager or their delegate;
i)
j)
b) in relation to a poison that is for animal or agricultural use, the name approved for use
by the Australian Pesticides and Veterinary Medicines Authority;
c) in relation to all other poisons:
i)
the name used in an entry in these Schedules; or, if no such name is given,
ii) the English name recommended by Standards Australia as the common name for
the poison; or, if no such name is given,
iii) the English name given to the poison by the International Organization for
Standardization; or, if no such name is given,
iv) the English name given to the poison by the British Standards Institution; or, if no
such name is given,
v) the name that would comply with the requirements of part (a) or (b) of this
definition, or, if no such name is given,
vi) the English name given to the poison by the European Committee for
Standardization (CEN); or, if no such name is given,
vii) the international non-proprietary name recommended for the poison by the World
Health Organization; or, if no such name is given,
viii) the International Nomenclature Cosmetic Ingredient name for the poison listed
in the International Cosmetic Ingredient Dictionary & Handbook published by
the Personal Care Products Council of America; or, if no such name is given,
ix) the accepted scientific name or the name descriptive of the true nature and origin
of the poison.
Australian Code for the Transport of Dangerous Goods by Road and Rail means the
seventh edition of the document of that name.
Authorised prescriber means a registered medical, dental or veterinary practitioner or such
other person authorised by the appropriate authority.
Blood means whole blood extracted from human donors.
Blood components means therapeutic components that have been manufactured from blood
(including red cells, white cells, stem cells, platelets and plasma), except for products
derived through fractionation of plasma.
Child-resistant closure means:
a) a closure that complies with the requirements for a child-resistant closure in the
Australian Standard AS 1928-2007 entitled Child-resistant packaging
Poisons Standard November 2016
PART 1 - INTERPRETATION
ii) the British Standards Institution Standard BS EN ISO 8317:2004 entitled Childresistant packaging. Requirements and testing procedures for reclosable
packages;
iii) the Canadian Standards Association Standard CSA Z76.1-06 entitled Reclosable
Child-Resistant Packages;
iv) the United States Code of Federal Regulations, Title 16, Section 1700.15, entitled
Poison prevention packaging standards and Section 1700.20, entitled Testing
procedure for special packaging;
c) is approved as child-resistant by any order made under subsection 10(3) of the
Commonwealth Therapeutic Goods Act 1989; or
d) is in the form of blister or strip packaging in which a unit of use is individually
protected until the time of release and that complies with Section 3 (Requirements for
non-reclosable packages) of Australian Standard AS 1928-2001 entitled Childresistant packages.
See also "Non-access packaging".
Compounded in relation to a substance means combined with one or more other
therapeutically active substances in such a way that it cannot be separated from them by
simple dissolution or other simple physical means.
Cosmetic means:
a) a substance or preparation intended for placement in contact with any external part of
the human body, including:
i)
PART 1 - INTERPRETATION
PART 1 - INTERPRETATION
Essential oils means products obtained from natural raw materials either by distillation with
water or steam or from the epicarp of citrus fruits by a mechanical process, or by dry
distillation. For scheduling purposes it also means:
a) oils of equivalent composition derived through synthetic means; or
b) prepared mixtures of oils of equivalent composition comprising a mixture of
synthetic and natural components.
External in relation to the use of a poison means application in the ears, eyes or nose or to a
body surface other than in the mouth, rectum, vagina, urethra or other body orifice.
First Group Paint means a paint containing the specified proportion of any substance in the
First Group to Part 2 Section 7 of this Standard.
Free formaldehyde includes all hydrated and non-hydrated formaldehyde present in aqueous
solution, including methylene glycol and formaldehyde released from formaldehyde
donors.
Graphic material means the material which is to be deposited on another material by a
graphic instrument during writing, drawing or marking and includes cores of pencils,
school pastels or crayons, blackboard chalks, finger or showcard colours, poster paints and
watercolour blocks.
Hawking means to sell or supply (including peddle or distribute or cause to be distributed) in
a public place.
Height in relation to letters used for words, expressions or statements on labels means the
height of capital letters or lower case letters having an ascender or a descender.
Hemp seed oil means the oil obtained by cold expression from the ripened fruits (seeds) of
Cannabis sativa.
Immediate container includes all forms of containers in which a poison is directly packed
but does not include any such container intended for consumption or any immediate
wrapper.
Immediate wrapper means metal foil, plastic foil, waxed paper, or any other such material
not intended for consumption, when used as the first wrapper for a dosage unit or dressing.
Internal use means administration:
a) orally, except for topical effect in the mouth; or
b) for absorption and the production of a systemic effect;
i)
PART 1 - INTERPRETATION
ii) on, or attached to, a container or primary pack in which the good is supplied; or
iii) supplied with such a container or pack.
Main label means, where there are two or more labels on a container or a label is divided into
two or more portions:
a) the part of a label that is most likely to be displayed, presented, shown, or examined
under ordinary or customary conditions of display; and
b) where there are two or more labels or two or more portions of a single label that
label or portion of the label where the product name is more or most conspicuously
shown; or
c) where the product name is equally conspicuous on two or more labels or portions of a
label each such label or portion.
Manufacturer means a person who manufactures, produces, or packs a poison.
Measure pack means a sealed container which contains a measured quantity of poison for
use on one occasion as a pesticide or domestic product and one or more of which is
enclosed in a primary pack.
Medicine means any poison for therapeutic use.
Note: To be preceded by human or veterinary where restriction of the medicine to
human or animal use is intended.
Name and address means the name and address, in Australia, of the manufacturer or
distributor of a poison but does not include a post office, cable, telegraphic or code address.
Where such manufacturer or distributor is a company incorporated in accordance with the
appropriate law of any State or Territory of the Commonwealth of Australia or a firm
registered under the Business Names Act of any State or Territory, the inclusion in the label
of the registered name of the corporation or firm or its branch or its division and the city or
town in which a registered office is situated shall be deemed to comply with the
requirements.
Non-access packaging is packaging that complies with the requirements of Australian
Standard AS4710-2001 entitled Packages for chemicals not intended for access or contact
with their contents by humans, in relation to products that are not intended for human
therapeutic use.
See also "Child-resistant closure" and "Child-resistant packaging.
Non-volatile content in relation to a paint or tinter means that portion of a paint or tinter
determined to be the non-volatile content by Method 301.1 of Australian Standard AS
1580-301.1-2005 entitled Paints and related materials Methods of test Non-volatile
content by mass.
Oromucosal use means administration to the oral mucosa, specifically the oral cavity and/or
the pharynx.
Paint, without limiting the ordinary meaning, includes any substance used or intended to be
used for application as a colouring or protective coating to any surface but does not include
graphic material or paints for therapeutic use.
Pesticide means any substance or mixture of substances used or intended to be used:
Poisons Standard November 2016
PART 1 - INTERPRETATION
PART 1 - INTERPRETATION
e) any vitamin, mineral substance, or additive, if, and only if, the vitamin, substance or
additive is used for a purpose mentioned in paragraph (a), (b), (c) or (d); or
f) any active ingredient included in a product declared by regulation under the
Agricultural and Veterinary Chemicals Code Act 1994 to be an veterinary chemical
product;
but does not include:
g) an agricultural chemical.
Veterinary chemical product has the meaning defined in the Agricultural and Veterinary
Chemicals Code Act 1994.
Writing includes the visible representation or reproduction of words or figures in any form,
and to write and written have corresponding meanings.
(2) Unless the contrary intention appears a reference to a substance in a Schedule or an
Appendix to this Standard includes:
Poisons Standard November 2016
PART 1 - INTERPRETATION
j)
in the case of a liquid preparation, 1 gram of the substance per 100 millilitres of
the preparation; or
ii) in the case of a solid, semi-solid or pressurised spray aerosol preparation, 1 gram
of the substance per 100 grams of the preparation; and
iii) any expression of greater or lesser percentages shall have a corresponding
meaning; and
c) in the case of codeine, such concentration, strength or quantity is calculated as
anhydrous codeine.
(4) A reference to a boiling or distillation temperature in the Schedules means that temperature
at an atmospheric pressure of 101.325 kPa (760 millimetres of mercury).
PART 2
CONTROL ON MEDICINES AND POISONS
SECTION ONE LABELS
1.1
General requirements
(1) A person must not sell or supply a poison unless it is labelled in accordance with Part 2
Section 1 of this Standard.
(2) Any word, expression or statement required by this Standard to be written on a label or
container must be written:
a) on the outside face of the label or container; and
b) in the English language; and
c) in durable characters; and
d) in a colour or colours to provide a distinct contrast to the background colour; and
e) in letters at least 1.5 millimetres in height.
(3) Section 1.1(2)(e) does not apply to a word, expression or statement on a container which has
a capacity of 20 millilitres or less, or on the label of such a container if:
a) an appropriate authority approves the use of smaller letters; and
b) the letters are at least 1 millimetre in height.
(4) The label must be printed on, or securely attached to:
a) the outside of the immediate container; and
b) if the immediate container is enclosed in a primary pack, the outside of that primary
pack.
1.2
Immediate wrapper
(1) A poison enclosed in an immediate wrapper must be contained in a primary pack labelled in
accordance with Section 1.3 of this Standard; and
(2) the immediate wrapper must be conspicuously labelled with:
a) the name of the manufacturer or distributor or the brand name or trade name used
exclusively by the manufacturer or distributor for that poison; and
b) the approved name of the poison; and
c) a statement of the quantity or strength of the poison in accordance with Section 1.4 of
this Standard.
1.3
(1) The primary pack and immediate container of a poison must be labelled as follows:
Poisons Standard November 2016
10
a) with the signal word or words relating to the Schedule in which the poison is included
and the purpose for which it is to be used, as shown in the following table:
Schedule
Purpose
PHARMACY MEDICINE
CAUTION
POISON
DANGEROUS POISON
CONTROLLED DRUG
written:
i)
11
written:
i)
e) if the poison is an alkaline salt in a dishwashing machine product, with the cautionary
statement
BURNS SKIN AND THROAT
written:
Poisons Standard November 2016
12
i)
13
FLAMMABLE
written on the main label in bold-face sans serif capital letters of uniform thickness,
unless already present in accordance with the requirements of the Australian Code for
the Transport of Dangerous Goods by Road and Rail;
i)
if the poison is for the treatment of animals, with the cautionary statement
FOR ANIMAL TREATMENT ONLY
written on the main label in bold-face sans serif capital letters of uniform thickness;
j)
if the poison is a Schedule 5 poison intended for any purpose other than internal or
pesticidal use, with the cautionary statement
DO NOT SWALLOW
written in sans serif capital letters on the main label or as part of the directions for use;
k) with the approved name of the poison and a statement of the quantity, proportion or
strength of the poison in accordance with Section 1.4:
i)
if the poison is for human therapeutic use, written in accordance with orders
made under subsection 10(3) of the Commonwealth Therapeutic Goods Act,
1989; or
ii) if the poison is not for human therapeutic use, written in bold-face sans serif
capital letters on the main label, unless:
A) list of approved names is required; and
B) it is impractical to include the list on the main label; and
C) an appropriate authority has authorised its inclusion on another part of the
label; or
iii) if the poison is a Schedule 5 poison referred to in column 1 of the following table
the appropriate name opposite thereto in column 2 may be used as the approved
name:
TABLE
Column 1
Column 2
Alkaline salts
Alkaline salts
Hydrocarbons, liquid
Liquid hydrocarbons
Poisons Standard November 2016
14
m) for any poison other than a poison for human therapeutic use labelled in accordance
with Therapeutic Goods Order 69 General requirements for labels for medicines or in
an agricultural or veterinary chemical product labelled in compliance with the
Agricultural and Veterinary Chemicals Code Act 1994, if the poison is prepared,
packed or sold for a specific purpose, with clear and adequate directions for use
unless:
i)
15
or statements are required for the poison (see Appendix F), with that warning
statement or those statements grouped together:
i)
if safety directions are included on the label, immediately after the words
SAFETY DIRECTIONS; or
ii) if there are no safety directions, immediately preceding the directions for use;
p) if the poison is not for human internal use and is not a Schedule 3, Schedule 4 or
Schedule 8 poison, with appropriate first aid instructions (see Appendix E):
i)
(1) The statement of the quantity, proportion or strength of a poison must be expressed in the
most appropriate of the following forms:
a) if the poison is for human therapeutic use, in the manner prescribed by orders made
under subsection 10(3) of the Commonwealth Therapeutic Goods Act 1989;
b) if the poison is for a purpose or purposes other than human therapeutic use and:
i)
ii) if the poison is a liquid in a liquid preparation, as the mass or volume of the
poison per stated volume of the preparation;
iii) if the poison is a liquid in a solid or semi-solid preparation, as the mass or volume
of the poison per stated mass of the preparation;
iv) if the poison is a solid or semi-solid in a liquid preparation, as the mass of the
poison per stated volume of the preparation;
v) if the poison is a solid or semi-solid in a solid or semi-solid preparation, as the
mass of the poison per stated mass of the preparation;
Poisons Standard November 2016
16
vi) if the poison is a gas in a liquid preparation, as the mass of the poison per stated
volume of the preparation;
vii) if the poison is a gas in a solid or semi-solid preparation, as the mass of the
poison per stated mass of the preparation;
viii) if the poison is a gas in a gaseous preparation, as the mass of the poison per
stated mass of the preparation;
c) if the poison is a solution of a mineral acid, the proportion of the acid (un-neutralised
by any bases present in the preparation) in a preparation may be expressed as the unneutralised mass of the acid per stated mass of the preparation;
Exemptions
1.5.1
(1) The requirements of Section 1.3 do not apply to an immediate container that is a measure
pack or a selected container (other than an ampoule, a pre-filled syringe or an injection vial
to which Section 1.5.2 (1) and (2) apply) when:
a) the immediate container is for a therapeutic good and is labelled in the manner
prescribed by orders made under subsection 10(3) of the Commonwealth Therapeutic
Goods Act 1989; or
b) the immediate container is:
i)
17
C) the name of the manufacturer or distributor or the brand name or trade name
used exclusively by the manufacturer or distributor for the poison; and
D) if the poison is for the treatment of animals, with the cautionary statement
FOR ANIMAL TREATMENT ONLY
written in sans serif capital letters.
1.5.2
(1) The requirements of Section 1.3 do not apply to a selected container, or an ampoule (other
than an ampoule to which Section 1.5.2(2) applies) when:
a) the selected container or ampoule is for a therapeutic good and is labelled in the
manner prescribed by orders made under subsection 10(3) of the Commonwealth
Therapeutic Goods Act 1989; or
b) the selected container or ampoule is:
i)
a) the selected container is a plastic ampoule that is continuous with a strip of the same
material and opens as it is detached from the strip, is for a therapeutic good and is
labelled in the manner prescribed by orders made under subsection 10(3) of the
Commonwealth Therapeutic Goods Act 1989; or
b) the selected container is a plastic ampoule that is continuous with a strip of the same
material and opens as it is detached from the strip, is:
i)
18
1.5.3
(1) The labelling requirements of this Standard do not apply to a transparent cover, or to any
wrapper, hamper, packing case, crate or other cover used solely for the purposes of
transport or delivery.
1.5.4
(1) The labelling requirements of this Standard do not apply to a poison that:
a) is packed and sold solely for dispensary, industrial, laboratory or manufacturing
purposes; and
b) is labelled in accordance with requirements under applicable jurisdictional Work
Health and Safety laws, as amended from time to time.
1.5.5
(1) the labelling requirements of Sections 1.3 to 1.5.3 do not apply to a poison where an
appropriate authority has granted a labelling exemption in whole or in part for these
sections for a specified product; and
(2) the labelling exemption from an appropriate authority referred to in Section 1.5.5(1) is
limited to no more than 12 months from the effective date of the decision for retail supply
of the product; and
(3) for the avoidance of doubt this paragraph does not apply to exemptions issued under Section
1.3(1)(m)(ii)(B) of this Standard.
1.5.6
Dispensed medicines
ii) a poison listed in Appendix K unless it is clearly labelled with a sedation warning
(being statement 39, 40 or 90 as specified in Appendix F Part 1 of this Standard).
1.5.7
Gas cylinders
(1) The requirements of Sections 1.3(1)(a)(iv), 1.3(1)(c)(iv), and 1.3(1)(g)(iv) do not apply to a
cylinder containing a poison that is a compressed gas.
Poisons Standard November 2016
19
1.5.8
Paints
ii) a poison included in the First Group or Second Group in Part 2 Section 7,
provided that it is labelled with the name and proportion of that poison, and
where the poison is a metal or metal salt, the proportion is expressed as the
metallic element present as calculated on the non-volatile content or in the
dried film.
1.5.9
(1) The labelling requirements of Section1.1(2)(d) and Section 1.3 do not apply to a device that
contains camphor or naphthalene in block, ball, disc, pellet or flake form if the device:
a) complies with Section 2.7; and
b) is sold or supplied in a primary pack labelled in accordance with Section 1.1 and
Section 1.3.
1.6
Prohibitions
(1) A label used in connection with any poison must not include:
a) any reference to this Standard, or any comment on, reference to, or explanation of
any expression required by this Standard that directly or by implication contradicts,
qualifies or modifies such expression; or
b) any expression or device suggesting or implying that the poison is safe, harmless,
non-toxic, non-poisonous, or is recommended or approved by the Government or any
government authority unless required by legislation; or
c) any expression or device which is false or misleading in any particular concerning the
safety of the poison or any of its ingredients; or
Poisons Standard November 2016
20
(1) A person must not sell or supply a poison unless the immediate container complies with
the requirements of Sections 2.1 and 2.3 to 2.7 of this Standard.
(2) If a poison, other than a Schedule 5 poison, is sold or supplied in a container with a nominal
capacity of 2 litres or less, the container must comply with Australian Standard AS 22161997, entitled Packaging for poisonous substances.
(3) Notwithstanding Section 2.1(2), a poison which is in Schedule 6 and is an essential oil may
be packed in an amber glass container which does not comply with the tactile identification
requirements of Australian Standard AS 2216-1997, entitled Packaging for poisonous
substances, if:
a) the other safety factors are not diminished; and
b) the container has a restricted flow insert and a child-resistant closure.
(4) If a poison, other than a Schedule 5 poison, is sold or supplied in a container with a nominal
capacity of more than 2 litres, the container must:
a) comply with subsection 1.4 (General Requirements) of Australian Standard AS 22161997 entitled Packaging for poisonous substances; and
b) have the word POISON:
i)
in sans serif capital letters the height of which is at least one thirty second part of
the length, height or width of the container, whichever is the greatest:
A) embossed; or
B) indelibly written in a colour in distinct contrast to the background colour;
(1) The container in which any Schedule 5 poison is sold or supplied must:
a) comply with the container requirements of Sections 2.1(2) or 2.1(4); or
Poisons Standard November 2016
21
ii) be securely closed and, except when containing a preparation for use on one
occasion only, be capable of being re-closed to prevent spillage of its contents;
and
iii) have the expression POISON, NOT TO BE TAKEN or NOT TO BE USED
AS A FOOD CONTAINER embossed or indelibly written thereon, or printed on
a permanent adhesive label designed to adhere to a substrate without lifting and
which cannot be removed without damaging either the label or the substrate.
(2) Notwithstanding Section 2.2(1), the following Schedule 5 poisons namely:
a) methylated spirit(s);
b) liquid hydrocarbons when packed as kerosene, lamp oil, mineral turpentine, thinners,
reducers, white petroleum spirit or dry cleaning fluid;
c) petrol;
d) toluene; or
e) xylene,
must not be sold or supplied in a bottle or jar having a nominal capacity of 2 litres or less,
unless the immediate container complies with the container requirements specified in
Section 2.1(2).
2.3
Approved containers
(1) Notwithstanding section 2.1(2), 2.1(4) and 2.2 a poison may be packed in a container that
does not comply with the tactile identification requirements of Australian Standard
AS2216-1997 entitled Packaging for poisonous substances or the requirements of Section
2.1(4)(b) or Section 2.2(1)(b)(iii) if:
Child-resistant closures
(1) If a poison, other than a poison included in a therapeutic good packaged in a manner
compliant with orders made under subsection 10(3) of the Commonwealth Therapeutic
Goods Act 1989, listed in column 1 of the following table is sold or supplied in a container
having a nominal capacity specified for that poison in column 2, it must be closed with a
child-resistant closure.
Column 1
Name of the poison
Column 2
Nominal capacity
22
All sizes
2 litres or less
5 litres or less
5 litres or less
23
2 litres or less
5 litres or less
5 litres or less
5 litres or less
Oil of turpentine.
5 litres or less
5 litres or less
24
5 litres or less
(2) The manufacturer or packer of a poison must ensure that the child-resistant closure is
appropriate for the container and the poison and that it retains its child-resistant properties
for the expected life of the poison.
2.5
Schedule 8 poisons
(1) A person who supplies any Schedule 8 poison must ensure that the Schedule 8 poison is
packaged in such a way that its primary pack is so sealed that, when the seal is broken, it is
readily distinguishable from other sealed primary packs.
(2) This paragraph does not apply to the supply of a Schedule 8 poison by an:
a) authorised prescriber or other authorised supplier;
b) pharmacist on the prescription of an authorised prescriber;
c) pharmacist employed at a hospital, on the written requisition of a medical
practitioner, a dentist or the nurse or midwife in charge of the ward in which the
Schedule 8 poison is to be used or stored; or
d) nurse or midwife on the direction in writing of an authorised prescriber.
2.6
Exemptions
(1) Section 2.1(2), Section 2.1(4) and Section 2.2 do not apply to the immediate container of a
poison prepared, packed and sold:
a) for human internal or animal internal use; or
25
(1) The container requirements of Section 2.1(2) do not apply to a device that contains only
camphor or naphthalene in block, ball, disc, pellet or flake form for domestic use, if the
device:
a) in normal use, prevents removal or ingestion of its contents; and
b) is incapable of reacting with the poison; and
c) is sufficiently strong to withstand the ordinary risks of handling, storage or transport;
and
d) has the word POISON and the approved name of the poison embossed or indelibly
printed on it.
(2) A person must not sell or supply camphor or naphthalene in ball, block, disc, pellet or flake
form for domestic use unless the balls, blocks, discs, pellets or flakes are enclosed in a
device which prevents removal or ingestion of its contents.
2.8
Prohibitions
(1) A person must not sell or supply a poison in a container which has the name of another
poison embossed or indelibly marked thereon.
(2) A person must not sell any poison which is for internal use or any food, drink or condiment
in a container prescribed by Sections 2.1(2), 2.1(4) and Section 2.2 of this Standard.
(3) A person must not sell any poison in a container that is not readily distinguishable from a
container in which food, alcohol, other beverage or condiment is sold.
SECTION THREE
3.1
STORAGE
General requirements
(1) A person who sells or supplies Schedule 6 poisons by way of retail sale must keep those
poisons in such a way as to prevent access by children.
(2) A person who sells or supplies Schedule 7 poisons must not keep those poisons for retail
sale in any areas or in any area or in any manner that allows physical access by any person
unless they are:
a) the owner of the retail establishment; or
b) an employee of the owner; or
c) legally permitted to purchase the substance and are under the supervision of the
owner or an employee of the owner.
Poisons Standard November 2016
26
(3) Controls on storage of Schedule 2, 3, 4 and 8 poisons require referral to Part 3 of this
Standard and relevant legislation.
General requirements
General Requirements
(1) A person who sells or supplies Schedule 7 poisons must keep a record of:
a) Name and address of seller or supplier and purchaser; and
b) Date of order and supply; and
c) Approved name or trade name that identifies the poison to be supplied or sold; and
SECTION SIX
6.1
(1) A person must not sell or supply or distribute free a product sample containing a Schedule 5
or Schedule 6 poison in any manner unless the recipient has the opportunity to refuse at the
time of sale or supply.
(2) A person must not sell or supply or distribute free a product sample containing a Schedule 5
or Schedule 6 poison in an unsolicited manner for example via the post / mailbox or
attached to any other product.
(3) A person must not sell or supply a Schedule 5 or Schedule 6 poison product sample in a
manner that does not promote disposal in accordance with section four.
6.2
Schedule 7 Poisons
(1) A person must not possess or use a Schedule 7 poison for domestic or domestic garden
purposes.
(2) A person must not sell or supply:
Poisons Standard November 2016
27
(1) A person must not knowingly have in his or her possession or sell, supply or use a poison
listed in Schedule 10 of this Standard for the purpose or purposes indicated in relation to
that poison in Schedule 10.
6.4
Hawking
SECTION SEVEN/Appendix I
7.1
PAINT OR TINTERS
General Requirements
(1) A person must not manufacture, sell, supply or use a First Group Paint for application to:
a) a roof or any surface to be used for the collection or storage of potable water; or
b) furniture; or
c) any fence, wall, post, gate or building (interior or exterior) other than a building
which is used exclusively for industrial purposes or mining or any oil terminal; or
d) any premises used for the manufacture, processing, preparation, packing or serving of
products intended for human or animal consumption.
(2) A person must not manufacture, sell, supply or use a paint or tinter containing more than
0.1% Lead (the proportion of Lead for the purposes of this section is calculated as a
percentage of the element present in the non-volatile content of the paint).
(3) A person must not manufacture, sell, supply or use a paint for application to toys unless the
paint complies with the specification for coating materials contained in Australian/New
Zealand Standard AS/NZS ISO 8124.3:2012 entitled Safety of toys Part 3: Migration of
certain elements (ISO 8124-03:2010, MOD).
(4) A person must not manufacture, sell, supply, or use a paint or tinter containing a pesticide
except a fungicide, algaecide, bactericide or antifouling agent.
The First Group
The proportion of a substance for the purposes of this Group is calculated as a percentage of the
element present in the non-volatile content of the paint.
Poisons Standard November 2016
28
Substance
Proportion
Proportion
HEXYLOXYETHANOL
TOLUENE
XYLENE
29
PART 3
MISCELLANEOUS REGULATIONS
(It is recommended that the States and Territories implement regulations which provide controls
similar to those included in this Part of the Standard.)
General requirements
(1) A person must not include any reference to a poison included in:
a) Schedule 3 unless included in Appendix H; or
b) Schedule 4 or Schedule 8,
of this Standard in any advertisement except in genuine professional or trade
journals or other publications intended for circulation only within the medical,
nursing, veterinary, dental or pharmaceutical professions or the wholesale drug
industry.
(2) A person must not include any reference to a poison included in Schedule 9 or Schedule 10
(previously Appendix C) of this Standard in any advertisement.
Schedule 2 poisons
(1) A person, other than a pharmacist (or an assistant under the direction of a pharmacist) or a
medical, dental or veterinary practitioner in the lawful practice of their professions, must
not sell or supply a Schedule 2 poison unless licensed to do so.
(2) A person is not eligible to be granted a licence to sell a Schedule 2 poison by way of retail
sale unless:
a) he or she is carrying on the business of selling goods by retail; and
b) the premises from which the poison will be sold is more than 25 kilometres by the
shortest practical route from the nearest pharmacy; and
c) he or she produces such evidence, as may be required, that he or she is a fit and
proper person to be so licensed.
3.3
Schedule 3 poisons
(1) A person, other than a pharmacist, or a medical, dental or veterinary practitioner, in the
lawful practice of his or her profession, must not sell or supply a Schedule 3 poison.
(2) The person who sells or supplies a Schedule 3 poison must:
a) provide adequate instructions for use, either written or verbal, at the time of supply or
sale; and
Poisons Standard November 2016
30
b) label the container with his or her name or the name of the pharmacy and the address
from which it was sold or supplied; and
c) if required by regulation, make a record of the transaction in a prescription book or
other approved recording system.
3.4
Schedule 4 poisons
(1) A person, other than a medical, dental or veterinary practitioner in the ordinary course of
their professions or a pharmacist dispensing a legal prescription must not sell or supply a
Schedule 4 poison.
(2) Section 3.4(1) does not apply to a pharmacist who sells or supplies a Schedule 4 poison,
other than a poison excepted by regulation from this provision, without a prescription if:
a) the patient is under medical treatment with the poison and continuation of medication
is essential; and
b) the quantity sold or supplied does not exceed 3 days' medication; and
c) the pharmacist is satisfied that an emergency exists.
(3) Section 3.2(1), Sections 3.3(1) and (2) and Section 3.4(1) do not apply to sale by way of
wholesale dealing to a pharmacist, medical practitioner, veterinary practitioner, dentist or a
person licensed or otherwise authorised to possess, sell or supply such poisons.
3.5
SECTION THREE
STORAGE
(1) A person who sells or supplies Schedule 2 poisons must keep those poisons in such a way
that public access to advice from a pharmacist is available if required.
(2) A person who sells or supplies Schedule 3 or Schedule 4 poisons must keep those poisons in
a part of the premises to which the public does not have access.
31
PART 4
THE SCHEDULES
SCHEDULE 1
SCHEDULE 2
ACETIC ACID (excluding its salts and derivatives) and preparations containing more than 80
per cent of acetic acid (CH3COOH) for therapeutic use.
ACETYLCYSTEINE in preparations for oral use except when labelled with a recommended
daily dose of 1 g or less of acetylcysteine.
ACONITUM spp. for therapeutic use in adults:
a) in preparations for oral use in packs each containing 0.2 mg or less of total alkaloids
except in packs containing 0.02 mg or less of total alkaloids; or
b) in preparations for dermal use containing 0.02 per cent or less of total alkaloids, in
packs each containing 0.2 mg or less of total alkaloids except in packs containing
0.02 mg or less of total alkaloids.
ALIMEMAZINE when combined with one or more other therapeutically active substances in
solid oral preparations when:
a) at least one of the other therapeutically active substances is a sympathomimetic
decongestant; or
b) in a day-night pack containing alimemazine in the bed-time dose where the day and
night doses are in the same immediate container or immediate wrapper,
except in preparations for the treatment of children under 2 years of age.
ALOXIPRIN.
AMOROLFINE in preparations for topical use except in preparations for the treatment of tinea
pedis.
ANTAZOLINE in eye drops.
ASPIRIN except:
a) when included in Schedule 4, 5 or 6;
32
ii) compliant with the requirements of the Required Advisory Statements for
Medicine Labels;
c) in tablets or capsules each containing no other therapeutically active constituent other
than an effervescent agent when:
i)
ii) in a primary pack of not more than 25 tablets or capsules, each containing 325
mg or less of aspirin, or in a primary pack of not more than 16 tablets or capsules,
each containing 500 mg or less of aspirin; and
iii) compliant with the requirements of the Required Advisory Statements for
Medicine Labels;
d) in tablets or capsules each containing no other therapeutically active constituent other
than an effervescent agent when:
i)
ii) in a primary pack containing 100 or less tablets or capsules, each containing 100
mg or less of aspirin when packed and labelled for the prevention of
cardiovascular disease or for the inhibition of platelet aggregation; and
iii) compliant with the requirements of the Required Advisory Statements for
Medicine Labels.
ATROPA BELLADONNA (belladonna):
a) for external use in preparations containing 0.03 per cent or less of total solanaceous
alkaloids; or
33
34
35
b)
36
ii) in a day-night pack containing diphenhydramine in the bed-time dose where the
day and night doses are in the same immediate container or immediate wrapper,
except in preparations for the treatment of children under 2 years of age.
DOXYLAMINE when combined with one or more other therapeutically active substances in
oral preparations when:
a) at least one of the other therapeutically active substances is a sympathomimetic
decongestant; or
Poisons Standard November 2016
37
b) in a day-night pack containing doxylamine in the bed-time dose where the day and
night doses are in the same immediate container or immediate wrapper,
except in preparations for the treatment of children under 2 years of age.
DUBOISIA LEICHHARDTII for oral use:
a) in undivided preparations containing 0.03 per cent or less of total solanaceous
alkaloids when labelled with a dose of 0.3 mg or less of total solanaceous alkaloids
and a recommended daily dose of 1.2 mg or less of total solanaceous alkaloids; or
38
FEXOFENADINE in preparations for oral use except in divided preparations for the treatment
of seasonal allergic rhinitis in adults and children 12 years of age and over when:
a) in a primary pack containing 10 dosage units or less and not more than 5 days
supply; and
b) labelled with a recommended daily dose not exceeding 120 mg of fexofenadine.
FLUORIDES for human use:
a) in preparations for ingestion containing 0.5 mg or less of fluoride ion per dosage unit;
or
b) in liquid preparations for topical use containing 1000 mg/kg or less of fluoride ion, in
a container with a child-resistant closure:
i)
for therapeutic use when compliant with the requirements of the Required
Advisory Statements for Medicine Labels except in preparations containing 220
mg/kg or less of fluoride ion, in packs containing not more than 120 mg total
fluoride when fitted with a child-resistant closure and compliant with the
requirements of Required Advisory Statements for Medicine Labels; or
ii) for non-therapeutic use when labelled with warnings to the following effect:
A) Do not swallow; and
B) Do not use (this product/insert name of product) in children 6 years of
age or less,
except in preparations containing 220 mg/kg or less of fluoride ion, in packs
containing not more than 120 mg total fluoride, when fitted with a childresistant closure and labelled with warnings to the following effect:
A) Do not swallow; and
B) Do not use (this product/insert name of product) in children 6 years of
age or less,
except in preparations containing 15 mg/kg or less of fluoride ion or preparations for
supply to registered dental professionals or by approval of an appropriate authority.
FLURBIPROFEN in preparations for topical oral use when:
a) in divided preparations containing 10 mg or less of flurbiprofen per dosage unit; or
b) in undivided preparations containing 0.25 per cent or less, or 10 mg or less per dose,
of flurbiprofen.
FLUTICASONE in aqueous nasal sprays delivering 50 micrograms or less of fluticasone per
actuation when the maximum recommended daily dose is no greater than 400 micrograms
and when packed in a primary pack containing 200 actuations or less, for the prophylaxis or
treatment of allergic rhinitis for up to 6 months in adults and children 12 years of age and
over.
FOLIC ACID for human therapeutic use except:
a) when included in Schedule 4; or
b) in preparations containing 500 micrograms or less of folic acid per recommended
daily dose.
Poisons Standard November 2016
39
for the treatment of tinea (tinea pedis, tinea cruris, tinea corporis) and other
fungal skin infections; and
ii) not labelled for the treatment of children under 12 years of age; or
c) for rectal use in preparations containing 0.5 per cent or less of hydrocortisone, when
combined with a local anaesthetic substance but no other therapeutically active
constituent except unscheduled astringents:
i)
40
41
42
LANSOPRAZOLE in oral preparations 15 mg or less of lansoprazole per dosage unit for the
relief of heartburn and other symptoms of gastro-oesophageal reflux disease, in packs
containing not more than 7 days supply.
LEVOCABASTINE in topical eye or nasal preparations.
LEVOCETIRIZINE in preparations for oral use except in divided preparations for the treatment
of seasonal allergic rhinitis in adults and children 12 years of age and over when:
a) in a primary pack containing not more than 5 days supply; and
43
MEFENAMIC ACID in divided preparations for oral use in packs of 30 or less dosage units for
the treatment of dysmenorrhoea.
MEPYRAMINE for dermal use.
MERCUROCHROME in preparations for external use containing 2 per cent or less of
mercurochrome except when included in Schedule 6.
MERCURY for external use in preparations containing 0.5 per cent or less of mercury.
METHOXAMINE in preparations for external use except in preparations containing 1 per cent
or less of methoxamine.
METHOXYPHENAMINE.
METHYLEPHEDRINE.
MICONAZOLE for human use in dermal preparations and for application to the nails except in
preparations for the treatment of tinea pedis.
MINOXIDIL in preparations for dermal use containing 5 per cent or less of minoxidil.
MOMETASONE in aqueous nasal sprays delivering 50 micrograms or less of mometasone per
actuation when the maximum recommended daily dose is no greater than 200 micrograms
for the prophylaxis or treatment of allergic rhinitis for up to six months in adults and
children 12 years of age and over.
NAPHAZOLINE.
NAPROXEN in divided preparations containing 250 mg or less of naproxen per dosage unit in
packs of 30 or less dosage units.
NICLOSAMIDE for human therapeutic use.
NIZATIDINE when sold in the manufacturers original pack containing not more than 14 days'
supply.
NOSCAPINE.
NYSTATIN in dermal preparations.
OMEPRAZOLE in oral preparations containing 20 mg or less of omeprazole per dosage unit for
the relief of heartburn and other symptoms of gastro-oesophageal reflux disease, in packs
containing not more than 7 days supply except when included in Schedule 2.
OXETACAINE (oxethazaine) in preparations for internal use.
OXICONAZOLE for dermal use except in preparations for the treatment of tinea pedis.
OXYMETAZOLINE.
OXYQUINOLINE and its non-halogenated derivatives for human therapeutic use, except in
preparations for external use containing 1 per cent or less of such substances.
PAPAVERINE except when included in Schedule 4.
Poisons Standard November 2016
44
(B)
(C)
not labelled for the treatment of children 6 years of age or less, and
(D)
not labelled for the treatment of children under 12 years of age when
combined with phenylephrine and/or guaifenesin; or
iii) in tablets or capsules each containing 500 mg or less of paracetamol as the only
therapeutically active constituent (other than phenylephrine and/or guaifenesin or
when combined with effervescent agents) when:
(A)
(B)
(C)
(D)
not labelled for the treatment of children 6 years of age or less, and
(E)
not labelled for the treatment of children under 12 years of age when
combined with phenylephrine and/or guaifenesin.
45
a) in oral hygiene preparations containing 0.1 per cent or less of free formaldehyde; or
b) in other preparations containing 0.2 per cent or less of free formaldehyde.
PENCICLOVIR for external use for the treatment of herpes labialis.
PHEDRAZINE.
PHENAZONE for human external use.
PHENIRAMINE:
a) in eye drops; or
b) when combined with one or more other therapeutically active substances in oral
preparations when:
i)
ii) in a day-night pack containing pheniramine in the bed-time dose where the day
and night doses are in the same immediate container or immediate wrapper,
except in preparations for the treatment of children under 2 years of age.
PHENOL, or any homologue boiling below 220C, for human therapeutic use except:
a) when included in Schedule 4; or
b) in preparations for external use containing 3 per cent or less of such substances.
PHENYLEPHRINE except:
a) when included in Schedule 4;
b) in oral preparations containing 50 mg or less of phenylephrine per recommended
daily dose in packs containing 250 mg or less of phenylephrine; or
c) in topical eye or nasal preparations containing 1 per cent or less of phenylephrine.
PHOLCODINE:
a) in liquid preparations containing 0.5 per cent or less of pholcodine and with a
recommended dose not exceeding 25 mg of pholcodine; or
b) when compounded with one or more other therapeutically active substances in
divided preparations containing 10 mg or less of pholcodine per dosage unit and with
a recommended dose not exceeding 25 mg of pholcodine.
PIPERAZINE for human therapeutic use.
PODOPHYLLOTOXIN in preparations containing 0.5 per cent or less of podophyllotoxin for
human use for the treatment of warts other than anogenital warts.
PODOPHYLLUM EMODI (podophyllin) in preparations containing 10 per cent or less of
podophyllin for human use for the treatment of warts other than anogenital warts.
PODOPHYLLUM PELTATUM (podophyllin) in preparations containing 10 per cent or less of
podophyllin for human use for the treatment of warts other than anogenital warts.
Poisons Standard November 2016
46
POTASSIUM CHLORATE for therapeutic use except in preparations containing 10 per cent or
less of potassium chlorate.
PRILOCAINE in preparations for dermal use containing 10 per cent or less of total local
anaesthetic substances.
PROCYCLIDINE in preparations containing 5 per cent or less of procyclidine for dermal use.
PROMETHAZINE in oral preparations:
a) in a primary pack containing 10 dosage units or less for the prevention or treatment of
motion sickness; or
b) when combined with one or more other therapeutically active substances when:
i)
ii) in a day-night pack containing promethazine in the bed-time dose where the day
and night doses are in the same immediate container or immediate wrapper,
except in preparations for the treatment of children under 2 years of age.
PROPAMIDINE for ophthalmic use.
PYRANTEL for human therapeutic use.
PYRETHRINS, naturally occurring, being pyrethrolone, cinerolone or jasmolone esters of
chrysanthemic or pyrethric acids, for human therapeutic use in preparations containing
more than 10 per cent of such substances.
PYRITHIONE ZINC for human therapeutic use, except in preparations for the treatment of the
scalp containing 2 per cent or less of pyrithione zinc when compliant with the requirements
of the Required Advisory Statements for Medicine Labels.
RABEPRAZOLE in oral preparations containing 10 mg or less of rabeprazole per dosage unit
for the relief of heartburn and other symptoms of gastro-oesophageal reflux disease, in
packs containing not more than 7 days supply.
RANITIDINE in preparations supplied in the manufacturers original pack containing not more
than 14 days' supply except:
a) in divided preparations for oral use containing 150 mg or less of ranitidine per dosage
unit in the manufacturers original pack containing not more than 14 dosage units; or
b) in divided preparations for oral use containing 300 mg or less of ranitidine per dosage
unit in the manufacturers original pack containing not more than 7 dosage units.
SALICYLAMIDE except when included in Schedule 4.
SELENIUM in preparations for human therapeutic use except:
a) for topical use containing 3.5 per cent or less of selenium sulfide;
b) when included in Schedule 4; or
c) for oral use with a recommended daily dose of 150 micrograms or less.
Poisons Standard November 2016
47
48
SCHEDULE 3
ADRENALINE in preparations containing 1 per cent or less of adrenaline except in
preparations containing 0.02 per cent or less of adrenaline unless packed and labelled for
injection.
ALCLOMETASONE as the only therapeutically active substance in preparations for dermal use
containing 0.05 per cent or less of alclometasone in packs containing 30 g or less of the
preparation.
ALIMEMAZINE:
a) in solid oral preparations except when included in Schedule 2; or
b) in liquid oral preparations containing 10 mg or less of alimemazine per 5 mL,
except in preparations for the treatment of children under 2 years of age.
AMINOPHYLLINE in liquid oral preparations containing 2 per cent or less of aminophylline.
AZATADINE in oral preparations.
BROMPHENIRAMINE in oral preparations except:
a) when included in Schedule 2; or
b) for the treatment of children under 2 years of age.
BUCLIZINE in oral preparations.
BUTOCONAZOLE in preparations for vaginal use.
CHLORAMPHENICOL for ophthalmic use only.
CHLORBUTANOL in preparations for human use except:
49
50
in preparations for therapeutic use containing 1500 mg/kg or less of fluoride ion
and, when containing more than 1000 mg/kg fluoride ion, compliant with the
requirements of the Required Advisory Statements for Medicine Labels;
ii) in preparations for non-therapeutic use containing 1500 mg/kg or less of fluoride
ion and, when containing more than 1000 mg/kg fluoride ion, labelled with
warnings to the following effect:
A) Do not swallow; and
B) Do not use [this product/name of product] in children six years of age
or less; or
iii) in preparations for supply to registered dental professionals or by approval of an
appropriate authority.
GLUCAGON.
GLYCERYL TRINITRATE:
a) in preparations for oral use; or
Poisons Standard November 2016
51
52
53
54
55
SCHEDULE 4
ABACAVIR.
ABATACEPT.
ABIRATERONE ACETATE.
ABCIXIMAB.
ACAMPROSATE CALCIUM.
ACARBOSE.
ACEBUTOLOL.
ACEPROMAZINE.
ACETANILIDE and alkyl acetanilides (excluding when present as an excipient) for human
therapeutic use.
ACETARSOL.
ACETAZOLAMIDE.
ACETOHEXAMIDE.
ACETYL ISOVALERYLTYLOSIN.
ACETYLCARBROMAL.
ACETYLCHOLINE.
ACETYLCYSTEINE except:
a) when included in Schedule 2; or
b) in preparations for oral use when labelled with a recommended daily dose of 1 g or
less of acetylcysteine.
ACETYLDIGITOXIN.
ACETYLMETHYLDIMETHYLOXIMIDOPHENYLHYDRAZINE.
ACETYLSTROPHANTHIDIN.
ACICLOVIR except in preparations containing 5 per cent or less of aciclovir for the treatment
of herpes labialis in packs containing 10 g or less.
ACIPIMOX.
# ACITRETIN.
ACLIDINIUM BROMIDE.
Poisons Standard November 2016
56
ACOKANTHERA OUABAIO.
ACOKANTHERA SCHIMPERI.
ACONITUM spp. except:
a) when included in Schedule 2;
b) in preparations for oral use in adults in packs containing 0.02 mg or less of total
alkaloids; or
c) in preparations for dermal use in adults containing 0.02 per cent or less of total
alkaloids in packs containing 0.02 mg or less of total alkaloids.
ACRIVASTINE.
ADALIMUMAB.
ADAPALENE.
ADEFOVIR.
ADENOSINE for human therapeutic use in preparations for injection.
ADIPHENINE.
ADONIS VERNALIS.
ADRAFINIL.
ADRENALINE except:
a) when included in Schedule 3; or
b) in preparations containing 0.02 per cent or less of adrenaline unless packed and
labelled for injection.
ADRENOCORTICAL HORMONES except when separately specified in these Schedules.
AFAMELANOTIDE.
AFATINIB DIMALEATE.
AFLIBERCEPT.
AGALSIDASE.
AGLEPRISTONE.
AGOMELATINE.
ALATROFLOXACIN MESILATE.
ALBENDAZOLE except:
a) when included in Schedule 5 or 6; or
Poisons Standard November 2016
57
58
ALTEPLASE.
ALTRENOGEST.
ALTRETAMINE (hexamethylmelamine).
AMANTADINE.
AMBENONIUM CHLORIDE.
# AMBRISENTAN.
AMBUCETAMIDE.
AMBUTONIUM BROMIDE.
AMCINONIDE.
AMIFOSTINE.
AMIKACIN.
AMILORIDE.
AMINOCAPROIC ACID.
AMINOGLUTETHIMIDE.
5-AMINOLEVULINIC ACID.
AMINOMETRADINE.
AMINOPHENAZONE (amidopyrine) and derivatives for the treatment of animals.
AMINOPHYLLINE except when included in Schedule 3.
AMINOPTERIN.
4-AMINOPYRIDINE for therapeutic use.
AMINOREX.
AMINOSALICYLIC ACID.
AMIODARONE.
AMIPHENAZOLE.
AMISOMETRADINE.
AMISULPRIDE.
AMITRIPTYLINE.
AMLODIPINE.
Poisons Standard November 2016
59
AMMI VISNAGA.
AMMONIUM BROMIDE for therapeutic use.
AMOBARBITAL when packed and labelled for injection.
AMODIAQUINE.
AMOROLFINE except:
AMYLOCAINE.
# ANABOLIC STEROIDAL AGENTS.
ANAGRELIDE.
ANAKINRA.
ANASTROZOLE.
ANCESTIM.
ANCROD and its immunoglobulin antidote.
ANECORTAVE.
# ANDROGENIC STEROIDAL AGENTS.
# ANDROISOXAZOLE.
# ANDROSTANOLONE.
Poisons Standard November 2016
60
# ANDROSTENEDIOL.
# ANDROSTENEDIONE.
ANGIOTENSIN AMIDE.
ANIDULAFUNGIN.
ANISTREPLASE.
ANTAZOLINE except when included in Schedule 2.
ANTIBIOTIC SUBSTANCES except:
a) when separately specified in these Schedules; or
b) nisin.
ANTIGENS for human therapeutic use except when separately specified in this Schedule.
ANTIHISTAMINES except:
a) when included in Schedule 2 or 3; or
61
ARSENIC for human therapeutic use except when separately specified in these Schedules.
ARTEMETHER.
ARTICAINE.
ASENAPINE.
ASFOTASE ALFA.
ASPARAGINASE.
ASPIRIN:
a) when combined with caffeine, paracetamol or salicylamide or any derivative of these
substances; or
b) for injection.
ASTEMIZOLE.
ASUNAPREVIR.
# ATAMESTANE.
ATAZANAVIR.
ATENOLOL.
ATIPAMEZOLE.
ATOMOXETINE.
ATORVASTATIN.
ATOSIBAN.
ATOVAQUONE.
ATRACURIUM BESILATE.
ATROPA BELLADONNA (belladonna) except when included in Schedule 2.
ATROPINE except when included in Schedule 2.
ATROPINE METHONITRATE.
AURANOFIN.
AUROTHIOMALATE SODIUM.
AVILAMYCIN except:
a) in animal feed premixes containing 15 per cent or less of avilamycin activity; or
b) in animal feeds containing 50 mg/kg or less of avilamycin activity.
Poisons Standard November 2016
62
AVIPTADIL.
AXITINIB.
AVOPARCIN.
AZACITIDINE.
AZACYCLONOL.
AZAPERONE.
AZAPROPAZONE.
AZARIBINE.
AZATADINE except when included in Schedule 3.
AZATHIOPRINE.
AZELAIC ACID except:
a) when included in Schedule 2; or
b) in preparations containing 1 per cent or less of azelaic acid for non-human use.
AZELASTINE except when included in Schedule 2.
AZITHROMYCIN.
AZLOCILLIN.
AZTREONAM.
BACAMPICILLIN.
BACITRACIN.
BACLOFEN.
BALSALAZIDE.
BAMBERMYCIN (flavophospholipol) except:
a) when included in Schedule 6; or
b) in animal feeds for growth promotion containing 50 mg/kg or less of antibiotic
substances.
BAMBUTEROL.
BAMETHAN.
BAMIPINE.
BARBITURATES except when separately specified in these Schedules.
Poisons Standard November 2016
63
BASILIXIMAB.
BAZEDOXIFENE.
BECAPLERMIN.
BECLAMIDE.
BECLOMETASONE except when included in Schedule 2.
BELATACEPT.
BELIMUMAB.
BEMEGRIDE.
BENACTYZINE.
BENAZEPRIL.
BENDAMUSTINE.
BENDROFLUAZIDE.
BENETHAMINE PENICILLIN.
BENORYLATE.
BENOXAPROFEN.
BENPERIDOL.
BENSERAZIDE.
BENZATHINE PENICILLIN.
BENZILONIUM.
BENZOCAINE except:
a) when included in Schedule 2;
b) in dermal preparations containing 2 per cent or less of total local anaesthetic
substances; or
c) in lozenges containing 30 mg or less of total local anaesthetic substances per dosage
unit.
# BENZODIAZEPINE derivatives except when separately specified in these Schedules.
BENZOYL PEROXIDE in preparations for human therapeutic use except:
a) when included in Schedule 2; or
b) in preparations for external use containing 5 per cent or less of benzoyl peroxide.
Poisons Standard November 2016
64
BENZPHETAMINE.
BENZTHIAZIDE.
BENZATROPINE.
BENZYDAMINE except:
a) when included in Schedule 2;
b) in preparations for dermal use;
c) in divided topical oral preparations containing 3 mg or less of benzydamine; or
d) in undivided topical oral preparations containing 0.3 per cent or less of benzydamine
in a primary pack containing not more than 50 mL.
BENZYLPENICILLIN.
BEPRIDIL.
BERACTANT.
BESIFLOXACIN.
BETAHISTINE.
BETAMETHASONE.
BETAXOLOL.
BETHANECHOL CHLORIDE.
BETHANIDINE.
BEVACIZUMAB.
BEVANTOLOL.
# BEXAROTENE.
BEZAFIBRATE.
BICALUTAMIDE.
BIFONAZOLE except:
a) when included in Schedule 2;
b) in preparations for dermal use containing 1 per cent or less of bifonazole for the
treatment of the scalp; or
c) in preparations for dermal use for the treatment of tinea pedis.
BIMATOPROST.
BIPERIDEN.
Poisons Standard November 2016
65
66
# BROMAZEPAM.
BROMIDES, inorganic, for therapeutic use except when separately specified in these
Schedules.
BROMOCRIPTINE.
BROMOFORM for therapeutic use.
BROMPHENIRAMINE except when included in Schedule 2 or 3.
BROMVALETONE.
BRUGMANSIA spp.
BUCLIZINE except when included in Schedule 3.
BUDESONIDE except when included in Schedule 2.
BUFEXAMAC except:
a) in preparations for dermal use containing 5 per cent or less of bufexamac; or
b) in suppositories.
BUMETANIDE.
BUPHENINE.
BUPIVACAINE except when included in Schedule 5.
BUPROPION.
BUSERELIN.
BUSPIRONE.
BUSULPHAN.
BUTACAINE.
BUTAMBEN except in dermal preparations containing 2 per cent or less of total local
anaesthetic substances.
BUTOCONAZOLE except when included in Schedule 3.
BUTRACONAZOLE.
BUTYLCHLORAL HYDRATE.
BUTYL NITRITE.
CABAZITAXEL.
CABERGOLINE.
Poisons Standard November 2016
67
68
CARBACHOL.
CARBAMAZEPINE.
CARBARYL for human therapeutic use.
CARBAZOCHROME.
CARBENICILLIN.
CARBENOXOLONE for internal use.
CARBETOCIN.
CARBIDOPA.
CARBIMAZOLE.
CARBOCROMEN.
CARBOPLATIN.
CARBOPROST.
CARBROMAL.
CARBUTAMIDE.
CARBUTEROL.
CARGLUMIC ACID (N-carbamoyl-L-glutamic acid)
CARINDACILLIN.
CARISOPRODOL.
CARMUSTINE.
CARNIDAZOLE.
CARPROFEN.
CARVEDILOL.
CASPOFUNGIN.
CATHINE.
CATUMAXOMAB.
CEFACETRILE.
CEFACLOR.
CEFADROXIL.
Poisons Standard November 2016
69
CEFALEXIN.
CEFALORIDINE.
CEFALOTHIN.
CEFAMANDOLE.
CEFAPIRIN.
CEFAZOLIN.
CEFEPIME.
CEFETAMET.
CEFIXIME.
CEFODIZIME.
CEFONICID.
CEFOPERAZONE.
CEFOTAXIME.
CEFOTETAN.
CEFOTIAM.
CEFOVECIN for veterinary use.
CEFOXITIN.
CEFPIROME.
CEFPODOXIME.
CEFQUINOME.
CEFTAROLINE FOSAMIL.
CEFSULODIN.
CEFTAZIDIME.
CEFTIBUTEN.
CEFTIOFUR.
CEFTRIAXONE.
CEFUROXIME.
CELECOXIB.
Poisons Standard November 2016
70
CELIPROLOL.
CEPHAELIS ACUMINATA (ipecacuanha) except in preparations containing 0.2 per cent or
less of emetine.
CEPHAELIS IPECACUANHA except in preparations containing 0.2 per cent or less of
emetine.
CEPHALONIUM.
CEPHRADINE.
CERIVASTATIN.
CERTOLIZUMAB PEGOL.
CERULETIDE.
CETIRIZINE except
a) when included in Schedule 2; or
b) in divided preparations for oral use for the treatment of seasonal allergic rhinitis in
adults and children 12 years of age and over when:
i)
71
CHLORMETHIAZOLE.
CHLORMEZANONE.
CHLOROFORM for use in anaesthesia.
# 4-CHLOROMETHANDIENONE.
2-(4-CHLOROPHENYL)-(1,2,4)TRIAZOLO[5,1-A]ISOQUINOLINE.
CHLOROQUINE.
CHLOROTHIAZIDE.
CHLOROTRIANISENE.
# CHLOROXYDIENONE.
CHLORPHENAMINE except when included in Schedule 2 or 3.
CHLORPHENTERMINE.
CHLORPROMAZINE.
CHLORPROPAMIDE.
CHLORPROTHIXENE.
CHLORQUINALDOL for human topical use.
CHLORTALIDONE
CHLORTETRACYCLINE except when included in Schedule 5.
CHLORZOXAZONE.
CHOLERA VACCINE.
CHOLIC ACID.
CHYMOPAPAIN for human therapeutic use.
CICLACILLIN.
CICLESONIDE.
CICLOPIROX except:
72
CILASTATIN.
CILAZAPRIL.
CILOSTAZOL.
CIMETIDINE except when included in Schedule 3.
CINACALCET.
CINCHOCAINE except when included in Schedule 2.
CINOXACIN.
CIPROFLOXACIN.
CISAPRIDE.
CISATRACURIUM BESILATE.
CISPLATIN.
CITALOPRAM.
# CJC-1295 (CAS No. 863288-34-0).
CLADRIBINE.
CLANOBUTIN.
CLARITHROMYCIN.
CLAVULANIC ACID.
CLEMASTINE except when included in Schedule 3.
CLEMIZOLE.
CLENBUTEROL.
CLEVIDIPINE.
CLIDINIUM BROMIDE.
CLINDAMYCIN.
CLIOQUINOL and other halogenated derivatives of oxyquinoline for human topical use except
when separately specified in this Schedule.
CLOBAZAM.
CLOBETASOL.
CLOBETASONE (clobetasone-17-butyrate) except when included in Schedule 3.
Poisons Standard November 2016
73
CLOCORTOLONE.
CLODRONIC ACID (includes sodium clodronate).
CLOFARABINE.
CLOFAZIMINE.
CLOFENAMIDE.
CLOFIBRATE.
# CLOMIFENE.
CLOMIPRAMINE.
CLOMOCYCLINE.
# CLONAZEPAM.
CLONIDINE.
CLOPAMIDE.
CLOPIDOGREL.
CLOPROSTENOL.
# CLORAZEPATE.
CLOREXOLONE.
CLORPRENALINE.
# CLOSTEBOL (4-chlorotestosterone).
CLOTRIMAZOLE except:
a) when included in Schedule 2, 3 or 6; or
b) in preparations for dermal use for the treatment of tinea pedis.
CLOXACILLIN.
# CLOZAPINE.
COBALT for human therapeutic use except as dicobalt edetate in preparations for the treatment
of cyanide poisoning.
COBICISTAT.
CODEINE when compounded with one or more other therapeutically active substances:
a) in divided preparations containing 30 mg or less of codeine per dosage unit; or
b) in undivided preparations containing 1 per cent or less of codeine,
Poisons Standard November 2016
74
75
CURARE.
CYCLANDELATE.
CYCLIZINE except when included in Schedule 3.
CYCLOBENZAPRINE.
# CYCLOFENIL.
CYCLOHEXIMIDE.
CYCLOPENTHIAZIDE.
CYCLOPENTOLATE.
CYCLOPHOSPHAMIDE.
CYCLOPROPANE for therapeutic use.
CYCLOSERINE.
CYCLOTHIAZIDE.
CYCRIMINE.
CYMARIN.
CYPROHEPTADINE except when included in Schedule 3.
CYPROTERONE.
CYTARABINE.
DABRAFENIB MESILATE.
DABIGATRAN.
DACARBAZINE.
DACLATASVIR.
DACLIZUMAB.
DACTINOMYCIN.
DALFOPRISTIN.
DALTEPARIN (includes dalteparin sodium).
DANAPAROID (includes danaparoid sodium).
# DANAZOL.
DANTHRON for human use.
Poisons Standard November 2016
76
DANTROLENE.
DAPAGLIFLOZIN.
DAPOXETINE.
DAPSONE.
DAPTOMYCIN.
# DARBEPOETIN.
DARIFENACIN.
DARUNAVIR.
DATURA spp. except:
a) when included in Schedule 2; or
b) when separately specified in this Schedule.
DASABUVIR.
DASATINIB.
DATURA STRAMONIUM (stramonium) except:
a) when included in Schedule 2; or
b) for smoking or burning.
DATURA TATULA (stramonium) except:
a) when included in Schedule 2; or
b) for smoking or burning.
DAUNORUBICIN.
DEANOL for therapeutic use.
DEBRISOQUINE.
DECAMETHONIUM.
DEFERASIROX.
DEFERIPRONE.
DEFLAZACORT.
DEGARELIX.
# DEHYDROCHLOROMETHYLTESTOSTERONE.
DEHYDROCORTICOSTERONE.
Poisons Standard November 2016
77
DELAVIRDINE MESILATE.
DEMBREXINE except when included in Schedule 5.
DEMECARIUM.
DEMECLOCYCLINE.
DENOSUMAB.
DEOXYCHOLIC ACID.
DEOXYCORTONE.
DEOXYRIBONUCLEASE except:
a) when separately specified in this Schedule; or
b) for external use.
DERACOXIB.
DESFERRIOXAMINE.
DESFLURANE.
DESIPRAMINE.
DESIRUDIN.
DESLANOSIDE.
DESLORATADINE except when included in Schedule 2.
DESLORELIN.
DESMOPRESSIN (D.D.A.V.P.).
DESOGESTREL.
DESONIDE.
DESOXYMETHASONE.
DESVENLAFAXINE.
DETOMIDINE.
DEXAMETHASONE.
DEXCHLORPHENAMINE except when included in Schedule 2 or 3.
DEXFENFLURAMINE.
DEXMEDETOMIDINE.
Poisons Standard November 2016
78
79
DIFENOXIN in preparations containing, per dosage unit, 0.5 mg or less of difenoxin and a
quantity of atropine sulfate equivalent to at least 5 per cent of the dose of difenoxin.
DIFLORASONE.
DIFLOXACIN.
DIFLUCORTOLONE.
DIFLUNISAL.
DIGITALIS LANATA.
DIGITALIS PURPUREA.
DIGITOXIN.
DIGOXIN.
DIGOXIN-SPECIFIC ANTIBODY FRAGMENT F (Ab).
DIHYDRALAZINE.
DIHYDROCODEINE when compounded with one or more other therapeutically active
substances:
a) in divided preparations containing not more than 100 mg of dihydrocodeine per
dosage unit; or
b) in undivided preparations with a concentration of not more than 2.5 per cent of
dihydrocodeine,
except when included in Schedule 2 or 3.
DIHYDROERGOTOXINE.
# DIHYDROLONE.
DIHYDROSTREPTOMYCIN.
DIHYDROTACHYSTEROL.
DIIODOHYDROXYQUINOLINE (iodoquinol) except:
a) when included in Schedule 3; or
b) for human internal use.
DIISOPROPYLAMINE DICHLOROACETATE.
DILTIAZEM.
DIMENHYDRINATE except when included in Schedule 2 or 3.
DIMERCAPROL.
Poisons Standard November 2016
80
# DIMETHANDROSTANOLONE.
# DIMETHAZINE.
DIMETHINDENE except when included in Schedule 3.
DIMETHOTHIAZINE.
DIMETHOXANATE.
DIMETHYL FUMARATE.
DIMETHYL SULFOXIDE (excluding dimethyl sulfone) for therapeutic use except:
a) when included in Schedule 6; or
b) in in vitro test kits.
DIMETRIDAZOLE.
2,4-DINITROCHLOROBENZENE for therapeutic use.
DINITROCRESOLS for therapeutic use except when separately specified in these Schedules.
DINITRONAPHTHOLS for therapeutic use except when separately specified in these
Schedules.
DINITROPHENOLS for therapeutic use.
DINITROTHYMOLS for therapeutic use except when separately specified in these Schedules.
# DINOPROST.
# DINOPROSTONE.
DIPERODON.
DIPHEMANIL except in preparations for dermal use.
DIPHENHYDRAMINE except when included in Schedule 2 or 3.
DIPHENIDOL.
DIPHENOXYLATE in preparations containing, per dosage unit, 2.5 mg or less of
diphenoxylate and a quantity of atropine sulfate equivalent to at least 1 per cent of the dose
of diphenoxylate except when included in Schedule 3.
DIPHENYLPYRALINE.
DIPHTHERIA TOXOID.
DIPIVEFRIN.
DIPYRIDAMOLE.
Poisons Standard November 2016
81
DIRITHROMYCIN.
DIRLOTAPIDE.
DISOPHENOL.
DISOPYRAMIDE.
DISTIGMINE.
DISULFIRAM for therapeutic use.
DISULPHAMIDE.
DITHIAZANINE except when included in Schedule 6.
DITIOCARB.
DOBUTAMINE.
DOCETAXEL.
DOFETILIDE.
DOLASETRON.
DOLUTEGRAVIR.
DOMPERIDONE.
DONEPEZIL.
DOPAMINE.
DOPEXAMINE.
DORIPENEM.
DORNASE.
DORZOLAMIDE.
DOSULEPIN.
DOXANTRAZOLE.
DOXAPRAM.
DOXAZOSIN.
DOXEPIN.
DOXORUBICIN.
DOXYCYCLINE.
Poisons Standard November 2016
82
83
ELTENAC.
ELTROMBOPAG.
ELVITEGRAVIR.
EMEPRONIUM.
EMETINE except in preparations containing 0.2 per cent or less of emetine.
EMPAGLIFLOZIN.
EMTRICITABINE.
ENALAPRIL.
# ENESTEBOL.
ENFLURANE for therapeutic use.
ENFUVIRTIDE.
# ENOBOSARM.
ENOXACIN.
ENOXAPARIN.
ENOXIMONE.
ENPROSTIL.
ENROFLOXACIN.
ENTACAPONE.
ENTECAVIR.
ENZALUTAMIDE.
EPHEDRA spp. except in preparations containing 0.001 per cent or less of ephedrine.
# EPHEDRINE.
EPICILLIN.
EPINASTINE.
EPIRUBICIN.
# EPITIOSTANOL.
EPLERENONE.
# EPOETINS.
Poisons Standard November 2016
84
EPOPROSTENOL.
EPROSARTAN.
EPTIFIBATIDE.
ERGOMETRINE.
ERGOT.
ERGOTAMINE.
ERGOTOXINE.
ERIBULIN MESILATE.
ERLOTINIB.
ERTAPENEM.
ERYSIMUM spp.
ERYTHROMYCIN.
# ERYTHROPOIETIN.
# ERYTHROPOIETINS except when separately specified in these Schedules.
ESCITALOPRAM.
ESMOLOL.
ESOMEPRAZOLE except when included in Schedule 2 or 3.
ESTRADIOL except when included in Schedule 5.
ESTRIOL.
ESTRAMUSTINE.
ESTROGENS except when separately specified in these Schedules.
ESTRONE.
ESTROPIPATE (piperazine estrone sulfate).
ETACRYNIC ACID.
ETANERCEPT.
ETHAMBUTOL.
ETHAMIVAN.
ETHCHLORVYNOL.
Poisons Standard November 2016
85
86
87
FENPROSTALENE.
FEXOFENADINE except:
a) when included in Schedule 2; or
b) in divided preparations for oral use for the treatment of seasonal allergic rhinitis in
adults and children 12 years of age and over when:
i)
in a primary pack containing 10 dosage units or less and not more than 5 days
supply; and
ii) labelled with a recommended daily dose not exceeding 120 mg of fexofenadine.
FIBRINOLYSIN except for external use.
FIBROBLAST GROWTH FACTORS
FIDAXOMICIN.
FILGRASTIM.
FINASTERIDE.
FINGOLIMOD.
FIROCOXIB.
FLECAINIDE.
FLEROXACIN.
FLOCTAFENINE.
FLORFENICOL.
FLUANISONE.
FLUCLOROLONE.
FLUCLOXACILLIN.
FLUCONAZOLE except when included in Schedule 3.
FLUCYTOSINE.
FLUDARABINE.
FLUDROCORTISONE.
FLUFENAMIC ACID.
FLUMAZENIL.
FLUMETASONE.
Poisons Standard November 2016
88
FLUMETHIAZIDE.
FLUNISOLIDE.
FLUNIXIN MEGLUMINE.
FLUOCINOLONE.
FLUOCINONIDE.
FLUOCORTIN.
FLUOCORTOLONE.
FLUORESCEIN in preparations for injection.
FLUORIDES in preparations for human use except when included in or expressly excluded
from Schedule 2 or 3.
FLUOROMETHOLONE.
FLUOROURACIL.
FLUOXETINE.
# FLUOXYMESTERONE.
FLUPENTIXOL.
FLUPHENAZINE.
FLUPROSTENOL.
FLURANDRENOLONE.
# FLURAZEPAM.
FLURBIPROFEN except when included in Schedule 2.
FLUROXENE for human therapeutic use.
FLUSPIRILENE.
FLUTAMIDE.
FLUTICASONE except when included in Schedule 2.
FLUVASTATIN.
FLUVOXAMINE.
FOLIC ACID in preparations for human use for injection.
FOLINIC ACID in preparations for human use for injection.
Poisons Standard November 2016
89
90
GANCICLOVIR.
GANIRELIX.
GATIFLOXACIN.
GRAZOPREVIR.
GEFITINIB.
GEMCITABINE.
GEMEPROST.
GEMFIBROZIL.
GEMIFLOXACIN.
GEMTUZUMAB OZOGAMICIN.
GENTAMICIN.
GESTODENE.
GESTONORONE.
# GESTRINONE.
GHRH INJECTABLE PLASMID.
GITALIN.
GLATIRAMER ACETATE.
GLIBENCLAMIDE.
GLIBORNURIDE.
GLICLAZIDE.
GLIMEPIRIDE.
GLIPIZIDE.
GLISOXEPIDE.
GLUTATHIONE for parenteral use.
# GLUTETHIMIDE.
GLYCERYL TRINITRATE except when included in Schedule 3.
GLYCOPYRRONIUM in preparations for injection.
GLYMIDINE.
Poisons Standard November 2016
91
GnRH VACCINE.
GOLIMUMAB.
GONADORELIN.
GONADOTROPHIC HORMONES except when separately specified in this Schedule.
GOSERELIN.
GRAMICIDIN.
GRANISETRON.
GREPAFLOXACIN.
GRISEOFULVIN.
# GROWTH HORMONE RELEASING HORMONES* (GHRHs).
# GROWTH HORMONE RELEASING PEPTIDES (GHRPs).
# GROWTH HORMONE RELEASING PEPTIDE-6 (GHRP-6).
# GROWTH HORMONE SECRETAGOGUES* (GHSs).
GUAIFENESIN for human therapeutic use except:
a) when included in Schedule 2;
b) in oral liquid preparations containing 2 per cent or less of guaifenesin; or
c) in divided preparations containing 200 mg or less of guaifenesin per dosage unit.
GUANABENZ.
GUANACLINE.
GUANETHIDINE.
GUANIDINE for therapeutic use.
HACHIMYCIN.
HAEMATIN.
HAEMOPHILUS INFLUENZAE VACCINE.
HALCINONIDE.
HALOFANTRINE.
HALOFENATE.
HALOFUGINONE in preparations containing 0.1 per cent or less of halofuginone for the
treatment of animals.
Poisons Standard November 2016
92
HALOPERIDOL.
HALOTHANE for therapeutic use.
HEMEROCALLIS (Hemerocallis flava).
HEPARINS for internal use except when separately specified in this Schedule.
HEPATITIS A VACCINE.
HEPATITIS B VACCINE.
HETACILLIN.
HEXACHLOROPHENE:
a) in preparations for use on infants; or
b) in other preparations except:
i)
93
HYDRALAZINE.
HYDRARGAPHEN.
HYDROCHLOROTHIAZIDE.
HYDROCORTISONE:
a) for human use except when included in Schedule 2 or 3; or
b) for the treatment of animals.
HYDROCYANIC ACID for therapeutic use.
HYDROFLUMETHIAZIDE.
HYDROQUINONE (other than its alkyl ethers separately specified in this Schedule) in
preparations for human therapeutic or cosmetic use except:
a) when included in Schedule 2; or
b) in hair preparations containing 0.3 per cent or less of hydroquinone; or
c) in cosmetic nail preparations containing 0.02 per cent or less of hydroquinone.
HYDROXYCARBAMIDE.
HYDROXYCHLOROQUINE.
HYDROXYEPHEDRINE.
HYDROXYPHENAMATE.
HYDROXYPROGESTERONE.
# HYDROXYSTENOZOL.
HYDROXYZINE.
HYGROMYCIN.
HYOSCINE except when included in Schedule 2.
HYOSCYAMINE except when included in Schedule 2.
HYOSCYAMUS NIGER except:
a) when included in Schedule 2; or
b) in a pack containing 0.03 mg or less of total solanaceous alkaloids.
HYPOTHALAMIC RELEASING FACTORS except when separately specified in this
Schedule.
HYPROMELLOSE in preparations for injection.
IBAFLOXACIN for veterinary use.
Poisons Standard November 2016
94
IBANDRONIC ACID.
IBOGAINE.
IBRITUMOMAB.
IBRUTINIB.
IBUFENAC.
IBUPROFEN except:
a) when included in or expressly excluded from Schedule 2 or 3; or
b) in preparations for dermal use.
IBUTEROL.
IBUTILIDE.
ICATIBANT.
IDARUBICIN.
IDARUCIZUMAB
IDOXURIDINE except in preparations containing 0.5 per cent or less of idoxuridine for dermal
use.
IDURSULFASE.
IFOSFAMIDE.
ILOPROST.
IMATINIB.
IMEPITOIN.
IMIDAPRIL.
IMIGLUCERASE.
IMIPENIM.
IMIPRAMINE.
IMIQUIMOD.
IMMUNOGLOBULINS for human parenteral use except when separately specified in these
Schedules.
INDACATEROL.
INDAPAMIDE.
Poisons Standard November 2016
95
INDINAVIR.
INDOMETACIN except when included in Schedule 2.
INDOPROFEN.
INDORAMIN.
INFLIXIMAB.
INFLUENZA AND CORYZA VACCINES:
a) for parenteral use; or
b) for nasal administration.
INGENOL MEBUTATE.
INSULIN GLARGINE.
# INSULIN-LIKE GROWTH FACTOR I.
# INSULIN-LIKE GROWTH FACTORS except when separately specified in this Schedule.
INSULINS.
INTERFERONS.
INTERLEUKINS except when separately specified in these Schedules.
IODOTHIOURACIL.
# IPAMORELIN.
IPILIMUMAB.
IPRATROPIUM except when included in Schedule 2.
IPRIFLAVONE.
IPRINDOLE.
IPRONIAZID.
IRBESARTAN.
IRINOTECAN.
IRON COMPOUNDS in injectable preparations for human use.
ISOAMINILE.
ISOAMYL NITRITE.
ISOBUTYL NITRITE.
Poisons Standard November 2016
96
ISOCARBOXAZID.
ISOCONAZOLE except when included in Schedule 2, 3 or 6.
ISOETARINE.
ISOFLURANE for therapeutic use.
ISOMETHEPTENE.
ISONIAZID.
ISOPRENALINE.
ISOPRINOSINE.
ISOPROPAMIDE except when included in Schedule 2.
ISOSORBIDE DINITRATE except when included in Schedule 3.
ISOSORBIDE MONONITRATE.
# ISOTRETINOIN.
ISOXICAM.
ISOXSUPRINE.
ISRADIPINE.
ITRACONAZOLE.
IVABRADINE.
IVACAFTOR.
IVERMECTIN:
a) for human use; or
b) for the treatment of mange in dogs.
IXABEPILONE.
IXEKIZUMAB.
JAPANESE ENCEPHALITIS VACCINE.
KANAMYCIN.
KETANSERIN except in topical veterinary preparations containing 0.5 per cent or less of
ketanserin.
# KETAZOLAM.
KETOCONAZOLE except:
Poisons Standard November 2016
97
98
99
LEVOMEPROMAZINE.
LEVOMILNACIPRAN.
LEVONORGESTREL except when included in Schedule 3.
LEVOSIMENDAN.
LIDOCAINE except:
100
101
MAVACOXIB.
MAZINDOL.
MEASLES VACCINE.
MEBANAZINE.
MEBEVERINE.
MEBHYDROLIN.
# MEBOLAZINE.
MEBUTAMATE.
MECAMYLAMINE.
MECASERMIN.
MECILLINAM.
MECLOCYCLINE.
MECLOFENAMATE.
MECLOFENOXATE.
MECLOZINE except when included in Schedule 2.
# MEDAZEPAM.
MEDETOMIDINE.
MEDIGOXIN (methyldigoxin).
MEDROXYPROGESTERONE.
MEDRYSONE.
MEFENAMIC ACID except when included in Schedule 2.
MEFENOREX.
MEFLOQUINE.
MEFRUSIDE.
MEGESTROL.
MELAGATRAN.
MELATONIN for human use.
MELENGESTROL except when included in Schedule 6.
Poisons Standard November 2016
102
MELOXICAM.
MELPHALAN.
MEMANTINE.
MENINGOCOCCAL VACCINE.
MENOTROPHIN.
MEPACRINE.
MEPENZOLATE.
MEPHENESIN.
MEPHENTERMINE.
MEPINDOLOL.
# MEPITIOSTANE.
MEPIVACAINE.
MEPROBAMATE.
MEPTAZINOL.
MEPYRAMINE except when included in Schedule 2 or 3.
MEQUITAZINE.
MERCAPTAMINE for human therapeutic use.
MERCAPTOMERIN.
MERCAPTOPURINE.
MERCUROCHROME except when included in Schedule 2 or 6.
MERCURY for cosmetic or therapeutic use except:
a) when separately specified in these Schedules; or
b) in a sealed device which prevents access to the mercury.
MEROPENEM.
MERSALYL.
# MESABOLONE.
MESALAZINE.
MESNA.
Poisons Standard November 2016
103
# MESTANOLONE (androstalone).
# MESTEROLONE.
MESTRANOL.
# METANDIENONE.
METARAMINOL.
# METENOLONE.
METERGOLINE.
METFORMIN.
METHACHOLINE.
METHACYCLINE.
METHALLENESTRIL.
# METHANDRIOL.
METHANTHELINIUM.
METHAZOLAMIDE.
METHDILAZINE except when included in Schedule 3.
# METHENOLONE.
METHICILLIN.
METHIMAZOLE.
METHISAZONE.
METHIXENE.
METHOCARBAMOL.
METHOHEXITONE.
METHOIN.
METHOTREXATE.
METHOXAMINE except:
a) when included in Schedule 2; or
b) in preparations for external use containing 1 per cent or less of methoxamine.
METHOXSALEN.
Poisons Standard November 2016
104
METHOXYFLURANE.
METHSUXIMIDE.
METHYCLOTHIAZIDE.
METHYL AMINOLEVULINATE.
#METHYLANDROSTANOLONE.
# METHYLCLOSTEBOL.
METHYLDOPA.
METHYLENE BLUE in preparations for injection.
METHYLERGOMETRINE.
METHYL MERCURY for therapeutic use.
METHYLNALTREXONE.
METHYLPENTYNOL.
METHYLPHENOBARBITAL.
METHYLPREDNISOLONE.
METHYLROSANILINIUM CHLORIDE for human use except when used as a dermal marker.
METHYL SALICYLATE in preparations for internal therapeutic use.
# METHYLTESTOSTERONE.
METHYLTHIOURACIL.
# METHYLTRIENOLONE.
METHYPRYLONE.
METHYSERGIDE.
METOCLOPRAMIDE except when included in Schedule 3.
METOLAZONE.
METOPROLOL.
# METRIBOLONE.
METRIFONATE (trichlorfon) for human therapeutic use.
METRONIDAZOLE.
METYRAPONE.
Poisons Standard November 2016
105
MEXILETINE.
MEZLOCILLIN.
MIANSERIN.
MIBEFRADIL.
# MIBOLERONE.
MICAFUNGIN.
MICONAZOLE except:
a) when included in Schedule 2, 3 or 6; or
b) in preparations for dermal use for the treatment of tinea pedis.
# MIDAZOLAM.
MIDODRINE.
MIFEPRISTONE.
MIGLITOL.
MIGLUSTAT.
MILBEMYCIN OXIME except when included in Schedule 5.
MILNACIPRAN.
MILRINONE.
MINOCYCLINE.
MINOXIDIL except when included in Schedule 2.
MIRABEGRON.
MIRTAZAPINE.
MISOPROSTOL.
MITOBRONITOL.
MITOMYCIN.
MITOTANE.
MITOXANTRONE.
MITRATAPIDE.
MIVACURIUM CHLORIDE.
Poisons Standard November 2016
106
MOCLOBEMIDE.
MODAFINIL.
MOLGRAMOSTIM.
MOLINDONE.
MOMETASONE except when included in Schedule 2.
MONENSIN except:
a) when included in Schedule 5 or 6; or
b) in animal feeds containing 360 mg/kg or less of antibiotic substances.
MONOBENZONE and alkyl ethers of hydroquinone for human therapeutic use or cosmetic use
except in cosmetic nail preparations containing 0.02 per cent or less of monobenzone or alkyl
ethers of hydroquinone.
MONOCLONAL ANTIBODIES for therapeutic use except:
a) in diagnostic test kits; or
107
108
NEOMYCIN.
NEOSTIGMINE.
NEPAFENAC.
NERIUM OLEANDER.
NESIRITIDE.
NETILMICIN.
NETUPITANT.
NEVIRAPINE.
NIALAMIDE.
NICARDIPINE.
NICERGOLINE.
NICOFURANOSE.
NICORANDIL.
NICOTINE in preparations for human therapeutic use except for use as an aid in withdrawal
from tobacco smoking in preparations for oromucosal or transdermal use.
NICOTINIC ACID for human therapeutic use except:
a) when separately specified in these Schedules;
b) in preparations containing 100 mg or less of nicotinic acid per dosage unit; or
c) nicotinamide.
NICOUMALONE.
NIFEDIPINE.
NIFENAZONE.
NIKETHAMIDE.
NILOTINIB.
NILUTAMIDE.
NIMESULIDE.
NIMODIPINE.
NIMORAZOLE.
NINTEDANIB.
Poisons Standard November 2016
109
NIRIDAZOLE.
NISOLDIPINE.
NITISINONE.
# NITRAZEPAM.
NITRENDIPINE.
NITRIC OXIDE for human therapeutic use.
NITROFURANTOIN.
NITROFURAZONE.
NITROUS OXIDE for therapeutic use.
NITROXOLINE.
NIZATIDINE except when included in Schedule 2.
NOMEGESTROL.
NOMIFENSINE.
NORADRENALINE.
# 19-NORANDROSTENEDIOL.
# 19-NORANDROSTENEDIONE.
# NORANDROSTENOLONE.
# NORBOLETHONE.
# NORCLOSTEBOL.
NORELGESTROMIN.
# NORETHANDROLONE.
NORETHISTERONE.
NORFLOXACIN.
NORGESTREL.
NORIBOGAINE.
NORMAL HUMAN IMMUNOGLOBULIN.
# NORMETHANDRONE.
NORTRIPTYLINE.
Poisons Standard November 2016
110
NOVOBIOCIN.
NOXIPTYLINE.
NYSTATIN except when included in Schedule 2 or 3.
OCLACITINIB.
OCRIPLASMIN.
OCTAMYLAMINE.
OCTATROPINE.
OCTREOTIDE.
OCTYL NITRITE.
OFATUMUMAB.
OFLOXACIN.
OLANZAPINE.
OLEANDOMYCIN except:
a) when included in Schedule 5; or
b) in animal feeds for growth promotion containing 50 mg/kg or less of antibiotic
substances.
OLEANDRIN.
OLMESARTAN.
OLODATEROL.
OLOPATADINE.
OLSALAZINE.
OMALIZUMAB.
OMBITASVIR.
OMEGA-3-ACID ETHYL ESTERS (excluding salts and derivatives) for human therapeutic
use, for the treatment of post-myocardial infarction and/or hypertriglyceridaemia.
OMEPRAZOLE except when included in Schedule 2 or 3.
ONDANSETRON.
OPIPRAMOL.
ORBIFLOXACIN.
Poisons Standard November 2016
111
ORCIPRENALINE.
ORGANOPHOSPHORUS COMPOUNDS with anticholinesterase activity for human
therapeutic use except:
a) when separately specified in these Schedules; or
b) in preparations containing 2 per cent or less of malathion for external use.
ORLISTAT except when included in Schedule 3.
ORNIDAZOLE.
ORNIPRESSIN.
ORPHENADRINE.
ORTHOPTERIN.
OSELTAMIVIR.
OUABAIN.
# OVANDROTONE.
# OXABOLONE.
OXACILLIN.
OXALIPLATIN.
# OXANDROLONE.
OXAPROZIN.
# OXAZEPAM.
OXCARBAZEPINE.
OXEDRINE for human internal use except in preparations labelled with a recommended daily
dose of 30 mg or less of oxedrine.
OXETACAINE (oxethazaine) except when included in Schedule 2.
OXICONAZOLE except:
a) when included in Schedule 2 or 3; or
b) in preparations for the treatment of tinea pedis.
OXITROPIUM.
OXOLAMINE.
OXOLINIC ACID.
Poisons Standard November 2016
112
OXPRENOLOL.
OXYBUPROCAINE.
OXYBUTYNIN.
# OXYMESTERONE.
# OXYMETHOLONE.
OXYPHENBUTAZONE.
OXYPHENCYCLIMINE.
OXYPHENONIUM.
OXYTETRACYCLINE except when included in Schedule 5.
OXYTOCIN.
PACLITAXEL.
PALIFERMIN.
PALIPERIDONE.
PALIVIZUMAB.
PALONOSETRON.
PAMAQUIN.
PAMIDRONIC ACID (includes pamidronate disodium)
PANCREATIC ENZYMES except:
a) in preparations containing 20,000 BP units or less of lipase activity per dosage unit;
or
b) when separately specified in these Schedules.
PANCURONIUM.
PANITUMUMAB.
PANTOPRAZOLE except when included in Schedule 2 or 3.
PAPAVERINE in preparations for injection.
PARACETAMOL:
a) when combined with aspirin or salicylamide or any derivative of these substances
except when separately specified in these Schedules;
b) when combined with ibuprofen in a primary pack containing more than 30 dosage
units;
Poisons Standard November 2016
113
114
115
PHENETICILLIN.
PHENFORMIN.
PHENGLUTARIMIDE.
PHENINDIONE.
PHENIRAMINE except when included in Schedule 2 or 3.
PHENISATIN.
PHENOBARBITAL.
PHENOL in preparations for injection.
PHENOLPHTHALEIN for human therapeutic use.
PHENOXYBENZAMINE.
PHENOXYMETHYLPENICILLIN.
PHENSUXIMIDE.
# PHENTERMINE.
PHENTHIMENTONIUM.
PHENTOLAMINE.
PHENYLBUTAZONE.
PHENYLEPHRINE:
a) in preparations for injection; or
116
the tablet or capsule form contains 125 mg or less of kavalactones per tablet or
capsule; or
ii) the amount of dried whole or peeled rhizome in the teabag does not exceed 3 g;
and, where containing more than 25 mg of kavalactones per dose, compliant with the
requirements of the Required Advisory Statements for Medicine Labels;
b) in topical preparations for use on the rectum, vagina or throat containing dried whole
or peeled rhizome or containing aqueous dispersions or aqueous extracts of whole or
peeled rhizome; or
c) in dermal preparations.
PIPERACILLIN.
PIPERIDINE.
PIPERIDOLATE.
PIPOBROMAN.
Poisons Standard November 2016
117
PIPOTHIAZINE.
PIPRADROL.
PIRACETAM.
PIRBUTEROL.
PIRENOXINE (catalin).
PIRENZEPINE.
PIRETANIDE.
PIRFENIDONE.
PIROXICAM except in preparations for dermal use.
PIRPROFEN.
PITAVASTATIN.
PITUITARY HORMONES except when separately specified in these Schedules.
PIVAMPICILLIN.
PIZOTIFEN.
PLICAMYCIN.
PLERIXAFOR.
PNEUMOCOCCAL VACCINE.
PODOPHYLLOTOXIN for human use:
a) internally;
b) in preparations for the treatment of anogenital warts; or
c) in other preparations except when included in Schedule 2 or 3.
PODOPHYLLUM EMODI (podophyllin) for human use:
a) internally;
b) in preparations for the treatment of anogenital warts; or
c) in other preparations except when included in Schedule 2 or 3.
PODOPHYLLUM PELTATUM (podophyllin) for human use:
a) internally;
b) in preparations for the treatment of anogenital warts; or
c) in other preparations except when included in Schedule 2 or 3.
Poisons Standard November 2016
118
POLIDEXIDE.
POLIOMYELITIS VACCINE.
POLYACRYLAMIDE in preparations for injection or implantation:
a) for tissue augmentation; or
b) for cosmetic use.
POLYCAPROLACTONE in preparations for injection or implantation:
a) for tissue augmentation; or
b) for cosmetic use.
POLYESTRADIOL.
POLYLACTIC ACID in preparations for injection or implantation:
a) for tissue augmentation; or
b) for cosmetic use.
POLYMYXIN.
POLYSULFATED GLYCOSAMINOGLYCANS in preparations for injection, except when
separately specified in these Schedules.
POLYTHIAZIDE.
POMALIDOMIDE.
PORACTANT.
POSACONAZOLE.
POTASSIUM BROMIDE for therapeutic use.
POTASSIUM CHLORIDE in oral preparations for human therapeutic use except:
a) when containing less than 550 mg of potassium chloride per dosage unit;
b) in preparations for oral rehydration therapy;
c) in preparations for oral use for bowel cleansing prior to diagnostic medical and
surgical procedures; or
d) in preparations for enteral feeding.
POTASSIUM PERCHLORATE for therapeutic use.
PRACTOLOL.
PRADOFLOXACIN.
PRALATREXATE.
Poisons Standard November 2016
119
PRALIDOXIME.
PRAMIPEXOLE.
PRAMOCAINE.
# PRALMORELIN (GROWTH HORMONE RELEASING PEPTIDE-2 (GHRP-2)).
PRAMPINE.
# PRASTERONE (dehydroepiandrosterone, dehydroisoandrosterone).
PRASUGREL.
PRAVASTATIN.
# PRAZEPAM.
PRAZIQUANTEL for human therapeutic use.
PRAZOSIN.
PREDNISOLONE.
PREDNISONE.
PREGABALIN.
PREGNENOLONE.
PRENALTEROL.
PRENYLAMINE.
PRILOCAINE except when included in Schedule 2.
PRIMAQUINE.
PRIMIDONE.
PROBENECID.
PROBUCOL.
PROCAINAMIDE.
PROCAINE.
PROCAINE BENZYLPENICILLIN.
PROCARBAZINE.
PROCHLORPERAZINE except when included in Schedule 3.
PROCYCLIDINE except when included in Schedule 2.
Poisons Standard November 2016
120
121
PROTOVERATRINES.
PROTRIPTYLINE.
PROXYMETACAINE.
PRUCALOPRIDE.
PSEUDOEPHEDRINE except when included in Schedule 3.
PYRAZINAMIDE.
PYRIDINOLCARBAMATE.
PYRIDOSTIGMINE.
PYRIDOXINE, PYRIDOXAL OR PYRIDOXAMINE for human therapeutic use except:
a) in oral preparations containing 200 mg or less but more than 50 mg of pyridoxine,
pyridoxal or pyridoxamine per recommended daily dose when compliant with the
requirements of the Required Advisory Statements for Medicine Labels; or
b) in oral preparations containing 50 mg or less of pyridoxine, pyridoxal or
pyridoxamine per recommended daily dose.
PYRIMETHAMINE.
PYROVALERONE.
PYRVINIUM.
# QUAZEPAM.
QUETIAPINE.
QUINAGOLIDE.
QUINAPRIL.
# QUINBOLONE.
QUINETHAZONE.
QUINIDINE.
QUININE for human therapeutic use except when the maximum recommended daily dose is
50 mg or less of quinine.
QUINISOCAINE (dimethisoquin).
QUINUPRISTIN.
RABEPRAZOLE except when included in Schedule 2 or 3.
RABIES VACCINE.
Poisons Standard November 2016
122
123
RIDAFOROLIMUS.
RIFABUTIN.
RIFAMPICIN.
RIFAMYCIN.
RIFAPENTINE.
RIFAXIMIN.
RILPIVIRINE.
RILUZOLE.
RIMEXOLONE.
RIMITEROL.
RIMONABANT.
RIOCIGUAT.
RISEDRONIC ACID.
RISPERIDONE.
RITODRINE.
RITONAVIR.
RITUXIMAB.
RIVAROXABAN.
RIVASTIGMINE.
RIZATRIPTAN.
ROBENACOXIB.
ROCURONIUM.
ROFECOXIB.
ROFLUMILAST.
ROLITETRACYCLINE.
ROMIDEPSIN.
ROMIFIDINE.
ROMIPLOSTIM.
Poisons Standard November 2016
124
RONIDAZOLE.
ROPINIROLE.
ROPIVACAINE.
ROSIGLITAZONE.
ROSOXACIN.
ROSUVASTATIN.
ROTIGOTINE.
# ROXIBOLONE.
ROXITHROMYCIN.
RUBELLA VACCINE.
RUBOXISTAURIN.
RUPATADINE.
RUXOLITINIB.
SACUBITRIL.
SALBUTAMOL except when included in Schedule 3.
SALICYLAMIDE when combined with aspirin, caffeine or paracetamol or any derivative of
these substances.
SALINOMYCIN except:
a) when included in Schedule 6; or
b) in animal feeds containing 60 mg/kg or less of antibiotic substances.
SALMETEROL.
SAPROPTERIN.
SAQUINAVIR.
SAXAGLIPTIN.
SCHOENOCAULON OFFICINALE (sabadilla) except in preparations containing 10 mg/kg or
10 mg/L or less of total alkaloids of Schoenocaulon officinale.
SCOPOLIA CARNIOLICA for therapeutic use.
# SELECTIVE ANDROGEN RECEPTOR MODULATORS (SARM).
SELEGILINE.
Poisons Standard November 2016
125
SELENIUM:
a) for human oral use with a recommended daily dose of more than 300 micrograms; or
b) for the treatment of animals except:
i)
ii) in solid, slow release bolus preparations each weighing 100 g or more and
containing 300 mg or less of selenium per dosage unit;
iii) in other divided preparations containing 30 micrograms or less of selenium per
dosage unit;
iv) as elemental selenium, in pellets containing 100 g/kg or less of selenium; or
v) in feeds containing 1 g/tonne or less of selenium.
SERELAXIN.
SELEXIPAG.
SERMORELIN.
SERTINDOLE.
SERTRALINE.
SEVELAMER.
SEVOFLURANE.
SEX HORMONES and all substances having sex hormonal activity except when separately
specified in these Schedules.
SIBUTRAMINE.
# SILANDRONE.
SILDENAFIL.
SILICONES for intra-ocular use.
SILVER SULFADIAZINE.
SIMEPREVIR.
SIMVASTATIN.
SIROLIMUS.
SISOMICIN (sisomycin).
SITAGLIPTIN.
# SITAXENTAN.
SODIUM BROMIDE for therapeutic use.
Poisons Standard November 2016
126
127
STILBESTROL (diethylstilbestrol).
STREPTODORNASE.
STREPTOKINASE.
STREPTOMYCIN.
STRONTIUM RANELATE.
STROPHANTHINS.
STROPHANTHUS spp.
STRYCHNINE in preparations containing 1.5 per cent or less of strychnine for the treatment of
animals.
STRYCHNOS spp. except in preparations containing 1 mg or less per litre or per kilogram of
strychnine.
STYRAMATE.
SUCCIMER.
SUGAMMADEX.
SULBACTAM.
SULCONAZOLE except when included in Schedule 2.
SULFACETAMIDE except when included in Schedule 3 or 5.
SULFADIAZINE except when included in Schedule 5.
SULFADIMETHOXINE.
SULFADIMIDINE except when included in Schedule 5.
SULFADOXINE.
SULFAFURAZOLE.
SULFAGUANIDINE.
SULFAMERAZINE except when included in Schedule 5.
SULFAMETHIZOLE.
SULFAMETHOXAZOLE.
SULFAMETHOXYDIAZINE.
SULFAMETHOXYPYRIDAZINE.
SULFAMETROLE.
Poisons Standard November 2016
128
SULFAMONOMETHOXINE.
SULFAMOXOLE.
SULFAPHENAZOLE.
SULFAPYRIDINE.
SULFAQUINOXALINE.
SULFASALAZINE.
SULFATHIAZOLE except when included in Schedule 5.
SULFATROXAZOLE.
SULFINPYRAZONE.
SULFOMYXIN.
SULFONAMIDES except:
a) when separately specified in this Schedule;
b) when included in Schedule 3, 5 or 6; or
c) when packed and labelled solely for use as a herbicide.
SULFONMETHANE (sulfonal) and alkyl sulfonals.
SULINDAC.
SULTAMICILLIN.
SULTHIAME.
SUMATRIPTAN.
SUNITINIB.
SUPROFEN.
SUTILAINS.
SUXAMETHONIUM.
SUXETHONIUM.
SUVOREXANT.
TACRINE.
TACROLIMUS.
TADALAFIL.
Poisons Standard November 2016
129
TAFLUPROST.
TALIGLUCERASE ALFA.
TAMOXIFEN.
TAMSULOSIN.
TANACETUM VULGARE except in preparations containing 0.8 per cent or less of oil of
tansy.
TASONERMIN.
TAZAROTENE.
TAZOBACTAM.
TB-500
T-CELL RECEPTOR ANTIBODY.
TEGAFUR.
TEGASEROD.
TELAPREVIR.
TELITHROMYCIN.
TEICOPLANIN.
TELBIVUDINE.
TELMISARTAN.
# TEMAZEPAM.
TEMOZOLOMIDE.
TEMSIROLIMUS.
TENECTEPLASE.
TENIPOSIDE.
TENOFOVIR.
TENOXICAM.
TEPOXALIN.
TERAZOSIN.
TERBINAFINE except:
Poisons Standard November 2016
130
131
THIAMBUTOSINE.
THIAZOSULFONE.
THIETHYLPERAZINE.
THIOACETAZONE.
THIOCARLIDE.
# THIOMESTERONE (tiomesterone).
THIOPENTONE.
THIOPROPAZATE.
THIOPROPERAZINE.
THIORIDAZINE.
THIOSTREPTON.
THIOTEPA.
THIOTHIXENE.
THIOURACIL.
THIOUREA for therapeutic use except in preparations containing 0.1 per cent or less of
thiourea.
THYMOSIN BETA 4 (THYMOSIN 4)
THYMOXAMINE (includes thymoxamine hydrochloride).
THYROID except when separately specified in this Schedule.
THYROTROPHIN.
THYROXINE (includes thyroxine sodium).
TIAGABINE.
TIAMULIN.
TIAPROFENIC ACID.
TIARAMIDE.
TIBOLONE.
TICAGRELOR.
TICARCILLIN.
Poisons Standard November 2016
132
TICLOPIDINE.
TIEMONIUM.
TIENILIC ACID.
TIGECYCLINE.
TIGLOIDINE.
TILDIPIROSIN.
TILETAMINE.
TILMICOSIN.
TILUDRONIC ACID (includes disodium tiludronate).
TIMOLOL.
TINIDAZOLE.
TINZAPARIN (includes tinzaparin sodium).
TIOCONAZOLE except:
a) when included in Schedule 2 or 3; or
b) in preparations for dermal use for the treatment of tinea pedis.
TIOGUANINE.
TIOTROPIUM.
TIPEPIDINE.
TIPRANAVIR.
TIRILAZAD.
TIROFIBAN.
TOBRAMYCIN.
TOCAINIDE.
TOCERANIB.
TOCILIZUMAB.
TOFACITINIB.
TOLAZAMIDE.
TOLAZOLINE.
Poisons Standard November 2016
133
TOLBUTAMIDE.
TOLCAPONE.
TOLFENAMIC ACID.
TOLMETIN.
TOLONIUM.
TOLPROPAMINE.
TOLRESTAT.
TOLTERODINE.
TOLVAPTAN.
TOPIRAMATE.
TOPOTECAN.
TORASEMIDE.
TOREMIFENE.
TOXOIDS for human parenteral use except when separately specified in these Schedules.
TRAMADOL.
TRANDOLAPRIL.
TRAMETINIB DIMETHYL SULFOXIDE.
TRANEXAMIC ACID except in preparations containing 3 per cent or less of cetyl tranexamate
hydrochloride for dermal cosmetic use.
TRANYLCYPROMINE.
TRASTUZUMAB.
TRASTUZUMAB EMTANSINE.
TRAVOPROST.
TRAZODONE.
# TRENBOLONE (trienbolone, trienolone) except when included in Schedule 5.
TREOSULPHAN.
TREPROSTINIL.
# TRESTOLONE.
Poisons Standard November 2016
134
TRETAMINE.
# TRETINOIN.
TRIACETYLOLEANDOMYCIN.
TRIAMCINOLONE except when included in Schedule 2 or 3.
TRIAMTERENE.
TRIAZIQUONE.
# TRIAZOLAM.
TRICHLORMETHIAZIDE.
TRICHLOROACETIC ACID for human dermal use except when in preparations containing
12.5 per cent or less of trichloroacetic acid for the treatment of warts other than anogenital
warts.
TRICHLOROETHYLENE for therapeutic use.
TRICLOFOS.
TRICYCLAMOL.
TRIDIHEXETHYL.
TRIFLUOPERAZINE.
TRIFLUPERIDOL.
TRIFLUPROMAZINE.
TRIHEXYPHENIDYL
TRILOSTANE.
TRIMETAPHAN.
TRIMETHOPRIM.
TRIMIPRAMINE.
TRIMUSTINE.
TRINITROPHENOL (excluding its derivatives) in preparations for human therapeutic use.
TRIOXYSALEN.
TRIPELENNAMINE.
TRIPLE ANTIGEN VACCINE.
TRIPROLIDINE except when included in Schedule 2 or 3.
Poisons Standard November 2016
135
TRIPTORELIN.
TROGLITAZONE.
TROLAMINEwhen in preparations for tattoo removal.
TROMETAMOL in preparations for injection except in preparations containing 3 per cent or
less of trometamol.
TROPICAMIDE.
TROPISETRON.
TROVAFLOXACIN.
TROXIDONE.
TRYPTOPHAN for human therapeutic use except in preparations labelled with a recommended
daily dose of 100 mg or less of tryptophan.
TUBERCULIN.
TUBOCURARINE.
TULATHROMYCIN.
TULOBUTEROL.
TYLOSIN.
TYPHOID VACCINE.
ULIPRISTAL.
UMECLIDINIUM.
UNOPROSTONE.
URACIL.
URAPIDIL.
URETHANE (excluding its derivatives) for therapeutic use.
# UROFOLLITROPIN.
UROKINASE.
URSODEOXYCHOLIC ACID.
USTEKINUMAB.
VACCINES for human therapeutic use except when separately specified in this Schedule.
VACCINES, veterinary live virus except:
Poisons Standard November 2016
136
a) poultry vaccines;
b) pigeon pox vaccine; or
c) scabby mouth vaccine.
VACCINIA VIRUS VACCINE.
VALACICLOVIR.
VALDECOXIB.
VALGANCICLOVIR.
VALNOCTAMIDE.
VALPROIC ACID.
VALSARTAN.
VANCOMYCIN.
VANDETANIB.
VARDENAFIL.
VARENICLINE.
VARICELLA VACCINE.
VASOPRESSIN.
VECURONIUM.
VEDAPROFEN.
VEDOLIZUMAB.
VELAGLUCERASE ALFA.
VELPATASVIR.
VEMURAFENIB.
VENLAFAXINE.
VERAPAMIL.
VERATRUM spp. except when separately specified in this Schedule.
VERNAKALANT.
VERTEPORFIN.
VIDARABINE.
Poisons Standard November 2016
137
VIGABATRIN.
VILANTEROL.
VILDAGLIPTIN.
VILOXAZINE.
VINBLASTINE.
VINCAMINE.
VINCRISTINE.
VINDESINE.
VINFLUNINE.
VINORELBINE.
VINYL ETHER for therapeutic use.
VIRGINIAMYCIN except when included in Schedule 5.
VISMODEGIB.
VISNADINE.
VITAMIN A for human therapeutic or cosmetic use except:
a) in preparations for topical use containing 1 per cent or less of Vitamin A;
b) in preparations for internal use containing 3000 micrograms retinol equivalents or
less of Vitamin A per daily dose; or
c) in preparations for parenteral nutrition replacement.
VITAMIN D for human internal therapeutic use except:
a) in preparations containing 25 micrograms or less of vitamin D per recommended
daily dose ; or
b) when included in Schedule 3.
VORAPAXAR.
VORICONAZOLE.
VORINOSTAT.
VORTIOXETINE.
WARFARIN for therapeutic use.
XAMOTEROL.
Poisons Standard November 2016
138
XANTHINOL NICOTINATE.
XIMELAGATRAN.
XIPAMIDE.
XYLAZINE.
YOHIMBINE.
ZAFIRLUKAST.
ZALCITABINE.
ZALEPLON.
ZANAMIVIR.
ZERANOL except when included in Schedule 6.
ZIDOVUDINE.
ZILPATEROL.
ZIMELDINE.
ZINC COMPOUNDS for human internal use except:
a) in preparations with a recommended daily dose of 25 mg or less of zinc; or
b) in preparations with a recommended daily dose of more than 25 mg but not more than
50 mg of zinc when compliant with the requirements of the Required Advisory
Statements for Medicine Labels.
ZIPRASIDONE.
ZOLAZEPAM.
ZOLEDRONIC ACID.
ZOLMITRIPTAN.
ZOLPIDEM.
ZONISAMIDE.
ZOPICLONE.
ZOXAZOLAMINE.
ZUCLOPENTHIXOL.
139
SCHEDULE 5
ABAMECTIN in preparations, for internal use for the treatment of animals, containing 1 per
cent or less of abamectin.
ABSCISIC ACID.
ACETIC ACID (excluding its salts and derivatives) in preparations containing more than 30 per
cent of acetic acid (CH3COOH) except:
ii) in automatic dish washing preparations for domestic use with a pH of more than
12.5,
except when separately specified in these Schedules.
ALKOXYLATED FATTY ALKYLAMINE POLYMER in preparations containing 50 per cent
or less of alkoxylated fatty alkylamine polymer except in preparations containing 20 per
cent or less of alkoxylated fatty alkylamine polymer.
Poisons Standard November 2016
140
141
142
143
n-BUTYL ALCOHOL in preparations containing 10 per cent or less of n-butyl alcohol except:
a) in preparations containing 5 per cent or less of n-butyl alcohol; or
b) in preparations for cosmetic or therapeutic use other than spray form.
CAMPHOR as a natural component in essential oils containing 10 per cent or less of camphor
except:
a) in medicines for human therapeutic use, in essential oils when packed in containers
having a nominal capacity of 25 mL or less fitted with a restricted flow insert and
compliant with the requirements of the Required Advisory Statements for Medicine
Labels;
b) in preparations other than medicines for human therapeutic use, in essential oils when
packed in containers having a nominal capacity of 25 mL or less fitted with a
restricted flow insert, and labelled with the warnings:
KEEP OUT OF REACH OF CHILDREN; and
NOT TO BE TAKEN;
c) in rosemary oil, sage oil (Spanish), or lavandin oils; or
d) in preparations containing 2.5 per cent or less of camphor.
CARBAMIDE PEROXIDE in preparations containing 18 per cent or less of carbamide
peroxide except in preparations containing 9 per cent or less of carbamide peroxide.
CARBARYL:
a) in preparations containing 10 per cent or less of carbaryl except when included in
Schedule 4; or
b) when impregnated into plastic resin material containing 20 per cent or less of
carbaryl.
CASSIA OIL except:
a) in food additives;
b) in preparations for dermal use as a rubefacient containing 5 per cent or less of cassia
oil; or
c) in other preparations containing 2 per cent or less of cassia oil.
CHLORFENAC.
CHLORFENAPYR. in preparations containing 0.5 per cent or less of chlorfenapyr.
CHLORFENSON.
CHLORHEXIDINE in preparations containing 3 per cent or less of chlorhexidine except:
a) in preparations containing 1 per cent or less of chlorhexidine; or
b) when in solid preparations.
CHLORINATING COMPOUNDS containing 20 per cent or less of available chlorine, except:
Poisons Standard November 2016
144
b) containing 40 per cent or less of chlortetracycline, when packed and labelled for the
treatment of ornamental caged birds or ornamental fish only.
CHLORTHAL-DIMETHYL.
CINMETHYLIN.
CINNAMON BARK OIL except:
a) in food additives; or
b) in preparations containing 2 per cent or less of cinnamon bark oil.
CLETHODIM.
CLIMBAZOLE in preparations containing 40 per cent or less of climbazole except in
preparations containing 2 per cent or less of climbazole.
CLOFENTEZINE.
Poisons Standard November 2016
145
CLOPYRALID.
CLOQUINTOCET.
CLORSULON.
CLOTHIANIDIN in preparations containing 20 per cent or less of clothianidin except in gel
preparations dispensed in sealed cartridges containing 1 per cent or less of clothianidin.
CLOVE OIL for topical use in the mouth in a pack containing 5 mL or less of clove oil except
in preparations containing 25 per cent or less of clove oil.
COPPER ACETATE in preparations containing 20 per cent or less of copper acetate except in
preparations containing 5 per cent or less of copper acetate.
COPPER COMPOUNDS in animal feed additives containing 5 per cent or less of copper
except in preparations containing 1 per cent or less of copper.
COPPER HYDROXIDE in preparations containing 50 per cent or less of copper hydroxide
except in preparations containing 12.5 per cent or less of copper hydroxide.
COPPER OXIDES in preparations containing 25 per cent or less of copper oxides except:
a) in preparations for internal use;
b) in marine paints; or
c) in other preparations containing 5 per cent or less of copper oxides.
COPPER OXYCHLORIDE in preparations containing 50 per cent or less of copper oxychloride
except in preparations containing 12.5 per cent or less of copper oxychloride.
COPPER SULFATE in preparations containing 15 per cent or less of copper sulfate except:
a) in preparations for internal use; or
b) in other preparations containing 5 per cent or less of copper sulfate.
COUMATETRALYL in rodenticides containing 0.05 per cent or less of coumatetralyl.
4-CPA.
CYANATRYN.
CYANOACRYLATE ESTERS in contact adhesives except:
a) when labelled with the warning:
KEEP OUT OF REACH OF CHILDREN. Avoid contact with skin and eyes
and avoid breathing vapour. Bonds on contact. Should fingers stick together
apply a solvent such as acetone to contact areas then wash off with water. Do
not use solvents near eyes or open wounds. In case of eye contact immediately
flush with water; or
b) when packed in sealed measure packs each containing 0.5 g or less of cyanoacrylate
esters:
Poisons Standard November 2016
146
i)
labelled with the approved name or trade name of the poison, the quantity and the
warning:
Can cause eye injury. Instantly bonds skin; and
147
2,4-DB.
DECOQUINATE:
DELTAMETHRIN:
a) when impregnated in plastic resin strip material containing 4 per cent or less of
deltamethrin;
b) in aqueous preparations containing 5 per cent or less of deltamethrin when no organic
solvent other than a glycol is present;
148
149
DIFLUBENZURON.
DIMETHICODIETHYLBENZALMALONATE except when included in preparations
containing 10 per cent or less of dimethicodiethylbenzalmalonate.
DIMETHIRIMOL.
DIMETHOMORPH except in preparations containing 10 per cent or less of dimethomorph.
DIMETHYLACETAMIDE in preparations containing 20 per cent or less of dimethylacetamide.
DIMETHYLFORMAMIDE in preparations containing 10 per cent or less of
dimethylformamide except in silicone rubber mastic containing 2 per cent or less of
dimethylformamide.
3,7-DIMETHYL-2,6-OCTADIENAL and its isomers in cosmetic and household cleaning
preparations except in preparations containing 5 per cent or less of 3,7-dimethyl-2,6,octadienal isomers.
DINICONAZOLE.
DINOTEFURAN.
DI-n-PROPYL ISOCINCHOMERONATE except in preparations containing 25 per cent or less
of di-n-propyl isocinchomeronate.
DIPHENAMID.
DITHIOPYR.
N-(N-DODECYL)-2-PYRROLIDONE in preparations containing 50 per cent or less of N-(Ndodecyl)-2-pyrrolidone or preparations containing 50 per cent or less of a mixture of any
two or more of N-(N-dodecyl)-2-pyrrolidone, N-methyl-2-pyrrolidone or N-(N-octyl)-2pyrrolidone except in preparations containing 25 per cent or less of designated solvents.
DORAMECTIN for internal use for the treatment of animals, in preparations containing 2 per
cent or less of doramectin.
EMAMECTIN in preparations containing 2 per cent or less of emamectin.
EMODEPSIDE in preparations:
a) containing 2.5 per cent or less of emodepside for the external treatment of animals; or
b) containing 30 mg or less of emodepside per dosage unit for the oral treatment of
animals.
EPOXICONAZOLE.
EPOXY RESINS, LIQUID.
EPRINOMECTIN in preparations containing 0.5 per cent or less of eprinomectin.
ESBIOTHRIN in preparations containing 10 per cent or less of esbiothrin except in pressurised
spray packs containing 1 per cent or less of esbiothrin.
Poisons Standard November 2016
150
151
152
FURALAXYL.
FURATHIOCARB in microencapsulated suspensions containing 50 per cent or less of
furathiocarb.
GAMMA-CYHALOTHRIN in aqueous preparations containing 15 per cent or less of
microencapsulated gamma-cyhalothrin.
GLUFOSINATE-AMMONIUM.
GLUTARAL in preparations containing 5 per cent or less of glutaral except:
a) when included in Schedule 2; or
b) in preparations containing 0.5 per cent or less of glutaral when labelled with the
statements:
IRRITANT; and
Avoid contact with eyes.
GLYPHOSATE.
HALOSULFURON-METHYL.
HEXACONAZOLE except in preparations containing 5 per cent or less of hexaconazole.
HEXAZINONE in preparations containing 25 per cent or less of hexazinone.
HYDRAMETHYLNON in solid baits containing 2 per cent or less of hydramethylnon in
welded plastic labyrinths.
HYDROCARBONS, LIQUID, including kerosene, diesel (distillate), mineral turpentine, white
petroleum spirit, toluene, xylene and light mineral and paraffin oils (but excluding their
derivatives), except:
a) toluene and xylene when included in Schedule 6;
b) benzene and liquid aromatic hydrocarbons when included in Schedule 7;
c) food grade and pharmaceutical grade white mineral oils;
d) in solid or semi-solid preparations;
e) in preparations containing 25 per cent or less of designated solvents;
f) in preparations packed in pressurised spray packs;
g) in adhesives packed in containers each containing 50 grams or less of adhesive;
h) in writing correction fluids and thinners for writing correction fluids packed in
containers having a capacity of 20 mL or less; or
i)
HYDROCHLORIC ACID (excluding its salts and derivatives) in preparations containing 10 per
cent or less of hydrochloric acid (HCl) except:
a) in preparations containing 0.5 per cent or less of hydrochloric acid (HCl); or
b) for therapeutic use.
Poisons Standard November 2016
153
HYDROFLUORIC ACID (excluding its salts and derivatives) and admixtures that generate
hydrofluoric acid, in preparations containing 0.1 per cent or less of hydrogen fluoride.
HYDROGEN PEROXIDE (excluding its salts and derivatives):
a) in hair dye preparations containing 12 per cent or less of hydrogen peroxide except in
hair dyes containing 6 per cent or less of hydrogen peroxide; or
b) in other preparations containing 6 per cent (20 volume) or less of hydrogen peroxide
except in preparations containing 3 per cent (10 volume) or less of hydrogen
peroxide.
HYDROSILICOFLUORIC ACID (excluding its salts and derivatives) in preparations
containing 0.1 per cent or less of hydrosilicofluoric acid (H2SiF6).
2-HYDROXYETHYL METHACRYLATE except when included in dental restorative
preparations for therapeutic use or in nail preparations when labelled Avoid contact with
skin.
2-HYDROXYPROPYL METHACRYLATE in nail preparations except when labelled 'avoid
contact with skin'.
IMAZALIL.
IMAZAMOX except in preparations containing 25 per cent or less of imazamox.
IMAZAPIC except in preparations containing 25 per cent or less of imazapic.
IMAZAPYR except in preparations containing 25 per cent or less of imazapyr.
IMAZETHAPYR except in preparations containing 25 per cent or less of imazethapyr.
IMIDACLOPRID in preparations containing 20 per cent or less of imidacloprid except in
preparations containing 5 per cent or less of imidacloprid.
IMIPROTHRIN in preparations containing 50 per cent or less of imiprothrin except in
preparations containing 10 per cent or less of imiprothrin.
INDOXACARB (includes the R and S enantiomers) in preparations containing 1 per cent or
less of indoxacarb.
3-IODO-2-PROPYNYL BUTYL CARBAMATE (Iodocarb) ) in preparations containing 10 per
cent or less of 3-iodo-2-propynyl butyl carbamate except:
a) in aqueous preparations not for cosmetic use containing 10 per cent or less 3-iodo-2propynyl butyl carbamate; or
b) in cosmetic preparations (other than aerosolised preparations) containing 0.1 per cent
or less of 3-iodo-2-propynyl butyl carbamate.
IODOSULFURON-METHYL-SODIUM.
IPCONAZOLE in preparations containing 2 per cent or less of ipconazole.
IRON COMPOUNDS:
Poisons Standard November 2016
154
a) for the treatment of animals (excluding up to 1 per cent of iron oxides when present
as an excipient):
i)
155
156
157
158
METOFLUTHRIN:
a) in impregnated fabric mosquito repellent preparations for use in a vaporiser
containing 15 mg or less of metofluthrin per disk; or
b) when impregnated into a polyethylene slow release matrix containing 250 mg or less
of metofluthrin for use as a mosquito repellent.
METOLACHLOR.
METRAFENONE in preparations containing 50 per cent or less of metrafenone.
MILBEMECTIN in preparations containing 1 per cent or less of milbemectin.
MILBEMYCIN OXIME
a) for the prophylaxis of heartworm in dogs and cats; or
b) for the treatment and prevention of flea infestations, control of ticks, gastrointestinal
nematodes and heartworm in dogs, when combined with afoxolaner, in oral divided
preparations each containing 150 mg or less of afoxolaner per dosage unit.
MONENSIN in intraruminal implants for cattle, each containing 35 g or less of monensin.
MONEPANTEL.
MONOETHANOLAMINE (excluding its salts and derivatives) in preparations containing 20
per cent or less of monoethanolamine except:
a) when included in Schedule 4; or
b) in preparations containing 5 per cent or less of monoethanolamine.
MORANTEL in preparations containing 25 per cent or less of morantel except in preparations
containing 10 per cent or less of morantel.
MOXIDECTIN:
a) in preparations for external use for the treatment of animals other than cats and dogs,
containing 0.5 per cent or less of moxidectin;
b) in preparations for external use for the treatment of cats and dogs, containing 2.5 per
cent or less of moxidectin packed in single dose tubes with a volume of 1 mL or less;
or
c) for internal use for the treatment of animals:
i)
159
160
161
162
a) solid preparations, the pH of which in a 10 g/L aqueous solution is more than 11.5; or
b) liquid or semi-solid preparations, the pH of which is more than 11.5 except in food
additive preparations for domestic use.
POTASSIUM METABISULPHITE when packed for domestic use except in preparations
containing 10 per cent or less of potassium metabisulphite.
POTASSIUM NITRITE in preparations containing 1 per cent or less of potassium nitrite
except:
163
a) when impregnated in plastic resin strip material containing 10 per cent or less of
propoxur;
b) in dust preparations containing 3 per cent or less of propoxur;
c) in granular sugar-based fly baits containing 1 per cent or less of propoxur, a dark
colouring agent and a separate bittering agent;
d) in pressurised spray packs containing 2 per cent or less of propoxur; or
e) in printed paper sheets for pest control containing 0.5 per cent or less of propoxur and
in any case not more than 100 mg of propoxur per sheet.
n-PROPYL ALCOHOL in preparations containing 10 per cent or less of n-propyl alcohol
except:
a) in preparations containing 5 per cent or less of n-propyl alcohol; or
b) in preparations for cosmetic or therapeutic use other than in spray form.
PROPYZAMIDE.
PROTHIOCONAZOLE-DESCHLORO except in preparations containing 0.5 per cent or less of
prothioconazole-deschloro.
PROTHIOCONAZOLE-TRIAZOLIDINETHIONE except in preparations containing 0.5 per
cent or less of prothioconazole-triazolidinethione.
PYMETROZINE.
PYRACLOSTROBIN.
PYRAFLUFEN-ETHYL.
PYRASULFOTOLE.
PYRETHRINS, naturally occurring, being pyrethrolone, cinerolone or jasmolone esters of
chrysanthemic or pyrethric acids except:
164
165
a) in medicines for human therapeutic use, when packed in containers having a nominal
capacity of 50 mL or less fitted with a restricted flow insert and compliant with the
requirements of the Required Advisory Statements for Medicine Labels;
b) in preparations other than medicines for human therapeutic use, when packed in
containers having a nominal capacity of 50 mL or less fitted with a restricted flow
insert, and labelled with the warning:
Poisons Standard November 2016
166
167
168
TOLCLOFOS-METHYL.
TOLTRAZURIL.
TOPRAMEZONE
TRALKOXYDIM.
TRENBOLONE in implant preparations for growth promotion in animals.
TRIADIMEFON in wettable powders containing 25 per cent or less of triadimefon.
TRIADIMENOL.
TRI-ALLATE.
TRIBENURON-METHYL.
TRICHLOROACETIC ACID, alkali salts of.
1,1,1-TRICHLOROETHANE except:
a) in preparations packed in pressurised spray packs;
the word Trichloroethane written in letters not less than 1 mm in height and in
distinct contrast to the background; and
169
170
SCHEDULE 6
ABAMECTIN:
a) in preparations for pesticidal use containing 4 per cent or less of abamectin except
when included in Schedule 5; or
b) in slow-release plastic matrix ear tags for livestock use containing 1 g or less of
abamectin.
ACEPHATE.
ACETAMIPRID except in preparations containing 1 per cent or less of acetamiprid.
ACETIC ACID (excluding its salts and derivatives) and preparations containing more than 80
per cent of acetic acid (CH3COOH) except when included in Schedule 2.
ACETIC ANHYDRIDE excluding its derivatives.
ACIFLUORFEN.
ACINITRAZOLE except in preparations containing 20 per cent or less of acinitrazole.
ALBENDAZOLE for the treatment of animals except:
a) when included in Schedule 5; or
b) in intraruminal implants each containing 3.85 g or less of albendazole.
ALDRIN.
ALKALINE SALTS, being the carbonate, silicate or phosphate salts of sodium or potassium
alone or in any combination for non-domestic use:
a) in solid automatic dishwashing preparations, the pH of which in a 500 g/L aqueous
solution or mixture is more than 12.5; or
b) in liquid or semi-solid automatic dishwashing preparations, the pH of which is more
than 12.5.
ALKOXYLATED FATTY ALKYLAMINE POLYMER except:
a) when included in Schedule 5; or
b) in preparations containing 20 per cent or less of alkoxylated fatty alkylamine
polymer.
ALLETHRIN except:
a) when included in Schedule 5;
b) in insecticidal mats containing 20 per cent or less of allethrin; or
c) in other preparations containing 1 per cent or less of allethrin.
ALPHA-CYPERMETHRIN:
Poisons Standard November 2016
171
172
173
b) in eyelash and eyebrow tinting products containing 1.5 per cent or less of 4-amino-2hydroxytoluene after mixing for use when the immediate container and primary pack
are labelled with the following statement:
WARNING This product contains ingredients which may cause skin
sensitisation to certain individuals, and when used for eyelash or eyebrow
tinting may cause injury to the eye. A preliminary test according to the
accompanying directions should be made before use.
written in letters not less than 1.5mm in height.
AMINOCARB in preparations containing 25 per cent or less of aminocarb.
AMINOETHOXYVINYLGLYCINE except in preparations containing 15 per cent or less of
aminoethoxyvinylglycine.
1-AMINOMETHANAMIDE DIHYDROGEN TETRAOXOSULFATE.
4-AMINO-3-NITROPHENOL except:
a) in non-oxidative hair dye preparations and eyebrow/eyelash colouring products
containing 1 per cent or less of 4-amino-3-nitrophenol when the immediate container
and primary pack are labelled with the following statements:
KEEP OUT OF REACH OF CHILDREN, and
WARNING - This product contains ingredients which may cause skin sensitisation to
certain individuals. A preliminary test according to the accompanying directions should
be made before use, and
Written in letters not less than 1.5 mm in height; or
b) in oxidative hair dye preparations and eyebrow/eyelash colouring products containing 1
per cent or less of 4-amino-3-nitrophenol after mixing under oxidative conditions when
the immediate container and primary pack are labelled with the following statements:
KEEP OUT OF REACH OF CHILDREN, and
WARNING - This product contains ingredients which may cause skin sensitisation to
certain individuals. A preliminary test according to the accompanying directions should
be made before use, and
Written in letters not less than 1.5 mm in height.
AMINOPYRALID except when included in Schedule 5.
AMITRAZ.
AMMONIA (excluding its salts and derivatives other than ammonium hydroxide) except:
a) when included in Schedule 5;
b) in preparations for human internal therapeutic use;
c) in preparations for inhalation when absorbed in an inert solid material; or
d) in preparations containing 0.5 per cent or less of ammonia.
Poisons Standard November 2016
174
175
176
(b)
N,N-BIS(PHENYLMETHYLENE)-BICYCLO-(2.2.1)HEPTANE-2,5-DIMETHANAMINE
except in preparations containing 1 per cent or less of N,N-bis(phenylmethylene)-bicycloPoisons Standard November 2016
177
(2.2.1)heptane-2,5-dimethanamine, or a combination of N,N-bis(phenylmethylene)-bicyclo(2.2.1)heptane-2,5-dimethanamine and N,N-bis(phenylmethylene)-bicyclo-(2.2.1)heptane2,6-dimethanamine, when labelled with statements to the effect of:
IRRITANT;
REPEATED EXPOSURE MAY CAUSE SENSITISATION;
Avoid contact with eyes;
Avoid contact with skin;
Wear protective gloves when mixing or using; and
Ensure adequate ventilation when using.
N,N-BIS(PHENYLMETHYLENE)-BICYCLO-(2.2.1)HEPTANE-2,6-DIMETHANAMINE
except in preparations containing 1 per cent or less of N,N-bis(phenylmethylene)-bicyclo(2.2.1)heptane-2,6-dimethanamine, or a combination of N,N-bis(phenylmethylene)-bicyclo(2.2.1)heptane-2,5-dimethanamine and N,N-bis(phenylmethylene)-bicyclo-(2.2.1)heptane2,6-dimethanamine, when labelled with statements to the effect of:
IRRITANT;
REPEATED EXPOSURE MAY CAUSE SENSITISATION;
Avoid contact with eyes;
Avoid contact with skin;
Wear protective gloves when mixing or using; and
Ensure adequate ventilation when using.
BITHIONOL for the treatment of animals.
BORON TRIFLUORIDE in preparations containing 1 per cent or less of boron trifluoride (BF3)
except when included in Schedule 5.
BRODIFACOUM in preparations containing 0.25 per cent or less of brodifacoum.
BROMADIOLONE in preparations containing 0.25 per cent or less of bromadiolone.
BROMETHALIN in rodent baits containing 0.01 per cent or less of bromethalin.
BROMOFORM except when included in Schedule 4.
BROMOPHOS.
BROMOPHOS-ETHYL.
BROMOXYNIL.
BROMUCONAZOLE except when included in Schedule 5.
BROTIANIDE.
Poisons Standard November 2016
178
BUNAMIDINE.
BUTACARB.
BUTOXYCARBOXIM except when included in Schedule 5.
2-BUTOXYETHANOL and its ACETATES except in preparations containing 10 per cent or
less of such substances.
2-BUTOXY-2-THIOCYANODIETHYL ETHER.
n-BUTYL ALCOHOL except:
a) when included in Schedule 5;
b) in preparations containing 5 per cent or less of n-butyl alcohol; or
c) in preparations for cosmetic or therapeutic use other than in spray form.
BUTYRIC ACID in preparations for use as insect lures.
CACODYLIC ACID:
a) in animal feed premixes containing 4 per cent or less of arsenic; or
179
d) in preparations other than medicines for human therapeutic use, when packed in
containers having a nominal capacity of 25 mL or less fitted with a restricted flow
insert and a child-resistant closure and labelled with the warnings:
KEEP OUT OF REACH OF CHILDREN; and
NOT TO BE TAKEN;
e) in preparations containing 25 per cent or less of cajuput oil; or
f) in oils containing 25 per cent or less of cajuput oil.
CALCIFEROL in rodent baits containing 0.1 per cent or less of calciferol.
CAMBENDAZOLE.
CAMPHOR except:
a) when included in Schedule 4 or 5;
b) when enclosed in an inhaler device which prevents ingestion of its contents;
c) in solid or semi-solid preparations containing 12.5 per cent or less of camphor;
d) in liquid preparations containing 2.5 per cent or less of camphor;
e) in essential oils when the camphor is present as a natural component of the oil:
i)
ii) in medicines for human therapeutic use, when packed in containers having a
nominal capacity of 25 mL or less fitted with a restricted flow insert and a childresistant closure and compliant with the requirements of the Required Advisory
Statements for Medicine Labels;
iii) in essential oils other than medicines for human therapeutic use, when packed in
containers having a nominal capacity of 15 mL or less fitted with a restricted
flow insert and labelled with the warnings:
KEEP OUT OF REACH OF CHILDREN; and
NOT TO BE TAKEN; or
iv) in essential oils other than medicines for human therapeutic use, when packed in
containers having a nominal capacity of 25 mL or less fitted with a restricted
flow insert and a child-resistant closure and labelled with the warnings:
KEEP OUT OF REACH OF CHILDREN; and
NOT TO BE TAKEN; or
f) in rosemary oil, sage oil (Spanish), or lavandin oil as such.
CAPTAN.
CARBARYL except when included in Schedule 4 or 5.
CARBON DISULFIDE.
Poisons Standard November 2016
180
181
182
a) in medicines for human therapeutic use, when packed in containers having a nominal
capacity of 15 mL or less fitted with a restricted flow insert and compliant with the
requirements of the Required Advisory Statements for Medicine Labels;
b) in medicines for human therapeutic use, when packed in containers having a nominal
capacity of 25 mL or less fitted with a restricted flow insert and a child-resistant
closure and compliant with the requirements of the Required Advisory Statements for
Medicine Labels;
c) in preparations other than medicines for human therapeutic use, when packed in
containers having a nominal capacity of 15 mL or less fitted with a restricted flow
insert and labelled with the warnings:
KEEP OUT OF REACH OF CHILDREN; and
NOT TO BE TAKEN;
d) in preparations other than medicines for human therapeutic use, when packed in
containers having a nominal capacity of 25 mL or less fitted with a restricted flow
insert and a child-resistant closure and labelled with the warnings:
KEEP OUT OF REACH OF CHILDREN; and
NOT TO BE TAKEN; or
b) in medicines for human therapeutic use, when packed in containers having a nominal
capacity of 15 mL or less fitted with a restricted flow insert and compliant with the
requirements of the Required Advisory Statements for Medicine Labels;
c) in medicines for human therapeutic use, when packed in containers having a nominal
capacity of 25 mL or less fitted with a restricted flow insert and a child-resistant
Poisons Standard November 2016
183
closure and compliant with the requirements of the Required Advisory Statements for
Medicine Labels;
d) in preparations other than medicines for human therapeutic use, when packed in
containers having a nominal capacity of 15 mL or less fitted with a restricted flow
insert and labelled with the warnings:
KEEP OUT OF REACH OF CHILDREN; and
NOT TO BE TAKEN;
e) in preparations other than medicines for human therapeutic use, when packed in
containers having a nominal capacity of 25 mL or less fitted with a restricted flow
insert and a child-resistant closure and labelled with the warnings:
KEEP OUT OF REACH OF CHILDREN; and
NOT TO BE TAKEN; or
f) in preparations containing 25 per cent or less of clove oil.
N-COCO-1,3-DIAMINOPROPANE.
COCOYL GLYCINATE in cosmetic preparations except:
184
COPPER NITRATE in preparations containing copper chloride for the treatment of footrot in
sheep.
COPPER OXIDES except:
a) when included in Schedule 5;
b) in preparations for internal use;
c) in marine paints; or
d) in other preparations containing 5 per cent or less of copper oxides.
COPPER OXYCHLORIDE except:
a) when included in Schedule 5; or
b) in preparations containing 12.5 per cent of less of copper oxychloride.
COPPER SULFATE except:
a) when included in Schedule 5;
b) in preparations for internal use; or
c) in other preparations containing 5 per cent or less of copper sulfate.
COUMAPHOS:
a) in slow-release plastic matrix ear tags for livestock use containing 6 g or less of
coumaphos; or
b) in other preparations containing 5 per cent or less of coumaphos.
COUMATETRALYL in rodenticides containing 1 per cent or less of coumatetralyl except
when included in Schedule 5.
CREOSOTE derived from wood other than beechwood except:
a) when included in Schedule 2;
b) in preparations for human therapeutic use containing 10 per cent or less of creosote
derived from wood other than beechwood; or
c) in other preparations containing 3 per cent or less of phenols and homologues of
phenol boiling below 220C.
CROTOXYPHOS.
CRUFOMATE.
CYANAMIDE.
CYANAZINE.
CYCLANILIDE.
N-CYCLOHEXYLDIAZENIUMDIOXY-POTASSIUM.
CYFLUTHRIN except:
Poisons Standard November 2016
185
186
DICHLOFENTHION.
DICHLOFLUANID.
ortho-DICHLOROBENZENE.
DICHLOROETHYL ETHER.
DICHLOROISOCYANURIC ACID except:
a) when included in Schedule 5;
b) in liquid preparations containing not less than 2 per cent but not more than 4 per cent
of available chlorine when labelled with the statements:
WARNING Ensure adequate ventilation when using. Vapour may be
harmful. May give off dangerous gas if mixed with other products;
c) in liquid preparations containing less than 2 per cent of available chlorine; or
d) in other preparations containing 4 per cent or less of available chlorine.
4,5-DICHLORO-2-N-OCTYL-3(2H)-ISOTHIAZOLONE.
DICHLOROPHEN except:
a) when included in Schedule 4 or 5; or
b) in fabrics other than when:
i)
187
188
ii) in liquid preparations containing copper salicylate and 1 per cent or less of
methyl salicylate as the only other therapeutic substances; or
iii) in clay poultices containing 2 per cent or less of dimethyl sulfoxide.
DINITROCRESOLS and their homologues in preparations containing 5 per cent or less of such
compounds except:
a) when included in Schedule 4; or
b) when separately specified in this Schedule.
DINITROPHENOLS and their homologues in preparations containing 5 per cent or less of such
compounds except:
a) when included in Schedule 4; or
b) when separately specified in this Schedule.
DIOXACARB.
DIOXANE.
DIPHACINONE.
DIQUAT in preparations containing 20 per cent or less of diquat.
DISPERSE YELLOW 3 except when in Schedule 10.
DISULFIRAM except when included in Schedule 4.
DISULFOTON in granular preparations containing 5 per cent or less of disulfoton.
DITHIANON.
DITHIAZANINE in preparations containing 2 per cent or less of dithiazanine for the treatment
of animals.
DIUREDOSAN.
N-(N-DODECYL)-2-PYRROLIDONE except:
a) when included in Schedule 5; or
b) in preparations containing 25 per cent or less of designated solvents.
DODINE.
DORAMECTIN for external use for the treatment of animals, in preparations containing 2 per
cent or less of doramectin.
DSMA in herbicide or defoliant preparations containing 10 per cent or less of DSMA.
Poisons Standard November 2016
189
190
191
192
b) in preparations containing 0.5 per cent or less of glutaral when labelled with the
statements:
IRRITANT; and
Avoid contact with eyes.
193
194
b) in hair dye preparations containing 6 per cent (20 volume) or less of hydrogen
peroxide; or
c) in other preparations containing 3 per cent (10 volume) or less of hydrogen peroxide.
HYDROQUINONE except:
a) when included in Schedule 2 or 4; or
b) in preparations containing 10 per cent or less of hydroquinone.
HYDROSILICOFLUORIC ACID (excluding its salts and derivatives) in preparations
containing 1 per cent or less of hydrosilicofluoric acid (H2SiF6) except when included in
Schedule 5.
IMIDACLOPRID except:
a) when included in Schedule 5; or
b) in preparations containing 5 per cent or less of imidacloprid.
IMIDOCARB.
IMINOCTADINE TRIALBESILATE.
IMIPROTHRIN except:
a) when included in Schedule 5; or
b) in preparations containing 10 per cent or less of imiprothrin.
INDAZIFLAM.
INDOXACARB (includes the R and S enantiomers) except when included in Schedule 5.
IODINE (excluding its salts, derivatives and iodophors) except:
a) when included in Schedule 2; or
b) in solid or semi-solid preparations containing 2.5 per cent or less of available iodine.
IODOPHORS except in preparations containing 1.5 per cent or less of available iodine.
3-IODO-2-PROPYNYL BUTYL CARBAMATE (Iodocarb) except:
a) when included in Schedule 5;
b) in aqueous preparations not for cosmetic use containing 10 per cent or less of 3-iodo2-propynyl butyl carbamate (Iodocarb); or
c) in cosmetic preparations (other than aerosolised preparations) containing 0.1 per cent
or less of 3-iodo-2-propynyl butyl carbamate.
IOXYNIL.
IPCONAZOLE except when included in Schedule 5.
IRON COMPOUNDS (excluding up to 1 per cent of iron oxides when present as an excipient)
for the treatment of animals except:
Poisons Standard November 2016
195
196
197
d) in preparations other than medicines for human therapeutic use, when packed in
containers having a nominal capacity of 25 mL or less fitted with a restricted flow
insert and a child-resistant closure and labelled with the warnings;
KEEP OUT OF REACH OF CHILDREN; and
NOT TO BE TAKEN; or
e) in preparations containing 25 per cent or less of Leptospermum scoparium oil.
LEVAMISOLE for the treatment of animals except:
198
d) in preparations other than medicines for human therapeutic use, when packed in
containers having a nominal capacity of 25 mL or less fitted with a restricted flow
insert and a child-resistant closure and labelled with the warnings:
KEEP OUT OF REACH OF CHILDREN; and
NOT TO BE TAKEN; or
e) in preparations containing 25 per cent or less of melaleuca oil.
MELENGESTROL ACETATE when used as an animal feed additive.
MENAZON.
MERCAPTAMINE for cosmetic use except:
a) when included in Schedule 5; or
b) in preparations containing 1 per cent or less of mercaptamine.
MERCAPTOACETIC ACID and its salts, but excluding its derivatives, in cosmetic
preparations except:
a) when included in Schedule 5
b) in preparations containing 5 per cent or less of mercaptoacetic acid or its salts (as
mercapturic acid).
2-MERCAPTOETHANOL in preparations for use as insect lures.
MERCURIC OXIDE for the treatment of animals, in preparations for ocular use.
MERCUROCHROME for the treatment of animals, in preparations for topical use.
METACRESOLSULPHONIC ACID AND FORMALDEHYDE CONDENSATION
PRODUCT for the treatment of animals.
METALAXYL except when included in Schedule 5.
METALDEHYDE except when included in Schedule 5.
METHACRIFOS in preparations containing 60 per cent or less of methacrifos.
METHAM.
METHANOL (excluding its derivatives) except:
a) when included in Schedule 5; or
b) in preparations containing 2 per cent or less of methanol.
METHIOCARB in preparations containing 20 per cent or less of methiocarb except when
included in Schedule 5.
METHOMYL in fly-baits containing 1 per cent or less of methomyl and not less than 0.002 per
cent of denatonium benzoate as a bittering agent.
2-METHOXY-5-NITROPHENOL.
Poisons Standard November 2016
199
200
201
a) in preparations containing 2.5 per cent or less of moxidectin when packed in single
dose tubes for the treatment of cats and dogs; or
b) in preparations containing 2 per cent or less of moxidectin for the treatment of
animals,
except when included in Schedule 5.
MSMA in herbicide or defoliant preparations containing 10 per cent or less of MSMA.
NALED except when included in Schedule 5.
NAPHTHALENE (excluding its derivatives) except in liquid hydrocarbons as an impurity.
1,5-NAPHTHALENEDIOL except:
a) in non-oxidative hair dye preparations containing 1 per cent or less of 1,5naphthalenediol when the immediate container and primary pack are labelled with the
following statements:
KEEP OUT OF REACH OF CHILDREN, and
WARNING - This product contains ingredients which may cause skin sensitisation to
certain individuals. A preliminary test according to the accompanying directions should
be made before use. This product must not be used for dyeing eyelashes or eyebrows; to
do so may be injurious to the eye, and
Written in letters not less than 1.5 mm in height; or
b) in oxidative hair dye preparations containing 1 per cent or less of 1,5-naphthalenediol
after mixing under oxidative conditions when the immediate container and primary pack
are labelled with the following statements:
KEEP OUT OF REACH OF CHILDREN, and
WARNING - This product contains ingredients which may cause skin sensitisation to
certain individuals. A preliminary test according to the accompanying directions should
be made before use. This product must not be used for dyeing eyelashes or eyebrows; to
do so may be injurious to the eye, and
Written in letters not less than 1.5 mm in height.
2,7-NAPHTHALENEDIOL except:
a) in non-oxidative hair dye preparations containing 1 per cent or less of 2,7naphthalenediol when the immediate container and primary pack are labelled with
the following statements:
KEEP OUT OF REACH OF CHILDREN, and
WARNING This product contains ingredients which may cause skin sensitisation
to certain individuals. A preliminary test according to the accompanying directions
should be made before use. This product must not be used for dyeing eyelashes or
eyebrows; to do so may be injurious to the eye, and
Written in letters not less than 1.5 mm in height; or
Poisons Standard November 2016
202
b) in oxidative hair dye preparations containing 1 per cent or less of 2,7naphthalenediol after mixing under oxidative conditions when the immediate
container and primary pack are labelled with the following statements:
KEEP OUT OF REACH OF CHILDREN, and
WARNING This product contains ingredients which may cause skin sensitisation
to certain individuals. A preliminary test according to the accompanying directions
should be made before use. This product must not be used for dyeing eyelashes or
eyebrows; to do so may be injurious to the eye, and
Written in letters not less than 1.5 mm in height.
1-NAPHTHOL except in hair dye preparations containing 1 per cent or less of 1-naphthol after
mixing under oxidative conditions when the immediate container and primary pack are
labelled with the following statements:
KEEP OUT OF REACH OF CHILDREN, and
WARNING - This product contains ingredients which may cause skin sensitisation to
certain individuals. A preliminary test according to the accompanying directions should be
made before use. This product must not be used for dyeing eyelashes or eyebrows; to do so
may be injurious to the eye, and
Written in letters not less than 1.5 mm in height.
NAPHTHALOPHOS in preparations containing 80 per cent or less of naphthalophos.
NARASIN in animal feed premixes containing 12 per cent or less of narasin.
NETOBIMIN for the treatment of animals except when included in Schedule 5.
NICKEL SULFATE.
NICOTINE in preparations containing 3 per cent or less of nicotine when labelled and packed
for the treatment of animals.
NIMIDANE in preparations containing 25 per cent or less of nimidane.
NITENPYRAM except in divided preparations containing 100 mg or less of nitenpyram.
NITRIC ACID (excluding its salts and derivatives) except:
a) when included in Schedule 5; or
b) in preparations containing 0.5 per cent or less of nitric acid (HNO3).
NITROBENZENE except:
203
204
d) in nail hardener cosmetic preparations containing 0.2 per cent or less of free
formaldehyde when labelled with the statement:
PROTECT CUTICLES WITH GREASE OR OIL;
e) in all other cosmetic preparations; or
f) in other preparations containing 0.2 per cent or less of free formaldehyde when
labelled with the warning statement:
CONTAINS FORMALDEHYDE.
PARATHION-METHYL in aqueous preparations containing 45 per cent or less of
microencapsulated parathion-methyl.
PARBENDAZOLE.
PEBULATE.
PENNYROYAL OIL except:
a) in medicines for human therapeutic use, when packed in containers having a nominal
capacity of 15 mL or less fitted with a restricted flow insert and a child-resistant
closure and compliant with the requirements of the Required Advisory Statements for
Medicine Labels;
b) in preparations other than medicines for human therapeutic use, when packed in
containers having a nominal capacity of 15 mL or less fitted with a restricted flow
insert and a child-resistant closure and labelled with the warnings:
KEEP OUT OF REACH OF CHILDREN; and
NOT TO BE TAKEN; or
c) in preparations containing 4 per cent or less of d-pulegone.
PENTACHLOROPHENOL in preparations containing 1.5 per cent or less of
pentachlorophenol.
PERACETIC ACID except when included in Schedule 5.
PERFLUIDONE.
PERMANGANATES except potassium permanganate in aqueous solutions containing 1 per
cent or less of potassium permanganate.
PERMETHRIN except:
a) when included in Schedule 4 or 5;
b) in preparations for human therapeutic use containing 5 per cent or less of permethrin;
or
c) in preparations containing 2 per cent or less of permethrin.
2-PHENOXYETHANOL except:
a) in cosmetic preparations containing 1 per cent or less of 2-phenoxyethanol; or
Poisons Standard November 2016
205
206
PHOXIM.
ortho-PHTHALALDEHYDE except when included in Schedule 5.
PINDONE.
PINE OILs when packed and labelled as a herbicide except when included in Schedule 5.
PINOXADEN except when included in Schedule 5.
PIPEROPHOS.
PIRIMICARB except when included in Schedule 5.
PIRIMIPHOS-ETHYL.
PIRIMIPHOS-METHYL.
POLIHEXANIDE except:
a) in preparations containing 5 per cent or less of polihexanide; or
b) when packed and labelled for therapeutic use.
POLIXETONIUM SALTS except:
a) when included in Schedule 5; or
b) in preparations containing 1 per cent or less of polixetonium salts.
POTASSIUM AZELOYL DIGLYCINATE except in preparations for cosmetic use containing
1 per cent or less of potassium azeloyl diglycinate.
POTASSIUM BROMATE except in preparations containing 0.5 per cent or less of potassium
bromate.
POTASSIUM CYANATE.
POTASSIUM HYDROXIDE (excluding its salts and derivatives) except:
a) when included in Schedule 5 or Schedule 10;
b) in preparations containing 5 per cent or less of potassium hydroxide being:
i)
207
208
PROSULFURON.
PROTHIOFOS.
d-PULEGONE except in preparations containing 4 per cent or less of d- pulegone.
PYRACLOFOS.
PYRAZOPHOS.
PYRIDABEN except when included in Schedule 5.
PYRIDALYL.
PYRIDATE.
PYRIPROLE.
PYRITHIONE COPPER.
PYRITHIONE ZINC except:
a) when included in Schedule 2 or 5;
b) for human use in preparations for the treatment of the scalp containing 2 per cent or
less of pyrithione zinc when compliant with the requirements of the Required
Advisory Statements for Medicine Labels;
c) in semi-solid hair preparations for animal use;
d) in shampoos for animal use containing 2 per cent or less of pyrithione zinc when
labelled with the statements Keep out of eyes and If in eyes rinse well with
water;
e) when immobilised in solid preparations containing 0.5 per cent or less of pyrithione
zinc; or
f) in paints, jointing materials or sealants containing 0.1 per cent or less of pyrithione
zinc calculated on the non-volatile content.
PYRIOFENONE except when included in Schedule 5.
PYROXASULFONE.
PYROXSULAM.
QUATERNARY AMMONIUM COMPOUNDS except:
a) when separately specified in these Schedules;
b) when included in Schedule 5;
209
b) in coated granules containing 1 per cent or less of selenium for application to pasture
except in fertilisers containing 200 g/tonne or less of selenium; or
c) for the treatment of animals:
i)
210
ii) in animal feed premixes containing 2 per cent or less of selenium for the
preparation of feeds containing 1 g/tonne or less of selenium;
iii) in controlled release bolus preparations containing 25 mg or less of selenium with
a release rate not greater than 0.25 mg/day; or
iv) as barium selenate in preparations for injection containing 5 per cent or less of
selenium.
SEMDURAMICIN in animal feed premixes for coccidiosis prevention containing 5 per cent or
less of antibiotic substances.
SILICOFLUORIDES except:
a) when included in Schedule 5; or
b) in preparations containing 15 mg/kg or less of fluoride ion.
SILVER NITRATE except:
a) when included in or expressly excluded from Schedule 2; or
b) in preparations containing 1 per cent or less of silver.
SINBIOALLETHRIN except:
a) when included in Schedule 5; or
b) in preparations containing 1 per cent or less of sinbioallethrin.
SODIUM ALUMINATE (excluding its salts and derivatives) except:
a) in solid preparations, the pH of which in a 10 g/L aqueous solution is 11.5 or less; or
b) in liquid preparations, the pH of which is 11.5 or less.
SODIUM BROMATE except in preparations containing 0.5 per cent or less of sodium bromate.
SODIUM HYDROXIDE (excluding its salts and derivatives) except:
a) when included in Schedule 5 or Schedule 10;
b) in preparations containing 5 per cent or less of sodium hydroxide being:
i)
211
a) in fire extinguishers; or
b) in preparations containing 0.5 per cent or less of sulfuric acid (H2SO4).
SULFURYL FLUORIDE.
SULPROFOS.
2,4,5-T.
N-TALLOW ALKYL-1,3-PROPANEDIAMINE DIACETATE and TALLOW
ALKYLAMINE ACETATES.
TAR ACIDS distilling within the range 230-290C inclusive.
TCMTB (2-[thiocyanomethylthio]benzothiazole).
TDE (1,1-dichloro-2,2-bis[4-chlorophenyl]ethane) except when included in Schedule 5.
TEBUFENPYRAD.
TEBUTHIURON.
TEMEPHOS except when in Schedule 5.
TERBUTHYLAZINE except in preparations containing 5 per cent or less of terbuthylazine.
TERPENES, CHLORINATED.
TESTOSTERONE in implant preparations for use in animals.
TETRACHLOROETHYLENE except:
Poisons Standard November 2016
212
213
b) in eyelash and eyebrow tinting products when the immediate container and primary
pack are labelled with the following statement:
WARNING This product contains ingredients which may cause skin irritation
to certain individuals, and when used for eyelash and eyebrow tinting may
cause injury to the eye. A preliminary test according to the accompanying
directions should be made before use.
written in letters not less than 1.5 mm in height.
c) in nail polish preparations containing 2,5-toluenediamine except when labelled
avoid contact with skin
TOLYLFLUANID.
TRANSFLUTHRIN except:
a) in preparations containing 1 per cent or less of transfluthrin; or
b) in a cartridge for vaporiser use containing 600 mg or less of transfluthrin per
cartridge.
TRIADIMEFON except:
214
(b)
215
SCHEDULE 7
ABAMECTIN except when included in Schedule 5 or 6.
ACIBENZOLAR-S-METHYL.
ACRIFLAVINIUM CHLORIDE for veterinary use except when in Schedule 5.
ACROLEIN.
ACRYLONITRILE.
ALACHLOR.
ALDICARB.
ALDOXYCARB.
ALLYL ALCOHOL.
ALPHA-CYPERMETHRIN except when included in Schedule 5 or 6.
AMINOACRIDINE for veterinary use except when included in Schedule 5.
AMINOCARB except when included in Schedule 6.
4-AMINOPROPIOPHENONE.
4-AMINOPYRIDINE except when included in Schedule 4.
AMITON.
ARPRINOCID.
ARSENIC except:
a) when separately specified in this Schedule;
b) when included in Schedule 4 or 6;
c) as selenium arsenide in photocopier drums;
d) as 10,10-oxydiphenoxarsine in silicone rubber mastic containing 120 mg/kg or less
of arsenic;
e) as 10,10-oxydiphenoxarsine contained in polyvinyl chloride and polyurethane
extruded and moulded articles containing 160 mg/kg or less of arsenic other than
when included in articles:
i)
216
g) in paints containing 0.1 per cent or less of arsenic calculated on the non-volatile
content of the paint.
AZAFENIDIN.
AZINPHOS-ETHYL.
AZINPHOS-METHYL.
AZOCYCLOTIN.
AZO DYES that are derivatives by diazotisation of any of the following substances:
p-aminoazobenzene (CAS No. 60-09-3)
o-aminoazotoluene (CAS No. 97-56-3)
o-anisidine (CAS No. 90-04-0)
p-chloroaniline (CAS No. 106-47-8)
4-chloro-o-toluidine (CAS No. 95-69-2)
6-methoxy-m-toluidine (p-cresidine) (CAS No. 120-71-8)
2-naphthylamine (CAS No. 91-59-8)
5-nitro-o-toluidine (CAS No. 99-55-8)
2,4-toluenediamine (CAS No. 95-80-7)
o-toluidine (CAS No. 95-53-4)
2,4,5-trimethylaniline (CAS No. 137-17-7)
BENDIOCARB except when included in Schedule 5 or 6.
BENOMYL except in paints containing 0.5 per cent or less of benomyl.
BENZENE (excluding its derivatives) except:
a) preparations containing 15 mL/L or less of benzene; or
b) petrol containing 50 mL/L or less of benzene.
BENZIDINE-BASED AZO DYES being:
2,2'-[[1,1'-biphenyl]-4,4'-diylbis(azo)]bis[N-(4-chlorophenyl)-3-oxobutanamide]
(CAS No. 94249-03-3)
Acid Red 85 (Acid Fast Red A)
1,3-Naphthalenedisulfonic acid, 7-hydroxy-8-[[4'-[[4-[[(4methylphenyl)sulfonyl]oxy]phenyl]azo][1,1'-biphenyl]-4-yl]azo]-, disodium salt
(CAS No. 3567-65-5)
Poisons Standard November 2016
217
218
(b)
BIFLUORIDES (including ammonium, potassium and sodium salts) except when included in
Schedule 5 or 6.
BORON TRIFLUORIDE except when included in Schedule 5 or 6.
BRODIFACOUM except when included in Schedule 6.
BROMADIOLONE except when included in Schedule 6.
BROMETHALIN except when included in Schedule 6.
BROMINE (excluding its salts and derivatives).
BRUCINE except in alcohol containing 0.02 per cent or less of brucine as a denaturant.
CACODYLIC ACID except:
a) when included in Schedule 6; or
b) in animal feeds containing 75 g/tonne or less of arsenic.
CADUSAFOS except when included in Schedule 6.
CALCIFEROL for use as a rodenticide except when included in Schedule 6.
CAPTAFOL.
CARBADOX.
CARBENDAZIM except in paints, jointing compounds and sealants containing 0.1 per cent or
less of carbendazim.
CARBOFURAN.
CARBON TETRACHLORIDE except in chlorinated rubber based paint containing 1 per cent
or less of carbon tetrachloride.
CARBONYL SULFIDE when packed and labelled for use as a fumigant.
CARBOPHENOTHION.
CARBOSULFAN.
Poisons Standard November 2016
219
CHLORDECONE.
CHLORDIMEFORM.
CHLORFENAPYR except when included in Schedule 5 or 6.
CHLORFENVINPHOS.
CHLORINE (excluding its salts and derivatives).
CHLORHEXIDINE except:
a) when included in Schedule 5 or 6;
b) in preparations containing 1 per cent or less of chlorhexidine; or
c) in solid preparations.
CHLOROMETHIURON.
5-CHLORO-3-METHYL-4-NITROPYRAZOLE.
4-CHLORO-o-TOLUIDINE.
CHLOROPICRIN except when included in Schedule 6.
CHLORTHIOPHOS.
COLECALCIFEROL for use as a rodenticide.
COUMAPHOS except when included in Schedule 6.
COUMATETRALYL except when included in Schedule 5 or 6.
CREOSOTE derived from coal.
CREOSOTE derived from beechwood.
CYANIDES, metallic except:
a) ferricyanides;
b) ferrocyanides; or
c) when separately specified in these Schedules.
CYANOGEN.
CYHALOTHRIN (aRS,1R,cis,Z):(aRS,1S,cis,Z) = 50:50.
CYHEXATIN.
DELTAMETHRIN except:
a) when included in Schedule 5 or 6; or
b) in factory prepared mosquito nets containing 1 per cent or less of deltamethrin; or
c) in preparations containing 0.1 per cent or less of deltamethrin.
Poisons Standard November 2016
220
DEMETON.
DEMETON-O-METHYL.
DEMETON-S-METHYL.
DIALIFOS.
4,4-DIAMINODIPHENYLMETHANE (Methylene dianiline).
1,2-DIBROMO-3-CHLOROPROPANE.
1,3-DICHLOROPROPENE except in biocidal preparations containing 0.3 per cent or less of
1,3-dichloropropene.
DICHLORVOS except when included in Schedule 5 or 6.
DICROTOPHOS.
DIFENACOUM except when included in Schedule 6.
DIFETHIALONE except when included in Schedule 6.
DIMEFOX.
4-DIMETHYLAMINOAZOBENZENE (N,N-dimethyl-4-[phenylazo]-benzenamine).
DIMETHYL SULFATE.
DIMETILAN.
DINITROCRESOLS except when included in Schedule 4 or 6.
DINITROPHENOLS except when included in Schedule 4 or 6.
DINOCAP.
DINOSEB.
DIQUAT except when included in Schedule 6.
DISULFOTON except when included in Schedule 6.
DORAMECTIN except when included in Schedule 5 or 6.
DSMA except when included in Schedule 6.
EMAMECTIN except when included in Schedule 5 or 6.
ENDOSULFAN except when included in Schedule 6.
ENDOTHAL except when included in Schedule 6.
ENDRIN.
EPICHLOROHYDRIN.
Poisons Standard November 2016
221
222
223
MECARBAM.
2-METHOXYETHANOL and its acetates except in preparations containing 0.5 per cent or les
of 2-methoxyethanol.
MERCURIC CHLORIDE when prepared for use for agricultural, industrial, pastoral or
horticultural purposes.
MERCURY except:
a) when separately specified in this Schedule;
b) when included in Schedule 2, 4 or 6;
c) in preparations containing 0.01 per cent or less of mercury in organic form as a
preservative;
d) mercury (metallic) in scientific instruments;
e) dental amalgams; or
f) in a sealed device, for therapeutic use, which prevents access to the mercury.
METHACRIFOS except when included in Schedule 6.
METHAMIDOPHOS.
METHAPYRILENE.
METHAZOLE.
METHIDATHION.
METHIOCARB except when included in Schedule 5 or 6.
METHOMYL except when included in Schedule 6.
METHOXYETHYLMERCURIC ACETATE.
METHOXYETHYLMERCURIC CHLORIDE.
METHYL BROMIDE.
METHYLCYCLOPENTADIENYL MANGANESE TRICARBONYL except:
a) when included in Schedule 6;
b) when used in laboratory analysis; or
c) when packed for industrial use in containers with a nominal capacity of 100 L or
more.
4,4-METHYLENEBIS[2-CHLOROANILINE] (MOCA).
METHYLENE BLUE for veterinary use except when included in Schedules 4 or 5.
MEVINPHOS.
MIPAFOX.
Poisons Standard November 2016
224
MIREX.
MOLINATE.
MONOCROTOPHOS.
MOXIDECTIN except when included in Schedule 4, 5 or 6.
MSMA except when included in Schedule 6.
NAPHTHALOPHOS except when included in Schedule 6.
NICOTINE except:
a) when included in Schedule 6;
b) in preparations for human therapeutic use; or
c) in tobacco prepared and packed for smoking.
NIMIDANE except when included in Schedule 6.
NITROFEN.
NITROPRUSSIDES except when included in Schedule 4 or 6.
2-NITROTOLUENE.
OMETHOATE except when included in Schedule 5 or 6.
OXAMYL.
OXYDEMETON METHYL.
PARAQUAT.
PARATHION.
PARATHION-METHYL except when included in Schedule 6.
PENTACHLOROPHENOL except when included in Schedule 6.
PHENYLMERCURIC ACETATE except in preparations containing 0.01 per cent or less of
mercury as a preservative.
PHORATE.
PHOSFOLAN.
PHOSPHIDES, METALLIC.
PHOSPHINE.
PHOSPHORUS, YELLOW (excluding its salts and derivatives).
POTASSIUM NITRITE except:
Poisons Standard November 2016
225
226
SULFOTEP.
TEFLUTHRIN except when included in Schedule 5.
TEPP.
TERBUFOS.
TETRACHLOROETHANE.
2,2,6,6-TETRAISOPROPYL-DIPHENYL-CARBODIIMIDE except when included in
Schedule 6.
THALLIUM.
THIOFANOX.
TIN ORGANIC COMPOUNDS, being dialkyl, trialkyl and triphenyl tin compounds where the
alkyl group is methyl, ethyl, propyl or butyl except:
a) when separately specified in this Schedule;
b) in plastics;
c) in semi-solid sealants, adhesives or elastomers containing 1 per cent or less of the
dialkyl, trialkyl or triphenyl tin component; or
d) in paint containing 1 per cent or less of such compounds calculated as tin in the nonvolatile content of the paint.
ortho-TOLIDINE except in solid-state diagnostic therapeutic reagents.
TRIAMIPHOS.
TRIAZBUTIL.
TRIBUFOS (S,S,S-tributylphosphorotrithioate).
VINCLOZOLIN.
VINYL CHLORIDE.
ZETA-CYPERMETHRIN except when included in Schedule 6.
ZIRAM except when included in Schedule 6.
227
SCHEDULE 8
ACETYLDIHYDROCODEINE.
ACETYLMETHADOL.
ACETYLMORPHINES.
ALFENTANIL.
ALPHACETYLMETHADOL.
ALPHAPRODINE.
# ALPRAZOLAM.
AMFETAMINE.
AMOBARBITAL except when included in Schedule 4.
ANILERIDINE.
BENZYLMORPHINE.
BEZITRAMIDE.
BUPRENORPHINE.
BUTOBARBITONE.
BUTORPHANOL.
# CANNABIS (including seeds, extracts, resins and the plant, and any part of the plant) when
prepared or packed for human therapeutic use, when:
a) cultivated or produced, or in products manufactured1, in accordance with the Narcotic
Drugs Act 1967; and/or
b) for use in products manufactured in accordance with the Narcotic Drugs Act 1967;
and/or
c) imported as therapeutic goods, or for use in therapeutic goods, for supply, in
accordance with the Therapeutic Goods Act 1989; and/or
d) in therapeutic goods supplied in accordance with the Therapeutic Goods Act 1989,
except when:
i)
Cultivation, production and manufacture have the same meaning as in the Narcotic
Drugs Act 1967
Poisons Standard November 2016
228
229
KETAMINE.
LEVAMFETAMINE.
LEVOMETHAMFETAMINE.
LEVOMORAMIDE.
LEVORPHANOL (excluding its stereoisomers).
LISDEXAMFETAMINE.
METHADONE.
METHYLAMFETAMINE.
METHYLDIHYDROMORPHINE.
METHYLPHENIDATE.
1-METHYL-4-PHENYLPIPERIDINE-4-CARBOXYLIC ACID (Pethidine intermediate C).
MORPHINE.
MORPHINE METHOBROMIDE.
MORPHINE-N-OXIDE.
NABILONE.
# NABIXIMOLS (botanical extract of Cannabis sativa which includes the following
cannabinoids: tetrahydrocannabinols, cannabidiol, cannabinol, cannabigerol,
cannabichromene, cannabidiolic acid, tetrahydrocannabinolic acids,
tetrahydrocannabivarol, and cannabidivarol, where tetrahydrocannabinols and cannabidiol
(in approximately equal proportions) comprise not less than 90 per cent of the total
cannabinoid content) in a buccal spray for human therapeutic use.
NORCODEINE.
NORMETHADONE.
OPIUM except the alkaloids noscapine in Schedule 2 and papaverine when included in
Schedule 2 or 4.
OXYCODONE.
OXYMORPHONE.
PENTAZOCINE.
PENTOBARBITAL except when included in Schedule 4.
PETHIDINE.
PHENDIMETRAZINE.
Poisons Standard November 2016
230
PHENMETRAZINE.
PHENOPERIDINE.
4-PHENYLPIPERIDINE-4-CARBOXYLIC ACID ETHYL ESTER (Pethidine intermediate B).
PHOLCODINE except when included in Schedule 2 or 4.
PIRITRAMIDE.
PROPIRAM.
QUINALBARBITONE.
RACEMORAMIDE.
REMIFENTANIL.
SECBUTOBARBITONE.
# SODIUM OXYBATE for human therapeutic use.
SUFENTANIL.
TAPENTADOL.
# TETRAHYDROCANNABINOLS when extracted from cannabis for human therapeutic use,
when:
a) included in products manufactured in accordance with the Narcotic Drugs Act 1967;
and/or
b)
c) in therapeutic goods supplied in accordance with the Therapeutic Goods Act 1989,
except when:
i)
(B)
Not to be taken; or
iii) in products for purposes other than for internal human use containing
50 mg/kg or less of tetrahydrocannabinols; or
iv) separately specified in the NABIXIMOLS entry in this Schedule.
THEBACON.
THEBAINE.
TILIDINE.
Poisons Standard November 2016
231
SCHEDULE 9
ACETORPHINE.
ACETYL-ALPHA-METHYLFENTANYL.
ALKOXYAMFETAMINES and substituted alkoxyamfetamines except when separately
specified in these Schedules.
ALKOXYPHENYLETHYLAMINES and substituted alkoxyphenylethylamines except when
separately specified in these Schedules.
ALKYLTHIOAMFETAMINES and substituted alkylthioamfetamines except when separately
specified in these Schedules.
ALLYLPRODINE.
ALPHAMEPRODINE.
ALPHA-METHYLFENTANYL.
ALPHA-METHYLTHIOFENTANYL.
ALPHAMETHADOL.
2-AMINO-1-(2,5-DIMETHOXY-4-METHYL)PHENYLPROPANE *(STP or DOM).
5-(2-AMINOPROPYL)INDAN and substituted 5-(2-aminopropyl)indans except when
separately specified in these Schedules.
BENZETHIDINE.
BENZOYLINDOLES except when separately specified in these Schedules.
BENZYLPIPERAZINE *(BZP).
BETACETYLMETHADOL.
BETA-HYDROXYFENTANYL.
BETA-HYDROXY-3-METHYLFENTANYL.
BETAMEPRODINE.
BETAMETHADOL.
BETAPRODINE.
1-(8-BROMOBENZO[1,2-B;4,5-B]DIFURAN-4-YL)-2-AMINOPROPANE *(BromoDragonfly).
4-BROMO-2,5-DIMETHOXYPHENETHYLAMINE *(BDMPEA).
BUFOTENINE.
Poisons Standard November 2016
232
CANNABIS (including seeds, extracts, resins, and the plant and any part of the plant when
packed or prepared), except:
a) when separately specified in these Schedules; or
b) processed hemp fibre containing 0.1 per cent or less of tetrahydrocannabinols and
hemp fibre products manufactured from such fibre; or
c) in hemp seed oil for purposes other than internal human use containing 50 mg/kg or
less of cannabinols.
CATHINONE.
CLONAZOLAM.
CLONITAZENE.
COCA LEAF.
CODOXIME.
4-CYANO-2-DIMETHYLAMINO-4,4-DIPHENYLBUTANE.
CYCLOHEXYLPHENOLS except
a) when separately specified in these Schedules; or
b) in preparations containing 0.5 per cent or less of cyclohexylphenols.
DESCHLOROETIZOLAM.
DESOMORPHINE.
DIAMPROMIDE.
DIBENZOPYRANS except when separately specified in these Schedules.
DICYCLAZEPAM.
3,4-DICHLORO-N-{[1- (DIMETHYLAMINO)CYCLOHEXYL]METHYL}BENZAMIDE
*(AH-7921).
DIETHYLTHIAMBUTENE.
N,N-DIETHYLTRYPTAMINE *(DET).
DIMENOXADOL.
DIMEPHEPTANOL.
2,5-DIMETHOXYAMFETAMINE *(DMA).
2,5-DIMETHOXY-4-BROMOAMFETAMINE *(DOB).
2,5-DIMETHOXY-4-ETHYL-a-AMFETAMINE *(DOET).
Poisons Standard November 2016
233
2,5-DIMETHOXY-4-ETHYLTHIOPHENETHYLAMINE *(2C-T-2).
2,5-DIMETHOXY-4-IODOPHENETHYLAMINE *(2C-I).
2,5-DIMETHOXY-4-(N)-PROPYLTHIOPHENETHYLAMINE *(2C-T-7).
3-(2-DIMETHYLAMINOETHYL)-4-HYDROXYINDOLE *(PSILOCINE or PSILOTSIN).
3-(1,2-DIMETHYLHEPTYL)-1-HYDROXY-7,8,9,10-TETRAHYDRO-6,6,9- TRIMETHYL6H-DIBENZO (b,d) PYRAN *(DMHP).
N, -DIMETHYL-3,4-(METHYLENEDIOXY)PHENYLETHYLAMINE *(MDMA).
N,N-DIMETHYLAMFETAMINE (Dimetamfetamine).
DIMETHYLTHIAMBUTENE.
N,N-DIMETHYLTRYPTAMINE *(DMT).
DIOXAPHETYL BUTYRATE.
ECGONINE.
N-ETHYL--METHYL-3,4-(METHYLENEDIOXY)PHENETHYLAMINE *(N-ETHYL
MDA).
ETHYLMETHYLTHIAMBUTENE.
ETICYCLIDINE *(PCE).
ETONITAZENE.
ETORPHINE.
ETOXERIDINE.
FENETYLLINE.
4-FLUORO-N-METHYLAMFETAMINE.
FLUBROMAZEPAM.
FLUBROMAZOLAM.
1-(5-FLUOROPENTYL)-3-(2-IODOBENZOYL)INDOLE *(AM-694).
FURETHIDINE.
HARMALA ALKALOIDS except in herbs, or preparations, for therapeutic use:
a) containing 0.1 per cent or less of harmala alkaloids; or
b) in divided preparations containing 2 mg or less of harmala alkaloids per
recommended daily dose.
Poisons Standard November 2016
234
HEROIN.
3-HEXYL-1-HYDROXY-7,8,9,10-TETRAHYDRO-6,6,9-TRIMETHYL-6H-DIBENZO (b,d)
PYRAN *(PARAHEXYL).
4-HYDROXYBUTANOIC ACID and its salts except for sodium oxybate when in Schedule 8.
*(GAMMA HYDROXYBUTYRATE (GHB)).
2-[(1R,3S)-3-HYDROXYCYCLOHEXYL]-5-(2-METHYLNONAN-2-YL)PHENOL
*(Cannabicyclohexanol or CP 47,497 C8 homologue).
2-[(1R,3S)-3-HYDROXYCYCLOHEXYL]-5-(2-METHYLOCTAN-2-YL)PHENOL *(CP
47,497).
HYDROXYPETHIDINE.
ISOMETHADONE.
KETOBEMIDONE.
LEVOMETHORPHAN (excluding its stereoisomers).
LEVOPHENACYLMORPHAN.
LYSERGIC ACID.
LYSERGIDE.
MECLONAZEPAM.
MECLOQUALONE.
METAZOCINE.
METHAQUALONE.
METHCATHINONE.
5-METHOXY- METHYLTRYPTAMINE *(5-MeO-AMT).
5-METHOXY-3,4-METHYLENEDIOXYAMFETAMINE *(MMDA).
4-METHOXY- METHYLPHENYLETHYLAMINE *(PMA).
2-(2-METHOXYPHENYL)-1-(1-PENTYLINDOL-3-YL)ETHANONE *(JWH-250).
METHYL (2S, 4aR, 6aR, 7R, 9S, 10aS, 10bR)-9-ACETOXY-6a,10b-DIMETHYL-4,10DIOXO-DODECAHYDRO-2-(3-FURYL)-2H-NAPHTHO[2,1-c]PYRAN-7-CARBOXYLATE
*(SALVINORIN A).
4-METHYLAMINOREX.
METHYLDESORPHINE.
3,4-METHYLENEDIOXYAMFETAMINE *(MDA).
Poisons Standard November 2016
235
3,4-METHYLENEDIOXYPYROVALERONE *(MDPV).
3-METHYLFENTANYL.
4-METHYLMETHCATHINONE *(MEPHEDRONE).
N- -[METHYL-3,4-(METHYLENEDIOXY)PHENETHYL]HYDROXYLAMINE *(NHYDROXY MDA).
N-METHYL-1-(3,4-METHYLENEDIOXYPHENYL)-2-BUTANAMINE *(MBDB).
2-METHYL-3-MORPHOLINO-1, 1-DIPHENYLPROPANE CARBOXYLIC ACID
(Moramide intermediate).
1-METHYL-4-PHENYL-4-PIPERIDINOL PROPIONATE *(MPPP).
4-METHYLTHIOAMFETAMINE.
3-METHYLTHIOFENTANYL.
METOPON.
MITRAGYNA SPECIOSA.
MITRAGYNINE.
MORPHERIDINE.
(1-(2-MORPHOLIN-4-YLETHYL)INDOL-3-YL)-NAPTHALEN-1-YLMETHANONE
*(JWH-200).
MUSCIMOL.
MYROPHINE.
NAPHTHOYLINDOLES except when separately specified in these Schedules.
NAPHTHYLMETHYLINDOLES except when separately specified in these Schedules.
NAPHTHOYLPYRROLES except when separately specified in these Schedules.
NAPHTHYLMETHYLINDENES except when separately specified in these Schedules.
NAPHTHALEN-1-YL-(1-BUTYLINDOL-3-YL)METHANONE *(JWH-073).
NICOCODINE.
NICODICODINE.
NICOMORPHINE.
NIFOXIPAM.
NORACYMETHADOL.
Poisons Standard November 2016
236
NORLEVORPHANOL.
NORMORPHINE.
NORPIPANONE.
PARA-FLUOROFENTANYL.
1-PENTYL-3-(4-METHYL-1-NAPTHOYL)INDOLE. *(JWH-122).
1-PENTYL-3-(1-NAPHTHOYL)INDOLE *(JWH-018).
PHENADOXONE.
PHENAMPROMIDE.
PHENAZOCINE.
PHENCYCLIDINE *(PCP).
N-PHENETHYL-4-PIPERIDONE.
PHENOMORPHAN.
PHENYLACETYLINDOLES except when separately specified in these Schedules.
1-PHENYLETHYL-4-PHENYL-4-PIPERIDINOL ACETATE *(PEPAP).
PIMINODINE.
PROHEPTAZINE.
PROPERIDINE.
PSILOCYBINE.
PYRAZOLAM.
RACEMETHORPHAN.
RACEMORPHAN.
ROLICYCLIDINE *(PHP or PCPY).
SALVIA DIVINORUM.
SYNTHETIC CANNABINOMIMETICS except when separately specified in these Schedules.
TENOCYCLIDINE *(TCP).
TETRAHYDROCANNABINOLS and their alkyl homologues, except:
a) when included in Schedule 4 or Schedule 8; or
b) processed hemp fibre containing 0.1 per cent or less of tetrahydrocannabinols, and
hemp fibre products manufactured from such fibre; or
Poisons Standard November 2016
237
238
SCHEDULE 10
SUBSTANCES OF SUCH DANGER TO HEALTH AS TO WARRANT PROHIBITION OF
SALE, SUPPLY AND USE
ABRUS PRECATORIUS (Jequirity) seed or root for therapeutic use.
ACORUS CALAMUS (calamus) for human therapeutic use.
ALKALINE SALTS, being the carbonate, silicate or phosphate salts of sodium or potassium
alone or in any combination for domestic use:
a) in liquid or semi-solid food additive preparations, the pH of which is more than 11.5;
b) in solid automatic dishwashing preparations, the pH of which in a 500 g/L aqueous
solution or mixture is more than 12.5; or
c) in liquid or semi-solid automatic dishwashing preparations, the pH of which is more
than 12.5.
ALLYLISOPROPYLACETYLUREA for therapeutic use.
AMINOPHENAZONE (amidopyrine) and its derivatives for human therapeutic use.
AMYGDALIN for therapeutic use.
ANCHUSA OFFICINALIS for therapeutic use.
ARISTOLOCHIA spp. for therapeutic use.
ARISTOLOCHIC ACID(S) for human therapeutic use.
ASARUM spp. containing aristolochic acid(s) for human therapeutic use.
AZADIRACHTA INDICA (neem) including its extracts and derivatives, in preparations for
human internal use except debitterised neem seed oil
BASIC ORANGE 31 (2-[(4-aminophenyl)azo]-1,3-dimethyl-1H-imidazolium chloride) in
preparations for skin colouration and dyeing of eyelashes or eyebrows.
1,2-BENZENEDIAMINE in preparations for cosmetic use and skin colouration (including
tattooing).
1,3-BENZENEDIAMINE in preparations for cosmetic use and skin colouration (including
tattooing).
BITHIONOL for human therapeutic use.
BORAGO OFFICINALIS (Borage) for therapeutic use except the fixed oil derived from the
seeds of Borago officinalis.
BRAGANTIA spp. containing aristolochic acid(s) for human therapeutic use.
BUCLOSAMIDE for therapeutic use.
Poisons Standard November 2016
239
ii) any conditions specified in the Therapeutic Goods Regulations 1990 for the
purposes of subsection 19(1A) of the Therapeutic Goods Act 1989; and
iii) any conditions specified in the Therapeutic Goods Regulations 1990 for the
purposes of subsection 19(4A) of the Therapeutic Goods Act 1989; or
b) is in accordance with the requirements of item 3 of Schedule 5A to the Therapeutic
Goods Regulations 1990.
COAL TAR for cosmetic use other than in therapeutic goods.
CONIUM MACULATUM (coniine) for therapeutic use.
COTARNINE for therapeutic use.
CROTALARIA spp. for therapeutic use.
CROTON TIGLIUM for therapeutic use.
CYNOGLOSSUM spp. for therapeutic use.
DIBUTYLPHTHALATE for cosmetic use.
DICOPHANE (DDT) for therapeutic use.
DIETHYLENE GLYCOL for use in toothpastes or mouthwashes except in preparations
containing 0.25 per cent or less of diethylene glycol.
DIETHYLENE GLYCOL MONOMETHYL ETHER for cosmetic use.
DIETHYLHEXYL PHTHALATE for cosmetic use.
240
241
manufactured for, and supplied solely by, registered dental practitioners as part of their
dental practice.
JUNIPERUS SABINE [savin(e)] for therapeutic use.
LEAD COMPOUNDS in paints, tinters, inks or ink additives except in preparations containing
0.1 per cent or less of lead calculated on the non-volatile content of the paint, tinter, ink or
ink additive.
LIGULARIA DENTATA for therapeutic use.
MELIA AZEDARACH including its extracts and derivatives.
METHYLDIBROMO GLUTARONITRILE in preparations intended to be in contact with the
skin, including cosmetic use..
METHYL METHACRYLATE for cosmetic use except in preparations containing 1 per cent or
less of methyl methacrylate as residual monomer in a polymer .
METHYLROSANILINIUM CHLORIDE (formerly known as crystal violet CAS No. 548-62-9)
and the following TRIARYLMETHANE DYES for use in hair dyes:
- Acid Violet 49 (CAS No. 1694-09-3),
- Ethyl Violet (CAS No. 2390-59-2),
- Basic Blue 7 (CAS No. 2390-60-5),
- Basic Blue 26 (CI 44045) (CAS No. 2580-56-5).
OXYPHENISATIN for therapeutic use.
PARAFORMALDEHYDE (excluding its derivatives):
a) in oral hygiene preparations containing more than 0.1 per cent of free formaldehyde;
b) in aerosol sprays for cosmetic use containing 0.005 per cent or more of free
formaldehyde;
c) in nail hardener cosmetic preparations containing 5 per cent or more of free
formaldehyde;
d) in all other cosmetic preparations containing 0.05 per cent or more of free
formaldehyde except in preparations containing 0.2 per cent or less of free
formaldehyde when labelled with the warning statement:
CONTAINS FORMALDEHYDE.
PETASITES spp. for therapeutic use.
PHENYLENEDIAMINES, including alkylated, arylated and nitro derivatives, in preparations
for skin colouration, tattooing and dyeing of eyelashes or eyebrows except when included
in Schedule 6.
POTASSIUM HYDROXIDE (excluding its salts and derivatives), in liquid or semi-solid food
additive preparations, for domestic use, the pH of which is more than 11.5.
Poisons Standard November 2016
242
243
PART 5
THE APPENDICES
APPENDIX A GENERAL EXEMPTIONS
This Standard does not apply to a poison in any of the following products:
ALGICIDES, BACTERIOCIDES OR SLIMICIDES for industrial use that do not fit the
definition of an agvet chemical product.
BACTERIAL CULTURE MEDIA containing antibiotics.
CERAMICS.
CHEMISTRY SETS for toy and educational use, when complying with the requirements of
Australian Standard AS 8124.4-2003 Safety of toys entitled Part 4: Experimental sets for
chemistry and related activities.
COPPER COMPOUNDS in paints.
DEXTRANS, GELATIN - SUCCINYLATED & ETHERIFIED STARCHES used as plasma
substitutes/blood volume expanders.
ELECTRICAL ACCUMULATORS, BATTERIES, COMPONENTS or LAMPS.
ELECTRONIC COMPONENTS.
ENHANCING AGENTS for use in ultrasonic and magnetic resonance imaging.
EXPLOSIVES.
FOOD except:
a) whole blood;
b) blood components including red cells, white cells, platelets and plasma (including
cryoprecipitate); and
c) the following plasma-derived therapeutic proteins; and their equivalent recombinant
alternatives:
Poisons Standard November 2016
244
i)
albumin;
245
PORCELAIN.
PRINTING INKS or INK ADDITIVES except:
a) when containing a pesticide; or
b) preparations containing more than 0.1 per cent of lead calculated on the non-volatile
content of the ink or ink additive.
RADIOGRAPHIC CONTRAST MEDIA (radiopaques) for therapeutic use.
RADIOISOTOPES for therapeutic use.
SEEDS treated with seed protectants.
SINGLE-USE TUBES for the estimation of alcohol content of breath.
TERMITE BARRIERS consisting of an active ingredient, other than arsenic, approved by the
relevant registration authority, and laminated between impervious sheeting.
TIMBER or WALLBOARD.
VITREOUS ENAMELS.
WRITING CORRECTION PENS which do not allow ingestion of the contents and which
contain no scheduled poison other than designated solvents included in Schedule 5.
246
Low Toxicity.
247
Agriculture
1.1
Herbicide
1.2
Insecticide
1.3
1.2.1
1.2.2
Termiticide
Fungicide
1.3.1
On seed fungicide
1.4
Bird Repellent
1.5
Fertiliser
1.6
1.7
Insect Pheromone
1.8
Mushroom Bactericide
1.9
Acaricide
1.10
1.11
Veterinary
2.1
2.2
248
4.
5.
2.3
Coccidiostat
2.4
Feed additive
2.5
Antiseptic
2.6
Scabicide
2.7
Anthelmintic
2.8
Vitamin/Mineral
2.9
Growth Promotant
2.10
Ectoparasiticide
Domestic
3.1
Aromatherapy
3.2
Food additive
3.3
Cosmetic
3.4
Human use
3.5
Miticide
Industrial
4.1
Water treatment
4.2
Environmental
249
5.1
6.
7.
Mosquito control
Diagnostic agent
6.2
Medical device
6.3
Antiseptic
6.4
Sunscreen
6.5
External use
6.6
Laxative
6.7
Antiseborrheic
6.8
Cytoprotective
6.9
Vitamin/Mineral
6.10
Eye Drops
General
7.1
Any use
7.2
Excipient
7.3
Synergist
7.4
Flux
7.5
Pesticide
250
7.6
Insect repellent
7.7
Solvent
7.8
Disinfectant
7.9
Preservative
7.10
Antioxidant
7.11
Resin activator/accelerant
7.12
Sweetener artificial
7.13
Food additive
DATE OF
ENTRY
REASON
FOR
LISTING
AREA
OF
USE
4-[4-(ACETYLOXY)PHENYL]-2-BUTANONE
Feb 2005
1.7
AGROBACTERIUM RADIOBACTER
Nov 1989
ALCOHOL, DEHYDRATED
Aug 2000
ALUM
May 1997
7.1
May 1997
7.1
May 1997
7.1
ALUMINIUM SILICATE
Nov 1974
7.1
Aug 1986
251
AMETOCTRADIN
May 2012
1.3
AMMONIUM PHOSPHATE
Nov 1974
7.1
AMMONIUM THIOSULPHATE
Nov 1974
7.1
AMPROLIUM
Jun 1969
2.3
AMYL ACETATE
Nov 1974
7.1
Feb 2005
2.4
Jun 2004
2.1
ASULAM
May 1986
AZIMSULFURON
Jun 2003
1.1
Feb 2003
5.1
BACILLUS THURINGIENSIS
May 1992
5.1
(excluding endotoxin)
Jun 2003
2.10
BACILLUS TOYOI
Aug 1980
2.9
Jun 2006
1.2
1.1
BENSULFURON-METHYL
Aug 1987
BENTONITE
Jun 2002
7.1
ASPARTIC ACID
BENFLURALIN
252
BENZYL BENZOATE
Aug 1989
1.3.4
BETAINE HYDROCHLORIDE
Nov 1974
7.1
BIFENAZATE
Oct 2002
1.9
BISMUTH SUBNITRATE
Nov 1999
b,c
2.1
BISTRIFLURON
Feb 2014
1.2.2
BIURET
Nov 1974
2.4
Feb 2016
1.3
BOSCALID
June 2003
1.3
BOVINE SOMATOTROPHIN
May 1992
BROMACIL
Aug 1987
BROMOPROPYLATE
Nov 1994
BUPIRIMATE
Nov 1990
BUTAFENACIL
May 2000
BUTOXYPOLYPROPYLENE GYLCOL
Nov 1974
7.7
n-BUTYL BUTYRATE
7.1
n-BUTYL LACTATE
7.1
CARBETAMIDE
Aug 1991
CARBOXIN
Aug 1987
253
CARFENTRAZONE-ETHYL
Aug 1998
Feb 2005
2.4
CETYL ALCOHOL
Nov 1974
7.1
CHAMOMILE OIL
Feb 2000
3.1
CHINA CLAY
Sep 2008
1.2
CHLORANTRANILIPROLE
Sep 2008
1.2
CHLORFLUAZURON
Oct 2005
1.2.2
CHLORFLURENOL
Feb 1974
1.6
CHLORIDAZON
May 1988
CHLOROXYLENOLS
Feb 1975
7.8
CITRONELLA OIL
Feb 2000
7.1
Feb 2000
7.1
Feb 2016
1.2
CLOPIDOL
Nov 1974
2.3
7.1
CROSPOVIDONE
Aug 1996
CULICINOMYCES CLAVOSPORUS
Nov 1982
5.1
CYCLAMIC ACID
Nov 1971
7.1
COBALT NAPHTHENATE
254
CYCLANILIPROLE
Oct 2016
1.2
CYCLOHEXANE
Nov 1974
7.7
7.7
CYROMAZINE
Nov 1980
DICLAZURIL
Nov 2001
2.3
7.1
DIFLUFENICAN
Feb 1987
DIKEGULAC-SODIUM
Mar 1980
1.6
DIMETHYL ETHER
Nov 1988
7.1
DIPHENYLAMINE
Feb 1988
Nov 1987
DIURON
Nov 1987
Feb 1970
7.1
2,2-DPA
Nov 1989
DROMETRIZOLE TRISILOXANE
Oct 2003
6.4
EPSIPRANTEL
Nov 1991
ETHAMETSULFURON-METHYL
Nov 2000
1.1
CYCLOHEXANOL ACETATE
DIETHYL CARBONATE
DIMETICONE
255
ETHOPABATE
Jun 1969
2.3
ETHYL ACETATE
Nov 1974
7.1
ETHYL ALCOHOL
Nov 1974
7.1
ETHYLBUTYLACETYL AMINOPROPRIONATE
Aug 2000
3.4
ETHYL BUTYRATE
7.1
ETHYL LACTATE
7.1
ETOXAZOLE
Oct 2003
1.2
Sep 2013
2.4
FENFURAM
May 1977
1.3.1
FENHEXAMID
Feb 1999
FENOXYCARB
Feb 1988
FLUFENOXURON
Feb 1997
FLUMETSULAM
Feb 1992
FLUOMETURON
Aug 1989
FLUOPICOLIDE
Oct 2016
1.3
FLUTOLANIL
Nov 2001
1.3
FLUROXYPYR
May 1986
a, c
FORCHLORFENURON
Feb 2005
1.6
256
FULLERS EARTH
Nov 1974
7.1
Feb 2005
2.4
GERANIUM OIL
Feb 2000
7.1
GIBBERELLIC ACID
Nov 1974
1.6
Feb 2005
2.4
HALAUXIFEN METHYL
Oct 2014
1, 1.1
HEXAFLURON
Nov 1988
7.7
HEXYTHIAZOX
Feb 1988
Aug 2001
6.2
HYDROPRENE
Feb 1988
HYDROXYPROPYL CELLULOSE
Nov 1982
7.1
ICODEXTRIN
Nov 2000
INDOLE-3-ACETIC ACID
Feb 1985
1.6
7.1
IPRODIONE
Feb 1997
Jun 2016
a, b
1.11
Nov 1999
5.1
HEXYL ACETATE
ISOPRENE ALCOHOL
257
KAOLIN
Nov 1974
7.1
KRESOXIM-METHYL
Aug 1999
KUNZEA OIL
Feb 2000
7.1
LAURIC ACID
Oct 2005
7.1
Nov 1974
7.1
LAVANDIN OIL
Feb 2000
7.1
LAVENDER OIL
Feb 2000
7.1
7.1
Nov 1990
LIMONENE (DIPENTENE)
Jun 2002
7.1
LINOLEIC ACID
Oct 2005
7.1
Aug 1990
2.1
LINURON
Feb 1990
LIQUORICE, DEGLYCYRRHISINISED
May 1999
7.1
MALEIC HYDRAZIDE
Nov 1992
MANGANESE DIOXIDE
May 1999
Sep 2013
2.4
MESOLSULFURON-METHYL
Feb 2002
1.1
LEAD METALLIC
258
METARHIZIUM ANISOPLIAE
Feb 2000
4.2
METARHIZIUM ANISOPLIAE
Jun 2003
1.10
METHOPRENE
Aug 1987
METHOXYFENOZIDE
Nov 2000
7.7
METHYL BENZOQUATE
Nov 1974
2.3
1-METHYLCYCLOPROPENE
Jun 2003
1.6
METHYL p-HYDROXYBENZOATE
Nov 1974
7.9
METSULFURONMETHYL
Nov 1985
1.1
MYRISTIC ACID
Oct 2005
7.1
NAPROPAMIDE
Aug 1987
NAPTHYL ACETAMIDE
Nov 1974
1.6
NEROLI OIL
Feb 2000
7.1
NICARBAZIN
Jun 1969
2.3
NISIN
Jun 2003
3.2
NORFLURAZON
Nov 1983
1.1
NOVALURON
Nov 2000
Feb 2004
1.2
METHYL ACETATE
259
OCTYL ALCOHOLS
Nov 1974
7.1
OLEIC ACID
Oct 2005
7.1
Aug 2000
7.1
OXABETRINIL
Feb 1987
OXATHIAPIPROLIN
Jun 2016
1.3
OXYFLUORFEN
May 2001
PALMAROSA OIL
Feb 2000
7.1
PALMITIC ACID
Oct 2005
7.1
PATCHOULI OIL
Feb 2000
7.1
Feb 2005
2.4
PENCYCURON
Aug 1994
PENTADECANOIC ACID
Oct 2005
7.1
PEPPERMINT OIL
Feb 2000
7.1
PHENMEDIPHAM
May 1989
1.1
d-PHENOTHRIN
Feb 1982
7.5, 1.2
PHYTASE
Feb 1996
2.4
PICLORAM
Aug 1987
PICOLINAFEN
May 2000
260
PIMELIC ACID
Oct 2005
7.1
PIPERONYL BUTOXIDE
Aug 1991
7.5
POLOXALENE
Nov 1974
7.1
Nov 1997
4.1
Nov 1996
Feb 1990
POLYSORBATE 20
May 2001
PORCINE SOMATOTROPHIN
Nov 1991
POTASSIUM SORBATE
Oct 2004
1.3
POTASSIUM BICARBONATE
Jun 2004
7.1
PROPYLENE GLYCOL
Nov 1974
7.1
Nov 1987
PROTHIOCONAZOLE
June 2005
1.3.1
PSEUDOMONAS FLUORESCENS
May 1985
1.8
PYRIMETHANIL
Feb 1996
PYRIPROXYFEN
Aug 1994
PROPYL ACETATES
261
QUASSIA
Nov 1974
6, 2.1
QUINOXYFEN
Nov 2001
1.3
ROSEMARY OIL
Feb 2000
7.1
Feb 2000
7.1
SANDALWOOD OIL
Feb 2000
7.1
Feb 1985
1.5
SIMAZINE
Nov 1987
1.1
SODIUM BICARBONATE
Jun 2004
SODIUM PROPIONATE
Oct 2004
1.3
STERIC ACID
Oct 2005
7.1
Oct 2016
1.3
SUCRALFATE
Aug 1982
6.8
SULESOMAB
Jun 2002
6.1
SULFOSULFURON
Feb 1998
7.1
TANNIC ACID
Dec 1965
7.1
Nov 1993
7.1
TERBACIL
Aug 1987
SULPHATED POLYSACCHARIDES
262
THAUMATIN
Nov 1990
3.2
THIDIAZURON
Nov 1989
TRIASULFURON
Feb 1988
TRICHODERMA HARZIANUM
May 1996
(Z)-9-TRICOSENE
Aug 1991
TRIETHYLENE GLYCOL
Nov 1974
7.1
TRIFLOXYSULFURON
Feb 2002
1.1
TRIFLURALIN
Aug 1990
TRIFORINE
Aug 1987
ULOCLADIUM OUDEMANSII
Oct 2003
1.10
UREA
Nov 1974
7.1
13
May 2001
6.1
VETIVER OIL
Feb 2000
7.1
VINYL ETHER
Nov 1987
VITAMIN K
Jul 1963
6.9, 2.8
XANTHOPHYLL (lutein)
Nov 1974
7.1
Feb 2005
2.4
Feb 2000
7.1
C-UREA
263
ZINC NAPHTHENATE
1.3
264
265
266
2.
(2)
(b)
3.
267
4.
Poisons available only from or on the order of a specialist physician and for which
the prescriber must, where the patient is a woman of child bearing age:
(a)
(b)
advise the patient to avoid becoming pregnant during or for a period of 1 month
after completion of treatment.
LENALIDOMIDE.
POMALIDOMIDE.
RIOCIGUAT for human use.
TRETINOIN for human oral use.
5.
Poisons for which possession without authority is illegal (e.g. possession other than
in accordance with a legal prescription).
ANABOLIC STEROIDAL AGENTS, including those separately specified in Schedule
4.
ANDROGENIC STEROIDAL AGENTS, including those separately specified in
Schedule 4.
AOD-9604 (CAS No. 221231-10-3).
BENZODIAZEPINE DERIVATIVES, including those separately specified in Schedule
4 and Schedule 8.
CJC-1295 (CAS No. 863288-34-0).
DARBEPOETIN.
DEXTROPROPOXYPHENE.
268
EPHEDRINE.
EPOETINS.
ERYTHROPOIETIN.
ERYTHROPOIETINS except when separately specified in this Appendix.
FIBROBLAST GROWTH FACTORS.
FOLLISTATIN.
GLUTETHIMIDE.
GROWTH HORMONE RELEASING HORMONES (GHRHs) including those
separately specified in Schedule 4.
GROWTH HORMONE RELEASING PEPTIDES (GHRPs) including those separately
specified in Schedule 4.
GROWTH HORMONE RELEASING PEPTIDE-6 (GHRP-6).
GROWTH HORMONE SECRETAGOGUES including those separately specified in
Schedule 4.
HEXARELIN.
INSULIN-LIKE GROWTH FACTORS.
IPAMORELIN.
PERAMPANEL for human use.
PHENTERMINE.
PRALMORELIN ((GROWTH HORMONE RELEASING PEPTIDE-2) (GHRP-2)).
269
6.
(b)
advise the patient to avoid becoming pregnant during and for a period of 3 months
after completion of treatment.
7.
270
271
For advice, contact a Poisons Information Centre (e.g. phone Australia 13 11 26; New
Zealand 0800 764 766) or a doctor (at once).
First aid is not generally required. If in doubt, contact a Poisons Information Centre
(e.g. phone Australia 13 11 26; New Zealand 0800 764 766) or a doctor.
General
G1
G2
G3
G4
G5
G6
272
Eyes
E1
E2
If in eyes, hold eyelids apart and flush the eye continuously with running water.
Continue flushing until advised to stop by a Poisons Information Centre (e.g. phone
Australia 13 11 26; New Zealand 0800 764 766) or a doctor, or for at least 15 minutes.
Respiratory system
R1
If inhaled, remove from contaminated area. Apply artificial respiration if not breathing.
R2
Skin
S1
If skin or hair contact occurs, remove contaminated clothing and flush skin and hair with
running water.
S2
If skin or hair contact occurs, remove contaminated clothing and flush skin and hair with
running water. Continue flushing with water until advised to stop by a Poisons
Information Centre (e.g. phone Australia 13 11 26; New Zealand 0800 764 766) or a
doctor.
S3
If on skin, remove any contaminated clothing, wash skin thoroughly with soap and
water, then methylated spirit if available. Contact a Poisons Information Centre (e.g.
phone Australia 13 11 26; New Zealand 0800 764 766) or a doctor.
S4
If on skin, immediately remove any contaminated clothing, wash skin with methylated
spirit or PEG (polyethylene glycol) 300 or 400 if available, then flush under running
water until advised to stop by a Poisons Information Centre (e.g. phone Australia 13 11
26; New Zealand 0800 764 766) or a doctor.
S5
If skin contact occurs, immediately remove contaminated clothing. Flush skin under
running water for 15 minutes. Then apply calcium gluconate gel. Contact a Poisons
Information Centre (e.g. phone Australia 13 11 26; New Zealand 0800 764 766).
Special Purpose
SP1 If swallowed, splashed on skin or in eyes, or inhaled, contact a Poisons Information
Centre (e.g. phone Australia 13 11 26; New Zealand 0800 764 766) or a doctor at once.
Remove any contaminated clothing and wash skin thoroughly. If swallowed, activated
Poisons Standard November 2016
273
STANDARD STATEMENTS
ACETIC ACID
A,G3,E2,S1
ACETIC ANHYDRIDE
A,G3,E2,S1
ACETONE
A,G3
ACROLEIN
A,G1,G2,G3,E2,R2,S2
ALKALINE SALTS
A,G3,E2,S1
AMIDOPROPYL BETAINES
in cosmetic wash-off preparations when included in
Schedule 6
E1
E1, S1
A,G3,E1,S1
2-AMINO-6-CHLORO-4-NITROPHENOL
A, E1
4-AMINO-m-CRESOL
A, E1
2-AMINO-5-ETHYLPHENOL
4-AMINO-2-HYDROXYTOLUENE
A, E1
274
4-AMINO-3-NITROPHENOL
4-AMINOPYRIDINE
A,G1,G2,E1,S1
AMMONIA
5 per cent or less
A,G3,E1,R1,S1
E1
AMMONIUM PERSULFATE
A,G3,E2
AMMONIUM THIOCYANATE
A,G3,E1,S1
ANILINE
A,E2,R1,S1
ANISE OIL
A,G3
ANITMONY CHLORIDE
A,E2,S2
A,E1
BASIL OIL
A,G3
BAY OIL
A,G3
275
BENZALKONIUM CHLORIDE
when included in Schedule 5
A,G3,E2
A,G3,E2,S1
BENZENE
A,G3,E1,R1,S1
1,2-BENZENEDIOL (Catechol)
A, E1, S1
BENZOYL PEROXIDE
above 20 per cent
A,E2,S1
A,E1
BERGAMOT OIL
A,G3
A,G3,E2,S5
BORAX
BORIC ACID
BORON TRIFLUORIDE
when included in Schedule 5
A,G3,E2,S5
276
BROMOFORM
A,G3,E2,R1,S2
BRUCINE
A,G1,G2,G3,R2
A,E2,S1
n-BUTYL ALCOHOL
A, E1, S1
CADMIUM COMPOUNDS
CAJUPUT OIL
A,G3
CAMPHOR
A,G1,G3,G5
CARBAMIDE PEROXIDE
more than 9 per cent up to 60 per cent
A,G3,E2,S1
A,G1,G3,G4,E2,S1
CARBON DISULFIDE
A,G3,E2,R1,S2
CARBON TETRACHLORIDE
A,G3,E1,R1,S1
CASSIA OIL
A,G3
CARBON DISULFIDE
A,G3,E2,R1,S2
CARBON TETRACHLORIDE
A,G3,E1,R1,S1
CASSIA OIL
A,G3
277
A,G3,E1,S1
A,G3,E2,S1
CHLORIDE (gas)
A,E1,R1
CHLOROCRESOL
A,G3,E2,S2
CHLOROFORM
A,G3,E1,R1,S1
CHROMATES
A,G3,E2,S1
CHROMIUM TRIOXIDE
A,G3,E2,S1
CHRYSOIDINE BASE
A, S1,E1
CINEOLE
A,G1,G3
A,G3
A,G3
CLIMBAZOLE
CLOVE OIL
A,G1,G3,E2
COCOYL GLYCINATE
E1
COPPER SULFATE
A,G3,E2,S1
CREOSOTE
A,G3,E2,S1
CRESOLS
A,G3,E2,S3
A,G6,E1,S1
278
CYANIDES
A,G1,E1,R2
CYANURIC ACID
CYCLOHEXANONE PEROXIDE
A,G3,E2,S1
CYCTEAMINE
E1
2,4-DIAMINO-PHENOXYETHANOL
A, E1
ortho-DICHLOROBENZENE
A,G3,E1,S1
para-DICHLOROBENZENE (PDB)
DICHLOROETHYL ETHER
A,G3,E1,R1,S1
DICHLOROISOCYANURATES
A,G3,E1,S1
A,G3,G5,E1,R1,S1
A,G6,S1
A,G1,G3,E2,S1
DIDECYLDIMETHYLAMMONIUM SALTS
A,G3
DIESEL (distillate)
A,G3
DIETHANOLAMINE
when included in Schedule 5
A,G3
A,G3,E2,S1
279
5,6-DIHYDROXYINDOLINE
E1
DIMETHYLFORMAMIDE
less than 75 per cent
A,E1,R1,S1
4,4-DIMETHYL-1-CYCLOHEXENE-1-PROPANAL
A,E2
DIMETHYL SULFOXIDE
A,G3,E1,S1
DINITROCRESOLS
A,G1,E1,S1
DINITROPHENOLS
A,G1,E1,S1
DIOXANE
A,G3,E1,R1,S1
DISPERSE YELLOW 3
A, S1
DISTILLATE
A,G3
N-(N-DODECYL)-2-PYRROLIDONE
when included in Schedule 5
A,G3,E1
A,G3,E2,S1
A,G3,E2,S1
A,G3
ETHER
A,G3,E1,R1
Poisons Standard November 2016
280
ETHYL BROMIDE
A,E2,S1,R1
ETHYLENE GLYCOL
A,G3,E2,S1
ETHYLENE OXIDE
A,E2,R1
2-ETHYLHEXANOIC ACID
EUCALYPTUS OIL
A,G1,G3
EUGENOL
A,G1,G3,E2
A,G1,G3,E2,S1
A,G3,E2,R1,S1
FORMIC ACID
A,G3,E2,S1
FURFURAL
A,E1,S1
GLUTARAL
below 5 per cent
A,G3,E1
A,G3,E2,S1
GLYCOLIC ACID
A,G3,E2
A,G3,E2,S1
281
GLYCOLIC ACID
A,G3,E2
A,G3,E2,S1
HEXYLOXYETHANOL
A,G3,E2,S1
HYDRAZINE
A,G1,G3,E2,R1,S1
HYDROCARBONS, liquid
A,G3
HYDROCHLORIC ACID
A,G3,E2,S1
A,G3
A,G3,E2,S5
HYDROGEN PEROXIDE
more than 3 per cent up to 20 per cent
A,G3,E2,S1
A,G1,G3,G4,E2,S1
HYDROQUINONE
when included in Schedule 2
A,G2,G3,E2,R2,S1
282
HYDROSILICOFLUORIC ACID
when included in Schedule 5
A,G3,E2,S5
2-HYDROXYETHYL METHACRYLATE
A, E1, S1
A,E2
A,E2,S1
IODOPHORS
A,E2,S1
ISOPHORONE
A,G3,E2,S1
KEROSENE
A,G3
E1
E1,S1
A,E1
LEAD COMPOUNDS
A
in hair cosmetics
283
A,S1
in other preparations
LEMON OIL
A,G3
A,G1,G3
LIME OIL
A,G3
MAGNESIUM CHLORATE
MARJORAM OIL
A,G3
MELALEUCA OIL
A,G1,G3
MERCAPTOACETIC ACID
A, E1
MERURIC CHLORIDE
for external therapeutic use
A,G1,G3,E2,R2,S1
MERCURIC IODIDE
A,G1,G3,E2,R2,S1
MERCURIC NIRATE
A,G1,G3,E2,R2,S1
MERCURIC OXIDE
A,G1,G3
A,G1,G3,E2,R2,S1
MERCURIC THIOCYANATE
A,G1,G3,E2,R2,S1
MERCUROCHROME
284
MERCUROUS CHLORIDE
MERCURY metallic
A,S1
A
A,E1,S1
METHANOL
above 10 per cent
A,G3
METHYLATED SPIRIT(S)
A,G3
A,G3
A,G3
A,E1,S1
A,G3,E2,S1
METHYLEUGENOL
A,G3
A,G3
N-METHYL-2-PYRROLIDONE
when included in Schedule 5
A,G3,E1
285
A,G3,E2
A,G3,E1
MONOETHANOLAMINE
when included in Schedule 5
A,G3,E1
A,G3,E2,S1
1,5-NAPHTHALENEDIOL
A,E1,S1
2,7-NAPHTHALENEDIOL
A,E1,S1
NAPHTHALENE
A,G1,G3
1-NAPHTHOL
A,E1,S1
NITRIC ACID
A,G3,E2,S1
NITROBENZENE
A,G3,E1,S1
NITROPHENOL
A,G3,E2,S1
NITROPRUSSIDES
in aerosols
A,G6,R1
in other preparations
A,G3
NONOXINOL 9
A,E2
NUTMEG OIL
A,G3
OCTHILINONE
A,G3,E2,S1
Poisons Standard November 2016
286
N-(N-OCTYL)-2-PYRROLIDONE
when included in Schedule 5
A,G3,E1
A,G3,E2
A,G3
OXALIC ACID
A,G3,E2,S1
PARAFORMALDEHYDE
A,G3,E2,R1,S1
PENNYROYAL OIL
A,G3
PERACETIC ACID
when included in Schedule 5
A,G3,E1,S1
A,G3,E2,S1
PETROL
A,G3,R1
2-PHENOXYETHANOL
PHENOLS
25 per cent and less
A,G3,E2,S3
A,G3,E2,S4
A,E1
in hair dyes.
Poisons Standard November 2016
287
A,G1,G3,E1,S1
A,G3,E1
N,N-BIS(PHENYLMETHYLENE)-BICYCLO
A,E2,S1
-(2.2.1)HEPTANE-2,5-DIMETHANAMINE
N,N-BIS(PHENYLMETHYLENE)-BICYCLO-
A,E2,S1
(2.2.1)HEPTANE-2,6-DIMETHANAMINE
ortho-PHENYLPHENOL
A,G3,E2,S1
A,G6,E2,S1
A,G3,E2,S1
neutralised to pH 6 (approx)
in spray packs
A,E2,S1
PHOSPHORIC ACID
A,G3,E2,S1
PHOSPHORUS, yellow
A,G1,G3,E2,R2,S2
ortho-PHTHALALDEHYDE
when included in Schedule 5
A,E1
A,G3,E2,S1
PICRIC ACID
A,G1,G3,E2,R1,S1
POLIHEXANIDE
E1
288
A,E2,S1
POLY(OXY-1,2-ETHANEDIYL), -
A,E1
[2-[(2-HYDROXYETHYL)AMINO]-2OXOETHYL]- -HYDROXY-,MONO-C13-15
-ALKYL ETHERS
POTASIUM BROMATE
POTASIUM CHLORATE
POTASSIUM CYANATE
A,E1,S1
POTASSIUM HYDROXIDE
A,G3,E2,S1
POTASSIUM METABISULPHITE
POTASSIUM NITRITE
when included in Schedule 7
A,G1,G3
A,G3
A,G3,E1
A,G3,E2,S1
POTASSIUM PERSULFATE
A,G3,E2
POTASSIUM SULFIDE
A,G3,E2,S1
PROPIONIC ACID
A,G3,E1,S1
289
n-PROPYL ALCOHOL
A, E1
d-PULEGONE
A,G3
PYRITHIONE ZINC
A,E1
A,G3,E2
A,E2
A,E2,G6
SAFROLE
A,G1,G3
A,G3
SASSAFRAS OIL
A,G1,G3
SELENIUM COMPOUNDS
A,G1,E1,S1
SILICOFLUORIDES
when included in Schedule 5
A,G1,G3,E2,S1
SILVER SALTS
A,E2
SODIUM ALUMINATE
A,G3,E2,S1
SODIUM BROMATE
A,G1
SODIUM CHLORATE
A
Poisons Standard November 2016
290
SODIUM DIACETATE
A,G3,E2,S1
SODIUM DICHLOROISOCYANURATE
A,G3,E1,S1
A,G3,E2,S1
A,G3,E1,S1
SODIUMHYDROSULFITE
A,G3,E2,S1
SODIUM HYDROXIDE
A,G3,E2,S1
E1
E1,S1
SODIUM METABISULPHITE
A, G3
SODIUM NITRITE
when included in Schedule 7
A,G1,G3
A,G3
SODIUM PRECARBONATE
when included in Schedule 5
A,G3,S1
A,G3,E2,S1
SODIUM PERSULFATE
A,G3,E2
291
SODIUM STANNATE
A,E1
SODIUM SULFIDE
A,G3,E2,S1
SODIUM TRICHLOROACETATE
STRYCHNINE
A,G1,G2,G3,R2
STYRENE
A,G3,S1,E1
SULCOFURON
SULFAMIC ACID
A,G3,E2,S1
SULFURIC ACID
A,G3,E2,S1
TERPENES, chlorinated
A,G3
TETRACHLOROETHANE
A,G3,E1,R1,S1
TETRACHLOROETHYLENE
A,G3,E2,R1,S1
THIOUREA
THUJONE
A,G3
THYME OIL
A,G3
ortho-TOLIDINE
TOLUENE
above 75 per cent
A,G3,E1,R1,S1
A,G3
292
A,E1
in other preparations
A,G1,G3,E1,S1
TRICHLOROACETIC ACID
A,G3,E2,S1
1,1,1-TRICHLOROETHANE
A,G3,E1,R1,S1
TRICHLOROETHYLENE
A,G3,E1,R1,S1
TRICHLOROISOCYANURIC ACID
A,G3,E1,S1
TRIETHYL PHOSPHATE
A,E1
TRIFLUOROMETHANESULFONIC ACID
A,G3,E2
A,E1,S1
TROLAMINE
A,G3,E1,S1
TURPENTINE (mineral)
A,G3
A,G3,E2
WHITE SPIRIT
A,G3
XYLENE
A,G3,E1,R1,S1
293
A,G3
A,G6,E1,S1
XYLENOLS
A,E1
A,G3,E2,S1
ZINC SULFATE
A,G3,E2,S1
294
Highly corrosive.
2.
Corrosive.
3.
Corrosive liquid.
295
4.
Strongly alkaline.
5.
Irritant.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
Contact with eyes even for short periods can cause blindness.
18.
19.
WARNING Skin contact may be dangerous. Take every precaution to avoid contact
wash off after spillage and after use.
20.
21.
WARNING This product contains ingredients which may cause skin irritation to
certain individuals. A preliminary test according to accompanying directions should be
Poisons Standard November 2016
296
made before use. This product must not be used for dyeing eyelashes or eyebrows; to do
so may be injurious to the eye.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
WARNING Do not use on face or on anal or genital areas except on doctors advice.
32.
This preparation should be part of an overall treatment plan regularly assessed with your
doctor.
33.
Do not take for periods longer than four weeks except on medical advice.
34.
WARNING This medication may be dangerous when used in large amounts or for a
long time (period).
35.
CAUTION This preparation is for the relief of minor and temporary ailments and
should be used strictly as directed. Prolonged use without medical supervision could be
harmful.
or
CAUTION This preparation is for the relief of minor and temporary ailments and
should be used strictly as directed. Prolonged or excessive use without medical
supervision could be harmful.
Poisons Standard November 2016
297
36.
37.
Consult a doctor before giving this medication to children or teenagers with chicken
pox, influenza or fever.
38.
CAUTION Do not use for children under 2 years unless a doctor has told you to.
39.
This medication may cause drowsiness. If affected do not drive a vehicle or operate
machinery. Avoid alcohol.
40.
This medication may cause drowsiness and may increase the effects of alcohol. If
affected do not drive a motor vehicle or operate machinery.
41.
Do not give to children under 12 years of age. Do not use beyond 48 hours or in
pregnancy or lactation except on doctors advice.
42.
43.
Use of this product is not necessary in areas supplied with fluoridated water.
44.
45.
WARNING If a pigmented spot or mole has recently become darker, changed colour,
become enlarged or itchy, or bleeds, do not use this product, see your doctor
immediately. Do not use on children. Do not use near the eyes. Mild irritation may
occur; stop use if it becomes severe. If fading is not evident in three months, seek
doctors advice.
46.
47.
WARNING This product contains (name of substance) which causes birth defects in
certain laboratory animals. Women of child bearing age are advised not to mix, load or
spray this product. They should keep out of crops being sprayed.
48.
WARNING This product forms cyhexatin which causes birth defects in certain
laboratory animals. Women of child bearing age are advised not to mix, load or spray
this product. They should keep out of crops being sprayed.
298
49.
50.
Unless adequately fired, utensils glazed with this preparation must not be used as
containers for food or beverages; to do so may cause lead poisoning.
51.
52.
Breathing vapour or spray mist is harmful and may cause an asthma-like reaction.
53.
54.
55.
Keep from eyes, lips, mouth and sensitive areas of the neck. If excessive swelling,
irritation, redness or peeling occurs, discontinue use. If these persist, consult a
physician. Avoid excessive exposure to sunlight and other sources of ultra violet light.
56.
WARNING Can cause elevated blood pressure and interact adversely with other
medication.
57.
58.
59.
60.
61.
WARNING - Can react with other medicines. Ask your doctor or pharmacist before
taking.
62.
63.
64.
See a doctor (or) (dentist) if no better after (Insert number of days as per approved
Product Information) days.
299
65.
If getting better, keep using for (Insert number of days as per approved Product
Information ) days.
66.
67.
68.
69.
If symptoms recur within two weeks of completing the course, consult a doctor.
70.
Use only under medical supervision if you are taking other medicines.
71.
72.
73.
74.
Do not use under waterproof bandages unless a doctor has told you to.
75.
Do not use for more than 7 days unless a doctor has told you to.
76.
Do not become pregnant during use or within (Insert number of months as per approved
Product Information) month(s) of stopping treatment.
77.
78.
79.
80.
WARNING: Do not attempt to refill burner while it is in use or still warm; it could lead
to serious burn injury
81.
(Intentionally blank)
300
82.
(Intentionally blank)
83.
84.
85.
This paint contains lead and is dangerous to health, even when dry.
For industrial use only.
Do not use on toys or furniture.
Do not use for painting any building or fixed structure.
Do not use where contact with food or drinking water is possible.
86.
87.
(Insert brand name) remains in the body for many months after treatment has stopped.
Do not become pregnant or father a child before consulting your doctor.
88.
89.
90.
This preparation is to aid sleep. Drowsiness may continue the following day. If affected
do not drive or operate machinery. Avoid alcohol.
301
91.
CAUTION Total iodine intake may exceed recommended level when taking this
preparation.
92.
93.
Causes severe burns, which are not likely to be immediately painful or visible.
94.
WARNING Contains nitrite. Substitution for table or cooking salt may be dangerous,
particularly for young children.
95.
CAUTION Do not use for children under 12 years unless a doctor has told you to.
96.
CAUTION This preparation is for the relief of minor and temporary ailments and
should be used strictly as directed. If symptoms persist or recur within two weeks,
consult a doctor.
97.
Adults: Keep to the recommended dose. Dont take this medicine for longer than a few
days at a time unless advised to by a doctor.
98.
Children and adolescents: Keep to the recommended dose. Do not give this medicine
for longer than 48 hours at a time unless advised to by a doctor.
99.
100. Do not take with other products containing paracetamol, unless advised to do so by a
doctor or pharmacist.
101. Dont use [this product/name of the product]:
If you have a stomach ulcer.
In the last 3 months of pregnancy. [This statement may be omitted in preparations used
exclusively for the treatment of dysmenorrhoea.]
If you are allergic to (name of substance) or anti-inflammatory medicines.
102. Unless a doctor has told you to, dont use [this product/name of the product]:
For more than a few days at a time.
Poisons Standard November 2016
302
2.
3.
303
4.
5.
6.
7.
8.
9.
10.
11.
No smoking.
12.
Do not allow product to come into contact with other chemicals, especially acids.
13.
Do not allow product to come into contact with combustible materials such as paper,
fabric, sawdust or kerosene.
14.
15.
Store under cover in a dry, clean, cool, well ventilated place away from sunlight.
16.
17.
18.
19.
20.
21.
Do not add water to product - add product to water, but in case of fire drench with
water.
Poisons Standard November 2016
304
22.
23.
24.
Avoid contact of the crystals or strong solutions with the eyes, mouth, nose and other
mucous membranes.
25.
26.
27.
28.
29.
30.
(Intentionally blank.)
31.
32.
33.
34.
May cause fire if it comes into contact with other chemicals, paper or other flammable
materials.
35.
36.
37.
305
WARNING
STATEMENTS
SAFETY
DIRECTION
1,4,8
ACETIC ANHYDRIDE
1,4,8
1,4,8
ACITRETIN
7,62,76
62,77
38,72,73,74,75
ALKALINE SALTS
AMBRISENTAN
1,4
7,62,76
1,3,4,5,8
2-AMINO-6-CHLORO-4-NITROPHENOL
28
4-AMINO-m-CRESOL
28
2 AMINO 5 ETHYLPHENOL
21
4-AMINO-2-HYDROXYTOLUENE
28
4-AMINO-3-NITROPHENOL
28
AMMONIA/AMMONIUM HYDROXIDE in
Poisons Standard November 2016
1,4,8
306
5,21,25
1,5,23,33,34
1,3,4,5,8
ANILINE
13
1,4,8
39 or 40
1,3,4,5,6
ASPIRIN
36
36
c) in other preparations.
101,102,103
ASTEMIZOLE
61
67
AZOCYCLOTIN
48
307
BENOMYL
46
BENZENE
12
1,4,9
51,59
1,4,8
1,2-BENZENEDIOL (Catechol)
BENZOYL PEROXIDE when included in Schedule 2.
55
1,4,8
89
BERYLLIUM
1,4,8
BEXAROTENE
a) for human use.
7,62,76
62,77
1,4
1,17,93
1,3,4,5,8,29,35
1,4,8
BOSENTAN
1,4
1,17,93
1,3,4,5,8,29,35
7,62,76
Poisons Standard November 2016
308
BROMOFORM
1,4,8
2-BUTOXY-2-THIOCYANODIETHYL ETHER
1,4,8
1,4,8
n-BUTYL ALCOHOL
2, 4, 8
CAMPHOR
a) in block, ball, disc, pellet or flake form,
enclosed in a device which, in normal use,
prevents removal or ingestion of its contents.
b) in other forms.
2,4
CARBON DISULFIDE
12
1,4,8,9,23
CARBON TETRACHLORIDE
12
1,4,8,9
CARAMIDE PEROXIDE
CASSIA OIL
CHLORINATING COMPOUNDS
a) in household cleaning or bleaching
preparations.
20
11
1,4,10
3,18
1,4,6,8,10,
15,16, 17,18,
309
19,20,22,26
10,18,22,23
1,4,8,12,13,
14,15,16,17, 18,
19,20,21, 22,26
10,18,22
1,4,8,12,13,
14,15,16,17,
18,19,20,21,
22,26
10,22,23
12,13,14,15,
17,18,19,21
10,22
12,13,14,15,
17,18,19,21
1,4,8
13,51
1,4,8,9
1,4,8
CHROMIUM TRIOXIDE
2,14,15,23
70,96
1,4,8,13
72,73,74,75,95
310
54,63,64,66
CLOVE OIL
13
4,8
CYANURIC ACID
1,4,8
CYCLOHEXANONE PEROXIDE
1,4,8
CYCTEAMINE
4,4-DIAMINODIPHENYLMETHANE (methylene
dianiline)
1,4,8
2,4-DIAMINO-PHENOXYETHANOL
21
ortho-DICHLOROBENZENE
1,4,8
para-DICHLOROBENZENE
1,4
DICHLOROETHYLENE
1,4,8
DICHLOEOETHYL ETHER
1,4,8
DICHLOROISOCYANURATES
a) in household cleaning or bleaching
preparations.
20
11
1,4,10
3,18
1,4,6,8,10,
15,16,17,18,
19,20,22,26
10,18,22,23
1,4,8,12,13,14,
15,16,17,18,19,
311
20,21,22,26
e) in dry preparations containing 10 per cent or
more of available chlorine certified by a
relevant State or Territory authority as not being
a Dangerous Good of Class 5, Division 5.1:
Oxidising substances, as specified in the
Australian Code for the Transport of
Dangerous Goods by Road and Rail.
f) in anti-bacterial tablets containing 2.5 g or less
of sodium dichloroisocyanurate.
g) in other compressed blocks or tablets containing
10 per cent or more of available chlorine except
in preparations containing 21 g or less of
sodium dichloroisocyanurate for use in toilet
cisterns only.
h) in other compressed blocks or tablets containing
10 per cent or more of available chlorine
certified by a relevant State or Territory
authority as not being a Dangerous Good of
Class 5, Division 5.1: Oxidising substances, as
specified in the Australian Code for the
Transport of Dangerous Goods by Road and
Rail except in preparations containing 21 g less
of sodium dichloroisocyanurate for use in toilet
cisterns only.
i)
1,4,8,12,13,14,
15,16,17,18,19,
20,21,22,26
60
10,22,23
12,13,14,15,
17,18,19,21
10,22
12,13,14,15,17,
18,19,21
10,22,23
12,13,14,15,17,
18,21
1,4,7,12
10,22
12,13,14,15,17,
during storage
10,18,22
during storage
Poisons Standard November 2016
312
18,21
ii) during use
1,4,7,12
12,16
1,4,8,11
1,4,8,25
DICLOFENAC
101,104
DIENESTROL
67
1,4
2,11,18
1,4,8
44
5,6-DIHYDROXYINDOLINE
21,28
2,6-DIMETHOXY-3,5-PYRIDINEDIAMINE
28
DIMETHYLFORMAMIDE
1,4,8
4,4-DIMETHYL-1-CYCLOHEXENE-1-PROPANAL
5,28
1,2
DIMETHYL SULFATE
1,4,8
27
1,4,5,8
49
1,4,5,8
DIMETHYL SULFOXIDE
313
1,4,8
1,4,8
DINOCAP
47
DIOXANE
1,4,8
39 or 40,41
DISPERSE YELLOW 3
28
54,63,64,66
ENZALUTAMIDE.
7, 67,87
29
EPICHLOROHYDRIN
1,4,8
1,3,4,5,8
1,4,8
2-ETHOXYETHANOL
77
1,4,8
ETHOXYETHYLMERCURIC CHLORIDE
1,4
ETHYL BROMIDE
1,4,8
ETHYLENE CHLOROHYDRIN
1,4,8
1,4,8
314
ETHYLENE OXIDE
1,4,8
2-ETHYLHEXANOIC ACID
53
ETHYLMERCURIC CHLORIDE
1,4
ETHYL METHACRYLATE
28
ETRETINATE
7,62,76
EUGENOL
4,9,23
96
32
64
1,4
FORMALDEHYDE
106
1,4,8,36
b) in other preparations.
106
1,4,8
FORMIC ACID
1,4,8
FURFURAL
50
1,4
5,59
Poisons Standard November 2016
1,4,5
315
3,59
1,4,5,8
GLYCOLIC ACID
79
1,5,6,31
24
HEXYLOXYETHANOL
HYDRAZINE
1,4,8
1,4,8
HYDROCLORIC ACID
a) 30 per cent or less of HCl.
1,4
1,4,8
HYDROCORTISONE
a) for dermal use when included in Schedule 2 or
3.
38,72,73,74,75
38,75
13
4,8
1,4
1,17,93
1,3,4,5,8,29,35
HYDROGEN PEROXIDE
a) more than 3 per cent up to 10 per cent.
316
2,4
HYDROQUINONE
a) when in Schedule 2.
45
1,4
1,4
1,17,93
1,3,4,5,8,29,35
2-HYDROXYETHYL METHACRYLATE
28
IBUPROFEN
101,104
IODINE
a) more than 20 per cent.
1,4,8
91,92
32
28,52
1,5,8,10,27
28,52
1,4,8
32
317
ISOTRETINOIN
a) for human oral use.
7,62,76
62,77
LEAD COMPOUNDS
a) in hair cosmetics.
25
b) when in Schedule 6.
1,4,8
LEFLUNOMIDE
7,62,87
LEMON OIL
89
LENALIDOMIDE
7,62,76
LEVOCABASTINE
a) in eye or nasal preparations containing 0.5
mg/mL or less of levocabastine.
62
b) in other preparations.
62 and either 39
or 40
LIME OIL
89
41
MAGNESIUM CHLORATE
1,4
MEFENAMIC ACID
101,104
MERCAPTOACETIC ACID
5, 28
MERCURIC THIOCYANATE
1, 31
1,4
318
1,4
1,4,8
29
2-METHOXYETHANOL
77
80
p-METHYLAMINOPHENOL
28
METHYL CHLORIDE
1,4,8
1,4,8
1,4,8
5,28
1,4
2,3,4,6
1,4,8
1,4,8
METHYL ISOTHIOCYANATE
5,12
1,4,8
METHYL METHACRYLATE
28
4,9,23
METHYLCHLOROISOTHIAZOLINONE
28
METHYLDIBROMO GLUTARONITRILE
28
1,4,7
METHYLENE BISTHIOCYANATE
1,4
METHYLEUGENOL
1,6
Poisons Standard November 2016
319
METHYLISOTHIAZOLINONE
28
METHYLNORBORNYLPYRIDINE
59
1,4,8
54,63,64,66
MISOPROSTOL
53
1,4
2,11,18
1,4,8
29
NAPHTHALENE
a) in block, ball, disc, pellet or flake form,
enclosed in a device which, in normal use,
prevents removal or ingestion of its contents.
9,105
b) in other forms.
9,105
1,5-NAPHTHALENEDIOL
28
2,7-NAPHTHALENEDIOL
28
1,3
1-NAPHTHOL
28
NAPROXEN
101,104
1,4
NITRIC ACID
320
1,4
1,4,8
NITROBENZENE
1,4,8
NITROPHENOLS
1,4
NITROPRUSSIDES in aerosols.
84
96
32
54,63,64,65,66
89
32
OXALATES, metallic
4,8
OXALIC ACID
29
33
4,8
PAINT
a) First Group paints.
83
84
PARACETAMOL
97 and/or
Poisons Standard November 2016
321
98,99,100
PENTACHLOROPEHNOL
1,4,8
PERACETIC ACID
1,4,8
PERMANGANATES
24
2-PHENOXYETHANOL
1,4
PHENOLS
21
28
29
POMALIDOMIDE.
7, 62, 76
N,N-BIS(PHENYLMETHYLENE)-BICYCLO-
5,28
1,4,8
1,4,5,10
(2.2.1)HEPTANE-2,5-DIMETHANAMINE
ortho-PHENYLPHENOL except when in antiseptics.
1,4
PHENYLPROPANOLAMINE
56
PHOSPHONIC ACID
1,4
PHOSPHORUS (yellow)
2
Poisons Standard November 2016
1,4
322
ortho-PHTHALADEHYDE
a) when included in Schedule 5.
51,52,59
1,4,5,8,10
51,52,59
2,4,5,8,10
1,4
PODOPHYLLIN
a) in preparations specifically for use on anal or
genital area.
36
31
30
PODOPHYLLOTOXIN
a) in preparations specifically for use on anal or
genital area.
36
31
30
POLIHEXANIDE
1,4,8
1,4
5,88
1,5
1,4,6
2,10,78
3,5,28
POTASSIUM HYDROXIDE
323
2,10,78
3,5
POTASSIUM PERSULFATE
5,21,25
1,5,23,33,34
POTASSIUM SULFIDE
1,4
1,4
n-PROPYL ALCOHOL
1, 9
96
ROSIN
108
37
SAFROLE
a) in preparations for therapeutic use.
1,4
32
SALICYLAMIDE
34 or 35
SASSAFRAS OIL
a) in preparations for therapeutic use.
1,4
1,4,8
42
SITAXENTAN
7,62,76
Poisons Standard November 2016
324
SODIUM ALUMINATE
SODIUM CHLORATE
1,4
1,4
79
43
1,4,8
5,26
1,4,8
1,4,6
2,10,78
3,5,28
2,10,78
SODIUM HYDROXIDE
3,5
79
5,26
1,4
94
SODIUM PERSULFATE
5,21,25
1,5,23,33,34
SODIUM SULFIDE
1,4
STYRENE
1,4,8
SULFAMIC ACID
1,4
SULFURIC ACID
1,4
325
31,32
77,62
32
TERFENADINE
61
TERIFLUNOMIDE.
7,62,87
TERPENES, chlorinated
1,4,8
TETRACHLOROETHANE
12
12,16
1,4,8,11
29
THALIDOMIDE
7,62,76
THIOUREA
1,4
TOLUENE
1,4,8
TOLUENEDIAMINES
a) in hair dyes.
21
1,4,8
29
TRETINOIN
a) for human oral use.
7,62,76
Poisons Standard November 2016
326
62,77
64 or 68
1,1,1-TRICHLOROETHANE
1,4
8,9
12
1,4,5,8,9
TRICHLOROPHENOL
1,4,8
TRIETHYL PHOSPHATE
1,4,8
TRIFLUOROMETHANESULFONIC ACID
a) more than 10 per cent.
1,17
1,4,8
1,4,8
1,4,6
3,6,9-TRIOXAUNDECANEDIOIC ACID
TROLAMINE
1,4
29
VINCLOZOLIN
46
XYLENE
1,4,8
29
327
use.
ZINC CHLORIDE
1,4
ZINC LACTATE
107
1,4
328
Column 2
Poison
ACETYLCHOLINE
1 mg
ALDOSTERONE
10 micrograms
ANTIMONY COMPOUNDS
1 mg
APOMORPHINE
1 mg
ARSENIC
1 mg
300 micrograms
ATROPINE
300 micrograms
CANTHARIDIN
10 micrograms
CHLORINE
5 mg
1 mg
DIOXANE
100 mg
ERYSIMUM spp.
1 mg
ESTRADIOL
10 micrograms
ESTRONE
100 micrograms
329
FOLLICLE-STIMULATING HORMONE
100 micrograms
GELSEMIUM SEMPERVIRENS
1 mg
GLUCAGON
100 micrograms
GLYCERYL TRINITRATE
100 micrograms
GROWTH HORMONE
10 micrograms
HALOPERIDOL
1 mg
HYDROCYANIC ACID
1 microgram
HYOSCINE
300 micrograms
HYOSCYAMINE
300 micrograms
HYOSCYAMUS NIGER
300 micrograms
10 micrograms
INDOMETACIN
1 mg
MERCURY
1 mg
METHYLMERCURY
300 micrograms
NAPHTHALENE
1 mg
NERIUM OLEANDER
1 mg
OXYTOCIN
1 microgram
PHOSPHORUS
1 mg
330
1 mg
PROGESTERONE
1 mg
PROPRANOLOL
1 mg
SELENIUM
100 micrograms
STROPHANTHUS spp.
1 mg
STRYCHNINE
1 mg
TESTOSTERONE
1 mg
THYROXINE
10 micrograms
331
APPENDIX I
This Appendix is intentionally blank
Poisons Standard November 2016
332
2.
3.
4.
Not to be used in industries which handle, process or store foods, animal feeds or
packaging materials.
PART 2
A poison listed in this Appendix is to be available only in accordance with the conditions
specified beside it in the Conditions column. The conditions apply only when the poison is
included in Schedule 7.
POISONS
CONDITIONS
ABAMECTIN
ACIBENZOLAR-S-METHYL
ACROLEIN
ACRYLONITRILE
ALACHLOR
ALLYL ALCOHOL
4-AMINOPROPIOPHENONE
2
Poisons Standard November 2016
333
4-AMINOPYRIDINE
ARPRINOCID
ARSENIC
AZOCYCLOTIN
BENZENE
BORON TRIFLUORIDE
BRODIFACOUM
BROMADIOLONE
BROMINE
BRUCINE
CALCIFEROL
CAPTAFOL
CARBADOX
CARBON TETRACHLORIDE
CARBONYL SULFIDE
CHLORDECONE
CHLORDIMEFORM
334
CHLORINE
CHLOROMETHIURON
CHLOROPICIN
4-CHLORO-O-TOLUIDINE
COLECALCIFEROL
COUMATETRALYL
CYANOGEN
CYHEXATIN
1,2-DIBROMO-3-CHLOROPROPANE
1,3-DICHLOROPROPENE
DIFENACOUM
4-DIMETHYLAMINOAZOBENZENE
DINITROCRESOLS
DINITROPHENOLS
DINOSEB
EPICHLOROHYDRIN
335
ETACONAZOLE
ETHYLENE DIBROMIDE
ETHYLENE OXIDE
FLUOROACETAMIDE
FLUOROACETIC ACID
FOLPET
HALOFUGINONE
HCB
HYDROFLUORIC ACID
HYDROSILICOFLUORIC ACID
IODOMETHANE
MADURAMICIN
MERCURY
METHACRIFOS
METHOXYETHYLMERCURIC ACETATE
METHOXYETHYLMERCURIC CHLORIDE
336
METHYL BROMIDE
4,4-METHYLENEBIS[2-CHLOROANILINE]
MIREX
MOLINATE
NICOTINE
NITROFEN
PHENYLMERCURIC ACETATE
PHOSPHIDE, metallic
PHOSPHINE
PROPYLENE OXIDE
PYRINURON
STRYCHNINE
SULCOFURON
TETRACHLOROETHANE
2,2,6,6-TETRAISOPROPYL-DIPHENYL-CARBODIIMIDE
THALLIUM
ORTHO-TOLIDINE
TRICHLOROISOCYANURIC ACID
337
VINYL CHLORIDE
338
339
CETIRIZINE
CHLORAL HYDRATE
CHLORDIAZEPOXIDE
CHLORMETHIAZOLE
CHLORPHENAMINE
CHLORPROMAZINE
CLEMASTINE
CLOMIPRAMINE
CLONAZEPAM
CLONIDINE
CLORAZEPATE
CLOZAPINE
CODEINE except when included in Schedule 2 or 3.
CYCLIZINE
CYCLOBARBITONE
CYCLOSERINE
CYPROHEPTADINE
DANTROLENE
340
DESIPRAMINE
DEXCHLORPHENAMINE
DEXTROMORAMIDE
DEXTROPROPOXYPHENE
DIAZEPAM
DIFENOXIN
DIHYDROCODEINE
DIMENHYDRINATE
DIMETHINDENE
DIPHENHYDRAMINE
DIPHENOXYLATE
DIPHENYLPYRALINE
DOSULEPIN
DOXEPIN
DOXYLAMINE
DRONABINOL (delta-9-TETRAHYDROCANNABINOL)
DROPERIDOL
DULOXETINE
341
ETHYLMORPHINE
FENFLURAMINE
FLUNITRAZEPAM
FLUPENTIXOL
FLUPHENAZINE
FLURAZEPAM
GABAPENTIN
GEMCITABINE
GLUTETHIMIDE
HALOPERIDOL
HYDROCODONE
HYDROMORPHONE
HYDROXYZINE
IMIPRAMINE
LAMOTRIGINE
LEVETIRACETAM
LEVOCABASTINE
LEVOCETIRIZINE
342
LORAZEPAM
LURASIDONE.
MAZINDOL
MEBHYDROLIN
MECLOZINE
MEDAZEPAM
MEPROBAMATE
MEPYRAMINE
MERCAPTAMINE
METHADONE
METHDILAZINE
METHOCARBAMOL
METHYLPHENOBARBITAL
MIANSERIN
MIRTAZAPINE
MORPHINE
NABIXIMOLS .
NALBUPHINE
343
NITRAZEPAM
NORMETHADONE
NORTRIPTYLINE
OLANZAPINE
OPIUM in any form except the alkaloids noscapine and papaverine.
OXAZEPAM
OXYCODONE
PALIPERIDONE
PAPAVERETUM
PENTAZOCINE
PENTOBARBITAL
NITRAZEPAM
PHENOBARBIT
PERAMPANEL
PERICIAZINE
PERPHENAZINE
PETHIDINE
PHENELZINE
344
PHENIRAMINE
PHENOBARBITAL
PHENOPERIDINE
PHENYLTOLOXAMINE
PHOLCODINE
PIMOZIDE
PIZOTIFEN
PRAZEPAM
PREGABALIN
PROCHLORPERAZINE
PROMAZINE
PROMETHAZINE
PROTRIPTYLINE
QUETIAPINE
QUINALBARBITONE
RETIGABINE
RISPERIDONE
ROTIGOTINE
345
RUPATADINE
SECBUTOBARBITONE
SUVOREXANT
TAPENTADOL
TEMAZEPAM
TETRAHYDROCANNABINOLS
THENYLDIAMINE
THIETHYLPERAZINE
THIOPROPAZATE
THIORIDAZINE
THIOTHIXENE
TRAMADOL
TRANYLCYPROMINE
TRIFLUOPERAZINE
TRIMIPRAMINE
TRIPROLIDINE
ZIPRASIDONE
ZOLPIDEM
346
ZONISAMIDE
ZOPICLONE
347
if the substance is a veterinary chemical, the species of animal, the name of the
animals owner and the words FOR ANIMAL TREATMENT ONLY.
(4) The label on a container of a medicine or veterinary chemical that is supplied on prescription
must also include:
a) the prescription reference number;
b) the date on which the prescription was supplied (unless that date is clear from the
prescription reference number); and
c) the directions for use set out in the prescription.
PART 2 - ADDITIONAL LABELLING REQUIREMENTS FOR CERTAIN HUMAN
MEDICINES
(see Part 2, Controls on Medicines and Poisons Section 1.5.6(1)(a))
Medicines required to be labelled with certain warning statements A substance listed in Column
1 of the following table must be labelled with the warning statement in Appendix F, Part 1, as
specified opposite in Column 2.
Column 1
Column 2
348
Substance
Warning statement
ACITRETIN:
(i)
7,62 and 76
(ii)
62 and 77
ADAPALENE:
(i)
7, 62 and 76
(ii)
62 and 77
AMBRISENTAN.
7, 62 and 76
BEXAROTENE:
(i)
7, 62 and 76
(ii)
62 and 77
BOSENTAN.
7, 62 and 76
DIENESTROL.
67
349
ETRETINATE:
(i)
7, 62 and 76
(ii)
62 and 77
ENZALUTAMIDE
7, 67 and 87
FINGOLIMOD.
76
ISOTRETINOIN:
(i)
7, 62 and 76
(ii)
62 and 77
LEFLUNOMIDE.
7, 62 and 87
LENALIDOMIDE:
(i)
7, 62 and 76
(ii)
62 and 77
350
LEVOCABASTINE.
62
MACITENTAN.
7, 62 and 76
MISOPROSTOL.
53
POMALIDOMIDE.
7,62 and 76
RIOCIGUAT.
7, 62 and 76
SITAXENTAN.
7, 62 and 76
TERIFLUOMIDE.
7, 62 and 87
THALIDOMIDE:
(i)
7, 62 and 76
(ii)
62 and 77
351
TRETINOIN:
(i)
7, 62 and 76
(ii)
62 and 77
352
INDEX
INDEX
1
(1-(2-MORPHOLIN-4-YLETHYL)INDOL-3-YL)-NAPTHALEN-1- YLMETHANONE
cross reference: JWH-200
Schedule 9
1-(3,4,5-TRIMETHOXYPHENYL)-2-AMINOBUTANE
Schedule 9
1-(3-TRIFLUOROMETHYLPHENYL)PIPERAZINE
cross reference: TFMPP
Schedule 9
1-(5-FLUOROPENTYL)-3-(2-IODOBENZOYL)INDOLE
cross reference: AM-694
Schedule 9
1-(8-BROMOBENZO[1,2-B;4,5-B]DIFURAN-4-YL)-2-AMINOPROPANE
cross reference: BROMO-DRAGONFLY
Schedule 9
1-(BETA-METHYL SULPHONAMIDOETHYL)- 2-AMINO-3
Appendix F, Part 3
1-(1,1-DIMETHYLETHYL)-2-METHOXY-4-METHYL-3,5-DINITROBENZENE (musk
ambrette)
cross reference: Amber musk
Schedule 10
1,1,1-TRICHLOROETHANE
cross reference: DESIGNATED SOLVENT
Schedule 10
Schedule 5
Appendix E, Part 2
Appendix F, Part 3
Part 1 - Interpretation
1,2-BENZENEDIAMINE
Schedule 10
1,2-BENZENEDIOL
cross reference: CATECHOL
353
INDEX
Schedule 6
Appendix E, Part 2
Appendix F, Part 3
1,2-DIBROMO-3-CHLOROPROPANE
Schedule 7
Appendix J, Part 2
1,2-DICHLOROPROPANE
Schedule 6
1,2-ETHANEDIAMINE POLYMER WITH (CHLOROMETHYL)OXIRANE AND NMETHYLMETHANAMINE
cross reference: N-METHYLMETHANAMINE
Schedule 5
1,3,5,7-TETRAAZATRICYLO[3.3.1.13,7] DECANE
cross reference: HEXAMINE, HEXAMETHYLENETETRAMINE
Schedule 5
1,3-BENZENEDIAMINE
Schedule 10
1,3-DICHLOROPROPENE
Schedule 7
Appendix J, Part 2
1,3-DIMETHYLAMYLAMINE
cross reference: 4-METHYLHEXANE-2-AMINE, DMAA
Schedule 10
1,4-BUTANEDIOL
Schedule 10
2-ETHYLHEXANOIC ACID
Schedule 6
Appendix E, Part 2
Appendix F, Part 3
2,4-DIAMINOPHENOXYETHANOL
Schedule 6
Appendix E, Part 2
Appendix F, Part 3
13
C-UREA
Poisons Standard November 2016
354
INDEX
Appendix B, Part 3
19-NORANDROSTENEDIOL
Schedule 4
Appendix D, Item 5 (Anabolic and/or androgenic steroidal agents)
19-NORANDROSTENEDIONE
Schedule 4
Appendix D, Item 5 (Anabolic and/or androgenic steroidal agents)
1-AMINOMETHANAMIDE DIHYDROGEN TETRAOXOSULFATE
Schedule 6
1-METHYL-4-PHENYL-4-PIPERIDINOL PROPIONATE
cross reference: ACIDMPPP
Schedule 9
1-METHYL-4-PHENYLPIPERIDINE-4-CARBOXYLIC ACID
cross reference: PETHIDINE INTERMEDIATE C
Schedule 8
1-METHYLCYCLOPROPENE
Appendix B, Part 3
1-OCTEN-3-OL
Schedule 6
1-PENTYL-3-(1-NAPHTHOYL)INDOLE
cross reference: JWH-018
Schedule 9
1-PENTYL-3-(4-METHYL-1-NAPTHOYL)INDOLE
cross reference: JWH-122
Schedule 9
1-PHENYLETHYL-4-PHENYL-4-PIPERIDINOL ACETATE
cross reference: PEPAP
Schedule 9
2
2-(2-METHOXYPHENYL)-1-(1-PENTYLINDOL-3-YL)ETHANONE
cross reference: JWH-250
Schedule 9
Poisons Standard November 2016
355
INDEX
2-(4-CHLOROPHENYL)-(1,2,4)TRIAZOLO[5,1-A]ISOQUINOLINE
Schedule 4
2,2,6,6-TETRAISOPROPYL-DIPHENYL-CARBODIIMIDE
cross reference: STABAXOL
Schedule 6
Schedule 7
Appendix J, Part 2
2,2-DPA
cross reference: SODIUM 2,2-DICHLOROPROPIONATE
Appendix B, Part 3
2,3,6-TBA
Schedule 5
2,4,5-T
Schedule 6
2,4-D
Schedule 6
Schedule 5
2,4-DB
Schedule 5
2,4-DES
Schedule 5
2,4-DIAMINO-PHENOXYETHANOL
Schedule 6
Appendix E, Part 2
Appendix F, Part 3
2,4-DICHLORPROP
Schedule 6
2,4-DINITROCHLOROBENZENE
Schedule 4
2,4-TOLUENEDIAMINE
Schedule 10
356
INDEX
2,5-DIMETHOXY-4-IODOPHENETHYLAMINE DIMETHOXY-4-(N)PROPYLTHIOPHENETHYLAMINE
cross reference: 2C-T-7
Schedule 9
2,5-DIMETHOXY-4-BROMOAMFETAMINE
cross reference: 2,5-DIMETHOXY-4-BROMOAMPHETAMINE, DOB
Schedule 9
2,5-DIMETHOXY-4-ETHYL-a-AMFETAMINE
cross reference: 2,5-DIMETHOXY-4-ETHYL-a-AMPHETAMINE, DOET
Schedule 9
2,5-DIMETHOXY-4-ETHYLTHIOPHENETHYLAMINE
cross reference: 2C-T-2
Schedule 9
2,5-DIMETHOXY-4-IODOPHENETHYLAMINE
cross reference: 2C-I
Schedule 9
2,5-DIMETHOXYAMFETAMINE
cross reference: 2,5-DIMETHOXYAMPHETAMINE, DMA
Schedule 9
2-[(1R,3S)-3-HYDROXYCYCLOHEXYL]-5-(2-METHYLNONAN-2-YL)PHENOL
cross reference: CANNABICYCLOHEXANOL, CP 47,497 C8 HOMOLOGUE, CP 47,497
Schedule 9
2-AMINO-1-(2,5-DIMETHOXY-4-METHYL)PHENYLPROPANE
cross reference: DOM, STP
Schedule 9
2-AMINO-5-ETHYLPHENOL
Schedule 6
Appendix E, Part 2
Appendix F, Part 3
2-BUTOXY-2-THIOCYANODIETHYL ETHER
Schedule 6
Appendix F, Part 3
2-BUTOXYETHANOL
357
INDEX
Schedule 6
Appendix E, Part 2
Appendix F, Part 3
2-CHLORO-6-(TRICHLOROMETHYL)-PYRIDINE
Schedule 6
2-ETHOXYETHANOL
Schedule 7
Appendix F, Part 3
2-HYDROXYETHYL METHACRYLATE
Schedule 5
Appendix E, Part 2
Appendix F, Part 3
2-METHOXY-5-NITROPHENOL
cross reference: SODIUM 5-NITROGUAIACOLATE
Schedule 6
2-METHOXYETHANOL
Schedule 7
Appendix F, Part 3
2-MERCAPTOETHANOL
Schedule 6
2-METHYL-3-MORPHOLINO-1, 1-DIPHENYLPROPANE CARBOXYLIC ACID
cross reference: MORAMIDE INTERMEDIATE
Schedule 9
2-METHYLTHIO-4-(2-METHYLPROP-2-YL) AMINO-6-CYCLOPROPYLAMINO-5TRIAZINE
Schedule 5
2-NITROTOLUENE
Schedule 7
2-PHENOXYETHANOL
Schedule 6
Appendix E, Part 2
Appendix F, Part 3
2-PROPYLENE GLYCOL 1-MONOMETHYL
Appendix B, Part 3
Poisons Standard November 2016
358
INDEX
3
3-(1,2-DIMETHYLHEPTYL)-1-HYDROXY-7,8,9,10-TETRAHYDRO-6,6,9TRIMETHYL-6H-DIBENZO (b,d) PYRAN
cross reference: DMHP
Schedule 9
3-(2-DIMETHYLAMINOETHYL)-4-HYDROXYINDOLE
cross reference: PSILOCINE, PSILOTSIN
Schedule 9
3,4,5-TRIMETHOXY- METHYLPHENYLETHYLAMINE
cross reference: TMA
Schedule 9
3,4,5-TRIMETHOXYPHENETHYLAMINE
cross reference: MESCALINE, METHOXYPHENAMINE, METHOXYPHENYLETHYLAMINE
Schedule 9
3,4-DICHLORO-N-{[1DIMETHYLAMINO)CYCLOHEXYL]METHYL}
BENZAMIDE
Schedule 9
3,4-METHYLENEDIOXYAMFETAMINE
cross reference: 3,4-METHYLENEDIOXYAMPHETAMINE, MDA
Schedule 9
3,4-METHYLENEDIOXYPYROVALERONE
cross reference: MDPV
Schedule 9
3,7-DIMETHYL-2,6-OCTADIENAL
cross reference: CITRAL, NERAL, GERANIAL
Schedule 5
3,6,9-TRIOXAUNDECANEDIOIC ACID
Schedule 5
Appendix F, Part 3
3-HEXYL-1-HYDROXY-7,8,9,10-TETRAHYDRO-6,6,9-TRIMETHYL-6H-DIBENZO
(b,d) PYRAN
cross reference: PARAHEXYL
Schedule 9
359
INDEX
360
INDEX
Schedule 4
Appendix D, Item D (Anabolic and/or androgenic steroidal agents)
4-CHLORO-O-TOLUIDINE
Schedule 7
Appendix J, Part 2
4-CPA
Schedule 5
4-CYANO-1-METHYL-4-PHENYLPIPERIDINE
cross reference: PETHIDINE INTERMEDIATE A
Schedule 8
4-CYANO-2-DIMETHYLAMINO-4,4-DIPHENYLBUTANE
cross reference: METHADONE INTERMEDIATE
Schedule 9
4-DIMETHYLAMINOAZOBENZENE
cross reference: MOCA, N,N-DIMETHYL-4-[PHENYLAZO]-BENZENAMINE
Schedule 7
Appendix J, Part 2
4-FLUORO-N-METHYLAMFETAMINE
cross reference: 4-FLUORO-N-METHYLAMPHETAMINE, 4-FLUORO-NMETHAMFETAMINE
Schedule 9
4-HYDROXYBUTANOIC ACID
Schedule 9
4-METHOXY- METHYLPHENYLETHYLAMINE
cross reference: PMA
Schedule 9
4-METHYLAMINOREX
Schedule 9
4-METHYLMETHCATHINONE
cross reference: MEPHEDRONE
Schedule 9
4-METHYLTHIOAMFETAMINE
cross reference: 4-METHYLTHIOAMPHETAMINE
Schedule 9
Poisons Standard November 2016
361
INDEX
362
INDEX
Schedule 7
Schedule 6
Schedule 5
Appendix J, Part 2
ABATACEPT
Schedule 4
ABCIXIMAB
Schedule 4
ABIRATERONE ACETATE
Schedule 4
ABRUS PRECATORIUS
cross reference: JEQUIRITY
Schedule 10
ABSCISIC ACID
Schedule 5
ACAMPROSATE CALCIUM
Schedule 4
ACARBOSE
Schedule 4
ACEBUTOLOL
Schedule 4
ACEPHATE
Schedule 6
ACEPROMAZINE
Schedule 4
ACETAMIPRID
Schedule 6
ACETANILIDE
cross reference: ALKYL ACETANILIDES
Schedule 4
ACETARSOL
Poisons Standard November 2016
363
INDEX
Schedule 4
ACETAZOLAMIDE
Schedule 4
ACETIC ACID
Schedule 6
Schedule 5
Schedule 2
Appendix E, Part 2
Appendix F, Part 3
ACETIC ANHYDRIDE
Schedule 6
Appendix E, Part 2
Appendix F, Part 3
ACETOHEXAMIDE
Schedule 4
ACETONE
cross reference: DESIGNATED SOLVENT
Schedule 5
Appendix E, Part 2
Appendix F, Part 3
Part 1 Interpretation
ACETORPHINE
Schedule 9
ACETYL ISOVALERYLTYLOSIN
Schedule 4
ACETYL-ALPHA-METHYLFENTANYL
Schedule 9
ACETYLCARBROMAL
Schedule 4
ACETYLCHOLINE
Schedule 4
Appendix G
ACETYLCYSTEINE
364
INDEX
Schedule 4
Schedule 2
ACETYLDIGITOXIN
Schedule 4
ACETYLDIHYDROCODEINE
Schedule 8
ACETYLMETHADOL
Schedule 8
ACETYLMETHYLDIMETHYLOXIMIDOPHENYLHYDRAZINE
Schedule 4
ACETYLMORPHINES
Schedule 8
ACETYLSTROPHANTHIDIN
Schedule 4
ACIBENZOLAR-S-METHYL
Schedule 7
Appendix J, Part 2
ACICLOVIR
Schedule 4
ACIFLUORFEN
Schedule 6
ACINITRAZOLE
Schedule 6
ACIPIMOX
Schedule 4
ACITRETIN
Schedule 4
Appendix D, Item 2
Appendix F, Part 3
Appendix L, Part 2
ACLIDINIUM BROMIDE
Poisons Standard November 2016
365
INDEX
Schedule 4
ACOKANTHERA OUABAIO
Schedule 4
ACOKANTHERA SCHIMPERI
Schedule 4
ACONITUM spp.
Schedule 4
Schedule 2
ACORUS CALAMUS
cross reference: CALAMUS
Schedule 10
ACRIFLAVINE
cross reference: ACRIFLAVINIUM CHLORIDE
ACRIFLAVINUM CHLORIDE
Schedule 7
Schedule 5
ACRIVASTINE
Schedule 4
ACROLEIN
Schedule 7
Appendix E, Part 2
Appendix F, Part 3
ACRYLONITRILE
Schedule 7
Appendix J, Part 2
ADALIMUMAB
Schedule 4
ADAPALENE
Schedule 4
Appendix F, Part 3
Appendix L, Part 2
ADEFOVIR
Schedule 4
Poisons Standard November 2016
366
INDEX
ADENOSINE
Schedule 4
ADIPHENINE
Schedule 4
ADONIS VERNALIS
Schedule 4
ADRAFINIL
Schedule 4
ADRENALINE
Schedule 4
Schedule 3
ADRENOCORTICAL HORMONES
Schedule 4
AFAMELANOTIDE
cross reference: MELANOCYTE STIMULATING HORMONE
Schedule 4
AFATINIB DIMALEATE
Schedule 4
AFLIBERCEPT
Schedule 4
AFOXOLANER
Schedule 5
AGALSIDASE
Schedule 4
AGLEPRISTONE
Schedule 4
AGOMELATINE
Schedule 4
AGROBACTERIUM RADIOBACTER
Poisons Standard November 2016
367
INDEX
Appendix B, Part 3
AKLOMIDE
Schedule 5
ALACHLOR
Schedule 7
Appendix J, Part 2
ALATROFLOXACIN MESILATE
cross reference: ALATROFLOXACIN MESYLATE
Schedule 4
ALBENDAZOLE
Schedule 6
Schedule 5
Schedule 4
ALCLOFENAC
Schedule 4
ALCLOMETASONE
Schedule 4
Schedule 3
Appendix F, Part 3
ALCOHOL, DEHYDRATED
Appendix B, Part 3
ALCURONIUM
Schedule 4
ALDESLEUKIN
Schedule 4
ALDICARB
Schedule 7
ALDOSTERONE
Schedule 4
Appendix G
ALDOXYCARB
Schedule 7
Poisons Standard November 2016
368
INDEX
ALDRIN
Schedule 6
ALEFACEPT
Schedule 4
Appendix D, Item 7
ALEMTUZUMAB
Schedule 4
ALENDRONIC ACID
Schedule 4
ALFACALCIDOL
Schedule 4
ALFENTANIL
Schedule 8
ALFUZOSIN
Schedule 4
ALGICIDES
Appendix A
ALGLUCERASE
Schedule 4
ALGLUCOSIDASE
Schedule 4
ALIMEMAZINE
cross reference: TRIMEPRAZINE
Schedule 4
Schedule 3
Schedule 2
Appendix K
ALIROCUMAB
Schedule 4
ALISKIREN
Schedule 4
Poisons Standard November 2016
369
INDEX
ALKALINE SALTS
cross reference: LYE WATER, POTASSIUM CARBONATE. POTASSIUM PHOSPHATE,
POTASSIUM SALTS, POTASSIUM SILICATE, SODIUM CARBONATE, SODIUM SALTS,
SODIUM SILICATE(S)
Schedule 10
Schedule 6
Schedule 5
Appendix E, Part 2
Appendix F, Part 3
ALKOXYAMFETAMINES
cross reference: ALKOXYAMPHETAMINES
Schedule 9
ALKOXYLATED FATTY ALKYLAMINE POLYMER
Schedule 6
Schedule 5
ALKOXYPHENYLETHYLAMINES
Schedule 9
ALKYLTHIOAMFETAMINES
cross reference: ALKYLTHIOAMPHETAMINES
Schedule 9
ALLERGENS
Schedule 4
ALLETHRIN
Schedule 6
Schedule 5
ALLOPURINOL
Schedule 4
ALLOXYDIM
Schedule 5
ALLYL ALCOHOL
Schedule 7
Appendix J, Part 2
ALLYLESTRENOL
cross reference: ALLYLOESTRENOL
Schedule 4
Poisons Standard November 2016
370
INDEX
ALLYLISOPROPYLACETYLUREA
Schedule 10
ALLYLOESTRENOL
cross reference: ALLYLESTRENOL
ALLYLPRODINE
Schedule 10
ALOGLIPTIN
Schedule 4
ALOSETRON
Schedule 4
ALOXIPRIN
Schedule 2
ALPHA1-PROTEINASE INHIBITOR (HUMAN)
Schedule 4
ALPHACETYLMETHADOL
Schedule 8
ALPHA-CHLOROHYDRIN
Schedule 6
Appendix F, Part 3
ALPHA-CYPERMETHRIN
Schedule 7
Schedule 6
Schedule 5
ALPHADOLONE
Schedule 4
ALPHAMEPRODINE
Schedule 9
ALPHAMETHADOL
Schedule 9
ALPHA-METHYLFENTANYL
Poisons Standard November 2016
371
INDEX
Schedule 9
ALPHA-METHYLTHIOFENTANYL
Schedule 9
ALPHAPRODINE
Schedule 8
ALPHAXALONE
Schedule 4
ALPRAZOLAM
Schedule 8
Appendix D, Item 5 (Benzodiazepine group entry)
Appendix K
ALPRENOLOL
Schedule 4
ALPROSTADIL
Schedule 4
ALSEROXYLON
Schedule 4
ALTEPLASE
Schedule 4
ALTRENOGEST
Schedule 4
ALTRETAMINE
cross reference: HEXAMETHYLMELAMINE
Schedule 4
ALUM
Appendix B, Part 3
ALUMINIUM AMMONIUM SULFATE
Appendix B, Part 3
ALUMINIUM POTASSIUM SULFATE
Appendix B, Part 3
Poisons Standard November 2016
372
INDEX
ALUMINIUM SILICATE
Appendix B, Part 3
ALUMINIUM tris (ETHYLPHOSPHONATE)
Appendix B, Part 3
AMANTADINE
Schedule 4
AMBENONIUM CHLORIDE
Schedule 4
AMBRISENTAN
Schedule 4
Appendix D, Item 6
Appendix F, Part 3
Appendix L, Part 2
AMBUCETAMIDE
Schedule 4
AMBUTONIUM BROMIDE
Schedule 4
AMCINONIDE
Schedule 4
AMETOCTRADIN
Appendix B, Part 3
AMETRYN
Schedule 5
AMICARBAZONE
Schedule 6
AMIDITHION
Schedule 6
AMIDOPROPYL BETAINES
Schedule 6
Appendix E, Part 2
Poisons Standard November 2016
373
INDEX
AMIFOSTINE
Schedule 4
AMIKACIN
Schedule 4
AMILORIDE
Schedule 4
AMINACRINE
cross reference: AMINOACRIDINE
AMINES
cross reference: CURING AGENTS FOR EPOXY RESINS
Schedule 5
Appendix E, Part 2
Appendix F, Part 3
AMINOACRIDINE
cross reference: AMINACRINE
Schedule 7
Schedule 5
2-AMINO-6-CHLORO-4-NITROPHENOL
Schedule 6
Appendix E, Part 2
Appendix F, Part 3
4-AMINO-m-CRESOL
Schedule 6
Appendix E, Part 2
Appendix F, Part 3
5-AMINO-o-CRESOL
cross reference: 4-AMINO-2-HYDROXYTOLUENE
4-AMINO-2-HYDROXYTOLUENE
Schedule 6
Appendix E, Part 2
Appendix F, Part 3
AMINOCAPROIC ACID
Schedule 4
AMINOCARB
374
INDEX
Schedule 7
Schedule 6
AMINOCYCLOPYRACHLOR
Schedule 5
AMINOETHOXYVINYLGLYCINE
Schedule 6
AMINOGLUTETHIMIDE
Schedule 4
AMINOMETRADINE
Schedule 4
4-AMINO-3-NITROPHENOL
Schedule 6
Appendix E, Part 2
Appendix F, Part 3
AMINOPHENAZONE
cross reference: AMIDOPYRINE
Schedule 10
Schedule 4
AMINOPHYLLINE
Schedule 4
Schedule 3
AMINOPTERIN
Schedule 4
AMINOPYRALID
Schedule 6
Schedule 5
AMINOREX
Schedule 4
AMINOSALICYLIC ACID
Schedule 4
AMIODARONE
Schedule 4
Poisons Standard November 2016
375
INDEX
AMIPHENAZOLE
Schedule 4
AMISOMETRADINE
Schedule 4
AMISULBROM
Schedule 5
AMISULPRIDE
Schedule 4
Appendix K
AMITON
Schedule 7
AMITRAZ
Schedule 6
AMITRIPTYLINE
Schedule 4
Appendix K
AMITROLE
Schedule 5
AMLODIPINE
Schedule 4
AMMI VISNAGA
Schedule 4
AMMONIA
cross reference: AMMONIUM HYDROXIDE, CHROMATES
Schedule 6
Schedule 5
Appendix E, Part 2
Appendix F, Part 3
AMMONIUM BROMIDE
Schedule 4
AMMONIUM COCOYL ISETHIONATE
Poisons Standard November 2016
376
INDEX
Schedule 6
Appendix E, Part 2
AMMONIUM PERSULFATE
Schedule 6
Appendix E, Part 2
Appendix F, Part 3
AMMONIUM PHOSPHATE
Appendix B, Part 3
AMMONIUM THIOCYANATE
Schedule 5
Appendix E, Part 2
AMMONIUM THIOSULPHATE
Appendix B, Part 3
AMOBARBITAL
cross reference: AMYLOBARBITONE and AMYLOBARBITAL
Schedule 8
Schedule 4
Appendix K
AMODIAQUINE
Schedule 4
AMOROLFINE
Schedule 4
Schedule 3
AMOXAPINE
Schedule 4
AMOXICILLIN
Schedule 4
AMOXYCILLIN
cross reference: AMOXICILLIN
AMFETAMINE
cross reference: AMPHETAMINE
Schedule 8
AMPHOMYCIN
Poisons Standard November 2016
377
INDEX
Schedule 4
AMPHOTERICIN
cross reference: AMPHOTERICIN B
AMPHOTERICIN B
Schedule 4
AMPICILLIN
Schedule 4
AMPRENAVIR
Schedule 4
AMPROLIUM
Appendix B, Part 3
AMRINONE
Schedule 4
AMSACRINE
Schedule 4
AMYGDALIN 2
Schedule 10
AMYL ACETATE
Appendix B, Part 3
AMYL NITRITE
Schedule 4
-AMYLASE derived from Aspergillus niger
Appendix B, Part 3
AMYLOBARBITAL
cross reference: AMOBARBITAL
AMYLOBARBITONE
cross reference: AMOBARBITAL
AMYLOCAINE
Schedule 4
378
INDEX
379
INDEX
Appendix B, Part 3
ANECORTAVE
Schedule 4
ANGIOTENSIN AMIDE
Schedule 4
ANHYDRIDES, ORGANIC ACID
cross reference: CURING AGENTS FOR EPOXY RESINS
Schedule 5
Appendix E, Part 2
Appendix F, Part 3
ANIDULAFUNGIN
Schedule 4
ANILERIDINE
Schedule 8
ANILINE
Schedule 6
Appendix E, Part 2
Appendix F, Part 3
ANISE OIL
Schedule 5
Appendix E, Part 2, Part 4
ANISTREPLASE
Schedule 4
ANTAZOLINE
Schedule 4
Schedule 2
ANTIBIOTIC SUBSTANCES
cross reference: NISIN
Schedule 4
ANTIGENS
Schedule 4
380
INDEX
ANTIHISTAMINES
cross reference: ASTEMIZOLE, AZELASTINE, DESLORATADINE, FEXOFENADINE,
LORATADINE, TERFENADINE
Schedule 4
Appendix F, Part 3
ANTIMONY
cross reference: ANTIMONY COMPOUNDS, ANTIMONY CHLORIDE, ANTIMONY
TITANATE
Schedule 6
Schedule 4
Appendix E, Part 2
Appendix G
ANTISERA
cross reference: IMMUNOSERA
Schedule 4
AOD-9604 (CAS No. 221231-10-3)
Schedule 4
Appendix D, Item 5
APIXABAN
Schedule 4
APOCYNUM spp.
Schedule 4
APOMORPHINE
Schedule 4
Appendix G
APRACLONIDINE
Schedule 4
APRAMYCIN
Schedule 4
APREMILAST
Schedule 4
APREPITANT
Schedule 4
APRONAL
Poisons Standard November 2016
381
INDEX
Schedule 4
APROTININ
Schedule 4
ARECOLINE
Schedule 4
ARIPIPRAZOLE
Schedule 4
Appendix K
ARISTOLOCHIA spp.
Schedule 10
ARISTOLOCHIC ACID(S)
cross reference: ASARUM spp, BRAGANTIA
Schedule 10
ARPRINOCID
Schedule 7
Appendix J, Part 2
ARMODAFINIL
Schedule 4
ARSENIC
cross reference: ARSENIC TRIOXIDE, CACODYLIC ACID, TERMITE BARRIERS,
COPPER-CHROME-ARSENIC, SELENIUM ARSENIDE, THIACETARSAMIDE
Schedule 7
Schedule 6
Schedule 4
Appendix G
Appendix J, Part 2
ARTEMETHER
Schedule 4
ARTICAINE
Schedule 4
ASARUM spp
Schedule 10
ASENAPINE
Poisons Standard November 2016
382
INDEX
Schedule 4
Appendix K
ASFOTASE ALFA
Schedule 4
ASPARAGINASE
Schedule 4
ASPARTIC ACID
Appendix B, Part 3
ASPIRIN
cross reference: CAFFEINE, DIHYDROCODEINE, PARACETAMOL, SALICYLAMIDE
Schedule 6
Schedule 5
Schedule 4
Schedule 2
Appendix F, Part 3
ASTEMIZOLE
Schedule 4
Appendix F, Part 3
ASULAM
Appendix B, Part 3
ASUNAPREVIR
Schedule 4
ATAMESTANE
Schedule 4
Appendix D, Item 5 (Anabolic and/or androgenic steroidal agents)
ATAZANAVIR
Schedule 4
ATENOLOL
Schedule 4
ATIPAMEZOLE
Schedule 4
ATOMOXETINE
Poisons Standard November 2016
383
INDEX
Schedule 4
ATORVASTATIN
Schedule 4
ATOSIBAN
Schedule 4
ATOVAQUONE
Schedule 4
ATRACURIUM BESILATE
cross reference: ATRACURIUM BESYLATE
Schedule 4
ATRAZINE
Schedule 5
ATROPA BELLADONNA
cross reference: BELLADONNA
Schedule 4
Schedule 2
Appendix G
ATROPINE
Schedule 4
Schedule 2
Appendix G
ATROPINE METHONITRATE
Schedule 4
AURANOFIN
Schedule 4
AUROTHIOMALATE SODIUM
Schedule 4
AVILAMYCIN
Schedule 4
AVIPTADIL
Schedule 4
Poisons Standard November 2016
384
INDEX
AVOPARCIN
Schedule 4
AXITINIB
Schedule 4
AZACITIDINE
Schedule 4
AZACONAZOLE
Schedule 6
AZACYCLONOL
Schedule 4
AZADIRACHTA INDICA
cross reference: DEBITTERISED NEEM SEED OIL, NEEM
Schedule 10
Schedule 6
Appendix E, Part 2
Appendix F, Part 3
AZADIRACHTA INDICA EXTRACTS
Schedule 5
AZAFENIDIN
Schedule 7
AZAMETHIPHOS
Schedule 6
AZAPERONE
Schedule 4
AZAPROPAZONE
Schedule 4
AZARIBINE
Schedule 4
AZATADINE
Appendix K
Poisons Standard November 2016
385
INDEX
AZATADINE
Schedule 4
Schedule 3
AZATHIOPRINE
Schedule 4
AZELAIC ACID
Schedule 4
Schedule 2
AZELASTINE
Schedule 4
Schedule 2
AZIMSULFURON
Appendix B, Part 3
AZINPHOS-ETHYL
Schedule 7
AZINPHOS-METHYL
Schedule 7
AZITHROMYCIN
Schedule 4
AZLOCILLIN
Schedule 4
AZOBENZENE
Schedule 6
AZOCYCLOTIN
Schedule 7
Appendix F, Part 3
Appendix J, Part 2
AZO DYES (derivatives by diazotisation)
Schedule 7
AZOXYSTROBIN
Schedule 5
Poisons Standard November 2016
386
INDEX
AZTREONAM
Schedule 4
B
BACAMPICILLIN
Schedule 4
BACILLUS SPHAERICUS STRAIN 2362
Appendix B, Part 3
BACILLUS THURINGIENSIS
cross reference: ENDOTOXIN
Appendix B, Part 3
BACILLUS THURINGIENSIS DELTA ENDOTOXIN
Schedule 5
BACILLUS TOYOI
Appendix B, Part 3
BACITRACIN
Schedule 4
BACLOFEN
Schedule 4
Appendix K
BACTERIAL CULTURE MEDIA
cross reference: ANTIBIOTIC SUBSTANCES
Appendix A
BACTERIOCIDES
Appendix A
BACULOVIRUS CYDIA POMONELLA
Appendix B, Part 3
BALSALAZIDE
Schedule 4
BAMBERMYCIN
cross reference: FLAVOPHOSPHOLIPOL
Poisons Standard November 2016
387
INDEX
Schedule 6
Schedule 4
BAMBUTEROL
Schedule 4
BAMETHAN
Schedule 4
BAMIPINE
Schedule 4
BARBITURATES
Schedule 4
BARIUM SALTS
cross reference: BARIUM METABORATE, BARIUM SULFATE
Schedule 6
Appendix E, Part 2
BARIUM SILICOFLUORIDE
Schedule 5
BASIC BLUE 26
Schedule 10
Schedule 6
BASIC ORANGE 31
Cross reference: 2-[(4-AMINOPHENYL)AZO]-1,3-DIMETHYL-1H-IMIDAZOLIUM,
CHLORIDE
Schedule 10
Schedule 6
BASIL OIL
cross reference: METHYL CHAVICOL
Schedule 5
Appendix E, Part 2
BASILIXIMAB
Schedule 4
BATTERIES
Appendix A
BAY OIL
Poisons Standard November 2016
388
INDEX
Schedule 6
Appendix E, Part 2
BAZEDOXIFENE
Schedule 4
BEAUVERIA BASSIANA
Schedule 6
Schedule 5
BECAPLERMIN
Schedule 4
BECLAMIDE
Schedule 4
BECLOMETASONE
cross reference: BECLOMETHASONE
Schedule 4
Schedule 2
BECLOMETHASONE
cross reference: BECLOMETASONE
BELATACEPT
Schedule 4
BELIMUMAB
Schedule 4
BEMEGRIDE
Schedule 4
BENACTYZINE
Schedule 4
BENALAXYL
Schedule 5
BENAZEPRIL
Schedule 4
BENDAMUSTINE
Schedule 4
Poisons Standard November 2016
389
INDEX
BENDIOCARB
cross reference: DENATONIUM BENZOATE
Schedule 7
Schedule 6
Schedule 5
BENDROFLUAZIDE
Schedule 4
BENETHAMINE PENICILLIN
Schedule 4
BENFLURALIN
Appendix B, Part 3
BENOMYL
Schedule 7
Appendix F, Part 3
BENORYLATE
Schedule 4
BENOXAPROFEN
Schedule 4
BENPERIDOL
Schedule 4
BENQUINOX
Schedule 6
BENSERAZIDE
Schedule 4
BENSULFURON-METHYL
Appendix B, Part 3
BENSULIDE
Schedule 6
BENTAZONE
Schedule 5
Poisons Standard November 2016
390
INDEX
BENTONITE
Appendix B, Part 3
BENZALKONIUM CHLORIDE
Schedule 6
Schedule 5
Appendix E, Part 2
BENZATHINE PENICILLIN
Schedule 4
BENZENE
Schedule 7
Appendix E, Part 2
Appendix F, Part 3
Appendix J, Part 2
BENZETHIDINE
Schedule 9
BENZHEXOL
cross reference: TRIHEXYPHENIDYL
BENZIDINE-CONGENER (3,3'-disubstituted) AZO DYES
Schedule 7
BENZIDINE-BASED AZO DYES
Schedule 7
BENZILONIUM
Schedule 4
BENZOCAINE
Schedule 4
Schedule 2
BENZODIAZEPINE DERIVATIVES
Schedule 4
Appendix D, Item 5
BENZOFENAP
Schedule 5
BENZOYL PEROXIDE
Poisons Standard November 2016
391
INDEX
Schedule 5
Schedule 4
Schedule 2
Appendix E, Part 2
Appendix F, Part 3
BENZOYLINDOLES
Schedule 9
BENZPHETAMINE
Schedule 4
BENZTHIAZIDE
Schedule 4
BENZATROPINE
cross reference: BENZITROPINE
Schedule 4
Appendix K
BENZYDAMINE
Schedule 2
Schedule 4
BENZYL BENZOATE
Appendix B, Part 3
BENZYLMORPHINE
Schedule 8
BENZYLPENICILLIN
Schedule 4
BENZYLPIPERAZINE
cross reference: BZP
Schedule 9
BEPHENIUM SALTS
Schedule 2
BEPRIDIL
Schedule 4
BERACTANT
Poisons Standard November 2016
392
INDEX
Schedule 4
BERGAMOT OIL
Schedule 5
Appendix E, Part 2
Appendix F, Part 3
BERYLLIUM
Schedule 6
Appendix F, Part 3
BESIFLOXACIN
Schedule 4
BETACETYLMETHADOL
Schedule 9
BETACYFLUTHRIN
Schedule 7
Schedule 6
Schedule 5
BETA-CYPERMETHRIN
Schedule 6
BETAHISTINE
Schedule 4
BETA-HYDROXY-3-METHYLFENTANYL
Schedule 9
BETA-HYDROXYFENTANYL
Schedule 9
BETAINE HYDROCHLORIDE
Appendix B, Part 3
BETAMEPRODINE
Schedule 9
BETAMETHADOL
Schedule 9
BETAMETHASONE
Poisons Standard November 2016
393
INDEX
Schedule 4
BETAPRODINE
Schedule 9
BETAXOLOL
Schedule 4
BETHANECHOL CHLORIDE
Schedule 4
BETHANIDINE
Schedule 4
BEVACIZUMAB
Schedule 4
BEVANTOLOL
Schedule 4
BEXAROTENE
Schedule 4
Appendix D, Item 2
Appendix F, Part 3
Appendix L, Part 2
BEZAFIBRATE
Schedule 4
BEZITRAMIDE
Schedule 8
BHC
Schedule 6
BICALUTAMIDE
Schedule 4
BICYCLOPYRONE
Schedule 6
Schedule 5
BIFENAZATE
Poisons Standard November 2016
394
INDEX
Appendix B, Part 3
BIFENTHRIN
Schedule 7
Schedule 6
BIFLUORIDES
cross reference: AMMONIUM BIFLUORIDE, AMMONIUM SALTS, POTASSIUM SALTS,
SODIUM SALTS
Schedule 7
Schedule 6
Schedule 5
Appendix E, Part 2
Appendix F, Part 3
Appendix J
BIFONAZOLE
Schedule 4
Schedule 2
BIMATOPROST
Schedule 4
BIOALLETHRIN
Schedule 6
Schedule 5
BIORESMETHRIN
Schedule 5
BIPERIDEN
Schedule 4
BISMUTH COMPOUNDS
cross reference: BISMUTH CITRATE, BISMUTH FORMIC IODIDE, BISMUTH
OXYCHLORIDE, BISMUTH SUBIODIDE
Schedule 4
BISMUTH SUBNITRATE
Appendix B, Part 3
BISOPROLOL
Schedule 4
BISPYRIBAC
Poisons Standard November 2016
395
INDEX
Schedule 5
BISTRIFLURON
Appendix B, Part 3
BITHIONOL
Schedule 10
Schedule 6
Appendix F, Part 3
BIURET
Appendix B, Part 3
BIVALIRUDIN
Schedule 4
BIXAFEN
Schedule 5
BLAD (banda de Lupinus albus doce)
Appendix B, Part 3
BLEOMYCIN
Schedule 4
BOCEPREVIR
Schedule 4
BOLANDIOL
Schedule 4
Appendix D, Item 5 (Anabolic and/or androgenic steroidal agents)
BOLASTERONE
Schedule 4
Appendix D, Item 5 (Anabolic and/or androgenic steroidal agents)
BOLAZINE
Schedule 4
Appendix D, Item 5 (Anabolic and/or androgenic steroidal agents)
BOLDENONE
cross reference: DEHYDROTESTOSTERONE
Schedule 4
Appendix D, Item 5 (Anabolic and/or androgenic steroidal agents)
Poisons Standard November 2016
396
INDEX
BOLENOL
Schedule 4
Appendix D, Item 5 (Anabolic and/or androgenic steroidal agents)
BOLMANTALATE
Schedule 4
Appendix D, Item 5 (Anabolic and/or androgenic steroidal agents)
BORAGO OFFICINALIS
cross reference: BORAGE
Schedule 10
BORIC ACID
cross reference: BORAX
Schedule 5
Appendix E, Part 2
BORON
cross reference: BORATES, BORAX, BORIC ACID, BORON COMPOUNDS
Schedule 4
BORON TRIFLUORIDE
Schedule 7
Schedule 6
Schedule 5
Appendix E, Part 2
Appendix F, Part 3
Appendix J, Part 2
BORTEZOMIB
Schedule 4
BOSCALID
Appendix B, Part 3
BOSENTAN
Schedule 4
Appendix D, Item 6
Appendix F, Part 3
Appendix L, Part 2
BOSUTINIB
Schedule 4
BOTULINUM TOXINS
Poisons Standard November 2016
397
INDEX
Schedule 4
BOVINE SOMATOTROPHIN
Appendix B, Part 3
BRAGANTIA spp
Schedule 10
BRENTUXIMAB VEDOTIN
Schedule 4
BRETYLIUM TOSILATE
Schedule 4
BRETYLIUM TOSYLATE
cross reference: BRETYLIUM TOSILATE
BRIMONIDINE
Schedule 4
BRINZOLAMIDE
Schedule 4
BRODIFACOUM
Schedule 7
Schedule 6
Appendix J, Part 2
BROMACIL
Appendix B, Part 3
BROMADIOLONE
Appendix J, Part 2
BROMADIOLONE
Schedule 7
Schedule 6
BROMAZEPAM
Schedule 4
Appendix D, Item 5 (benzodiazepine derivatives)
Appendix K
BROMETHALIN
Poisons Standard November 2016
398
INDEX
Schedule 6
Schedule 7
BROMHEXINE
Schedule 2
BROMIDES
Schedule 4
BROMINE
Schedule 7
Appendix J, Part 2
BROMOCRIPTINE
Schedule 4
BROMOFORM
Schedule 6
Schedule 4
Appendix E, Part 2
Appendix F, Part 3
BROMOPHOS
Schedule 6
BROMOPHOS-ETHYL
Schedule 6
BROMOPROPYLATE
Appendix B, Part 3
BROMOXYNIL
Schedule 6
BROMPHENIRAMINE
Schedule 4
Schedule 3
Schedule 2
Appendix K
BROMUCONAZOLE
Schedule 5
Schedule 6
BROMVALETONE
Poisons Standard November 2016
399
INDEX
Schedule 4
BROTIANIDE
Schedule 6
BRUCINE
Schedule 7
Appendix E, Part 2
Appendix J, Part 2
BRUGMANSIA spp.
Schedule 4
BUCLIZINE
Appendix K
BUCLIZINE
Schedule 4
Schedule 3
BUCLOSAMIDE
Schedule 10
BUDESONIDE
Schedule 4
Schedule 2
BUFEXAMAC
Schedule 4
BUFOTENINE
Schedule 9
BUMETANIDE
Schedule 4
BUNAMIDINE
Schedule 6
BUNIODYL SODIUM
Schedule 10
BUPHENINE
Poisons Standard November 2016
400
INDEX
Schedule 4
BUPIRIMATE
Appendix B, Part 3
BUPIVACAINE
Schedule 5
Schedule 4
BUPRENORPHINE
Schedule 8
Appendix K
BUPROFEZIN
Schedule 5
BUPROPION
cross reference: AMFEBUTAMONE
Schedule 4
BUSERELIN
Schedule 4
BUSPIRONE
Schedule 4
BUSULPHAN
Schedule 4
BUTACAINE
Schedule 4
BUTACARB
Schedule 6
BUTAFENACIL
Appendix B, Part 3
BUTAMBEN
cross reference: BUTYL AMINOBENZOATE
Schedule 4
BUTHIDAZOLE
Poisons Standard November 2016
401
INDEX
Schedule 5
BUTOBARBITONE
Schedule 8
Appendix K
BUTOCONAZOLE
Schedule 4
Schedule 3
Appendix H
BUTORPHANOL
Schedule 8
BUTOXYCARBOXIM
Schedule 6
Schedule 5
BUTOXYPOLYPROPYLENE GYLCOL
Appendix B, Part 3
BUTRACONAZOLE
Schedule 4
BUTRALIN
Schedule 5
BUTROXYDIM
Schedule 5
n-BUTYL ALCOHOL
Schedule 6
Schedule 5
Appendix E, Part 2
Appendix F, Part 3
BUTYL AMINOBENZOATE
cross reference BUTAMBEN
BUTYL NITRITE
Schedule 4
BUTYLCHLORAL HYDRATE
Schedule 4
Poisons Standard November 2016
402
INDEX
BUTYRIC ACID
Schedule 6
C
CABAZITAXEL
Schedule 4
CABERGOLINE
Schedule 4
CACALIA spp.
Schedule 10
CACODYLIC ACID
Schedule 7
Schedule 6
CADMIUM COMPOUNDS
cross reference: CADMIUM, CADMIUM ACETATE, CADMIUM CHLORIDE, CADMIUM
NITRATE
Schedule 6
Schedule 4
Appendix E, Part 2
CADUSAFOS
Schedule 7
Schedule 6
CAJUPUT OIL
Schedule 6
Appendix E, Part 2
CALCIFEROL
Schedule 7
Schedule 6
Appendix J, Part 2
CALCIPOTRIOL
Schedule 4
CALCITONIN SALMON
Schedule 4
CALCITRIOL
Poisons Standard November 2016
403
INDEX
Schedule 4
CALCIUM CARBIMIDE
Schedule 4
CALCIUM HYDROXYLAPATITE
Schedule 4
CALCIUM POLYSTYRENE SULPHONATE
Schedule 4
CALOTROPIS GIGANTEA
Schedule 4
CALOTROPIS PROCERA
Schedule 4
CALUSTERONE
Schedule 4
Appendix D, Item 5 (Anabolic and/or androgenic steroidal agents)
CAMBENDAZOLE
Schedule 6
CAMPHOR
cross reference: ESSENTIAL OILS, LAVANDIN OIL, ROSEMARY OIL, SHUI OIL
Schedule 6
Schedule 5
Appendix E, Part 2
Appendix F, Part 3
CAMPHORATED OIL
Schedule 4
CAMPHOTAMIDE
Schedule 4
CANAGLIFLOZIN
Schedule 4
CANAKINUMAB
Schedule 4
CANDESARTAN CILEXETIL
Poisons Standard November 2016
404
INDEX
Schedule 4
CANDICIDIN
Schedule 4
CANINE TICK ANTI-SERUM
Schedule 4
CANNABICHROMENE
cross reference: CANNABIS, NABIXIMOLS
CANNABIDIOL
cross reference: CANNABIS, NABIXIMOLS
Schedule 4
CANNABIDIOLIC ACID
cross reference: CANNABIS, NABIXIMOLS
CANNABIDIVAROL
cross reference: CANNABIS, NABIXIMOLS
CANNABIGEROL
cross reference: CANNABIS, NABIXIMOLS
CANNABINOIDS
cross reference: CANNABIS, NABIXIMOLS, TETRAHYDROCANNABINOLS
CANNABINOL
cross reference: CANNABIS, NABIXIMOLS
CANNABIS
cross reference: CANNABIS SATIVA, HEMP, HEMP SEED OIL,
TETRAHYDROCANNABINOLS
Schedule 9
Schedule 8
Appendix D, Item 1
Appendix K
CANTHARIDIN
Schedule 4
Appendix G
CAPECITABINE
Schedule 4
CAPREOMYCIN
Schedule 4
CAPTAFOL
Poisons Standard November 2016
405
INDEX
Schedule 7
Appendix J, Part 2
CAPTAN
Schedule 6
CAPTODIAME
Schedule 4
CAPTOPRIL
Schedule 4
CAPURIDE
Schedule 4
CARAMIDE PEROXIDE
Appendix F, Part 3
CARAMIPHEN
Schedule 4
CARBACHOL
Schedule 4
CARBADOX
Schedule 7
Appendix J, Part 2
CARBAMAZEPINE
Schedule 4
CARBAMIDE PEROXIDE
Schedule 10
Schedule 6
Schedule 5
Appendix E, Part 2
CARBARYL
Schedule 6
Schedule 5
Schedule 4
CARBAZOCHROME
Schedule 4
Poisons Standard November 2016
406
INDEX
CARBENDAZIM
Schedule 7
CARBENICILLIN
Schedule 4
CARBENOXOLONE
Schedule 4
CARBETAMIDE
Appendix B, Part 3
CARBETAPENTANE
Schedule 2
CARBETOCIN
Schedule 4
CARBIDOPA
Schedule 4
CARBIMAZOLE
Schedule 4
CARBOCISTEINE
Schedule 2
CARBOCROMEN
Schedule 4
CARBOFURAN
Schedule 7
CARBON DISULFIDE
Schedule 6
Appendix E, Part 2
CARBON TETRACHLORIDE
Schedule 7
Appendix E, Part 2
Appendix F, Part 3
Appendix J, Part 2
Poisons Standard November 2016
407
INDEX
CARBONYL SULFIDE
Schedule 7
Appendix J, Part 2
CARBOPHENOTHION
Schedule 7
CARBOPLATIN
Schedule 4
CARBOPROST
Schedule 4
CARBOSULFAN
Schedule 7
CARBOXIN
Appendix B, Part 3
CARBROMAL
Schedule 4
CARBUTAMIDE
Schedule 4
CARBUTEROL
Schedule 4
CARFENTANYL
Schedule 8
CARFENTRAZONE-ETHYL
Appendix B, Part 3
CARGLUMIC ACID
Schedule 4
CARINDACILLIN
Schedule 4
CARISOPRODOL
Schedule 4
Poisons Standard November 2016
408
INDEX
CARMUSTINE
Schedule 4
CARNIDAZOLE
Schedule 4
CARPROFEN
Schedule 4
CARVEDILOL
Schedule 4
CASPOFUNGIN
Schedule 4
CASSIA OIL
Schedule 5
Appendix E, Part 2
Appendix F, Part 3
CASTOR OIL, MONOMALEATE
Schedule 6
CATHINE
Schedule 4
CATHINONE
Schedule 9
CATUMAXOMAB
Schedule 4
CEFACETRILE
cross reference: CEPHACETRILE
Schedule 4
CEFACLOR
Schedule 4
CEFADROXIL
Schedule 4
409
INDEX
CEFALEXIN
cross reference: CEPHALEXIN
Schedule 4
CEFALORIDINE
cross reference: CEPHALORIDINE
Schedule 4
CEFALOTHIN
cross reference: CEPHALOTHIN
Schedule 4
CEFAMANDOLE
cross reference: CEPHAMANDOLE
Schedule 4
CEFAPIRIN
cross reference: CEPHAPIRIN
Schedule 4
CEFAZOLIN
cross reference: CEPHAZOLIN
Schedule 4
CEFEPIME
Schedule 4
CEFETAMET
Schedule 4
CEFIXIME
Schedule 4
CEFODIZIME
Schedule 4
CEFONICID
Schedule 4
CEFOPERAZONE
Schedule 4
CEFOTAXIME
Poisons Standard November 2016
410
INDEX
Schedule 4
CEFOTETAN
Schedule 4
CEFOTIAM
Schedule 4
CEFOVECIN
Schedule 4
CEFOXITIN
Schedule 4
CEFPIROME
Schedule 4
CEFPODOXIME
Schedule 4
CEFQUINOME
Schedule 4
CEFSULODIN
Schedule 4
CEFTAROLINE FOSAMIL
Schedule 4
CEFTAZIDIME
Schedule 4
CEFTIBUTEN
Schedule 4
CEFTIOFUR
Schedule 4
CEFTRIAXONE
Schedule 4
CEFUROXIME
Poisons Standard November 2016
411
INDEX
Schedule 4
CELECOXIB
Schedule 4
CELIPROLOL
Schedule 4
CELLULASE derived from Aspergillus niger
Appendix B, Part 3
CEPHAELIS ACUMINATA
cross reference: IPECACUANHA
Schedule 4
CEPHAELIS IPECACUANHA
cross reference: IPECACUANHA
Schedule 4
CEPHALEXIN
cross reference: CEFALEXIN
CEPHALONIUM
Schedule 4
CEPHALOTHIN
cross reference: CEFALOTHIN
CEPHRADINE
Schedule 4
CERAMICS
Appendix A
CERIVASTATIN
Schedule 4
CERTOLIZUMAB PEGOL
Schedule 4
CERULETIDE
Schedule 4
CETIRIZINE
Poisons Standard November 2016
412
INDEX
Schedule 4
Schedule 2
Appendix K
CETRORELIX
Schedule 4
CETUXIMAB
Schedule 4
CETYL ALCOHOL
Appendix B, Part 3
CHAMOMILE OIL
Appendix B, Part 3
CHEMISTRY SETS
Appendix A
CHENODEOXYCHOLIC ACID
Schedule 4
CHINA CLAY
Appendix B, Part 3
CHLOPHEDIANOL
Schedule 2
CHLORAL FORMAMIDE
Schedule 4
CHLORAL HYDRATE
Schedule 4
Appendix K
CHLORALOSE
cross reference: ALPHA-CHLORALOSE
Schedule 6
Schedule 4
CHLORAMBUCIL
Schedule 4
CHLORAMPHENICOL
Poisons Standard November 2016
413
INDEX
Schedule 4
Schedule 3
CHLORANDROSTENOLONE
Schedule 4
Appendix D, Item 5 (Anabolic and/or androgenic steroidal agents)
CHLORANTRANILIPROLE
Appendix B, Part 3
CHLORAZANIL
Schedule 4
CHLORBUTANOL
Schedule 3
Schedule 2
CHLORBUTOL
cross reference: CHLOROBUTANOL
CHLORCYCLIZINE
Schedule 4
CHLORDANE
Schedule 6
CHLORDECONE
Schedule 7
Appendix J, Part 2
CHLORDIAZEPOXIDE
Schedule 4
Appendix D, Item 5 (benzodiazepine derivative)
Appendix K
CHLORDIMEFORM
Schedule 7
Appendix J, Part 2
CHLORFENAC
Schedule 5
CHLORFENAPYR
414
INDEX
Schedule 7
Schedule 6
Schedule 5
CHLORFENETHOL
Schedule 6
CHLORFENSON
Schedule 5
CHLORFENVINPHOS
Schedule 7
CHLORFLUAZURON
Appendix B, Part 3
CHLORFLURENOL
Appendix B, Part 3
CHLORHEXIDINE
Schedule 7
Schedule 6
Schedule 5
CHLORIDAZON
Appendix B, Part 3
CHLORIDE
Appendix E, Part 2
CHLORINATING COMPOUNDS
cross reference: BLEACHES, BROMOCHLORODIMETHYLHYDANTOIN,
TRICHLOROISOCYANURIC ACID, CALCIUM HYPOCHLORITE, CHLORINE,
DICHLOROETHYL ETHER, SODIUM HYPOCHLORITE, TRICHLOROISOCYANURIC
ACID
Schedule 6
Schedule 5
Appendix E, Part 2
Appendix F, Part 3
Appendix J, Part 2
CHLORINE
cross reference: CHLORINATING COMPOUNDS, DICHLOROISOCYANURATES,
DICHLOROISOCYANURIC ACID
415
INDEX
Schedule 7
Appendix G
Appendix J, Part 2
CHLORMEQUAT
Schedule 6
CHLORMERODRIN
Schedule 4
CHLORMETHIAZOLE
Schedule 4
Appendix K
CHLORMEZANONE
Schedule 4
CHLORNIDINE
Schedule 5
CHLOROCRESOL
Schedule 5
Appendix E, Part 2
CHLOROFORM
Schedule 6
Schedule 4
Schedule 2
Appendix E, Part 2
Appendix F, Part 3
CHLOROMETHIURON
Schedule 7
Appendix J, Part 2
2-CHLORO-5-NITRO-N-HYDROXYETHYL-p-PHENYLENEDIAMINE
cross reference: PHENYLENEDIAMINES
CHLOROPHACINONE
Schedule 6
CHLOROPICRIN
Schedule 7
Schedule 6
CHLOROPICRIN
Poisons Standard November 2016
416
INDEX
Appendix J, Part 2
CHLOROQUINE
Schedule 4
CHLOROTHALONIL
Schedule 6
CHLOROTHIAZIDE
Schedule 4
CHLOROTRIANISENE
Schedule 4
CHLOROXYDIENONE
Schedule 4
Appendix D, Item 5 (Anabolic and/or androgenic steroidal agents)
CHLOROXYLENOLS
Appendix B, Part 3
CHLORPHENAMINE
cross reference: CHLORPHENIRAMINE
Schedule 4
Schedule 3
Schedule 2
Appendix K
CHLORPHENIRAMINE
cross reference: CHLORPHENAMINE
CHLORPHENTERMINE
Schedule 4
CHLORPROMAZINE
Schedule 4
Appendix K
CHLORPROPAMIDE
Schedule 4
CHLORPROPHAM
Schedule 5
CHLORPROTHIXENE
Poisons Standard November 2016
417
INDEX
Schedule 4
CHLORPYRIFOS
Schedule 6
Schedule 5
CHLORPYRIFOS-METHYL
Schedule 6
CHLORQUINALDOL
Schedule 4
CHLORSULFURON
Schedule 5
CHLORTALIDONE
Schedule 4
CHLORTETRACYCLINE
Schedule 5
Schedule 4
CHLORTHAL-DIMETHYL
Schedule 5
CHLORTHALIDONE
cross reference: CHLORTALIDONE
CHLORTHIAMID
Schedule 6
CHLORTHIOPHOS
Schedule 7
CHLORZOXAZONE
Schedule 4
CHOLECALCIFEROL
cross reference: COLECALCIFEROL
Schedule 7
Appendix J, Part 2
CHOLERA VACCINE
Schedule 4
Poisons Standard November 2016
418
INDEX
CHOLESTYRAMINE
cross reference: COLESTYRAMINE
CHOLIC ACID
Schedule 4
CHROMATES
cross reference: AMMONIUM CHROMATE, BARIUM CHROMATE, CHROMIUM,
COPPER-CHROME-ARSENIC, DICHROMATES, POTASSIUM CHROMATE, ZINC
CHROMATE SODIUM CHROMATE, STRONTIUM CHROMATE
Schedule 6
Appendix E, Part 2
Appendix F, Part 3
CHROMIUM TRIOXIDE
cross reference: CHROMIC ACID
Schedule 6
Appendix E, Part 2
Appendix F, Part 3
CHRYSOIDINE BASE
Schedule 6
Schedule 10
Appendix E, Part 2
CHYMOPAPAIN
Schedule 4
CICLACILLIN
Schedule 4
CICLESONIDE
Schedule 4
CICLOPIROX
Schedule 4
Schedule 3
Schedule 2
CICLOSPORIN
Schedule 4
CIDOFOVIR
Schedule 4
CILASTATIN
Poisons Standard November 2016
419
INDEX
Schedule 4
CILAZAPRIL
Schedule 4
CILOSTAZOL
Schedule 4
CIMETIDINE
Schedule 4
Schedule 3
Appendix F, Part 3
CINACALCET
Schedule 4
CINCHOCAINE
Schedule 4
Schedule 2
CINCHOPHEN
Schedule 10
CINEOLE
cross reference: CAMPHOR OIL (white), ROSEMARY OIL
Schedule 7
Appendix E, Part 2
CINMETHYLIN
Schedule 5
CINNAMEDRINE
Schedule 2
CINNAMON BARK OIL
Schedule 5
Appendix E, Part 2
Appendix F, Part 3
CINNAMON LEAF OIL
Schedule 6
Appendix E, Part 2
CINOXACIN
Poisons Standard November 2016
420
INDEX
Schedule 4
CIPROFLOXACIN
Schedule 4
CISAPRIDE
Schedule 4
CISATRACURIUM BESILATE
cross reference: CISATRACURIUM BESYLATE
Schedule 4
CISPLATIN
Schedule 4
CITALOPRAM
Schedule 4
CITRONELLA OIL
Appendix B, Part 3
CJC-1295 (CAS No. 863288-34-0)
Schedule 4
Appendix D, Item 5
CLADRIBINE
Schedule 4
CLANOBUTIN
Schedule 4
CLARITHROMYCIN
Schedule 4
CLARY SAGE OIL
Appendix B, Part 3
CLAVULANIC ACID
Schedule 4
CLEMASTINE
421
INDEX
Schedule 4
Schedule 3
Appendix K
CLEMIZOLE
Schedule 4
CLENBUTEROL
Schedule 4
CLETHODIM
Schedule 5
CLEVIDIPINE
Schedule 4
CLIDINIUM BROMIDE
Schedule 4
CLIMBAZOLE
Schedule 6
Schedule 5
Appendix E, Part 2
CLINDAMYCIN
Schedule 4
CLIOQUINOL
cross reference: OXYQUINOLINE, CHLORQUINALDOL, HALQUINOL
Schedule 10
Schedule 4
CLITORIA TERNATEA EXTRACT
Appendix B, Part 3
CLOBAZAM
Schedule 4
CLOBETASOL
Schedule 4
CLOBETASONE
422
INDEX
Schedule 4
Schedule 3
Appendix F, Part 3
CLOCORTOLONE
Schedule 4
CLODINAFOP-PROPARGYL
Schedule 6
CLODRONIC ACID
cross reference: SODIUM CLODRONATE
Schedule 4
CLOFARABINE
Schedule 4
CLOFAZIMINE
Schedule 4
CLOFENAMIDE
Schedule 4
CLOFENTEZINE
Schedule 5
CLOFIBRATE
Schedule 4
CLOMAZONE
Schedule 6
CLOMIFENE
cross reference: CLOMIPHENE
Schedule 4
Appendix D, Item 1
CLOMIPHENE
cross reference: CLOMIFENE
CLOMIPRAMINE
Schedule 4
Appendix K
CLOMOCYCLINE
Poisons Standard November 2016
423
INDEX
Schedule 4
CLONAZEPAM
Schedule 4
Appendix D, Item 5 (benzodiazepine derivatives)
Appendix K
CLONAZOLAM
Schedule 9
CLONIDINE
Schedule 4
Appendix K
CLONITAZENE
Schedule 9
CLOPAMIDE
Schedule 4
CLOPIDOGREL
Schedule 4
CLOPIDOL
Appendix B, Part 3
CLOPROSTENOL
Schedule 4
CLOPYRALID
Schedule 5
CLOQUINTOCET
Schedule 5
CLORAZEPATE
Schedule 4
Appendix D, Item 5 (benzodiazepine derivatives)
Appendix K
CLOREXOLONE
Schedule 4
CLORPRENALINE
Poisons Standard November 2016
424
INDEX
Schedule 4
CLORSULON
Schedule 5
CLOSANTEL
Schedule 6
CLOSTEBOL
cross reference: 4-CHLOROTESTOSTERONE
Schedule 4
Appendix D, Item 5 (Anabolic and/or androgenic steroidal agents)
CLOTHIANIDIN
Schedule 6
Schedule 5
CLOTRIMAZOLE
Schedule 6
Schedule 4
Schedule 3
Schedule 2
Appendix F, Part 3
Appendix H
CLOVE OIL
Schedule 6
Schedule 5
Appendix E, Part 2
Appendix F, Part 3
CLOXACILLIN
Schedule 4
CLOZAPINE
Schedule 4
Appendix D, Item 1
Appendix K
COAL TAR
Schedule 10
COBALT
cross reference: DICOBALT EDETATE
Schedule 4
Poisons Standard November 2016
425
INDEX
COBALT NAPHTHENATE
Appendix B, Part 3
COBICISTAT
Schedule 4
COCA LEAF
Schedule 9
COCAINE
Schedule 8
COCOYL GLYCINATE
Schedule 6
Appendix E, Part 2
CODEINE
Schedule 8
Schedule 4
Schedule 3
Schedule 2
Appendix K
CODEINE-N-OXIDE
Schedule 8
CO-DERGOCRINE
Schedule 4
CODOXIME
Schedule 9
COLASPASE
cross reference: ASPARAGINASE
COLCHICINE
Schedule 4
COLCHICUM AUTUMNALE
Schedule 4
COLECALCIFEROL
cross reference: CHOLECALCIFEROL
426
INDEX
Schedule 7
Appendix J, Part 2
COLESTIPOL
Schedule 4
COLESTYRAMINE
Schedule 4
COLFOSCERIL PALMITATE
Schedule 4
COLISTIN
Schedule 4
COLLAGEN
Schedule 4
COLLAGENASE CLOSTRIDIUM HISTOLYTICUM
Schedule 4
CONCENTRATE OF POPPY STRAW
Schedule 8
CONIUM MACULATUM
cross reference: CONIINE
Schedule 10
CONVALLARIA KEISKI
Schedule 4
CONVALLARIA MAJALIS
Schedule 4
COPPER ACETATE
Schedule 6
Schedule 5
COPPER COMPOUNDS
cross reference: COPPER
Schedule 6
Schedule 5
Schedule 4
Appendix A
Poisons Standard November 2016
427
INDEX
COPPER HYDROXIDE
Schedule 6
Schedule 5
COPPER NITRATE
cross reference: COPPER CHLORIDE
Schedule 6
COPPER OXIDES
Schedule 6
Schedule 5
COPPER OXYCHLORIDE
Schedule 6
Schedule 5
COPPER SULFATE
Schedule 6
Schedule 5
Appendix E, Part 2
CORIFOLLITROPIN ALFA
cross reference: FOLLICLE STIMULANT, RECOMBINANT
Schedule 4
Appendix D, Item 1
CORONILLA spp.
Schedule 4
CORTICOSTERONE
Schedule 4
CORTICOTROPHIN
Schedule 4
CORTISONE
Schedule 4
COTARNINE
Schedule 10
CO-TRIMOXAZOLE
Schedule 4
Poisons Standard November 2016
428
INDEX
COUMAPHOS
Schedule 7
Schedule 6
COUMARIN
Schedule 4
COUMATETRALYL
Schedule 7
Schedule 6
Schedule 5,
Appendix J, Part 2
CREOSOTE
cross reference: BEECHWOOD, PHENOL, WOOD
Schedule 7
Schedule 6
Schedule 2
Appendix E, Part 2
CRESOLS
Appendix E, Part 2
CRIZOTINIB
Schedule 4
CROFELEMER
Schedule 4
CROSPOVIDONE
Appendix B, Part 3
CROTALARIA spp.
Schedule 10
CROTON TIGLIUM
cross reference: CROTON OIL
Schedule 10
Appendix G
CROTOXYPHOS
Schedule 6
CRUFOMATE
Poisons Standard November 2016
429
INDEX
Schedule 6
CRYSTAL VIOLET
cross reference: METHYLROSANILINIUM CHLORIDE, GENTIAN VIOLET
CULICINOMYCES CLAVOSPORUS
Appendix B, Part 3
CUPRIMYXIN
Schedule 4
CURARE
Schedule 4
CYANAMIDE
Schedule 6
CYANATRYN
Schedule 5
CYANAZINE
Schedule 6
CYANIDES
cross reference: FERRICYANIDES, FERROCYANIDES
Schedule 7
Appendix E, Part 2
Appendix F, Part 3
CYANOACRYLATE ESTERS
Schedule 5
CYANOACRYLIC ACID ESTERS
Appendix E, Part 2
CYANOGEN
cross reference: ETHANEDINITRILE, OXALONITRILE
Schedule 7
Appendix J, Part 2
CYANTRANILIPROLE
Schedule 5
CYANURIC ACID
Poisons Standard November 2016
430
INDEX
Schedule 5
Appendix E, Part 2
Appendix F, Part 3
CYAZOFAMID
Schedule 5
ARPRINOCID
Appendix J, Part 2
CYCLAMIC ACID
Appendix B, Part 3
CYCLANDELATE
Schedule 4
CYCLANILIDE
Schedule 6
CYCLANILIPROLE
Appendix B
CYCLIZINE
Schedule 4
Schedule 3
Appendix K
CYCLOBARBITONE
Schedule 8
Appendix K
CYCLOBENZAPRINE
Schedule 4
CYCLOFENIL
Schedule 4
Appendix D, Item 1
CYCLOHEXANE
Appendix B, Part 3
CYCLOHEXANOL ACETATE
Appendix B, Part 3
Poisons Standard November 2016
431
INDEX
CYCLOHEXANONE PEROXIDE
Schedule 5
Appendix E, Part 2
Appendix F, Part 3
CYCLOHEXIMIDE
Schedule 4
CYCLOHEXYLPHENOLS
Schedule 9
CYCLOPENTHIAZIDE
Schedule 4
CYCLOPENTOLATE
Schedule 4
CYCLOPHOSPHAMIDE
Schedule 4
CYCLOPROPANE
Schedule 4
CYCLOPROTHRIN
Schedule 5
CYCLOSERINE
Schedule 4
Appendix J, Part 2
CYCLOSPORIN
cross reference: CICLOSPORIN
CYCLOTHIAZIDE
Schedule 4
CYCLOXYDIM
Schedule 5
CYCRIMINE
Schedule 4
Appendix E, Part 2
Appendix F, Part 3
Poisons Standard November 2016
432
INDEX
CYFLUFENAMID
Schedule 5
CYFLUTHRIN
Schedule 6
Schedule 5
CYHALOFOP-BUTYL
Schedule 5
CYHALOTHRIN
Schedule 7
CYHEXATIN
Schedule 7
CYMARIN
Schedule 4
CYMIAZOLE
Schedule 5
CYNOGLOSSUM spp.
Schedule 10
CYOMETRINIL
Schedule 6
CYPERMETHRIN
cross reference: ALPHA-CYPERMETHRIN AND BETA-CYPERMETHRIN, ZETACYPERMETHRIN
Schedule 6
Schedule 5
CYPHENOTHRIN
Schedule 6
Schedule 5
CYPROCONAZOLE
Schedule 5
CYPRODINIL
Schedule 5
Poisons Standard November 2016
433
INDEX
CYPROHEPTADINE
Schedule 4
Schedule 3
Appendix K
CYPROTERONE
Schedule 4
CYROMAZINE
Appendix B, Part 3
CYSTEAMINE
cross reference: MERCAPTAMINE
CYTARABINE
Schedule 4
CYTHIOATE
Schedule 6
Schedule 5
D
DABIGATRAN
Schedule 4
DABRAFENIB MESILATE
Schedule 4
DACARBAZINE
Schedule 4
DACLATASVIR
Schedule 4
DACLIZUMAB
Schedule 4
DACTINOMYCIN
Schedule 4
DALFOPRISTIN
Schedule 4
Poisons Standard November 2016
434
INDEX
DALTEPARIN
Schedule 4
DAMINOZIDE
Schedule 5
DANAPAROID
Schedule 4
DANAZOL
Schedule 4
Appendix D, Item 5 (Anabolic and/or androgenic steroidal agents)
DANTHRON
Schedule 4
DANTROLENE
Schedule 4
Appendix K
DAPAGLIFLOZIN
Schedule 4
DAPOXETINE
Schedule 4
DAPSONE
Schedule 4
DAPTOMYCIN
Schedule 4
DARBEPOETIN
Schedule 4
Appendix D, Item 5
DARIFENACIN
Schedule 4
DARUNAVIR
Schedule 4
DASABUVIR
Poisons Standard November 2016
435
INDEX
Schedule 4
DASATINIB
Schedule 4
DATURA spp.
Schedule 4
Schedule 2
DATURA STRAMONIUM
cross reference: STRAMONIUM
Schedule 4
Schedule 2
DATURA TATULA
cross reference: STRAMONIUM
Schedule 4
Schedule 2
DAUNORUBICIN
Schedule 4
DAZOMET
Schedule 6
DEANOL
cross reference: 2-(DIMETHYLAMINO)ETHANOL, DMEA, DIMETHYL MEA
Schedule 4
DEBRISOQUINE
Schedule 4
DECAMETHONIUM
Schedule 4
DECOQUINATE
Schedule 5
DEFERASIROX
Schedule 4
DEFERIPRONE
Schedule 4
Poisons Standard November 2016
436
INDEX
DEFLAZACORT
Schedule 4
DEGARELIX
Schedule 4
DEHYDROCHLOROMETHYLTESTOSTERONE
cross reference: CHLOROMESTERONE
Schedule 4
Appendix D, Item 5 (Anabolic and/or androgenic steroidal agents)
DEHYDROCORTICOSTERONE
Schedule 4
DELAVIRDINE
cross reference: DELAVIRDINE MESILATE
Schedule 4
DELPHINIUM STAPHISAGRIA
cross reference: STAPHISAGRIA
Schedule 2
DELTAMETHRIN
Schedule 7
Schedule 6
Schedule 5
DEMBREXINE
Schedule 5
Schedule 4
DEMECARIUM
Schedule 4
DEMECLOCYCLINE
Schedule 4
DEMETON
Schedule 7
DEMETON-O-METHYL
Schedule 7
DEMETON-S-METHYL
Poisons Standard November 2016
437
INDEX
Schedule 7
DENOSUMAB
Schedule 4
DEOXYCHOLIC ACID
Schedule 4
DEOXYCORTONE
Schedule 4
DEOXYRIBONUCLEASE
Schedule 4
DERACOXIB
Schedule 4
DERQUANTEL
Schedule 6
DESCHLOROETIZOLAM
Schedule 9
DESFERRIOXAMINE
Schedule 4
DESFLURANE
Schedule 4
DESIPRAMINE
Schedule 4
Appendix K
DESIRUDIN
Schedule 4
DESLANOSIDE
Schedule 4
DESLORATADINE
Schedule 4
Schedule 2
Poisons Standard November 2016
438
INDEX
DESLORELIN
Schedule 4
DESMOPRESSIN
cross reference: D.D.A.V.P.
Schedule 4
DESOGESTREL
Schedule 4
DESOMORPHINE
Schedule 9
DESONIDE
Schedule 4
DESOXYMETHASONE
Schedule 4
DESVENLAFAXINE
Schedule 4
DETOMIDINE
Schedule 4
DEXAMETHASONE
Schedule 4
DEXAMFETAMINE
cross reference: DEXAMPHETAMINE
Schedule 8
DEXCHLORPHENAMINE
cross reference: DEXCHLORPHENIRAMINE
Schedule 4
Schedule 3
Schedule 2
Appendix K
DEXCHLORPHENIRAMINE
cross reference: DEXCHLORPHENAMINE
DEXFENFLURAMINE
Schedule 4
Poisons Standard November 2016
439
INDEX
DEXMEDETOMIDINE
Schedule 4
DEXTRANS, GELATIN - SUCCINYLATED & ETHERIFIED STARCHES
Appendix A
DEXTROMETHORPHAN
Schedule 4
Schedule 2
DEXTROMORAMIDE
cross reference: MORAMIDE
Schedule 8
Appendix K
DEXTROPROPOXYPHENE
Schedule 8
Schedule 4
Appendix D, Item 5
Appendix K
DEXTRORPHAN
Schedule 4
2,4-DIAMINO-5-METHYLPHENETOLE
cross reference: PHENYLENEDIAMINES
DIAFENTHIURON
Schedule 5
DIALIFOS
Schedule 7
DIAMPROMIDE
Schedule 9
DIAMTHAZOLE
Schedule 4
DIAVERIDINE
Schedule 4
DIAZEPAM
440
INDEX
Schedule 4
Appendix D, Item 5 (benzodiazepine derivatives)
Appendix K
DIAZINON
Schedule 6
Schedule 5,
DIAZOXIDE
Schedule 4
DIBENZEPIN
Schedule 4
DIBENZOPYRANS
Schedule 9
DIBOTERMIN
Schedule 4
DIBROMOPROPAMIDINE
Schedule 4
Schedule 2
DIBUTYLPHTHALATE
Schedule 10
DICAMBA
Schedule 6
Schedule 5
DICYCLAZEPAM
Schedule 9
DICHLOBENIL
Schedule 6
DICHLOEOETHYL ETHER
Appendix F, Part 3
DICHLOFENTHION
Schedule 6
DICHLOFLUANID
Poisons Standard November 2016
441
INDEX
Schedule 6
DICHLONE
Schedule 5
DICHLORALPHENAZONE
Schedule 4
DICHLORMETHANE
Appendix F, Part 3
DICHLOROBENZENE
Schedule 6
Schedule 5
Appendix E, Part 2
DICHLOROETHYL ETHER
Schedule 6
Appendix E, Part 2
DICHLOROETHYLENE
Appendix F, Part 3
DICHLOROISOCYANURIC ACID
cross reference: CHLORINE, CHLORINATING COMPOUNDS,
DICHLOROISOCYANURATES, SODIUM DICHLOROISOCYANURATE
Schedule 6
Schedule 5
Appendix E, Part 2
Appendix F, Part 3
DICHLOROMETHANE
cross reference: METHYLENE CHLORIDE
Schedule 5
Appendix E, Part 2
DICHLOROPHEN
Schedule 6
Schedule 5
Schedule 4
DICHLORPHENAMIDE
Schedule 4
DICHLORVOS
Poisons Standard November 2016
442
INDEX
Schedule 7
Schedule 6
Schedule 5
DICHROMATES
Appendix E, Part 2
DICLAZURIL
Appendix B, Part 3
DICLOBUTRAZOL
Schedule 5
DICLOFENAC
Schedule 4
Schedule 3
Schedule 2
Appendix F, Part 3
Appendix H
DICLOFOP-METHYL
Schedule 6
DICLORAN
Schedule 5
DICLOXACILLIN
Schedule 4
DICOFOL
Schedule 5
DICOPHANE
cross reference: DDT
Schedule 10
DICROTOPHOS
Schedule 7
DICYCLANIL
Schedule 6
DICYCLOMINE
Schedule 4
Poisons Standard November 2016
443
INDEX
DIDANOSINE
Schedule 4
DIDECYLDIMETHYLAMMONIUM SALTS
Schedule 6
DIELDRIN
Schedule 6
DIENESTROL
Schedule 4
Appendix F, Part 3
Appendix L
DIENOGEST
Schedule 4
DIESEL
Appendix E, Part 2
DIETHANOLAMINE
Schedule 6
Schedule 5
Appendix E, Part 2
Appendix F, Part 3
DIETHAZINE
Schedule 4
DIETHYL CARBONATE
Appendix B, Part 3
DIETHYLCARBAMAZINE
Schedule 4
DIETHYLENE GLYCOL
cross reference: DENATONIUM BENZOATE
Schedule 10
Schedule 6
Schedule 5
DIETHYLENE GLYCOL MONOBUTYL ETHER
444
INDEX
Schedule 5
Appendix E, Part 2
Appendix F, Part 3
DIETHYLENE GLYCOL MONOMETHYL ETHER
Schedule 10
Schedule 6
DIETHYLHEXYL PHTHALATE
Schedule 10
DIETHYLPHTHALATE
Schedule 10
DIETHYLPROPION
Schedule 4
DIETHYLTHIAMBUTENE
Schedule 9
DIETHYLTOLUAMIDE (DEET)
Schedule 5
Appendix F, Part 3
DIFENACOUM
Schedule 7
Schedule 6
Appendix J, Part 2
DIFENOCONAZOLE
Schedule 5
DIFENOXIN
Schedule 8
Schedule 4
Appendix K
DIFENZOQUAT
Schedule 6
DIFETHIALONE
Schedule 7
Schedule 6
DIFLORASONE
Poisons Standard November 2016
445
INDEX
Schedule 4
DIFLOXACIN
Schedule 4
DIFLUBENZURON
Schedule 5
DIFLUCORTOLONE
Schedule 4
DIFLUFENICAN
Appendix B, Part 3
DIFLUNISAL
Schedule 4
DIGITALIS LANATA
Schedule 4
DIGITALIS PURPUREA
Schedule 4
DIGITOXIN
Schedule 4
DIGOXIN
Schedule 4
DIGOXIN-SPECIFIC ANTIBODY FRAGMENT F (Ab)
Schedule 4
DIHYDRALAZINE
Schedule 4
DIHYDROCODEINE
Schedule 8
Schedule 4
Schedule 3
Schedule 2
Appendix K
DIHYDROERGOTOXINE
Poisons Standard November 2016
446
INDEX
Schedule 4
DIHYDROLONE
Schedule 4
Appendix D, Item 5 (Anabolic and/or androgenic steroidal agents)
DIHYDROMORPHINE
Schedule 8
DIHYDROSTREPTOMYCIN
Schedule 4
DIHYDROTACHYSTEROL
Schedule 4
DIIODOHYDROXYQUINOLINE
cross reference: IODOQUINOL
Schedule 10
Schedule 4
Schedule 3
DI-IODOHYDROXYQUINOLINE
cross reference: DIIODOHYDROXYQUINOLINE
DIISOBUTYL PHTHALATE
Schedule 10
DIISOPROPYLAMINE DICHLOROACETATE
Schedule 4
DIKEGULAC-SODIUM
Appendix B, Part 3
DILTIAZEM
Schedule 4
DIMEFOX
Schedule 7
DIMENHYDRINATE
Schedule 4
Schedule 3
Schedule 2
Appendix H
Appendix K
Poisons Standard November 2016
447
INDEX
DIMENOXADOL
Schedule 9
DIMEPHEPTANOL
Schedule 9
DIMERCAPROL
Schedule 4
DIMETHANDROSTANOLONE
Schedule 4
Appendix D, Item 5 (Anabolic and/or androgenic steroidal agents)
DIMETHAZINE
Schedule 4
Appendix D, Item 5 (Anabolic and/or androgenic steroidal agents)
DIMETHENAMID-P
Schedule 6
DIMETHICODIETHYLBENZALMALONATE
cross reference: POLYSILICONE-15
Schedule 5
DIMETHICONE
cross reference: DIMETICONE
DIMETHINDENE
Schedule 4
Appendix K
DIMETHIPIN
Schedule 6
DI(METHYLOXYETHYL) PHTHALATE
Schedule 10
DIMETHIRIMOL
Schedule 5
DIMETHOATE
Schedule 6
DIMETHOMORPH
Poisons Standard November 2016
448
INDEX
Schedule 5
DIMETHOTHIAZINE
Schedule 4
DIMETHOXANATE
Schedule 4
2,6-DIMETHOXY-3,5-PYRIDINEDIAMINE
Schedule 6
Appendix F, Part 3
DIMETHYL ETHER
Appendix B, Part 3
DIMETHYL FUMARATE
Schedule 4
DIMETHYL SULFATE
Schedule 7
Appendix F, Part 3
DIMETHYL SULFOXIDE
cross reference: COPPER SALICYLATE, METHYL SALICYLATE
Schedule 6
Schedule 4
Appendix E, Part 2
Appendix F, Part 3
DIMETHYLACETAMIDE
Schedule 6
Schedule 5
1-(1,1-DIMETHYLETHYL)-2-METHOXY-4-METHYL-3,5-DINITROBENZENE (musk
ambrette)
cross reference: Amber musk
Schedule 10
DIMETHYLFORMAMIDE
cross reference: DESIGNATED SOLVENT
Schedule 6
Schedule 5
Appendix E, Part 2
Appendix F, Part 3
Part 1 - Interpretation
Poisons Standard November 2016
449
INDEX
DIMETHYLPHTHALATE
Schedule 10
DIMETHYLTHIAMBUTENE
Schedule 9
DIMETICONE
cross reference: DIMETHICONE
Appendix B, Part 3
DIMETILAN
Schedule 7
DIMETRIDAZOLE
Schedule 4
DINICONAZOLE
Schedule 5
DINITROCRESOLS
Schedule 7
Schedule 6
Schedule 4
Appendix E, Part 2
Appendix J, Part 2
DINITRONAPHTHOLS
Schedule 4
DINITROPHENOLS
Schedule 7
Schedule 6
Schedule 4
Appendix E, Part 2
Appendix F, Part 3
Appendix J, Part 2
DINITROTHYMOLS
Schedule 4
DINOCAP
Schedule 7
Appendix F, Part 3
DINOPROST
Poisons Standard November 2016
450
INDEX
Schedule 4
Appendix D, Item 1
DINOPROSTONE
Schedule 4
Appendix D, Item 1
DINOSEB
Schedule 7
Appendix J, Part 2
DINOTEFURAN
Schedule 5
DI-n-PROPYL ISOCINCHOMERONATE (previoiusly di-N propyl isocinchomeronate)
Schedule 5
DIOXACARB
Schedule 6
DIOXANE
Schedule 6
Appendix E, Part 2
Appendix F, Part 3
Appendix G
DIOXAPHETYL BUTYRATE
Schedule 9
DIPERODON
Schedule 4
DIPHACINONE
Schedule 6
DIPHEMANIL
Schedule 4
DIPHENAMID
Schedule 5
DIPHENHYDRAMINE
Schedule 4
Schedule 3
Poisons Standard November 2016
451
INDEX
Schedule 2
Appendix K
DIPHENIDOL
Schedule 4
DIPHENOXYLATE
Schedule 8
Schedule 4
Schedule 3
Appendix F, Part 3
Appendix H
Appendix K
DIPHENYLAMINE
Appendix B, Part 3
DIPHENYLPYRALINE
Schedule 4
Appendix K
DIPHTHERIA TOXOID
Schedule 4
DIPIPANONE
Schedule 8
DIPIVEFRIN
Schedule 4
DIPROPYLENE GLYCOL
Appendix B, Part 3
DIPYRIDAMOLE
Schedule 4
DIQUAT
Schedule 7
Schedule 6
DIRITHROMYCIN
Schedule 4
DIRLOTAPIDE
Poisons Standard November 2016
452
INDEX
Schedule 4
DISOPHENOL
Schedule 4
DISOPYRAMIDE
Schedule 4
DISPERSE YELLOW 3
Schedule 10
Schedule 6
Appendix E, Part 2
Appendix F, Part 3
DISTIGMINE
Schedule 4
DISTILLATE
Appendix E, Part 2
DISULFIRAM
Schedule 6
Schedule 4
DISULFOTON
Schedule 7
Schedule 6
DISULPHAMIDE
Schedule 4
DITHIANON
Schedule 6
DITHIAZANINE
Schedule 6
Schedule 4
DITHIOPYR
Schedule 5
DITHRANOL
Schedule 3
Poisons Standard November 2016
453
INDEX
DITIOCARB
Schedule 4
DIUREDOSAN
Schedule 6
DIURON
Appendix B, Part 3
DOBUTAMINE
Schedule 4
DOCETAXEL
Schedule 4
DOCUSATE SODIUM
cross reference: DIOCTYL SODIUM SULFOSUCCINATE
Appendix B, Part 3
DODINE
Schedule 6
DOFETILIDE
Schedule 4
DOLASETRON
Schedule 4
DOLUTEGRAVIR
Schedule 4
DOMPERIDONE
Schedule 4
DONEPEZIL
Schedule 4
DOPAMINE
Schedule 4
DOPEXAMINE
Schedule 4
Poisons Standard November 2016
454
INDEX
DORAMECTIN
Schedule 7
Schedule 6
Schedule 5
DORIPENEM
Schedule 4
DORNASE
Schedule 4
DORZOLAMIDE
Schedule 4
DOSULEPIN
cross reference: DOTHIEPIN.
Schedule 4
Appendix K
DOTHIEPIN
cross reference: DOSULEPIN
DOXANTRAZOLE
Schedule 4
DOXAPRAM
Schedule 4
DOXAZOSIN
Schedule 4
DOXEPIN
Schedule 4
Appendix K
DOXORUBICIN
Schedule 4
DOXYCYCLINE
Schedule 4
DOXYLAMINE
Schedule 4
Schedule 3
Poisons Standard November 2016
455
INDEX
Schedule 2
Appendix K
d-PHENOTHRIN
Appendix B, Part 3
d-PULEGONE
Schedule 6
Appendix E, Part 2
DROMETRIZOLE TRISILOXANE
Appendix B, Part 3
DRONABINOL
cross reference: DELTA-9-TETRAHYDROCANNABINOL, NABIXIMOLS
Schedule 8
Appendix D, Item 3
Appendix K
DRONEDARONE
Schedule 4
DROPERIDOL
Schedule 4
Appendix K
DROSPIRENONE
Schedule 4
DROSTANOLONE
Schedule 4
Appendix D, Item 5 (Anabolic and/or androgenic steroidal agents)
DROTEBANOL
Schedule 8
DROTRECOGIN
Schedule 4
DSMA
Schedule 7
Schedule 6
DUBOISIA LEICHHARDTII
Poisons Standard November 2016
456
INDEX
Schedule 4
Schedule 2
DUBOISIA MYOPOROIDES
Schedule 4
Schedule 2
DULCIN
Schedule 10
DULOXETINE
Schedule 4
Appendix K
DUTASTERIDE
Schedule 4
DYDROGESTERONE
Schedule 4
E
(E)-(S)-1-(4-CHLOROPHENYL)-4,4-DIMETHYL-2-(1H-1,2,4-TRIAZOL-1-YL)PENT-1EN-3-OL
cross reference: UNICONAZOLE-P
Schedule 6
ECGONINE
Schedule 9
ECONAZOLE
Schedule 6
Schedule 4
Schedule 3
Schedule 2
Appendix F, Part 3
Appendix H
ECOTHIOPATE
cross reference: ECOTHIOPATE IODIDE
Schedule 4
ECTYLUREA
Schedule 4
ECULIZUMAB
Poisons Standard November 2016
457
INDEX
Schedule 4
EDETIC ACID
cross reference: DICOBALT EDETATE
Schedule 4
EDOXUDINE
Schedule 4
EDROPHONIUM
Schedule 4
EFALIZUMAB
Schedule 4
EFAVIRENZ
Schedule 4
EFLORNITHINE
Schedule 4
EFORMOTEROL
cross reference: FORMOTEROL
ELBASVIR
Schedule 4
ELECTRICAL ACCUMULATORS, BATTERIES, COMPONENTS or LAMPS
Appendix A
ELECTRONIC COMPONENTS
Appendix A
ELETRIPTAN
Schedule 4
ELOSULFASE ALFA
Schedule 4
ELTENAC
Schedule 4
ELTROMBOPAG
Poisons Standard November 2016
458
INDEX
Schedule 4
ELVITEGRAVIR
Schedule 4
EMAMECTIN
Schedule 7
Schedule 6
Schedule 5
EMEPRONIUM
Schedule 4
EMETINE
cross reference: CEPHAELIS ACUMINATA
Schedule 4
EMODEPSIDE
Schedule 6
Schedule 5
EMPAGLIFLOZIN
Schedule 4
EMTRICITABINE
Schedule 4
ENALAPRIL
Schedule 4
ENDOSULFAN
Schedule 7
Schedule 6
ENDOTHAL
Schedule 7
Schedule 6
ENDRIN
Schedule 7
ENESTEBOL
Schedule 4
Appendix D, Item 5 (Anabolic and/or androgenic steroidal agents)
Poisons Standard November 2016
459
INDEX
ENFLURANE
Schedule 4
ENFUVIRTIDE
Schedule 4
ENHANCING AGENTS
cross reference: MAGNETIC RESONANCE IMAGING ENHANCING AGENTS,
ULTRASONIC AND MAGNETIC RESONANCE IMAGING ENHANCING
Appendix A
ENOBOSARM
Schedule 4
Appendix D, Item 5 (SELECTIVE ANDROGEN RECEPTOR MODULATORS)
ENOXACIN
Schedule 4
ENOXAPARIN
Schedule 4
ENOXIMONE
Schedule 4
ENPROSTIL
Schedule 4
ENROFLOXACIN
Schedule 4
ENTACAPONE
Schedule 4
ENTECAVIR
Schedule 4
ENZALUTAMIDE
Schedule 4
Appendix D, Item 6
Appendix F, Part 3
Appendix L, Part 2
EPHEDRA spp.
Poisons Standard November 2016
460
INDEX
Schedule 4
EPHEDRINE
cross reference: EPHEDRA
Schedule 4
Appendix D, Item 5
Appendix F, Part 3
EPICHLOROHYDRIN
Schedule 7
Appendix F, Part 3
Appendix J, Part 2
EPICILLIN
Schedule 4
EPIDERMAL GROWTH FACTOR
Schedule 7
Appendix J, Part 2
EPINASTINE
Schedule 4
EPINEPHRINE
cross reference: ADRENALINE
EPIRUBICIN
Schedule 4
EPITIOSTANOL
Schedule 4
Appendix D, Item 5 (Anabolic and/or androgenic steroidal agents)
EPLERENONE
Schedule 4
EPOETINS
cross reference: METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA
Schedule 4
Appendix D, Item 5
EPOPROSTENOL
Schedule 4
EPOXICONAZOLE
Poisons Standard November 2016
461
INDEX
Schedule 5
EPOXY RESINS, LIQUID
cross reference: RESINS
Schedule 5
Appendix E, Part 2,
Appendix F, Part 3
EPRINOMECTIN
Schedule 7
Schedule 5
EPROSARTAN
Schedule 4
EPSIPRANTEL
Appendix B, Part 3
EPTC
Schedule 6
EPTIFIBATIDE
Schedule 4
ERGOMETRINE
Schedule 4
ERGOT
Schedule 4
ERGOTAMINE
Schedule 4
ERGOTOXINE
Schedule 4
ERIBULIN MESILATE
cross reference: ERIBULIN MESYLATE
Schedule 4
ERLOTINIB
Schedule 4
ERTAPENEM
Poisons Standard November 2016
462
INDEX
Schedule 4
ERYSIMUM spp.
Schedule 4
Appendix G
ERYTHRITYL TETRANITRATE
Schedule 3
ERYTHROMYCIN
Schedule 4
ERYTHROPOIETIN
Schedule 4
Appendix D, Item 5
ERYTHROPOIETINS
Schedule 4
Appendix D, Item 5
ESBIOTHRIN
Schedule 6
Schedule 5
ESCITALOPRAM
Schedule 4
ESFENVALERATE
Schedule 6
Schedule 5
ESMOLOL
Schedule 4
ESOMEPRAZOLE
Schedule 4
Schedule 3
Schedule 2
Appendix H
ESTRADIOL
Schedule 5
Schedule 4
Appendix G
Poisons Standard November 2016
463
INDEX
ESTRAMUSTINE
Schedule 4
ESTRIOL
Schedule 4
ESTROGENS
Schedule 4
ESTRONE
Schedule 4
Appendix G
ESTROPIPATE
cross reference: PIPERAZINE ESTRONE SULFATE
Schedule 4
ETACONAZOLE
Schedule 7
Appendix J, Part 2
ETACRYNIC ACID
Schedule 4
ETAFEDRINE
Schedule 2
ETANERCEPT
Schedule 4
ETHACRYNIC ACID
cross reference: ETACRYNIC ACID
ETHAMBUTOL
Schedule 4
ETHAMETSULFURON-METHYL
Appendix B, Part 3
ETHAMIVAN
Schedule 4
ETHANOL
cross reference: ETHYL ALCOHOL
Poisons Standard November 2016
464
INDEX
ETHANOLAMINE
cross reference: MONOETHANOLAMINE
ETHCHLORVYNOL
Schedule 4
ETHEPHON
Schedule 6
ETHER
Schedule 6
Schedule 5
Schedule 4
Schedule 2
Appendix E, Part 2
Appendix F, Part 3
ETHINAMATE
Schedule 4
ETHINYLESTRADIOL
Schedule 4
ETHINYLOESTRADIOL
cross reference: ETHINYLESTRADIOL
ETHIOFENCARB
Schedule 6
ETHION
Schedule 7
ETHIONAMIDE
Schedule 4
ETHISTERONE
Schedule 4
Appendix D, Item 5 (Anabolic and/or androgenic steroidal agents)
ETHOATE-METHYL
Schedule 6
ETHOFUMESATE
Schedule 5
Poisons Standard November 2016
465
INDEX
ETHOGLUCID
Schedule 4
ETHOHEPTAZINE
Schedule 4
ETHOPABATE
Appendix B, Part 3
ETHOPROPAZINE
Schedule 4
ETHOPROPHOS
cross reference: LINSEED OIL
Schedule 7
Schedule 6
ETHOSUXIMIDE
Schedule 4
ETHOTOIN
Schedule 4
ETHOXYETHYLMERCURIC CHLORIDE
Appendix F, Part 3
ETHOXYQUIN
Schedule 5
ETHOXYSULFURON
Schedule 5
ETHOXZOLAMIDE
Schedule 4
ETHYL ACETATE
Appendix B, Part 3
ETHYL ALCOHOL
Appendix B, Part 3
ETHYL BROMIDE
Poisons Standard November 2016
466
INDEX
Schedule 6
Appendix E, Part 2
Appendix F, Part 3
ETHYL BUTYRATE
Appendix B, Part 3
ETHYL CHLORIDE
Schedule 4
ETHYL FORMATE
Schedule 6
ETHYL LACTATE
Appendix B, Part 3
ETHYL METHACRYLATE
Schedule 5
Appendix F, Part 3
ETHYLAMFETAMINE
cross reference: ETHYLAMPHETAMINE
Schedule 8
ETHYLBUTYLACETYLAppendix B, Part 3
ETHYLDIENOLONE
Schedule 4
Appendix D, Item 5 (Anabolic and/or androgenic steroidal agents)
ETHYLENE CHLOROHYDRIN
Schedule 6
Appendix F, Part 3
ETHYLENE DIBROMIDE
Schedule 7
Appendix J, Part 2
ETHYLENE DICHLORIDE
Schedule 6
ETHYLENE GLYCOL
cross reference: DENATONIUM BENZOATE
Poisons Standard November 2016
467
INDEX
Schedule 10
Schedule 6
Schedule 5
Appendix E, Part 2
ETHYLENE GLYCOL MONOALKYL ETHERS
Schedule 6
Appendix E, Part 2
Appendix F, Part 3
ETHYLENE OXIDE
Schedule 7
Appendix E, Part 2
Appendix F, Part 3
Appendix J, Part 2
ETHYLESTRENOL
cross reference: ETHYLOESTRENOL
Schedule 4
Appendix D, Item 5 (Anabolic and/or androgenic steroidal agents)
ETHYLHEXANEDIOL
Schedule 10
Schedule 4
ETHYLMERCURIC CHLORIDE
Appendix F, Part 3
ETHYLMETHYLTHIAMBUTENE
Schedule 9
ETHYLMORPHINE
Schedule 8
Schedule 4
Schedule 2
Appendix K
ETHYLOESTRENOL
cross reference: ETHYLESTRENOL
ETHYNODIOL
cross reference: ETYNODIOL
ETICYCLIDINE
cross reference: PCE
Schedule 9
ETIDOCAINE
Poisons Standard November 2016
468
INDEX
Schedule 4
ETIDRONIC ACID
cross reference: ETIDRONATE DISODIUM
Schedule 4
ETILEFRIN
Schedule 4
ETIPROSTON
Schedule 4
ETODOLAC
Schedule 4
ETOFENAMATE
Schedule 4
Schedule 2
ETONITAZENE
Schedule 9
ETONOGESTREL
Schedule 4
ETOPOSIDE
Schedule 4
ETORICOXIB
Schedule 4
ETORPHINE
Schedule 9
ETOXAZOLE
Appendix B, Part 3
ETOXERIDINE
Schedule 9
ETRAVIRINE
Schedule 4
Poisons Standard November 2016
469
INDEX
ETRETINATE
Schedule 4
Appendix D, Item 5
Appendix F, Part 3
Appendix L, Part 2
ETRIDIAZOLE
Schedule 5
ETRIMFOS
Schedule 6
ETYNODIOL
cross reference: ETHYNODIOL
Schedule 4
EUBACTERIUM sp. strain DSM11798
Appendix B, Part 3
EUCALYPTUS OIL
Schedule 6
Appendix E, Part 2
EUGENOL
Schedule 6
Schedule 5
Appendix E, Part 2
Appendix F, Part 3
EUPATORIUM CANNABINUM
cross reference: HEMP AGRIMONY
Schedule 10
EVEROLIMUS
Schedule 4
EXEMESTANE
Schedule 4
EXENATIDE
Schedule 4
EXPLOSIVES
Appendix A
Poisons Standard November 2016
470
INDEX
471
INDEX
FENARIMOL
Schedule 5
FENAZAFLOR
Schedule 6
FENBENDAZOLE
Schedule 5
FENBUCONAZOLE
Schedule 5
FENBUFEN
Schedule 4
FENBUTATIN OXIDE
Schedule 6
FENCAMFAMIN
Schedule 4
FENCHLORAZOLE-ETHYL
Schedule 5
FENCHLORPHOS
Schedule 6
FENCLOFENAC
Schedule 4
FENETYLLINE
Schedule 9
FENFLURAMINE
Schedule 4
Appendix K
FENFURAM
Appendix B, Part 3
FENHEXAMID
Appendix B, Part 3
Poisons Standard November 2016
472
INDEX
FENITROTHION
Schedule 6
FENOFIBRATE
Schedule 4
FENOLDOPAM
Schedule 4
FENOPROFEN
Schedule 4
FENOPROP
Schedule 5
FENOTEROL
Schedule 4
FENOXACRIM
Schedule 7
Schedule 6
FENOXAPROP-ETHYL
Schedule 5
FENOXAPROP-P-ETHYL
Schedule 5
FENOXYCARB
Appendix B, Part 3
FENPIPRAMIDE
Schedule 4
FENPIPRANE
Schedule 4
FENPROPOREX
Schedule 4
FENPROSTALENE
Schedule 4
Poisons Standard November 2016
473
INDEX
FENPYRAZAMINE
Schedule 5
FENPYROXIMATE
Schedule 6
FENSON
Schedule 5
FENSULFOTHION
Schedule 7
FENTANYL
Schedule 8
FENTEROL
Appendix F, Part 3
FENTHION
Schedule 7
Schedule 6
Schedule 5
FENTHION-ETHYL
Schedule 7
FENVALERATE
Schedule 6
FEXOFENADINE
Schedule 4
Schedule 2
FIBRINOLYSIN
Schedule 4
FIDAXOMICIN
Schedule 4
FILGRASTIM
Schedule 4
FINASTERIDE
Poisons Standard November 2016
474
INDEX
Schedule 4
FINGOLIMOD
Schedule 4
Appendix L, Part 2
FIPRONIL
Schedule 6
Schedule 5
FIROCOXIB
Schedule 4
FLAMPROP-METHYL
Schedule 5
FLAMPROP-M-METHYL
Schedule 5
FLAVOXATE
Schedule 3
FLAZASULFURON
Schedule 5
FLECAINIDE
Schedule 4
FLEROXACIN
Schedule 4
FLOCOUMAFEN
Schedule 7
Schedule 6
FLOCTAFENINE
Schedule 4
FLONICAMID
Schedule 6
FLORASULAM
Schedule 5
Poisons Standard November 2016
475
INDEX
FLORFENICOL
Schedule 4
FLUANISONE
Schedule 4
FLUAZIFOP-BUTYL
Schedule 6
FLUAZIFOP-P-BUTYL
Schedule 6
FLUAZINAM
Schedule 6
FLUAZURON
Schedule 5
FLUBENDAZOLE
Schedule 5
FLUBENDIAMIDE
Schedule 5
FLUBROMAZEPAM
Schedule 9
FLUBROMAZOLAM
Schedule 9
FLUCHLORALIN
Schedule 5
FLUCLOROLONE
Schedule 4
FLUCLOXACILLIN
Schedule 4
FLUCOFURON
Schedule 7
Schedule 6
Poisons Standard November 2016
476
INDEX
FLUCONAZOLE
Schedule 4
Schedule 3
Appendix F, Part 3
Appendix H
FLUCYTHRINATE
Schedule 7
FLUCYTOSINE
Schedule 4
FLUDARABINE
Schedule 4
FLUDIOXONIL
Schedule 5
FLUDROCORTISONE
Schedule 4
FLUENSULFONE
Schedule 6
FLUFENAMIC ACID
Schedule 4
FLUFENOXURON
Appendix B, Part 3
FLUMAZENIL
Schedule 4
FLUMETASONE
cross reference: FLUMETHASONE
Schedule 4
FLUMETHASONE
cross reference: FLUMETASONE
FLUMETHIAZIDE
Schedule 4
FLUMETHRIN
Poisons Standard November 2016
477
INDEX
Schedule 6
Schedule 5
FLUMETSULAM
Appendix B, Part 3
FLUMICLORAC PENTYL
Schedule 5
FLUMIOXAZIN
Schedule 7
Schedule 6
FLUNISOLIDE
Schedule 4
FLUNITRAZEPAM
Schedule 8
Appendix D, Item 5 (Benzodiazepine derivatives)
Appendix K
FLUNIXIN MEGLUMINE
Schedule 4
FLUOCINOLONE
Schedule 4
FLUOCINONIDE
Schedule 4
FLUOCORTIN
Schedule 4
FLUOCORTOLONE
Schedule 4
FLUOMETURON
Appendix B, Part 3
FLUOPICOLIDE
Appendix B, Part 3
FLUOPYRAM
Poisons Standard November 2016
478
INDEX
Schedule 5
FLUORESCEIN
Schedule 4
FLUORIDES
cross reference: SILICOFLUORIDES
Schedule 6
Schedule 5
Schedule 4
Schedule 3
Schedule 2
Appendix E, Part 2
Appendix F, Part 3
FLUOROACETAMIDE
Schedule 7
FLUOROACETIC ACID
Schedule 7
Appendix J, Part 2
FLUOROMETHOLONE
Schedule 4
FLUOROURACIL
Schedule 4
FLUOXETINE
Schedule 4
FLUOXYMESTERONE
Schedule 4
Appendix D, Item 5 (Anabolic and/or androgenic steroidal agents)
FLUPENTIXOL
cross reference: FLUPENTHIXOL
Schedule 4
Appendix K
FLUPHENAZINE
Schedule 4
Appendix K
FLUPROPANATE
cross reference: TETRAPION
Poisons Standard November 2016
479
INDEX
Schedule 6
FLUPROSTENOL
Schedule 4
FLUPYRADIFURONE
Schedule 6
FLUQUINCONAZOLE
Schedule 6
FLURALANER
Schedule 5
FLURANDRENOLONE
Schedule 4
FLURAZEPAM
Schedule 4
Appendix D, Item 5 (Benzodiazepine derivatives)
Appendix K
FLURBIPROFEN
Schedule 4
Schedule 2
FLUOROACETAMIDE
Appendix J, Part 2
FLUROXENE
Schedule 4
FLUROXYPYR
Appendix B, Part 3
FLUSILAZOL
Schedule 6
FLUSPIRILENE
Schedule 4
FLUTAMIDE
Schedule 4
Poisons Standard November 2016
480
INDEX
FLUTICASONE
Schedule 4
Schedule 2
FLUTOLANIL
Appendix B, Part 3
FLUTRIAFOL
Schedule 6
FLUVALINATE
Schedule 6
Schedule 5
FLUVASTATIN
Schedule 4
FLUVOXAMINE
Schedule 4
FLUXAPYROXAD
Schedule 5
FOLIC ACID
Schedule 4
Schedule 2
FOLINIC ACID
cross reference: CALCIUM FOLINATE
Schedule 4
Schedule 2
FOLLICLE-STIMULATING HORMONE
Schedule 4
Appendix D, Item 1
FOLLISTATIN
Schedule 4
Appendix D, Item 5
FOLLITROPIN ALPHA
cross reference: FOLLICLE-STIMULATING HORMONE, RECOMBINANT HUMAN
Schedule 4
Appendix D, Item 1
Poisons Standard November 2016
481
INDEX
FOLLITROPIN BETA
cross reference: FOLLICLE-STIMULATING HORMONE, RECOMBINANT HUMAN
Schedule 4
Appendix D, Item 1
FOLPET
Schedule 7
Appendix J, Part 2
FOMIVIRSEN
Schedule 4
FONDAPARINUX
Schedule 4
FOOD
Appendix A
FORAMSULFURON
Schedule 5
FORCHLORFENURON
Appendix B, Part 3
FORMALDEHYDE
cross reference: FORMALDEHYDE CONDENSATION PRODUCT,
METACRESOLSULPHONIC ACID, FREE FORMALDEHYDE, METHYLENE GLYCOL
Schedule 10
Schedule 6
Schedule 2
Appendix E, Part 2
Appendix F, Part 3
FORMALDEHYDE CONDENSATION PRODUCT
Schedule 6
FORMEBOLONE
Schedule 4
Appendix D, Item 5 (Anabolic and/or androgenic steroidal agents)
FORMESTANE
Schedule 4
FORMETANATE
Poisons Standard November 2016
482
INDEX
Schedule 7
FORMIC ACID
Schedule 5
Appendix E, Part 2
Appendix F, Part 3
FORMOTEROL
Schedule 4
FORMOTHION
Schedule 6
FOSAMPRENAVIR
Schedule 4
FOSAPREPITANT
Schedule 4
FOSCARNET
Schedule 4
FOSFESTROL
cross reference: DIETHYLSTILBESTROL DIPHOSPHATE
Schedule 4
FOSINOPRIL
Schedule 4
FOSPHENYTOIN
Schedule 4
FOSPIRATE
Schedule 6
Schedule 5
FOSTHIAZATE
Schedule 7
FOTEMUSTINE
Schedule 4
FRAMYCETIN
Poisons Standard November 2016
483
INDEX
Schedule 4
FRITTED GLAZING OR ENAMELLING PREPARATIONS
Appendix A
FULLERS EARTH
Appendix B, Part 3
FULVESTRANT
Schedule 4
FUMAGILLIN
Schedule 6
FUNGAL PROTEASE derived from Aspergillus niger
Appendix B, Part 3
FURALAXYL
Schedule 5
FURALTADONE
Schedule 4
FURATHIOCARB
Schedule 7
Schedule 5
FURAZABOL
Schedule 4
FURAZOLIDONE
Schedule 4
Appendix D, Item 5 (Anabolic and/or androgenic steroidal agents)
FURETHIDINE
Schedule 9
FURFURAL
cross reference: 2-FURANCARBOXALDEHYDE
Schedule 6
Appendix E, Part 2
Appendix F, Part 3
484
INDEX
FUROSEMIDE
cross reference: FRUSEMIDE
Schedule 4
FUSIDIC ACID
Schedule 4
G
GABAPENTIN
Schedule 4
Appendix K
GALANTAMINE
Schedule 4
GALANTHUS spp.
Schedule 4
GALLAMINE
Schedule 4
GALSULFASE
Schedule 4
GAMMA BUTYROLACTONE
Schedule 10
GAMMA HYDROXYBUTYRATE
cross reference: 4-HYDROXYBUTANOIC ACID, GHB, SODIUM OXYBATE
Schedule 9
GAMMA-CYHALOTHRIN
Schedule 5
Schedule 7
GANCICLOVIR
Schedule 4
GANIRELIX
Schedule 4
GATIFLOXACIN
Poisons Standard November 2016
485
INDEX
Schedule 4
GEFITINIB
Schedule 4
GELSEMIUM SEMPERVIRENS
Schedule 2
Appendix G
GEMCITABINE
Schedule 4
Appendix K
GEMEPROST
Schedule 4
GEMFIBROZIL
Schedule 4
GEMIFLOXACIN
Schedule 4
GEMTUZUMAB OZOGAMICIN
Schedule 4
GENTAMICIN
Schedule 4
GENTIAN VIOLET
cross reference: METHYLROSANILINIUM CHLORIDE, CRYSTAL VIOLET
GERANIUM OIL
Appendix B, Part 3
GESTODENE
Schedule 4
GESTONORONE
Schedule 4
GESTRINONE
Schedule 4
Appendix D, Item 5 (Anabolic and/or androgenic steroidal agents)
Poisons Standard November 2016
486
INDEX
487
INDEX
Appendix B, Part 3
GLUFOSINATE-AMMONIUM
Schedule 5
GLUTARAL
Schedule 6
Schedule 5
Schedule 2
Appendix E, Part 2
Appendix F, Part 3
GLUTARALDEHYDE
cross reference: GLUTARAL
GLUTATHIONE
Schedule 4
GLUTETHIMIDE
Schedule 4
Appendix D, Item 5
Appendix K
GLYCERYL THIOGLYCOLLATE
Schedule 6
GLYCERYL TRINITRATE
Schedule 4
Schedule 3
Appendix G
GLYCOLIC ACID
Schedule 6
Appendix E, Part 2
Appendix F, Part 3
GLYCOPYRRONIUM
Schedule 4
Schedule 3
GLYMIDINE
Schedule 4
GLYPHOSATE
Schedule 5
Poisons Standard November 2016
488
INDEX
GnRH VACCINE
Schedule 4
GOLIMUMAB
Schedule 4
GONADORELIN
Schedule 4
GONADOTROPHIC HORMONES
Schedule 4
GOSERELIN
Schedule 4
GRAMICIDIN
Schedule 4
GRANISETRON
Schedule 4
GRAZOPREVIR
Schedule 4
GREPAFLOXACIN
Schedule 4
GRISEOFULVIN
Schedule 4
GROWTH HORMONE RELEASING HORMONES *(GHRHs)
Schedule 4
Appendix D, Item 5
GROWTH HORMONE RELEASING PEPTIDE-6 (GHRP-6)
Schedule 4
Appendix D, Item 5
GROWTH HORMONE RELEASING PEPTIDE *(GHRPs)
Schedule 4
Appendix D, Item 5
GROWTH HORMONE SECRETAGOGUES *(GHSs)
Poisons Standard November 2016
489
INDEX
Schedule 4
Appendix D, Item 5
GUAIFENESIN
cross reference: PARACETAMOL
Schedule 4
Schedule 2
GUAIPHENESIN
cross reference: GUAIFENESIN
GUANABENZ
Schedule 4
GUANACLINE
Schedule 4
GUANETHIDINE
Schedule 4
GUANIDINE
Schedule 6
Schedule 4
Appendix E, Part 2
GUAZATINE
Schedule 6
H
HACHIMYCIN
Schedule 4
HAEMATIN
Schedule 4
HAEMOPHILUS INFLUENZAE VACCINE
Schedule 4
HALAUXIFEN METHYL
Appendix B, Part 3
HALCINONIDE
Schedule 4
Poisons Standard November 2016
490
INDEX
HALOFANTRINE
Schedule 4
HALOFENATE
Schedule 4
HALOFUGINONE
Schedule 7
Schedule 4
Appendix J, Part 2
HALOGENATED DIBENZODIOXINS AND DIBENZOFURANS
cross reference: DIBENZODIOXINS, HALOGENATED - DIBENZOFURANS,
HALOGENATED, DIOXINS
Schedule 7
Appendix J, Part 2
HALOPERIDOL
cross reference: BUTYPHENONES
Schedule 4
Appendix G
Appendix K
HALOSULFURON-METHYL
Schedule 5
HALOTHANE
Schedule 4
HALOXON
Schedule 6
HALOXYFOP
Schedule 6
HARMALA ALKALOIDS
Schedule 9
HCB
Schedule 7
Appendix J, Part 2
HELIOTROPIUM spp.
Schedule 10
Poisons Standard November 2016
491
INDEX
HEMEROCALLIS
Schedule 4
HEPARINS
Schedule 4
HEPATITIS A VACCINE
Schedule 4
HEPATITIS B VACCINE
Schedule 4
HEPTACHLOR
Schedule 6
HEROIN
Schedule 9
HETACILLIN
Schedule 4
HEXACHLOROPHANE
cross reference: HEXACHLOROPHENE
HEXACHLOROPHENE
cross reference: HCB
Schedule 6
Schedule 4
Schedule 2
Appendix E, Part 2
Appendix F, Part 3
HEXACONAZOLE
Schedule 5
HEXAFLURON
Appendix B, Part 3
HEXAMETHONIUM
Schedule 4
HEXARELIN
Schedule 4
Appendix D, Item 5
Poisons Standard November 2016
492
INDEX
HEXAZINONE
Schedule 6
Schedule 5
HEXETIDINE
Schedule 4
HEXLOXYETHANOL
Appendix F, Part 3
HEXOBENDINE
Schedule 4
HEXOCYCLIUM
Schedule 4
HEXOPRENALINE
Schedule 4
HEXYL ACETATE
Appendix B, Part 3
HEXYL AMINOLEVULINATE (AS HYDROCHLORIDE)
Schedule 4
HEXYLOXYETHANOL
Schedule 6
Appendix E, Part 2
Appendix F, Part 3
HEXYTHIAZOX
Appendix B, Part 3
HISTAMINE
Schedule 4
HMG-CoA REDUCTASE INHIBITORS
cross reference: STATINS
Schedule 4
HOMATROPINE
Schedule 4
Poisons Standard November 2016
493
INDEX
494
INDEX
Schedule 5
Appendix E, Part 2
Part 1 - Interpretation
HYDROCHLORIC ACID
Schedule 6
Schedule 5
Appendix E, Part 2
Appendix F, Part 3
HYDROCHLOROTHIAZIDE
Schedule 4
HYDROCODONE
Schedule 8
Appendix K
HYDROCORTISONE
Schedule 4
Schedule 3
Schedule 2
Appendix F, Part 3,
Appendix H
HYDROCORTISONE ACETATE
Schedule 3
Schedule 2
HYDROCYANIC ACID
cross reference: CYANIDES
Schedule 7
Schedule 4,
Appendix F, Part 3,
Appendix J, Part 2
HYDROFLUMETHIAZIDE
Schedule 4
HYDROFLUORIC ACID
cross reference: HYDROGEN FLUORIDE
Schedule 7
Schedule 6
Schedule 5
Appendix J, Part 2
HYDROGEN PEROXIDE
Poisons Standard November 2016
495
INDEX
Schedule 10
Schedule 6
Schedule 5
Appendix E, Part 2
Appendix F, Part 3
HYDROGEN SULFIDE
Schedule 7
HYDROMORPHINOL
Schedule 8
HYDROMORPHONE
Schedule 8
Appendix K
HYDROPRENE
Appendix B, Part 3
HYDROQUINONE
cross reference: ARBUTIN, GLYCOSYLATED HYDROQUINONE, MONOBENZONE
Schedule 6
Schedule 4
Schedule 2
Appendix E, Part 2
Appendix F, Part 3
HYDROSILICOFLUORIC ACID
cross reference: FLUOROSILICIC ACID, HEXAFLUOROSILIC ACID,
HYDROFLUOSILICIC ACID, SILICOFLUORIC ACID
Schedule 7
Schedule 6
Schedule 5
Appendix E, Part 2
Appendix F, Part 3
HYDROXYCARBAMIDE
Schedule 4
HYDROXYCHLOROQUINE
Schedule 4
HYDROXYEPHEDRINE
Schedule 4
HYDROXYPETHIDINE
Poisons Standard November 2016
496
INDEX
Schedule 9
HYDROXYPHENAMATE
Schedule 4
HYDROXYPROGESTERONE
Schedule 4
HYDROXYPROPYL CELLULOSE
Appendix B, Part 3
2-HYDROXYPROPYL METHACRYLATE
Schedule 5
HYDROXYSTENOZOL
Schedule 4
Appendix D, Item 5 (Anabolic and/or androgenic steroidal agents)
HYDROXYUREA
cross reference: HYDROXYCARBAMIDE
HYDROXYZINE
Schedule 4, Appendix K
HYGROMYCIN
Schedule 4
HYOSCINE
cross reference: HYOSCINE BUTYLBROMIDE
Schedule 4
Schedule 2
Appendix G
HYOSCINE BUTYLBROMIDE
Schedule 2
HYOSCYAMINE
Schedule 2
Appendix G
HYOSCYAMUS NIGER
Schedule 2
Appendix G
HYPOTHALAMIC RELEASING FACTORS
Poisons Standard November 2016
497
INDEX
Schedule 4
Appendix G
HYPROMELLOSE
Schedule 4
I
IBAFLOXACIN
Schedule 4
IBANDRONIC ACID
Schedule 4
IBOGAINE
Schedule 4
IBRITUMOMAB
Schedule 4
IBRUTINIB
Schedule 4
IBUFENAC
Schedule 4
IBUPROFEN
cross reference: PARACETAMOL
Schedule 4
Schedule 3
Schedule 2
Appendix F, Part 3
IBUTEROL
Schedule 4
IBUTILIDE
Schedule 4
ICATIBANT
Schedule 4
ICODEXTRIN
Appendix B, Part 3
Poisons Standard November 2016
498
INDEX
IDARUBICIN
Schedule 4
IDARUCIZUMAB
Schedule 4
IDOXURIDINE
Schedule 4
IDURSULFASE
Schedule 4
IFOSFAMIDE
Schedule 4
ILOPROST
Schedule 4
IMATINIB
Schedule 4
IMAZALIL
cross reference: ENILCONAZOLE
Schedule 5
IMAZAMOX
Schedule 5
IMAZAPIC
Schedule 5
IMAZAPYR
Schedule 5
IMAZETHAPYR
Schedule 5
IMEPITOIN
Schedule 4
IMIDACLOPRID
499
INDEX
Schedule 6
Schedule 5
IMIDAPRIL
Schedule 4
IMIDOCARB
Schedule 6
IMIGLUCERASE
Schedule 4
IMINOCTADINE TRIALBESILATE
Schedule 6
IMIPENIM
Schedule 4
IMIPRAMINE
Schedule 4
Appendix K
IMIPROTHRIN
Schedule 6
Schedule 5
IMIQUIMOD
Schedule 4
IMMUNOGLOBULINS
cross reference: EQUINE ANTI-HUMAN THYMOCYTE IMMUNOGLOBULIN
Schedule 4
IN VITRO DIAGNOSTIC AND ANALYTICAL PREPARATIONS
Appendix A
INDACATEROL
Schedule 4
INDANAZOLINE
Schedule 2
INDAPAMIDE
Poisons Standard November 2016
500
INDEX
Schedule 4
INDAZIFLAM
Schedule 6
INDINAVIR
Schedule 4
INDOLE-3-ACETIC ACID
Appendix B, Part 3
INDOMETACIN
Schedule 4
Schedule 2
Appendix G
INDOMETHACIN
cross reference: INDOMETACIN
INDOPROFEN
Schedule 4
INDORAMIN
Schedule 4
INDOXACARB
Schedule 6
Schedule 5
INFLIXIMAB
Schedule 4
INFLUENZA AND CORYZA VACCINES
cross reference: H5N1 INFLUENZA VIRUS HAEMAGGLUTININ
Schedule 4
INGENOL MEBUTATE
Schedule 4
INOSITOL NICOTINATE
Schedule 3
INSULIN GLARGINE
Schedule 4
Poisons Standard November 2016
501
INDEX
502
INDEX
IPAMORELIN
Schedule 4,
Appendix D, Item 5
IPCONAZOLE
Schedule 6
Schedule 5
IPILIMUMAB
Schedule 4
IPRATROPIUM
Schedule 4
Schedule 2
IPRATROPIUM BROMIDE
Appendix F, Part 3
IPRIFLAVONE
Schedule 4
IPRINDOLE
Schedule 4
IPRODIONE
Appendix B, Part 3
IPRONIAZID
Schedule 4
IRBESARTAN
Schedule 4
IRINOTECAN
Schedule 4
IRON COMPOUNDS
cross reference: IRON OXIDES
Schedule 6
Schedule 5
Schedule 4
Schedule 2
ISETHIONATE
Poisons Standard November 2016
503
INDEX
Appendix B, Part 3
ISOAMINILE
Schedule 4
ISOAMYL NITRITE
Schedule 4
ISOBUTYL NITRITE
Schedule 4
ISOCARBOPHOS
Schedule 7
ISOCARBOXAZID
Schedule 4
ISOCONAZOLE
Schedule 6
Schedule 4
Schedule 3
Schedule 2
ISOCYANATES
Schedule 6
Appendix E, Part 2
Appendix F, Part 3
ISOETARINE
Schedule 4
ISOEUGENOL
Schedule 6
Schedule 5
ISOFENPHOS
Schedule 7
ISOFLURANE
Schedule 4
ISOMETHADONE
Schedule 9
Poisons Standard November 2016
504
INDEX
ISOMETHEPTENE
Schedule 4
ISONIAZID
Schedule 4
ISOPHORONE
Schedule 5
Appendix E, Part 2
ISOPRENALINE
Schedule 4
Appendix F, Part 3
ISOPRENE ALCOHOL
Appendix B, Part 3
ISOPRINOSINE
Schedule 4
ISOPROPAMIDE
Schedule 4
Schedule 2
ISOPROTURON
Schedule 7
ISOPYRAZAM
Schedule 6
ISOSORBIDE DINITRATE
Schedule 4
Schedule 3
ISOSORBIDE MONONITRATE
Schedule 4
ISOSTEARYL ALCOHOL ETHOXYLATE
Appendix B, Part 3
ISOTRETINOIN
Schedule 4
Appendix D, Item 5
Poisons Standard November 2016
505
INDEX
Appendix F, Part 3
Appendix L, Part 2
ISOXABEN
Schedule 5
ISOXAFLUTOLE
Schedule 5
ISOXICAM
Schedule 4
ISOXSUPRINE
Schedule 4
ISRADIPINE
Schedule 4
ITRACONAZOLE
Schedule 4
IVABRADINE
Schedule 4
IVACAFTOR
Schedule 4
IVERMECTIN
Schedule 7
Schedule 5
Schedule 4
IXABEPILONE
Schedule 4
IXEKIZUMAB
Schedule 4
J
JAPANESE ENCEPHALITIS VACCINE
Schedule 4
506
INDEX
JUNIPERUS SABINE
cross reference: SAVIN(E)
Schedule 10
K
KANAMYCIN
Schedule 4
KAOLIN
Appendix B, Part 3
KEROSENE
Appendix E, Part 2
KETAMINE
Schedule 8
KETANSERIN
Schedule 4
KETAZOLAM
Schedule 4
Appendix D, Item 5 (Benzodiazepine derivatives)
KETOBEMIDONE
Schedule 9
KETOCONAZOLE
Schedule 4
Schedule 2
KETOPROFEN
Schedule 4
Schedule 3
KETOROLAC
Schedule 4
KETOTIFEN
Schedule 4
Schedule 2
KHELLIN
Poisons Standard November 2016
507
INDEX
Schedule 4
KITASAMYCIN
Schedule 5
Schedule 4
KRESOXIM-METHYL
Appendix B, Part 3
KUNZEA OIL
Appendix B, Part 3
L
LABETALOL
Schedule 4
LACIDIPINE
Schedule 4
LACOSAMIDE
Schedule 4
LAMBDA-CYHALOTHRIN
Schedule 7
Schedule 6
Schedule 5
LAMIVUDINE
Schedule 4
LAMOTRIGINE
Appendix K
LAMOTRIGINE
Schedule 4
LANATOSIDES
Schedule 4
LANREOTIDE
Schedule 4
Poisons Standard November 2016
508
INDEX
LANSOPRAZOLE
Schedule 4
Schedule 3
Schedule 2
Appendix H
LANTHANUM
Schedule 4
LAPATINIB
Schedule 4
LARONIDASE
Schedule 4
LAROPIPRANT
Schedule 4
LASALOCID
Schedule 6
LASIODIPLODIA PSEUDOTHEOBROMAE
Schedule 5
LATAMOXEF
Schedule 4
LATANOPROST
Schedule 4
LAUDEXIUM
Schedule 4
LAURETH CARBOXYLIC ACIDS
Schedule 6
Appendix E, Part 2
LAURIC ACID
Appendix B, Part 3
LAUROMACROGOLS
cross reference: LAURETH-9
Schedule 4
Poisons Standard November 2016
509
INDEX
LAURYL ALCOHOL
cross reference: 1-DODECANOL
Appendix B, Part 3
LAURYL ISOQUINOLINIUM BROMIDE
Schedule 6
Appendix E, Part 2
LAURYL SULFATE SALTS
cross reference: SODIUM LAURYL SULPHATE, DODECYL SULFATES
Schedule 6
Appendix E, Part 2
LAVANDIN OIL
cross reference: CAMPHOR
Appendix B, Part 3
LAVENDER OIL
Appendix B, Part 3
LEAD
cross reference: GLAZING PREPARATIONS, PRINTING INKS or INK ADDITIVES,
SELENIUM
Schedule 4
LEAD COMPOUNDS
cross reference: GLAZING PREPARATIONS, PRINTING INKS or INK ADDITIVES,
SELENIUM
Schedule 10
Schedule 6
Schedule 5
Appendix E, Part 2
Appendix F, Part 3
Appendix F, Part 3
LEAD METALLIC
Appendix B, Part 3
LEDIPASVIR
Schedule 4
LEFETAMINE
Schedule 4
LEFLUNOMIDE
Poisons Standard November 2016
510
INDEX
Schedule 4
Appendix F, Part 3
Appendix L, Part 2
LEMON OIL
Schedule 5
Appendix E, Part 2
Appendix F, Part 3
LEMONGRASS OIL
Schedule 5
LENALIDOMIDE
Schedule 4
Appendix D, Item 4
Appendix F, Part 3
Appendix L
LENOGRASTIM
Schedule 4
LEPIDOPTEROUS SEX PHEROMONES
Appendix B, Part 3
LEPIRUDIN
Schedule 4
LEPTAZOL
Schedule 4
LEPTOPHOS
Schedule 7
LEPTOSPERMUM SCOPARIUM OIL
cross reference: MANUKA OIL
Schedule 6
Appendix E, Part 2
LERCANIDIPINE
Schedule 4
LESINURAD
Schedule 4
LETROZOLE
Poisons Standard November 2016
511
INDEX
Schedule 4
LEUPRORELIN
Schedule 4
LEVALLORPHAN
Schedule 4
LEVAMISOLE
Schedule 6
Schedule 5
Schedule 4
LEVAMFETAMINE
cross reference: LEVAMPHETAMINE
Schedule 8
LEVETIRACETAM
Schedule 4
Appendix K
LEVOBUNOLOL
Schedule 4
LEVOBUPIVACAINE
Schedule 4
LEVOCABASTINE
Schedule 4
Schedule 2
Appendix F, Part 3
Appendix L, Part 2
LEVOCETIRIZINE
Schedule 4
Schedule 2
Appendix K
LEVODOPA
Schedule 4
LEVOMEPROMAZINE
cross reference: METHOTRIMEPRAZINE
Schedule 4
Poisons Standard November 2016
512
INDEX
LEVOMETHAMFETAMINE
cross reference: LEVOMETHAMPHETAMINE
Schedule 8
LEVOMETHORPHAN
Schedule 9
LEVOMILNACIPRAN
Schedule 4
LEVOMORAMIDE
Schedule 8
LEVONORGESTREL
Schedule 4
Schedule 3
LEVOPHENACYLMORPHAN
Schedule 9
LEVORPHANOL
Schedule 8
LEVOSIMENDAN
Schedule 4
LIDOCAINE
Schedule 5
Schedule 4
Schedule 2
LIDOFLAZINE
Schedule 4
LIGNOCAINE
cross reference: LIDOCAINE
LIGULARIA DENTATA
Schedule 10
LIME OIL
Schedule 5
Appendix E, Part 2
Appendix F, Part 3
Poisons Standard November 2016
513
INDEX
LIMONENE
cross reference: DIPENTENE
Appendix B, Part 3
LINAGLIPTIN
Schedule 4
LINCOMYCIN
Schedule 4
LINDANE
cross reference: BHC
Schedule 6
Schedule 5
Schedule 4
Schedule 2
LINEZOLID
Schedule 4
LINOLEIC ACID
Appendix B, Part 3
LINSEED FATTY ACIDS
Appendix B, Part 3
LINURON
Appendix B, Part 3
LIOTHYRONINE
cross reference: TRIIODOTHYRONINE
Schedule 4
LIQUORICE, DEGLYCYRRHISINISED
Appendix B, Part 3
LIRAGLUTIDE
Schedule 4
LISDEXAMFETAMINE
Schedule 8
LISINOPRIL
Poisons Standard November 2016
514
INDEX
Schedule 4
LISURIDE
Schedule 4
LITHIUM
Schedule 4
Schedule 2
LITHIUM PERFLUOROOCTANE SULFONATE
Schedule 7
LIXISENATIDE
Schedule 4
LOBELIA INFLATA
Schedule 2
LOBELINE
Schedule 2
LODOXAMIDE
Schedule 4
Schedule 2
LOFEXIDINE
Schedule 4
LOGIPARIN
Schedule 4
LOMEFLOXACIN
Schedule 4
LOMUSTINE
Schedule 4
LOPERAMIDE
Schedule 4
Schedule 2
Appendix F, Part 3
LOPINAVIR
Poisons Standard November 2016
515
INDEX
Schedule 4
LOPRAZOLAM
Schedule 4
Appendix D, Item 5 (Benzodiazepine derivatives)
LORACARBEF
Schedule 4
LORATADINE
Schedule 4
Schedule 2
LORAZEPAM
Schedule 4
Appendix D, Item 5 (Benzodiazepine derivatives)
Appendix K
LORMETAZEPAM
Schedule 4
Appendix D, Item 5 (Benzodiazepine derivatives)
LOSARTAN
Schedule 4
LOTEPREDNOL
Schedule 4
LOXAPINE
Schedule 4
LUBRICANTS
Appendix A
LUFENURON
Schedule 5
LUMEFANTRINE
Schedule 4
LUMIRACOXIB
Schedule 4
LURASIDONE
Poisons Standard November 2016
516
INDEX
Schedule 4
Appendix K
LUTEINISING HORMONE
Schedule 4
Appendix D, Item 1
LYMECYCLINE
Schedule 4
LYSERGIC ACID
Schedule 9
LYSERGIDE
Schedule 9
M
MACITENTAN
Schedule 4
Appendix D, Item 6
Appendix L, Part 2
MACROGOLS
Schedule 3
Schedule 2
MACROPHOMINA PHASEOLINA
Schedule 5
MADURAMICIN
Schedule 7
Schedule 5
Appendix J, Part 2
MAFENIDE
Schedule 6
Schedule 4
MAGNESIUM CHLORATE
Schedule 5
Appendix E, Part 2
Appendix F, Part 3
MAGNESIUM SULFATE
Poisons Standard November 2016
517
INDEX
Schedule 3
MALACHITE GREEN
Schedule 7
Schedule 5
MALATHION
cross reference: MALDISON, ORGANOPHOSPHORUS COMPOUNDS
Schedule 6
Schedule 5
Schedule 3
Appendix E, Part 2
MALEIC HYDRAZIDE
Appendix B, Part 3
MANCOZEB
Schedule 5
MANDESTROBIN
Schedule 5
MANDIPROPAMID
Schedule 5
MANDRAGORA OFFICINARUM
Schedule 4
MANGANESE DIOXIDE
Appendix B, Part 3
MANNITYL HEXANITRATE
Schedule 3
MANNOMUSTINE
Schedule 4
MAPROTILINE
Schedule 4
MARAVIROC
Schedule 4
MARBOFLOXACIN
Poisons Standard November 2016
518
INDEX
Schedule 4
MARJORAM OIL
Schedule 5
Appendix E, Part 2
MAROPITANT
Schedule 4
MATCHES
Appendix A
MAVACOXIB
Schedule 4
MAZIDOX
Schedule 7
MAZINDOL
Schedule 4
Appendix K
MCPA
Schedule 6
Schedule 5
MCPB
Schedule 5
MEASLES VACCINE
Schedule 4
MEBANAZINE
Schedule 4
MEBENDAZOLE
Schedule 6
Schedule 5
Schedule 2
MEBEVERINE
Schedule 4
MEBHYDROLIN
Poisons Standard November 2016
519
INDEX
Schedule 4
Appendix K
MEBOLAZINE
Schedule 4
Appendix D, Item 5 (Anabolic and/or androgenic steroidal agents)
MEBUTAMATE
Schedule 4
MECAMYLAMINE
Schedule 4
MECARBAM
Schedule 7
MECASERMIN
Schedule 4
MECILLINAM
Schedule 4
MECLOCYCLINE
Schedule 4
MECLOFENAMATE
Schedule 4
MECLOFENAMIC ACID
Schedule 5
MECLOFENOXATE
Schedule 4
MECLONAZEPAM
Schedule 9
MECLOQUALONE
Schedule 9
MECLOZINE
520
INDEX
Schedule 4
Schedule 2
Appendix K
MECOPROP
Schedule 6
Schedule 5
MECOPROP-P
Schedule 6
MEDAZEPAM
Schedule 4
Appendix D, Item 5 (Benzodiazepine derivatives)
Appendix K
MEDETOMIDINE
Schedule 4
MEDICAL AND VETERINARY ADHESIVES, GLUES AND CEMENTS
Appendix A
MEDICAL DEVICES
cross reference: ANTICOAGULANT MEDICAL DEVICES, ARTIFICIAL TEARS,
COLLAGEN, INJECTABLE TISSUE RECONSTRUCTIVE, AUGMENTATION AND
RESTORATION MATERIALS, INTRA-ARTICULAR FLUIDS, URINARY CATHETERS
Appendix A
MEDIGOXIN
cross reference: METHYLDIGOXIN
Schedule 4
MEDROXYPROGESTERONE
Schedule 4
MEDRYSONE
Schedule 4
MEFENAMIC ACID
Schedule 4
Schedule 2
Appendix F, Part 3
MEFENOREX
Schedule 4
Poisons Standard November 2016
521
INDEX
MEFENPYR-DIETHYL
Schedule 5
MEFLOQUINE
Schedule 4
MEFLUIDIDE
Schedule 6
MEFRUSIDE
Schedule 4
MEGASPHAERA ELSDENII strain 41125
Appendix B, Part 3
MEGESTROL
Schedule 4
MELAGATRAN
Schedule 4
MELALEUCA OIL
cross reference: TEA TREE OIL
Schedule 6
Appendix E, Part 2
MELATONIN
Schedule 4
MELENGESTROL
Schedule 4
MELENGESTROL ACETATE
Schedule 6
MELIA AZEDARACH
Schedule 10
MELOXICAM
Schedule 4
MELPHALAN
Poisons Standard November 2016
522
INDEX
Schedule 4
MEMANTINE
Schedule 4
MENAZON
Schedule 6
MENINGOCOCCAL VACCINE
Schedule 4
MENOTROPHIN
Schedule 4
MEPACRINE
Schedule 4
MEPENZOLATE
Schedule 4
MEPHENESIN
Schedule 4
MEPHENTERMINE
Schedule 4
MEPINDOLOL
Schedule 4
MEPIQUAT
Schedule 5
MEPITIOSTANE
Schedule 4
Appendix D, Item 5 (Anabolic and/or androgenic steroidal agents)
MEPIVACAINE
Schedule 4
MEPROBAMATE
Schedule 4
Appendix K
Poisons Standard November 2016
523
INDEX
MEPTAZINOL
Schedule 4
MEPYRAMINE
MEPYRAMINE
Schedule 4
Schedule 3
Schedule 2
Appendix K
MEQUITAZINE
Schedule 4
MERCAPTAMINE
cross reference: CYSTEAMINE
Schedule 6
Schedule 5
Schedule 4
Appendix K
MERCAPTOACETIC ACID
cross reference: THIOGLYCOLIC ACID
Schedule 6
Schedule 5
Appendix E, Part 2
Appendix F, Part 3
MERCAPTOMERIN
Schedule 4
MERCAPTOPURINE
Schedule 4
MERCURIC CHLORIDE
cross reference: CALOMEL
Schedule 7
MERCURIC IODIDE
Appendix E, Part 2
MERCURIC NIRATE
Appendix E, Part 2
MERCURIC OXIDE
Poisons Standard November 2016
524
INDEX
Schedule 6
Appendix E, Part 2
MERCURIC POTASSIUM IODIDE
Appendix E, Part 2
MERCURIC THIOCYANATE
Appendix E, Part 2
Appendix F, Part 3
MERCUROCHROME
Schedule 6
Schedule 4
Schedule 2
Appendix E, Part 2
MERCUROUS CHLORIDE
cross reference: CORROSIVE SUBLIMATE
Appendix E, Part 2
MERCURY
cross reference: ETHOXYETHYLMERCURIC CHLORIDE, ETHOXYQUIN, PHENYL
MERCURIC CHLORIDE
Schedule 7
Schedule 4
Schedule 2
Appendix G
Appendix J, Part 2
MERCURY metallic
Appendix E, Part 2
MERCURY, organic compounds
Appendix E, Part 2
MEROPENEM
Schedule 4
MERSALYL
Schedule 4
MERURIC CHLORIDE
Appendix E, Part 2
MESABOLONE
Poisons Standard November 2016
525
INDEX
Schedule 4
Appendix D, Item 5 (Anabolic and/or androgenic steroidal agents)
MESALAZINE
Schedule 4
MESNA
Schedule 4
MESOLSULFURON-METHYL
Appendix B, Part 3
MESOTRIONE
Schedule 5
MESTANOLONE
cross reference: ANDROSTALONE
Schedule 4
Appendix D, Item 5 (Anabolic and/or androgenic steroidal agents)
MESTEROLONE
Schedule 4
Appendix D, Item 5 (Anabolic and/or androgenic steroidal agents)
MESTRANOL
Schedule 4
METACRESOLSULPHONIC ACID
Schedule 6
Appendix F, Part 3
METAFLUMIZONE
Schedule 5
METALAXYL
Schedule 6
Schedule 5
METALDEHYDE
Schedule 6
Schedule 5
Appendix E, Part 2
METANDIENONE
Poisons Standard November 2016
526
INDEX
Schedule 4
Appendix D, Item 5 (Anabolic and/or androgenic steroidal agents)
METARAMINOL
Schedule 4
METARHIZIUM ANISOPLIAE
Appendix B, Part 3
METAZOCINE
Schedule 9
METENOLONE
Schedule 4
Appendix D, Item 5 (Anabolic and/or androgenic steroidal agents)
METERGOLINE
Schedule 4
METFORMIN
Schedule 4
METHABENZTHIAZURON
Schedule 5
METHACHOLINE
Schedule 4
METHACRIFOS
Schedule 7
Schedule 6
Appendix J, Part 2
METHACYCLINE
Schedule 4
METHADONE
Schedule 8
Appendix K
METHALLENESTRIL
cross reference: METHALLENOESTRIL
Schedule 4
Poisons Standard November 2016
527
INDEX
METHAM
cross reference: METHAM SODIUM
Schedule 6
METHAMIDOPHOS
Schedule 7
METHANDRIOL
Schedule 4
Appendix D, Item 5 (Anabolic and/or androgenic steroidal agents)
METHANOL
Schedule 5
Schedule 6
Appendix E, Part 2
Appendix F, Part 3
METHANTHELINIUM
Schedule 4
METHAPYRILENE
Schedule 7
METHAQUALONE
Schedule 9
METHAZOLAMIDE
Schedule 4
METHAZOLE
Schedule 7
METHCATHINONE
Schedule 9
METHDILAZINE
Schedule 4
Schedule 3
Appendix K
METHENAMINE
cross reference: 1,3,5,7-TETRAAZATRICYLO[3.3.1.13,7] DECANE, HEXAMINE,
HEXAMETHYLENETETRAMINE
Schedule 5
Poisons Standard November 2016
528
INDEX
METHENOLONE
Schedule 4
Appendix D, Item 5 (Anabolic and/or androgenic steroidal agents)
METHICILLIN
Schedule 4
METHIDATHION
Schedule 7
METHIMAZOLE
cross reference: THIAMAZOLE
Schedule 4
METHIOCARB
Schedule 7
Schedule 6
Schedule 5
METHISAZONE
Schedule 4
METHIXENE
Schedule 4
METHOCARBAMOL
Schedule 4
Appendix K
METHOFLUTHRIN
Schedule 5
METHOHEXITONE
Schedule 4
METHOIN
Schedule 4
METHOMYL
cross reference: DENATONIUM BENZOATE
Schedule 7
Schedule 6
METHOPRENE
Poisons Standard November 2016
529
INDEX
Appendix B, Part 3
METHOTREXATE
Schedule 4
METHOXAMINE
Schedule 4
Schedule 2
Appendix F, Part 3
METHOXSALEN
Schedule 4
METHOXYCHLOR
Schedule 5
METHOXYETHYLMERCURIC ACETATE
Schedule 7
Appendix J, Part 2
METHOXYETHYLMERCURIC CHLORIDE
Schedule 7
METHOXYFENOZIDE
Appendix B, Part 3
METHOXYFLURANE
Schedule 4
METHOXYPHENAMINE
Schedule 2
METHSUXIMIDE
Schedule 4
METHYCLOTHIAZIDE
Schedule 4
METHYL (2S, 4aR, 6aR, 7R, 9S, 10aS, 10bR)-9-ACETOXY-6a,10b-DIMETHYL-4,10DIOXO-DODECAHYDRO-2-(3-FURYL)-2H-NAPHTHO[2,1-c]PYRAN-7CARBOXYLATE
cross reference: SALVINORIN A
Schedule 9
Poisons Standard November 2016
530
INDEX
METHYL ACETATE
Appendix B, Part 3
METHYL AMINOLEVULINATE
Schedule 4
p-METHYLAMINOPHENOL
Schedule 6
Appendix F, Part 3
METHYL BENZOQUATE
Appendix B, Part 3
METHYL BROMIDE
Schedule 7
Appendix J, Part 2
METHYL CHLORIDE
Appendix F, Part 3
METHYL ETHYL KETONE
cross reference: DESIGNATED SOLVENT
Schedule 5
Appendix E, Part 2
Appendix F, Part 3
Part 1 - Interpretation
METHYL ETHYL KETONE OXIME
Schedule 6
Appendix E, Part 2
Appendix F, Part 3
METHYL ETHYL KETONE PEROXIDE
Schedule 5
Appendix E, Part 2
Appendix F, Part 3
METHYL ISOAMYL KETONE
cross reference: DESIGNATED SOLVENT
Schedule 5
Appendix E, Part 2
Part 1 - Interpretation
METHYL ISOBUTYL KETONE
cross reference: DESIGNATED SOLVENT, METHYLATED SPIRIT(S)
Poisons Standard November 2016
531
INDEX
Schedule 5
Appendix E, Part 2
Part 1 - Interpretation
METHYL ISOTHIOCYANATE
Schedule 6
METHYL MERCURY
Schedule 4
METHYL METHACRYLATE
Schedule 10
Schedule 6
Appendix F, Part 3
METHYL NEODECANAMIDE
Schedule 6
METHYL p-HYDROXYBENZOATE
Appendix B, Part 3
METHYL SALICYLATE
Schedule 6
Schedule 5
Schedule 4
METHYL SALICYLATE LIQUID
Appendix E, Part 2
METHYLAMFETAMINE
cross reference: METHYLAMPHETAMINE, METHAMFETAMINE
Schedule 8
METHYLANDROSTANOLONE
Schedule 4
Appendix D, Item 5 (Anabolic and/or androgenic steroidal agents)
METHYLATED SPIRIT(S)
cross reference: DENATONIUM BENZOATE, ETHANOL, FLUORESCEIN
Schedule 5
Appendix E, Part 2
Appendix F, Part 3
METHYLCHLOROISOTHIAZOLINONE
532
INDEX
Schedule 6
Appendix F, Part 3
METHYLCLOSTEBOL
Schedule 4
Appendix D, Item 5 (Anabolic and/or androgenic steroidal agents)
METHYLCYCLOPENTADIENYL MANGANESE TRICARBONYL
Schedule 7
Schedule 6
METHYLDESORPHINE
Schedule 9
METHYLDIBROMO GLUTARONITRILE
Schedule 10
Schedule 6
Appendix F, Part 3
METHYLDIHYDROMORPHINE
Schedule 8
METHYLDOPA
Schedule 4
METHYLENE BISTHIOCYANATE
Schedule 6
Appendix F, Part 3
METHYLENE BLUE
Schedule 7
Schedule 5
Schedule 4
METHYLEPHEDRINE
Schedule 2
METHYLERGOMETRINE
Schedule 4
METHYLEUGENOL
Schedule 6
Appendix E, Part 2,
Appendix F, Part 3
Poisons Standard November 2016
533
INDEX
METHYLISOTHIAZOLINONE
Schedule 6
Appendix F, Part 3
METHYLMERCURY
Appendix G
METHYLNALTREXONE
Schedule 4
METHYLNORBORNYLPYRIDINE
Schedule 6
METHYLPENTYNOL
Schedule 4
METHYLPHENIDATE
Schedule 8
METHYLPHENOBARBITAL
cross reference: BARBITURATE METHYLPREDNISOLONE
Schedule 4
Appendix K
METHYLPHENOBARBITONE
cross reference: METHYLPHENOBARBITAL, BARBITURATE METHYLPREDNISOLONE
METHYLPREDNISOLONE
Schedule 4
METHYLROSANILINIUM CHLORIDE
cross reference: CRYSTAL VIOLET, GENTIAN VIOLET
Schedule 10
Schedule 6
Schedule 4
METHYLTESTOSTERONE
Schedule 4
Appendix D, Item 5 (Anabolic and/or androgenic steroidal agents)
METHYLTHIOURACIL
Schedule 4
METHYLTRIENOLONE
Poisons Standard November 2016
534
INDEX
Schedule 4
Appendix D, Item 5 (Anabolic and/or androgenic steroidal agents)
METHYPRYLONE
Schedule 4
METHYSERGIDE
Schedule 4
METIRAM
Schedule 5
METOCLOPRAMIDE
Schedule 4
Schedule 3
METOFLUTHRIN
Schedule 6
Schedule 5
METOLACHLOR
Schedule 5
METOLAZONE
Schedule 4
METOPON
Schedule 9
METOPROLOL
Schedule 4
METOSULAM
Schedule 6
METRAFENONE
Schedule 6
Schedule 5
METRIBOLONE
Schedule 4
Appendix D, Item 5 (Anabolic and/or androgenic steroidal agents)
METRIBUZIN
Poisons Standard November 2016
535
INDEX
Schedule 6
METRIFONATE
cross reference: TRICHLORFON
Schedule 4
METRONIDAZOLE
cross reference: BENZOYL METRONIDAZOLE
Schedule 4
METSULFURONMETHYL
Appendix B, Part 3
METYRAPONE
Schedule 4
MEVINPHOS
Schedule 7
MEXILETINE
Schedule 4
MEZLOCILLIN
Schedule 4
MIANSERIN
Schedule 4
Appendix K
MIBEFRADIL
Schedule 4
MIBOLERONE
Schedule 4
Appendix D, Item 5 (Anabolic and/or androgenic steroidal agents)
MICAFUNGIN
Schedule 4
MICONAZOLE
Schedule 6
Schedule 4
Schedule 3
Schedule 2
Poisons Standard November 2016
536
INDEX
Appendix F, Part 3
Appendix H
MIDAZOLAM
Schedule 4
Appendix D, Item 5 (Benzodiazepine derivatives)
MIDODRINE
Schedule 4
MIFEPRISTONE
Schedule 4
MIGLITOL
Schedule 4
MIGLUSTAT
Schedule 4
MILBEMECTIN
Schedule 6
Schedule 5
MILNACIPRAN
Schedule 4
MILBEMYCIN OXIME
Schedule 4
Schedule 5
MILRINONE
Schedule 4
MINOCYCLINE
Schedule 4
MINOXIDIL
Schedule 4
Schedule 2
MIPAFOX
Schedule 7
MIRABEGRON
Poisons Standard November 2016
537
INDEX
Schedule 4
MIREX
Schedule 7
Appendix J, Part 2
MIRTAZAPINE
Schedule 4
Appendix K
MISOPROSTOL
Schedule 4
Appendix F, Part 3
Appendix L, Part 2
MITOBRONITOL
Schedule 4
MITOMYCIN
Schedule 4
MITOTANE
Schedule 4
MITOXANTRONE
Schedule 4
MITRAGYNA SPECIOSA
Schedule 9
MITRAGYNINE
Schedule 9
MITRATAPIDE
Schedule 4
MIVACURIUM CHLORIDE
Schedule 4
MOCLOBEMIDE
Schedule 4
MODAFINIL
Poisons Standard November 2016
538
INDEX
Schedule 4
MOLGRAMOSTIM
Schedule 4
MOLINATE
Schedule 7
Appendix J, Part 2
MOLINDONE
Schedule 4
MOMETASONE
Schedule 2
Schedule 4
MOMFLUOROTHRIN
Schedule 6
MONENSIN
Schedule 6
Schedule 5
Schedule 4
MONEPANTEL
Schedule 5
MONOBENZONE
cross reference: HYDROQUINONE
Schedule 4
MONOCLONAL ANTIBODIES
Schedule 4
MONOCROTOPHOS
Schedule 7
MONOETHANOLAMINE
Schedule 6
Schedule 5
Schedule 4
Appendix E, Part 2
Appendix F, Part 3
MONTELUKAST
Poisons Standard November 2016
539
INDEX
Schedule 4
MOPERONE
Schedule 4
MORANTEL
Schedule 6
Schedule 5
MORAZONE
Schedule 4
MORICIZINE
Schedule 4
MORPHERIDINE
Schedule 9
MORPHINE
Schedule 8
Appendix K
MORPHINE METHOBROMIDE
Schedule 8
MORPHINE-N-OXIDE
Schedule 8
MOTOR, HEATING or FURNACE FUELS
cross reference: FUELS, FUELS, HOBBY - FUELS, TOY, KEROSENE, METHANOL,
PETROL
Appendix A
MOTRAZEPAM
Schedule 4
MOTRETINIDE
Schedule 4
MOXIDECTIN
Schedule 7
Schedule 6
Schedule 5
Schedule 4
Poisons Standard November 2016
540
INDEX
MOXIFLOXACIN
Schedule 4
MOXONIDINE
Schedule 4
MSMA
Schedule 7
Schedule 6
MUMPS VACCINE
Schedule 4
MUPIROCIN
Schedule 4
MURAGLITAZAR
Schedule 4
MUROMONAB
Schedule 4
MUSCIMOL
Schedule 9
MUSTINE
cross reference: NITROGEN MUSTARD
Schedule 4
MYCLOBUTANIL
Schedule 5
MYCOPHENOLIC ACID
cross reference: MYCOPHENOLATE MOFETIL
Schedule 4
MYRISTIC ACID
Appendix B, Part 3
MYROPHINE
Schedule 9
N
Poisons Standard November 2016
541
INDEX
N- -[METHYL-3,4-(METHYLENEDIOXY)PHENETHYL]HYDROXYLAMINE
cross reference: N-HYDROXY MDA
Schedule 9
N-(N-DODECYL)-2-PYRROLIDONE
cross reference: DESIGNATED SOLVENT, N-(N-OCTYL)-2-PYRROLIDONE, N-METHYL2-PYRROLIDONE
Schedule 6
Schedule 5
Appendix E, Part 2
Part 1 - Interpretation
N-(N-OCTYL)-2-PYRROLIDONE
cross reference: DESIGNATED SOLVENT, N-(N-DODECYL)-2-PYRROLIDONE, NMETHYL-2-PYRROLIDONE
Schedule 6
Schedule 5
Appendix E, Part 2
Part 1 - Interpretation
N, -DIMETHYL-3,4-(METHYLENEDIOXY)PHENYLETHYLAMINE
cross reference: 3,4-METHYLENEDIOXY-N--DIMETHYLPHENYLETHYLAMINE,
MDMA
Schedule 9
N,N-BIS(PHENYLMETHYLENE)-BICYCLO-(2.2.1)HEPTANE-2,5DIMETHANAMINE
cross reference: N,N-BIS(PHENYLMETHYLENE)-BICYCLO-(2.2.1)HEPTANE-2,6DIMETHANAMINE
Schedule 6
Appendix E, Part 2
Appendix F, Part 3
N,N-BIS(PHENYLMETHYLENE)-BICYCLO-(2.2.1)HEPTANE-2,6DIMETHANAMINE
cross reference: N,N-bIS(PHENYLMETHYLENE)-BICYCLO-(2.2.1)HEPTANE-2,6DIMETHANAMINE
Schedule 6
Appendix E, Part 2
Appendix F, Part 3
N,N-DIALLYLDICHLOROACETAMIDE
Schedule 5
N,N-DIETHYLTRYPTAMINE
cross reference: DET
Schedule 9
Poisons Standard November 2016
542
INDEX
N,N-DIMETHYLAMFETAMINE
cross reference: N,N-DIMETHYLAMPHETAMINE, DIMETAMFETAMINE
Schedule 9
N,N-DIMETHYLTRYPTAMINE
cross reference: DMT
Schedule 9
NAA
cross reference: NAPTHALENEACETIC ACID
Schedule 5
NABILONE
Schedule 8
NABIXIMOLS
cross reference: CANNABICHROMENE, CANNABIDIOL, CANNABIDIOLIC ACID,
CANNABIDIVAROL, CANNABIGEROL, CANNABINOIDS, CANNABINOL, CANNABIS
SATIVA, TETRAHYDROCANNABINOLIC ACID, TETRAHYDROCANNABINOLS,
TETRAHYDROCANNABIVAROL
Schedule 8
Appendix D, Item 1
Appendix K
NABUMETONE
Schedule 4
NADOLOL
Schedule 4
NADROPARIN
Schedule 4
NAFARELIN
Schedule 4
NAFTIDROFURYL
Schedule 4
NALBUPHINE
Schedule 4
Appendix K
NALED
Poisons Standard November 2016
543
INDEX
Schedule 6
Schedule 5
NALIDIXIC ACID
Schedule 4
NALMEFENE
Schedule 4
NALORPHINE
Schedule 4
NALOXEGOL
Schedule 4
NALOXONE
Schedule 4
Schedule 3
NALTREXONE
Schedule 4
NANDROLONE
Schedule 4
Appendix D, Item 5 (Anabolic and/or androgenic steroidal agents)
NAPHAZOLINE
Schedule 2
Appendix F, Part 3
NAPHTHALENE
Schedule 6
Appendix E, Part 2
Appendix F, Part 3
Appendix G
1,5-NAPHTHALENEDIOL
Schedule 6
Appendix E, Part 2
Appendix F, Part 3
2,7-NAPTHALENEDIOL
Schedule 6
Appendix E, Part 2
Appendix F, Part 3
Poisons Standard November 2016
544
INDEX
NAPHTHALEN-1-YL-(1-BUTYLINDOL-3-YL)METHANONE
cross reference: JWH-073
Schedule 9
NAPHTHALOPHOS
Schedule 6
Schedule 7
1-NAPHTHOL
Schedule 6
Appendix E, Part 2
Appendix F, Part 3
NAPHTHOYLINDOLES
Schedule 9
NAPHTHOYLPYRROLES
Schedule 9
NAPHTHYLMETHYLINDENES
Schedule 9
NAPHTHYLMETHYLINDOLES
Schedule 9
NAPROPAMIDE
Appendix B, Part 3
NAPROXEN
Schedule 4
Schedule 3
Schedule 2
Appendix F, Part 3
Appendix H
NAPTALAM
Schedule 5
NAPTHYL ACETAMIDE
Appendix B, Part 3
NARASIN
Schedule 6
Schedule 4
Poisons Standard November 2016
545
INDEX
NARATRIPTAN
Schedule 4
NATALIZUMAB
Schedule 4
NATAMYCIN
cross reference: PIMARCIN
Schedule 4
NATEGLINIDE
Schedule 4
n-BUTYL BUTYRATE
Appendix B, Part 3
n-BUTYL LACTATE
Appendix B, Part 3
N-COCO-1,3-DIAMINOPROPANE
Schedule 6
N-CYCLOHEXYLDIAZENIUMDIOXY-POTASSIUM
cross reference: K-HDO
Schedule 6
NEBACUMAB
Schedule 4
NEBIVOLOL
Schedule 4
NEDOCROMIL
Schedule 4
NEFAZODONE
Schedule 4
NEFOPAM
Schedule 4
NELFINAVIR
Poisons Standard November 2016
546
INDEX
Schedule 4
NEOMYCIN
Schedule 4
NEOSCYTALIDIUM NOVAEHOLLANDIAE
Schedule 5
NEOSTIGMIN
Schedule 4
NEPAFENAC
Schedule 4
NERIUM OLEANDER
Schedule 4
Appendix G
NEROLI OIL
Appendix B, Part 3
NESIRITIDE
Schedule 4
N-ETHYL--METHYL-3,4-(METHYLENEDIOXY)PHENETHYLAMINE
cross reference: N-ETHYL MDA
Schedule 9
NETILMICIN
Schedule 4
NETOBIMIN
Schedule 6
Schedule 5
NETUPITANT
Schedule 4
NEVIRAPINE
Schedule 4
NIALAMIDE
Schedule 4
Poisons Standard November 2016
547
INDEX
NICARBAZIN
Appendix B, Part 3
NICARDIPINE
Schedule 4
NICERGOLINE
Schedule 4
NICKEL SULFATE
Schedule 6
NICLOSAMIDE
Schedule 2
NICOCODINE
Schedule 9
NICODICODINE
Schedule 9
NICOFURANOSE
Schedule 4
NICOMORPHINE
Schedule 9
NICORANDIL
Schedule 4
NICOTINE
Schedule 7
Schedule 6
Schedule 4
Appendix F, Part 3
Appendix J, Part 2
NICOTINIC ACID
cross reference: NICOTINAMIDE
Schedule 4
Schedule 3
NICOTINYL ALCOHOL
Poisons Standard November 2016
548
INDEX
Schedule 3
NICOUMALONE
Schedule 4
NIFEDIPINE
Schedule 4
NIFENAZONE
Schedule 4
NIFOXIPAM
Schedule 9
NIKETHAMIDE
Schedule 4
NILOTINIB
Schedule 4
NILUTAMIDE
Schedule 4
NIMESULIDE
Schedule 4
NIMIDANE
Schedule 7
Schedule 6
NIMODIPINE
Schedule 4
NIMORAZOLE
Schedule 4
NINTEDANIB
Schedule 4
NIRIDAZOLE
Schedule 4
NISIN
Poisons Standard November 2016
549
INDEX
Appendix B, Part 3
NISOLDIPINE
Schedule 4
NITENPYRAM
Schedule 6
NITISINONE
Schedule 4
NITRAZEPAM
Schedule 4
Appendix D, Item 5 (benzodiazepine derivatives)
Appendix K
NITRENDIPINE
Schedule 4
NITRIC ACID
Schedule 6
Schedule 5
Appendix E, Part 2
Appendix F, Part 3
NITRIC OXIDE
Schedule 4
NITROBENZENE
Schedule 6
Appendix E, Part 2
Appendix F, Part 3
NITROFEN
Schedule 7
Appendix J, Part 2
NITROFURANTOIN
Schedule 4
NITROFURAZONE
Schedule 4
NITROPHENOLS
Poisons Standard November 2016
550
INDEX
Schedule 6
Appendix E, Part 2
Appendix F, Part 3
NITROPRUSSIDES
Schedule 7
Schedule 6
Appendix E, Part 2
Appendix F, Part 3
NITROSCANATE
Schedule 5
NITROUS OXIDE
Schedule 4
NITROXOLINE
Schedule 4
NITROXYNIL
Schedule 6
NIZATIDINE
Schedule 4
Schedule 2
Appendix F, Part 3
N-METHYL-1-(3,4-METHYLENEDIOXYPHENYL)-2-BUTANAMINE
cross reference: MBDB
Schedule 9
N-METHYL-2-PYRROLIDONE
Schedule 5
Schedule 6
Appendix E, Part 2
N-OCTYL BICYCLOHEPTENE DICARBOXIMIDE
Schedule 5
N-OLEYL-1,3-DIAMINOPROPANE
Schedule 6
NOMEGESTROL
Schedule 4
Poisons Standard November 2016
551
INDEX
NOMIFENSINE
Schedule 4
NONOXINOL 9
Schedule 6
Schedule 5
Appendix E, Part 2
NORACYMETHADOL
Schedule 9
NORADRENALINE
Schedule 4
Appendix F, Part 3
NORANDROSTENOLONE
Schedule 4
Appendix D, Item 5 (Anabolic and/or androgenic steroidal agents)
NORBOLETHONE
Schedule 4
Appendix D, Item 5 (Anabolic and/or androgenic steroidal agents)
NORBORMIDE
Schedule 5
NORCLOSTEBOL
Schedule 4
Appendix D, Item 5 (Anabolic and/or androgenic steroidal agents)
NORCODEINE
Schedule 8
NORELGESTROMIN
Schedule 4
NOREPINEPHRINE
cross reference: NORADRENALINE
NORETHANDROLONE
Schedule 4
Appendix D, Item 5 (Anabolic and/or androgenic steroidal agents)
NORETHISTERONE
Poisons Standard November 2016
552
INDEX
Schedule 4
NORFLOXACIN
Schedule 4
NORFLURAZON
Appendix B, Part 3
NORGESTREL
Schedule 4
NORIBOGAINE
Schedule 4
NORLEVORPHANOL
Schedule 9
NORMAL HUMAN IMMUNOGLOBULIN
Schedule 4
NORMETHADONE
Schedule 8
Appendix K
NORMETHANDRONE
Schedule 4
Appendix D, Item 5 (Anabolic and/or androgenic steroidal agents)
NORMORPHINE
Schedule 9
NORPIPANONE
Schedule 9
NORTRIPTYLINE
Schedule 4
Appendix K
NOSCAPINE
Schedule 2
NOVALURON
Appendix B, Part 3
Poisons Standard November 2016
553
INDEX
NOVOBIOCIN
Schedule 4
NOXIPTYLINE
Schedule 4
N-PHENETHYL-4-PIPERIDONE
Schedule 9
N-TALLOW ALKYL-1,3-PROPANEDIAMINE DIACETATE
Schedule 6
NUCLEAR POLYHEDROSIS VIRUS OF Helicoverpa armigera occlusion bodies
Appendix B, Part 3
NUTMEG OIL
Schedule 5
NUTRITION REPLACEMENT PREPARATIONS FOR PARENTERAL
ADMINISTRATION
Appendix A
NYSTATIN
Schedule 4
Schedule 3
Schedule 2
Appendix F, Part 3
Appendix H
O
OCLACITINIB
Schedule 4
OCRIPLASMIN
Schedule 4
OCTAMYLAMINE
Schedule 4
OCTATROPINE
Schedule 4
OCTHILINONE
Poisons Standard November 2016
554
INDEX
Schedule 6
OCTREOTIDE
Schedule 4
OCTYL ALCOHOLS
Appendix B, Part 3
OCTYL NITRITE
Schedule 4
OESTRADIOL
cross reference: ESTRADIOL
OESTRIOL
cross reference: ESTRIOL
OESTROGENS
cross reference: ESTROGENS
OESTRONE
cross reference: ESTRONE
OFATUMUMAB
Schedule 4
OFLOXACIN
Schedule 4
OLANZAPINE
Appendix K
OLANZAPINE
Schedule 4
OLAQUINDOX
Schedule 6
OLEANDOMYCIN
Schedule 5
Schedule 4
OLEANDRIN
Schedule 4
OLEIC ACID
Poisons Standard November 2016
555
INDEX
Appendix B, Part 3
OLMESARTAN
Schedule 4
OLODATEROL
Schedule 4
OLOPATADINE
Schedule 4
OLSALAZINE
Schedule 4
OMBITASVIR
Schedule 4
OMALIZUMAB
Schedule 4
OMEGA-3-ACID ETHYL ESTERS
Schedule 4
OMEPRAZOLE
Schedule 4
Schedule 3
Schedule 2
Appendix H
OMETHOATE
Schedule 7
Schedule 6
Schedule 5
ONDANSETRON
Schedule 4
OPIPRAMOL
Schedule 4
OPIUM
cross reference: NOSCAPINE, PAPAVERINE
Schedule 8
Appendix K
Poisons Standard November 2016
556
INDEX
557
INDEX
ORTHOPTERIN
Schedule 4
ORTHO-TOLIDINE
Appendix J, Part 2
OSELTAMIVIR
Schedule 4
OUABAIN
Schedule 4
OVANDROTONE
Schedule 4
Appendix D, Item 5 (Anabolic and/or androgenic steroidal agents)
OXABETRINIL
Appendix B, Part 3
OXABOLONE
Schedule 4
Appendix D, Item 5 (Anabolic and/or androgenic steroidal agents)
OXACILLIN
Schedule 4
OXADIARGYL
Schedule 5
OXADIAZON
Schedule 6
OXADIXYL
Schedule 5
OXALATES
Appendix F, Part 3
OXALIC ACID
Schedule 6
Appendix E, Part 2
Appendix F, Part 3
Poisons Standard November 2016
558
INDEX
OXALIPLATIN
Schedule 4
OXAMYL
Schedule 7
OXANDROLONE
Schedule 4
Appendix D, Item 5 (Anabolic and/or androgenic steroidal agents)
OXANTEL EMBONATE
Schedule 5
OXAPROZIN
Schedule 4
OXAZEPAM
Schedule 4
Appendix D, Item 5 (Benzodiazepine derivatives)
Appendix K
OXCARBAZEPINE
Schedule 4
OXATHIAPIPROLIN
Appendix B, Part 3
OXEDRINE
cross reference: SYNEPHRINE
Schedule 4
OXETACAINE
cross reference: OXETHAZAINE
Schedule 4
Schedule 2
OXFENDAZOLE
Schedule 5
OXIBENDAZOLE
Schedule 5
OXICONAZOLE
Poisons Standard November 2016
559
INDEX
Schedule 4
Schedule 3
Schedule 2
OXITROPIUM
Schedule 4
OXOLAMINE
Schedule 4
OXOLINIC ACID
Schedule 4
OXPENTIFYLLINE
cross reference: PENTOXIFYLLINE
OXPRENOLOL
Schedule 4
OXYBUPROCAINE
Schedule 4
OXYBUTYNIN
Schedule 4
OXYCARBOXIN
Schedule 5
OXYCLOZANIDE
Schedule 6
OXYCODONE
Appendix K
OXYCODONE
Schedule 8
OXYDEMETON METHYL
Schedule 7
OXYFLUORFEN
Appendix B, Part 3
OXYMESTERONE
Poisons Standard November 2016
560
INDEX
Schedule 4
Appendix D, Item 5 (Anabolic and/or androgenic steroidal agents)
OXYMETAZOLINE
Schedule 2
Appendix F, Part 3
OXYMETHOLONE
Schedule 4
Appendix D, Item 5 (Anabolic and/or androgenic steroidal agents)
OXYMORPHONE
Schedule 8
OXYPHENBUTAZONE
Schedule 4
OXYPHENCYCLIMINE
Schedule 4
OXYPHENISATIN
Schedule 10
OXYPHENONIUM
Schedule 4
OXYQUINOLINE
Schedule 2
Appendix F, Part 3
OXYTETRACYCLINE
Schedule 5
Schedule 4
OXYTHIOQUINOX
Schedule 5
OXYTOCIN
Schedule 4
Appendix G
P
PACLITAXEL
Poisons Standard November 2016
561
INDEX
Schedule 4
PACLOBUTRAZOL
Schedule 5
PAECILOMYCES LILACINUS STRAIN 251
Schedule 6
PAINT
Appendix F, Part 3
PALIFERMIN
Schedule 4
PALIPERIDONE
Schedule 4
Appendix K
PALIVIZUMAB
Schedule 4
PALMAROSA OIL
Appendix B, Part 3
PALMITIC ACID
Appendix B, Part 3
PALONOSETRON
Schedule 4
PAMAQUIN
Schedule 4
PAMIDRONIC ACID
cross reference: PAMIDRONATE DISODIUM
Schedule 4
PANCREATIC ENZYMES
cross reference: LIPASE
Schedule 4
PANCURONIUM
Schedule 4
Poisons Standard November 2016
562
INDEX
PANITUMUMAB
Schedule 4
PANTOPRAZOLE
Schedule 4
Schedule 3
Schedule 2
Appendix H
PAPAVERETUM
Appendix K
PAPAVERINE
cross reference: OPIUM
Schedule 4
Schedule 2
PAPER
Appendix A
PARACETAMOL
cross reference: ASPIRIN, IBUPROFEN, METOCLOPRAMIDE, SALICYLAMIDE
Schedule 4
Schedule 3
Schedule 2
Appendix F, Part 3
para-DICHLOROBENZENE
cross reference: PDB
Appendix F, Part 3
PARA-FLUOROFENTANYL
Schedule 9
PARAFORMALDEHYDE
cross reference: FREE FORMALDEHYDE
Schedule 10
Schedule 6
Schedule 2
Appendix E, Part 2
PARALDEHYDE
Schedule 4
PARAMETHADIONE
Poisons Standard November 2016
563
INDEX
Schedule 4
PARAMETHASONE
Schedule 4
PARAQUAT
Schedule 7
PARATHION
Schedule 7
PARATHION-METHYL
Schedule 7
Schedule 6
PARBENDAZOLE
Schedule 6
PARECOXIB
Schedule 4
PARICALCITOL
Schedule 4
PARITAPREVIR
Schedule 4
PAROMOMYCIN
Schedule 4
PAROXETINE
Schedule 4
PASIREOTIDE
Schedule 4
PATCHOULI OIL
Appendix B, Part 3
PAZOPANIB
Schedule 4
PEBULATE
Poisons Standard November 2016
564
INDEX
Schedule 6
PECAZINE
Schedule 4
PECTINASE derived from Aspergillus niger
Appendix B, Part 3
PEFLOXACIN
Schedule 4
PEGAPTANIB
Schedule 4
PEGFILGRASTIM
Schedule 4
PEGINTERFERON
Schedule 4
PEGVISOMANT
Schedule 4
PEHNOLS
Appendix E, Part 2
PEMBROLIZUMAB
Schedule 4
PEMETREXED
Schedule 4
PEMOLINE
Schedule 4
PEMPIDINE
Schedule 4
PENBUTOLOL
Schedule 4
PENCICLOVIR
Poisons Standard November 2016
565
INDEX
Schedule 4
Schedule 2
PENCONAZOLE
Schedule 5
PENCYCURON
Appendix B, Part 3
PENDIMETHALIN
Schedule 5
PENETHAMATE
Schedule 4
PENFLUFEN
Schedule 5
PENICILLAMINE
Schedule 4
PENNYROYAL OIL
Schedule 6
Appendix E, Part 2
PENTACHLOROPEHNOL
Appendix F, Part 3
PENTACHLOROPHENOL
Schedule 7
Schedule 6
PENTADECANOIC ACID
Appendix B, Part 3
PENTAERYTHRITYL TETRANITRATE
Schedule 4
PENTAGASTRIN
Schedule 4
PENTAMETHONIUM
Schedule 4
Poisons Standard November 2016
566
INDEX
PENTAMIDINE
Schedule 4
PENTAZOCINE
Schedule 8
Appendix K
PENTHIENATE
Schedule 4
PENTHIOPYRAD
Schedule 5
PENTOBARBITONE cross refeference: PENTOBARITAL
PENTOBARITAL
Schedule 8
Schedule 4
Appendix K
PENTOLINIUM
Schedule 4
PENTOSAN POLYSULFATE SODIUM
Schedule 4
PENTOXIFYLLINE
Schedule 4
PEPPERMINT OIL
Appendix B, Part 3
PERACETIC ACID
Schedule 6
Schedule 5
Appendix E, Part 2
Appendix F, Part 3
PERAMPANEL
Schedule 4
Appendix D, Item 5
Appendix K
PERFLUIDONE
Poisons Standard November 2016
567
INDEX
Schedule 6
PERGOLIDE
Schedule 4
PERHEXILINE
Schedule 4
PERICIAZINE
Schedule 4
Appendix K
PERICYAZINE
cross reference: PERICIAZINE
PERINDOPRIL
Schedule 4
PERMANGANATES
cross reference: POTASSIUM PERMANGANATE
Schedule 6
Appendix F, Part 3
PERMETHRIN
Schedule 6
Schedule 5
Schedule 4
PERPHENAZINE
Schedule 4
Appendix K
PERTUSSIS ANTIGEN
Schedule 4
PERTUZUMAB
Schedule 4
PETASITES spp.
Schedule 10
PETHIDINE
Schedule 8
Appendix K
Poisons Standard November 2016
568
INDEX
PETROL
Schedule 5
Appendix E, Part 2
PHEDRAZINE
Schedule 2
PHENACEMIDE
Schedule 4
PHENACETIN
Schedule 4
PHENADOXONE
Schedule 9
PHENAGLYCODOL
Schedule 4
PHENAMPROMIDE
Schedule 9
PHENAZOCINE
Schedule 9
PHENAZONE
Schedule 5
Schedule 4
Schedule 2
PHENAZOPYRIDINE
Schedule 4
PHENCYCLIDINE
cross reference: PCP
Schedule 9
PHENDIMETRAZINE
Schedule 8
PHENELZINE
Schedule 4
Appendix K
Poisons Standard November 2016
569
INDEX
PHENETICILLIN
Schedule 4
PHENFORMIN
Schedule 4
PHENGLUTARIMIDE
Schedule 4
PHENINDIONE
Schedule 4
PHENIRAMINE
Schedule 4
Schedule 3
Schedule 2
Appendix K
PHENISATIN
Schedule 4
PHENISOPHAM
Schedule 5
PHENMEDIPHAM
Appendix B, Part 3
PHENMETRAZINE
Schedule 8
PHENOBARBITAL
Schedule 4
Appendix K
PHENOBARBITONE
cross reference: PHENOBARBITAL
PHENOL
cross reference: CREOSOTE, PHENOLS, TAR, XYLENOLS
Schedule 6
Schedule 5
Schedule 4
Schedule 2
Appendix E, Part 2,
Appendix F, Part 3
Poisons Standard November 2016
570
INDEX
PHENOLPHTHALEIN
Schedule 4
PHENOMORPHAN
Schedule 9
PHENOPERIDINE
Schedule 8
Appendix K
PHENOTHIAZINE
Schedule 6
PHENOXYBENZAMINE
Schedule 4
PHENOXYMETHYLPENICILLIN
Schedule 4
PHENSUXIMIDE
Schedule 4
PHENTERMINE
Schedule 4
Appendix D, Item 5
PHENTHIMENTONIUM
Schedule 4
PHENTOLAMINE
Schedule 4
PHENYL METHYL KETONE
cross reference: DESIGNATED SOLVENT
Schedule 5
Appendix E, Part 2
Part 1 - Interpretation
PHENYLACETYLINDOLES
Schedule 9
PHENYLBUTAZONE
Schedule 4
Poisons Standard November 2016
571
INDEX
PHENYLENEDIAMINES
cross reference: ALKYLATED PHENYLENEDIAMINES, DIETHYL-PARAPHENYLENEDIAMINE, DIMETHYL-PARA-PHENYLENEDIAMINE
Schedule 10
Schedule 6
Appendix E, Part 2
Appendix F, Part 3
PHENYLEPHRINE
cross reference: CODEINE, IBUPROFEN, PARACETAMOL
Schedule 4
Schedule 2
Appendix F, Part 3
PHENYLMERCURIC ACETATE
cross reference: MERCURY
Schedule 7
Appendix J, Part 2
PHENYLPHENOL
Schedule 5
PHENYLPROPANOLAMINE
Schedule 4
PHENYLTOLOXAMINE
Schedule 4
Appendix K
PHENYTOIN
Schedule 4
Appendix F, Part 3
PHLEUM PRATENSE POLLEN EXTRACT (Timothy-grass pollen extract)
Schedule 4
PHOLCODINE
Schedule 8
Schedule 4
Schedule 2
Appendix K
PHORATE
Schedule 7
PHOSALONE
Poisons Standard November 2016
572
INDEX
Schedule 6
PHOSFOLAN
Schedule 7
PHOSMET
Schedule 6
PHOSPHIDES, METALLIC
cross reference: ALUMINIUM PHOSPHIDE, MAGNESIUM PHOSPHIDE, ZINC
PHOSPHIDE
Schedule 7
Appendix J, Part 2
PHOSPHINE
Schedule 7
Appendix J, Part 2
PHOSPHODIESTERASE TYPE 5 INHIBITORS
Schedule 4
PHOSPHONIC ACID
cross reference: PHOSPHOURUS ACID
Schedule 5
Appendix E, Part 2
Appendix F, Part 3
PHOSPHORIC ACID
Schedule 6
Schedule 5
Appendix E, Part 2
Appendix F, Part 3
PHOSPHORUS
Appendix F, Part 3
Appendix G
PHOSPHORUS,
Appendix E, Part 2
PHOSPHORUS, YELLOW
Schedule 7
PHOTOGRAPHIC PAPER or FILM
Appendix A
Poisons Standard November 2016
573
INDEX
PHOXIM
Schedule 6
PHTHALALDEHYDE
Schedule 6
Schedule 5
PHTHALYLSULFATHIAZOLE
Schedule 4
PHYSOSTIGMINE
Schedule 4
PHYTASE
Appendix B, Part 3
PICARIDIN
Schedule 5
PICLORAM
Appendix B, Part 3
PICOLINAFEN
Appendix B, Part 3
PICRIC ACID
Appendix E, Part 2
Appendix F, Part 3
PICROTOXIN
Schedule 4
PIGMENTS
Appendix A
PILOCARPINE
Schedule 4
PIMECROLIMUS
Schedule 4
PIMELIC ACID
Poisons Standard November 2016
574
INDEX
Appendix B, Part 3
PIMINODINE
Schedule 9
PIMOBENDAN
Schedule 4
PIMOZIDE
Schedule 4
Appendix K
PINACIDIL
Schedule 4
PINDOLOL
Schedule 4
PINDONE
Schedule 6
PINE OILS
Schedule 6
Schedule 5
PINOXADEN
Schedule 6
Schedule 5
PIOGLITAZONE
Schedule 4
PIPECURONIUM
Schedule 4
PIPEMIDIC ACID
Schedule 4
PIPENZOLATE
Schedule 4
PIPER METHYSTICUM
cross reference: KAVA, KAVALACTONES
Poisons Standard November 2016
575
INDEX
Schedule 4
PIPERACILLIN
Schedule 4
PIPERAZNE
Schedule 5
Schedule 2
PIPERIDINE
Schedule 4
PIPERIDOLATE
Schedule 4
PIPERONYL BUTOXIDE
Appendix B, Part 3
PIPEROPHOS
Schedule 6
PIPOBROMAN
Schedule 4
PIPOTHIAZINE
Schedule 4
PIPRADROL
Schedule 4
PIRACETAM
Schedule 4
PIRBUTEROL
Schedule 4
PIRENOXINE
cross reference: CATALIN
Schedule 4
PIRENZEPINE
Schedule 4
Poisons Standard November 2016
576
INDEX
PIRETANIDE
Schedule 4
PIRFENIDONE
Schedule 4
PIRIMICARB
Schedule 5
Schedule 6
PIRIMIPHOS-ETHYL
Schedule 6
PIRIMIPHOS-METHYL
Schedule 6
PIRITRAMIDE
Schedule 8
PIROXICAM
Schedule 4
PIRPROFEN
Schedule 4
PITAVASTATIN
Schedule 4
PITUITARY HORMONES
Schedule 4
PIVAMPICILLIN
Schedule 4
PIZOTIFEN
Schedule 4
Appendix K
PLERIXAFOR
Schedule 4
PLICAMYCIN
Poisons Standard November 2016
577
INDEX
Schedule 4
PNEUMOCOCCAL VACCINE
Schedule 4
PODOPHYLLOTOXIN
cross reference: PODOPHYLLIN
Schedule 4
Schedule 3
Schedule 2
Appendix F, Part 3
PODOPHYLLUM EMODI
cross reference: PODOPHYLLIN
Schedule 4
Schedule 3
Schedule 2
Appendix F, Part 3
PODOPHYLLUM PELTATUM
cross reference: PODOPHYLLIN
Schedule 4
Schedule 3
Schedule 2
Appendix F, Part 3
PODOPHYLLUM RESIN
cross reference: PODOPHYLLIN
Appendix G
POLIDEXIDE
Schedule 4
POLIHEXANIDE
Schedule 6
Appendix E, Part 2
Appendix F, Part 3
POLIOMYELITIS VACCINE
Schedule 4
POLIXETONIUM SALTS
Schedule 6
Schedule 5
POLOXALENE
Poisons Standard November 2016
578
INDEX
Appendix B, Part 3
POLY (GNRF) OVALBUMIN
Appendix B, Part 3
POLY DIALLYL DIMETHYL AMMONIUM CHLORIDE
cross reference: POLYDADMAC
Appendix B, Part 3
POLY(OXY-1,2-ETHANEDIYL), -[2-[(2-HYDROXYETHYL)AMINO]-2OXOETHYL]- -HYDROXY-,MONO-C13-15-ALKYL ETHERS
Schedule 5
Appendix E, Part 2
POLYACRYLAMIDE
Schedule 4
POLYCAPROLACTONE
Schedule 4
POLYESTRADIOL
Schedule 4
POLYETHANOXY (15) TALLOW AMINE
Schedule 5
Appendix E, Part 2
POLYHEDROSIS VIRUS of Helico zea occlusion bodies
Appendix B, Part 3
POLYLACTIC ACID
Schedule 4
POLYMYXIN
Schedule 4
POLYSORBATE 20
Appendix B, Part 3
POLYSULFATED GLYCOSAMINOGLYCANS
Schedule 4
POLYTHIAZIDE
Poisons Standard November 2016
579
INDEX
Schedule 4
POMALIDOMIDE
Schedule 4
Appendix D, Item 4
Appendix F, Part 3
Appendix L, Part 2
PORACTANT
Schedule 4
PORCELAIN
Appendix A
PORCINE SOMATOTROPHIN
Appendix B, Part 3
POSACONAZOLE
Schedule 4
POTASIUM BROMATE
Appendix E, Part 2
POTASIUM CHLORATE
Appendix E, Part 2
POTASSIUM AZELOYL DIGLYCINATE
Schedule 6
POTASSIUM BICARBONATE
Appendix B, Part 3
POTASSIUM BROMATE
Schedule 6
POTASSIUM BROMIDE
Schedule 4
POTASSIUM CHLORATE
Schedule 5
Schedule 2
POTASSIUM CHLORIDE
Poisons Standard November 2016
580
INDEX
Schedule 4
POTASSIUM CYANATE
Schedule 6
Appendix E, Part 2
POTASSIUM HYDROXIDE
Schedule 10
Schedule 6
Schedule 5
Appendix E, Part 2
Appendix F, Part 3
POTASSIUM METABISULPHITE
Schedule 5
Appendix F, Part 3
POTASSIUM NITRITE
Schedule 7
Schedule 6
Schedule 5
Appendix E, Part 2
Appendix F, Part 3
POTASSIUM PERCHLORATE
Schedule 4
POTASSIUM PEROXOMONOSULFATE TRIPLE SALT
Schedule 6
Schedule 5
POTASSIUM PERSULFATE
Schedule 6
Appendix E, Part 2
Appendix F, Part 3
POTASSIUM SORBATE
Appendix B, Part 3
POTASSIUM SULFIDE
Schedule 5
Appendix E, Part 2
Appendix F, Part 3
PRACTOLOL
Schedule 4
Poisons Standard November 2016
581
INDEX
PRADOFLOXACIN
Schedule 4
PRALATREXATE
Schedule 4
PRALIDOXIME
Schedule 4
PRALLETHRIN
Schedule 6
Schedule 5
PRALMORELIN (GROWTH HORMONE RELEASING PEPTIDE-2) (GHRP-2)
Schedule 4
Appendix D, Item 5
PRAMIPEXOLE
Schedule 4
PRAMOCAINE
Schedule 4
PRAMPINE
Schedule 4
PRASTERONE
cross reference: DEHYDROEPIANDROSTERONE, DEHYDROISOANDROSTERONE
Schedule 4
Appendix D, Item 5 (Anabolic and/or androgenic steroidal agents)
PRASUGREL
Schedule 4
PRAVASTATIN
Schedule 4
PRAZEPAM
Schedule 4
Appendix D, Item 5 (Benzodiazepine derivatives)
Appendix K
PRAZIQUANTEL
Poisons Standard November 2016
582
INDEX
Schedule 4
PRAZOSIN
Schedule 4
PREDNISOLONE
Schedule 4
PREDNISONE
Schedule 4
PREGABALIN
Schedule 4
Appendix K
PREGNENOLONE
Schedule 4
PRENALTEROL
Schedule 4
PRENYLAMINE
Schedule 4
PRILOCAINE
Schedule 4
Schedule 2
PRIMAQUINE
Schedule 4
PRIMIDONE
Schedule 4
PRINTING INKS or INK ADDITIVES
Appendix A
PROBENECID
Schedule 4
PROBUCOL
Schedule 4
Poisons Standard November 2016
583
INDEX
PROCAINAMIDE
Schedule 4
PROCAINE
Schedule 4
PROCAINE BENZYLPENICILLIN
Schedule 4
PROCAINE PENICILLIN
cross reference: PROCAINE BENZYLPENICILLIN
PROCARBAZINE
Schedule 4
PROCHLORAZ
Schedule 6
PROCHLORPERAZINE
Appendix K
PROCHLORPERAZINE
Schedule 4
Schedule 3
PROCYCLIDINE
Schedule 4
Schedule 2
PROCYMIDONE
Schedule 7
PROFENOFOS
Schedule 6
PROFOXYDIM
Schedule 5
PROGESTERONE
Schedule 5
Schedule 4
Appendix G
PROGESTOGENS
Poisons Standard November 2016
584
INDEX
Schedule 4
PROGLUMIDE
Schedule 4
PROGUANIL
Schedule 4
PROHEPTAZINE
Schedule 9
PROHEXADIONE CALCIUM
Schedule 5
PROLINTANE
Schedule 4
PROMACYL
Schedule 6
PROMAZINE
Schedule 4
Appendix K
PROMETHAZINE
Schedule 4
Schedule 3
Schedule 2
Appendix K
PROMETRYN
Schedule 5
PROMOXOLANE
Schedule 4
PROPACHLOR
Schedule 6
PROPAFENONE
Schedule 4
PROPAMIDINE
Poisons Standard November 2016
585
INDEX
Schedule 4
Schedule 2
PROPAMOCARB
Schedule 5
PROPANIDID
Schedule 4
PROPANIL
Schedule 5
PROPANTHELINE
Schedule 4
PROPAQUIZAFOP
Schedule 5
PROPARGITE
Schedule 6
PROPENTOFYLLINE
Schedule 4
PROPERIDINE
Schedule 9
PROPETAMPHOS
Schedule 6
PROPETANDROL
Schedule 4
Appendix D, Item 5 (Anabolic and/or androgenic steroidal agents)
PROPICONAZOLE
Schedule 6
Schedule 5
PROPINEB
Schedule 6
PROPIONIBACTERIUM ACNES
Schedule 4
Poisons Standard November 2016
586
INDEX
PROPIONIC ACID
Schedule 6
Schedule 5
Appendix E, Part 2
Appendix F, Part 3
PROPIRAM
Schedule 8
PROPOFOL
Schedule 4
PROPOXUR
Schedule 6
Schedule 5
PROPRANOLOL
Schedule 4
Appendix G
PROPYL ACETATES
Appendix B, Part 3
n-PROPYL ALCOHOL
Schedule 6
Schedule 5
Appendix E, Part 2
Appendix F, Part 3
PROPYLENE
Schedule 7
PROPYLENE GLYCOL
Appendix B, Part 3
PROPYLENE OXIDE
Appendix J, Part 2
PROPYLHEXEDRINE
Schedule 4
PROPYLTHIOURACIL
Schedule 4
Poisons Standard November 2016
587
INDEX
PROPYPHENAZONE
Schedule 4
PROPYZAMIDE
Schedule 5
PROQUAZONE
Schedule 4
PROQUINAZID
Schedule 6
PROSCILLARIDIN
Schedule 4
PROSTAGLANDINS
Schedule 4
PROSTIANOL
Schedule 4
PROSULFOCARB
Schedule 6
PROSULFURON
Schedule 6
PROTAMINE
Schedule 4
PROTHIOCONAZOLE
Appendix B, Part 3
PROTHIOCONAZOLE-DESCHLORO
Schedule 5
PROTHIOCONAZOLE-TRIAZOLIDINETHIONE
Schedule 5
PROTHIOFOS
Schedule 6
Poisons Standard November 2016
588
INDEX
PROTHIONAMIDE
Schedule 4
PROTHIPENDYL
Schedule 4
PROTIRELIN
Schedule 4
PROTOVERATRINES
Schedule 4
PROTRIPTYLINE
Appendix K
PROTRIPTYLINE
Schedule 4
PROXYMETACAINE
Schedule 4
PRUCALOPRIDE
Schedule 4
PSEUDOEPHEDRINE
Schedule 4
Schedule 3
PSEUDOMONAS FLUORESCENS
Appendix B, Part 3
PSILOCYBINE
Schedule 9
PTERIDIUM spp.
Schedule 10
PULMONARIA spp.
Schedule 10
PYMETROZINE
Schedule 5
Poisons Standard November 2016
589
INDEX
PYRACLOFOS
Schedule 6
PYRACLOSTROBIN
Schedule 5
PYRAFLUFEN-ETHYL
Schedule 5
PYRANTEL
Schedule 2
PYRASULFOTOLE
Schedule 5
PYRAZINAMIDE
Schedule 4
PYRAZOLAM
Schedule 9
PYRAZOPHOS
Schedule 6
PYRETHRINS
cross reference: CHRYSANTHEMIC ACID ESTERS, CINEROLONE, JASMOLONE,
PYRETHRIC ACIDS, PYRETHROLONE
Schedule 5
Schedule 2
PYRIDABEN
Schedule 6
Schedule 5
PYRIDALYL
Schedule 6
PYRIDATE
Schedule 6
PYRIDINOLCARBAMATE
Schedule 4
Poisons Standard November 2016
590
INDEX
PYRIDOSTIGMINE
Schedule 4
PYRIDOXAL
Schedule 4
PYRIDOXAMINE
Schedule 4
PYRIDOXINE
Schedule 4
PYRIFENOX
Schedule 5
PYRIMETHAMINE
Schedule 4
PYRIMETHANIL
Appendix B, Part 3
PYRINURON
Schedule 7
Appendix J, Part 2
PYRIOFENONE
Schedule 6
Schedule 5
PYRIPROLE
Schedule 6
PYRIPROXYFEN
Appendix B, Part 3
PYRITHIOBAC SODIUM
Schedule 5
PYRITHIONE COPPER
Schedule 6
PYRITHIONE ZINC
Poisons Standard November 2016
591
INDEX
Schedule 6
Schedule 5
Schedule 2
Appendix E, Part 2
PYROVALERONE
Schedule 4
PYROXASULFONE
Schedule 6
PYROXSULAM
Schedule 6
PYRVINIUM
cross reference: VIPRYNIUMA
Schedule 4
Q
QUASSIA
Appendix B, Part 3
QUATERNARY AMMONIUM COMPOUNDS
cross reference: BENZALKONIUM CHLORIDE, DIALKYL and DIALKOYL
QUATERNARY AMMONIUM COMPOUNDS
Schedule 6
Schedule 5
Appendix E, Part 5
QUAZEPAM
Schedule 4
Appendix D, Item 5 (Benzodiazepine derivatives)
QUETIAPINE
Schedule 4
Appendix K
QUINAGOLIDE
Schedule 4
QUINALBARBITONE
cross reference: SECOBARBITAL
Schedule 8
Appendix K
Poisons Standard November 2016
592
INDEX
QUINAPRIL
Schedule 4
QUINBOLONE
Schedule 4
Appendix D, Item 5 (Anabolic and/or androgenic steroidal agents)
QUINCLORAC
Schedule 5
QUINETHAZONE
Schedule 4
QUINIDINE
Schedule 4
QUININE
Schedule 7
Schedule 5
Schedule 4
QUINISOCAINE
cross reference: DIMETHISOQUINE
Schedule 4
QUINOXYFEN
Appendix B, Part 3
QUINTOZENE
cross reference: PENTACHLORONITROBENZENE
Schedule 5
QUINUPRISTIN
Schedule 4
QUIZALOFOP ETHYL
cross reference: QUIZALOFOP ETHYL (D + ISOMER)
Schedule 6
QUIZALOFOP-P-ETHYL
Schedule 6
Schedule 5
QUIZALOFOP-P-TEFURYL
Poisons Standard November 2016
593
INDEX
Schedule 6
R
RABEPRAZOLE
Schedule 4
Schedule 3
Schedule 2
Appendix H
RABIES VACCINE
Schedule 4
RACEMETHORPHAN
Schedule 9
RACEMORAMIDE
Schedule 8
RACEMORPHAN
Schedule 9
RACTOPAMINE
Schedule 5
Schedule 4
RADIOGRAPHIC CONTRAST MEDIA
cross reference: RADIOPAQUES
Appendix A
RADIOISOTOPES
Appendix A
RALOXIFENE
Schedule 4
RALTEGRAVIR
Schedule 4
RALTITREXED
Schedule 4
RAMIPRIL
Schedule 4
Poisons Standard November 2016
594
INDEX
RANIBIZUMAB
Schedule 4
RANITIDINE
Schedule 4
Schedule 2
Appendix F, Part 3
RANOLAZINE
Schedule 4
RAPACURONIUM
Schedule 4
RASAGILINE
Schedule 4
RASBURICASE
Schedule 4
RAUWOLFIA SERPENTINA
Schedule 4
RAUWOLFIA VOMITORIA
Schedule 4
RAZOXANE
Schedule 4
REBOXETINE
Schedule 4
RED YEAST RICE
Schedule 4
REGORAFENIB
Schedule 4
REMIFENTANIL
Schedule 8
REMOXIPRIDE
Poisons Standard November 2016
595
INDEX
Schedule 4
REPAGLINIDE
Schedule 4
RESERPINE
Schedule 4
RESMETHRIN
Schedule 6
Schedule 5
RETAPAMULIN
Schedule 4
RETEPLASE
Schedule 4
RETIGABINE
Schedule 4
Appendix K
RIBAVIRIN
Schedule 4
RIDAFOROLIMUS
Schedule 4
RIFABUTIN
Schedule 4
RIFAMPICIN
Schedule 4
RIFAMYCIN
Schedule 4
RIFAPENTINE
Schedule 4
RIFAXIMIN
Schedule 4
Poisons Standard November 2016
596
INDEX
RILPIVIRINE
Schedule 4
RILUZOLE
Schedule 4
RIMEXOLONE
Schedule 4
RIMITEROL
Schedule 4
RIMONABANT
Schedule 4
RIMSULFURON
Schedule 5
RIOCIGUAT
Schedule 4
Appendix D, Item 5
Appendix L, Part 2
RISEDRONIC ACID
Schedule 4
RISPERIDONE
Schedule 4
Appendix K
RITODRINE
Schedule 4
RITONAVIR
Schedule 4
RITUXIMAB
Schedule 4
RIVAROXABAN
Schedule 4
RIVASTIGMINE
Poisons Standard November 2016
597
INDEX
Schedule 4
RIZATRIPTAN
Schedule 4
ROBENACOXIB
Schedule 4
ROBENIDINE
Schedule 5
ROFECOXIB
Schedule 4
ROFLUMILAST
Schedule 4
ROLICYCLIDINE
cross reference: PCPY, PHP
Schedule 9
ROLITETRACYCLINE
Schedule 4
ROMIDEPSIN
Schedule 4
ROMIFIDINE
Schedule 4
ROMIPLOSTIM
Schedule 4
RONIDAZOLE
Schedule 4
ROPINIROLE
Schedule 4
ROPIVACAINE
Schedule 4
ROSEMARY OIL
Poisons Standard November 2016
598
INDEX
Appendix B, Part 3
ROSIGLITAZONE
Schedule 4
ROSIN
cross reference: COLOPHONY
Schedule 5
ROSOXACIN
Schedule 4
ROSUVASTATIN
Schedule 4
ROTENONE
cross reference: CUBE
Schedule 6
ROTIGOTINE
Schedule 4
Appendix K
ROXIBOLONE
Schedule 4
Appendix D, Item 5 (Anabolic and/or androgenic steroidal agents)
ROXITHROMYCIN
Schedule 4
RUBELLA VACCINE
Schedule 4
RUBOXISTAURIN
Schedule 4
RUPATADINE
Schedule 4
Appendix K
RUXOLITINIB
Schedule 4
S
Poisons Standard November 2016
599
INDEX
SACUBITRIL
Schedule 4
SAFLUFENACIL
Schedule 7
Schedule 5
SAFROLE
Schedule 10
Schedule 3
Appendix E, Part 2
Appendix F, Part 3
SAGE OIL
cross reference: DALMATIAN, THUJONE
Schedule 6
Appendix E, Part 2
SAGE OIL (Spanish)
cross reference: CAMPHOR
Appendix B, Part 3
SALBUTAMOL
Schedule 4
Schedule 3
Appendix F, Part 3
SALCATONIN
cross reference: CALCITONIN SALMON
SALICYLAMIDE
cross reference: ASPIRIN, CAFFEINE, PARACETAMOL
Schedule 4
Schedule 2
Appendix F, Part 3
SALICYLANILIDE
Schedule 5
SALICYLIC ACID
cross reference: CHOLINE SALICYLATE
Schedule 3
SALINOMYCIN
Schedule 6
Schedule 4
Poisons Standard November 2016
600
INDEX
SALMETEROL
Schedule 4
SALVIA DIVINORUM
Schedule 9
SANDALWOOD OIL
Appendix B, Part 3,
SANTONIN
Schedule 3
SAPROPTERIN
Schedule 4
SAQUINAVIR
Schedule 4
SAROLANER
Schedule 5
Schedule 6
SASSAFRAS OIL
cross reference: SAFROLE
Schedule 6
Appendix E, Part 2
Appendix F, Part 3
SAXAGLIPTIN
Schedule 4
SCHOENOCAULON OFFICINALE
cross reference: SABADILLA
Schedule 4
SCHRADAN
Schedule 7
SCOPOLIA CARNIOLICA
Schedule 4
SEAWEED
Appendix B, Part 3
Poisons Standard November 2016
601
INDEX
SECBUTOBARBITONE
Schedule 8
Appendix K
SEDAXANE
Schedule 5
SEEDS
Appendix A
SELAMECTIN
Schedule 5
SELECTIVE ANDROGEN RECEPTOR MODULATORS
cross reference: SARM
Schedule 4
Appendix D, Item 5
SELEGILINE
Schedule 4
SELENIUM
cross reference: BARIUM SELENATE, SELENIUM COMPOUNDS, SELENIUM
ARSENIDE, SELENIUM SULFIDE
Schedule 7
Schedule 6
Schedule 4
Schedule 2
Appendix E, Part 2
Appendix F, Part 3
Appendix G
SELEXIPAG
Schedule 4
SEMDURAMICIN
Schedule 7
Schedule 6
SENECIO spp.
Schedule 10
SERELAXIN
Schedule 4
Poisons Standard November 2016
602
INDEX
SERMORELIN
Schedule 4
SERTINDOLE
Schedule 4
SERTRALINE
Schedule 4
SETHOXYDIM
Schedule 5
SEVELAMER
Schedule 4
SEVOFLURANE
Schedule 4
SEX HORMONES
Schedule 4
SIBUTRAMINE
Schedule 4
SIDURON
Schedule 5
SILANDRONE
Schedule 4
Appendix D, Item 5 (Anabolic steroidal agent)
SILDENAFIL
Schedule 4
SILICOFLUORIDES
cross reference: BARIUM SILICOFLUORIDE, FLUORIDES, FLUOROSILICATES,
HEXAFLUOROSILICATES MAGNESIUM FLUOSILICATE,
Schedule 6
Schedule 5
SILICONES
603
INDEX
Schedule 10
Schedule 4
Appendix F, Part 3
SILVER
Schedule 2
SILVER NITRATE
cross reference: SILVER SALTS
Schedule 6
Appendix E, Part 2
SILVER SULFADIAZINE
Schedule 4
SIMAZINE
Appendix B, Part 3
SIMEPREVIR
Schedule 4
SIMVASTATIN
Schedule 4
SINBIOALLETHRIN
Schedule 6
Schedule 5
SINGLE-USE TUBES
Appendix A
SIROLIMUS
Schedule 4
SISOMICIN
Schedule 4
SITAGLIPTIN
Schedule 4
SITAXENTAN
Schedule 4
Appendix D, Item 6
Poisons Standard November 2016
604
INDEX
Appendix F, Part 3
Appendix L, Part 2
SLIMICIDES
Appendix A
SODIUM ALUMINATE
Schedule 6
Appendix E, Part 2
Appendix F, Part 3
SODIUM BICARBONATE
Appendix B, Part 3
SODIUM BROMATE
Schedule 6
Appendix E, Part 2
SODIUM BROMIDE
Schedule 4
SODIUM CELLULOSE PHOSPHATE
Schedule 4
SODIUM CHLORATE
Schedule 5
Appendix E, Part 2
Appendix F, Part 3
SODIUM CROMOGLYCATE
Schedule 4
Schedule 2
SODIUM DIACETATE
Schedule 5
Appendix E, Part 2
SODIUM DICHLOROISOCYANURATE
Appendix E, Part 2
SODIUM DODECYLBENZENE SULFONATE
Schedule 5
Appendix E, Part 2, Part
Appendix F, Part 3
Poisons Standard November 2016
605
INDEX
SODIUM FLUORIDE
Appendix F, Part 3
SODIUM HYDROGEN SULFATE
Schedule 5
Appendix E, Part 2
Appendix F, Part 3
SODIUM HYDROSULFITE
Schedule 5
Appendix F, Part 3
SODIUM HYDROXIDE
cross reference: LYE WATER
Schedule 10
Schedule 6
Schedule 5
Appendix E, Part 2
Appendix F, Part 3
SODIUM LAURETH-6 CARBOXYLATE
Schedule 5
Appendix E, Part 2
Appendix F, Part 3
SODIUM METABISULPHITE
Schedule 5
Appendix E, Part 2
Appendix F, Part 3
SODIUM MORRHUATE
Schedule 4
SODIUM NITRITE
Schedule 7
Schedule 6
Schedule 5
Schedule 2
Appendix E, Part 2
Appendix F, Part 3
SODIUM NITROPRUSSIDE
Schedule 4
SODIUM OXYBATE
606
INDEX
Schedule 8
Appendix D, Item 1
SODIUM PERCARBONATE
Schedule 6
Schedule 5
SODIUM PERSULFATE
Schedule 6
Appendix E, Part 2
Appendix F, Part 3
SODIUM PHOSPHATE
Schedule 4
Schedule 3
SODIUM PICOSULFATE
Schedule 3
SODIUM POLYSTYRENE SULPHONATE
Schedule 5
Schedule 4
SODIUM PRECARBONATE
Appendix E, Part 2
SODIUM PROPIONATE
Appendix B, Part 3
SODIUM SALICYLATE
Schedule 4
SODIUM STANNATE
Schedule 5,
Appendix E, Part 2
SODIUM SULFIDE
Schedule 5, Schedule 6, Appendix E, Part 2, Appendix F, Part 3
SODIUM TETRADECYLSULFATE
Schedule 4
SODIUM TRICHLOROACETATE
Appendix E, Part 2
Poisons Standard November 2016
607
INDEX
SODIUMHYDROSULFITE
Appendix E, Part 2
SOFOSBUVIR
Schedule 4
SOLASODINE
Schedule 4
SOLIFENACIN
Schedule 4
SOMATOSTATIN
Schedule 4
SOMATOTROPIN EQUINE
Schedule 4
SOMATROPIN
cross reference: HUMAN GROWTH HORMONE
Schedule 4
Appendix D, Item 5
Appendix G
SONTOQUINE
Schedule 4
SORAFENIB
-Schedule 4
SOTALOL
Schedule 4
SPARFLOXACIN
Schedule 4
SPARTEINE
Schedule 4
SPECTINOMYCIN
Schedule 4
SPINETORAM
Poisons Standard November 2016
608
INDEX
Schedule 5
SPINOSAD
Schedule 5
SPIRAMYCIN
Schedule 4
SPIRAPRIL
Schedule 4
SPIRONOLACTONE
Schedule 4
SPIROTETRAMAT
Schedule 6
SPIROXAMINE
Schedule 6
SQUILL
Schedule 2
STANOLONE
Schedule 4
Appendix D, Item 5 (Anabolic and/or androgenic steroidal agents)
STANOZOLOL
Schedule 4
Appendix D, Item 5 (Anabolic and/or androgenic steroidal agents)
STAR ANISE OIL
Schedule 5
STAVUDINE
Schedule 4
STENBOLONE
Schedule 4
Appendix D, Item 5 (Anabolic and/or androgenic steroidal agents)
STERIC ACID
Appendix B, Part 3
Poisons Standard November 2016
609
INDEX
STEROID HORMONES
Schedule 4
STILBESTROL
cross reference: STILBOESTROL, DIETHYLSTILBESTROL
Schedule 4
STRCHNINE
Appendix E, Part 2
STREPTODORNASE
Schedule 4
STREPTOKINASE
Schedule 4
STREPTOMYCES LYDICUS WYEC 108
Appendix B, Part 3
STREPTOMYCIN
Schedule 4
STRONTIUM RANELATE
Schedule 4
STROPHANTHINS
Schedule 4
STROPHANTHUS spp.
Schedule 4
Appendix G
STRYCHNINE
cross reference: NUX VOMICA
Schedule 7
Schedule 4
Appendix G
Appendix J, Part 2
STRYCHNOS spp.
Schedule 4
STYRAMATE
Poisons Standard November 2016
610
INDEX
Schedule 4
STYRENE
cross reference: DESIGNATED SOLVENT
Schedule 5
Appendix E, Part 2
Appendix F, Part 3
Part 1 - Interpretation
SUCCIMER
Schedule 4
SUCRALFATE
Appendix B, Part 3
SUFENTANIL
Schedule 8
SUGAMMADEX
Schedule 4
SULBACTAM
Schedule 4
SULCOFURON
Schedule 7
Schedule 6
Appendix E, Part 2
Appendix J, Part 2
SULCONAZOLE
Schedule 4
Schedule 2,
SULESOMAB
Appendix B, Part 3
SULFACETAMIDE
Schedule 5
Schedule 4
Schedule 3
SULFADIAZINE
Schedule 5
Schedule 4
Poisons Standard November 2016
611
INDEX
SULFADIMETHOXINE
Schedule 4
SULFADIMIDINE
Schedule 5
Schedule 4
SULFADOXINE
Schedule 4
SULFAFURAZOLE
Schedule 4
SULFAGUANIDINE
Schedule 4
SULFAMERAZINE
Schedule 5
Schedule 4
SULFAMETHIZOLE
Schedule 4
SULFAMETHOXAZOLE
Schedule 4
SULFAMETHOXYDIAZINE
Schedule 4
SULFAMETHOXYPYRIDAZINE
Schedule 4
SULFAMETROLE
Schedule 4
SULFAMIC ACID
Schedule 6
Schedule 5
Appendix E, Part 2
Appendix F, Part 3
SULFAMONOMETHOXINE
Schedule 4
Poisons Standard November 2016
612
INDEX
SULFAMOXOLE
Schedule 4
SULFAPHENAZOLE
Schedule 4
SULFAPYRIDINE
Schedule 4
SULFAQUINOXALINE
Schedule 4
SULFASALAZINE
Schedule 4
SULFATHIAZOLE
Schedule 5
Schedule 4,
SULFATROXAZOLE
Schedule 4
SULFENTRAZONE
Schedule 7
SULFINPYRAZONE
Schedule 4
SULFLURAMID
Schedule 6
SULFOMETURON-METHYL
Schedule 5
SULFOMYXIN
Schedule 4
SULFONAMIDES
cross reference: SULFACETAMIDE, SULPHANILAMIDE
Schedule 4
SULFONMETHANE
cross reference: ALKYL SULFONALS, SULFONAL
Poisons Standard November 2016
613
INDEX
Schedule 4
SULFOSULFURON
Appendix B, Part 3
SULFOTEP
Schedule 7
SULFOXAFLOR
Schedule 6
Schedule 5
SULFURIC ACID
Schedule 6
Appendix E, Part 2
Appendix F, Part 3
SULFURYL FLUORIDE
Schedule 6
SULINDAC
Schedule 4
SULPHATED POLYSACCHARIDES
Appendix B, Part 3
SULPROFOS
Schedule 6
SULTAMICILLIN
Schedule 4
SULTHIAME
Schedule 4
SUMATRIPTAN
Schedule 4
SUNITINIB
Schedule 4
SUPROFEN
Schedule 4
Poisons Standard November 2016
614
INDEX
SUTILAINS
Schedule 4
SUVOREXANT
Schedule 4
Appendix K
SUXAMETHONIUM
Schedule 4
SUXETHONIUM
Schedule 4
SYMPHYTUM spp.
cross reference: COMFREY
Schedule 10
Schedule 5
Appendix F, Part 3
SYNTHETIC CANNABINOMIMETICS
Schedule 9
T
TACRINE
Schedule 4
TACROLIMUS
Schedule 4
TADALAFIL
Schedule 4
TAFLUPROST
Schedule 4
TALIGLUCERASE ALFA
Schedule 4
TALLOW ALKYLAMINE ACETATES
Schedule 6
TAMOXIFEN
Poisons Standard November 2016
615
INDEX
Schedule 4
TAMSULOSIN
Schedule 4
TANACETUM VULGARE
cross reference: OIL OF TANSY, TANSY OIL
Schedule 4
TANNIC ACID
Appendix B, Part 3
TANNIC ACID/BENZYL ALCOHOL
Appendix B, Part 3
TAPENTADOL
Schedule 8
Appendix K
TAR ACIDS
Schedule 6
TASONERMIN
Schedule 4
TAZAROTENE
Schedule 4
Appendix F, Part 3
TAZOBACTAM
Schedule 4
T-CELL RECEPTOR ANTIBODY
Schedule 4
TCMTB
cross reference: 2-[THIOCYANOMETHYLTHIO]BENZOTHIAZOLE
Schedule 6
TDE
cross reference: 1,1-DICHLORO-2,2-BIS[4-CHLOROPHENYL]ETHANE
Schedule 6
Schedule5
Poisons Standard November 2016
616
INDEX
TEBUCONAZOLE
cross reference: TERBUCONAZOLE
Schedule 5
TEBUFENOZIDE
Schedule 5
TEBUFENPYRAD
Schedule 6
TEBUTHIURON
Schedule 6
TEFLUTHRIN
Schedule 7
Schedule 5
TEGAFUR
Schedule 4
TEGASEROD
Schedule 4
TEICOPLANIN
Schedule 4
TELAPREVIR
Schedule 4
TELBIVUDINE
Schedule 4
TELITHROMYCIN
Schedule 4
TELMISARTAN
Schedule 4
TEMAZEPAM
Schedule 4
Appendix D, Item 5 (Benzodiazepine derivatives)
TEMEPHOS
Poisons Standard November 2016
617
INDEX
Schedule 6
Schedule 5
TEMOZOLOMIDE
Schedule 4
TEMSIROLIMUS
Schedule 4
TENECTEPLASE
Schedule 4
TENIPOSIDE
Schedule 4
TENOCYCLIDINE
cross reference: TCP
Schedule 9
TENOFOVIR
Schedule 4
TENOXICAM
Schedule 4
TEPOXALIN
Schedule 4
TEPP
Schedule 8
TEPRALOXYDIM
Schedule 5
TERAZOSIN
Schedule 4
TERBACIL
Appendix B, Part 3,Part 3
TERBINAFINE
Schedule 4
Schedule 2
Poisons Standard November 2016
618
INDEX
TERBUFOS
Schedule 7
TERBUTALINE
Schedule 4
Schedule 3
Appendix F, Part 3
TERBUTHYLAZINE
Schedule 6
TERBUTRYN
Schedule 5
TERFENADINE
Schedule 4
Appendix F, Part 3
TERIFLUNOMIDE
Schedule 4
Appendix F, Part 3
Appendix L, Part 2
TERIPARATIDE
Schedule 4
Appendix D, Item 1
TERLIPRESSIN
Schedule 4
TERMITE BARRIERS
Appendix A
TERODILINE
Schedule 4
TEROPTERIN
Schedule 4
TERPENES, CHLORINATED
cross reference: CHLORINATED TERPENES
Schedule 6
Appendix E, Part 2
Appendix F, Part 3
Poisons Standard November 2016
619
INDEX
TESTOLACTONE
Schedule 4
Appendix D, Item 5 (Anabolic and/or androgenic steroidal agents)
TESTOSTERONE
Schedule 6
Schedule 4
Appendix D, Item 5 (Anabolic and/or androgenic steroidal agents)
Appendix G
TETANUS ANTITOXIN
Schedule 4
TETANUS TOXOID
Schedule 4
1,3,5,7-TETRAAZATRICYLO[3.3.1.13,7] DECANE
cross reference: HEXAMINE, HEXAMETHYLENETETRAMINE, METHENAMINE
TETRABENAZINE
Schedule 4
TETRACAINE
cross reference: AMETHOCAINE
Schedule 4
Schedule 2
TETRACHLOROETHANE
Schedule 7
Appendix E, Part 2
Appendix F, Part 3
Appendix J, Part 2
TETRACHLOROETHYLENE
cross reference: DESIGNATED SOLVENT
Schedule 6
Schedule 5
Schedule 2
Appendix E, Part 2
Appendix F, Part 3
Part 1 - Interpretation
TETRACHLORVINPHOS
Schedule 5
TETRACONAZOLE
Poisons Standard November 2016
620
INDEX
Schedule 6
Schedule 5
TETRACOSACTIDE
Schedule 4
TETRACOSACTRIN
cross reference: TETRACOSACTIDE
TETRACYCLINE
Schedule 5
Schedule 4
TETRADIFON
Schedule 6
TETRAETHYLAMMONIUM
Schedule 4
TETRAHYDROCANNABINOLIC ACID
cross reference: NABIXIMOLS, TETRAHYDROCANNABINOLS
TETRAHYDROCANNABINOLS
cross reference: CANNABIS, HEMP SEED OIL, NABIXIMOLS
Schedule 9
Schedule 8
Appendix D, Item 1
Appendix K
TETRAHYDROCANNABIDIVAROL
cross reference: NABIXIMOLS, TETRAHYDROCANNABINOLS
TETRAHYDROZOLINE
cross reference: TETRYZOLINE
TETRAMETHRIN
Schedule 5
TETRAMISOLE
Schedule 6
TETROXOPRIM
Schedule 4
TETRYZOLINE
cross reference: TETRAHYDROZOLINE
621
INDEX
Schedule 2
Appendix F, Part 3
THALIDOMIDE
Schedule 4
Appendix D, Item 2
Appendix F, Part 3
Appendix L, Part 2
THALLIUM
cross reference: THALLIUM SULFATE
Schedule 7
Appendix J, Part 2
THAUMATIN
Appendix B, Part 3
THEBACON
Schedule 8
THEBAINE
Schedule 8
THENYLDIAMINE
Schedule 4
Appendix K
THEOPHYLLINE
Schedule 4
Schedule 3
THEVETIA PERUVIANA
Schedule 4
THEVETIN
Schedule 4
THIABENDAZOLE
Schedule 5
Schedule 2
THIACETARSAMIDE
Schedule 4
THIACLOPRID
Poisons Standard November 2016
622
INDEX
Schedule 6
THIAMBUTOSINE
Schedule 4
THIAMETHOXAM
Schedule 6
Schedule 5
THIAZAFLURON
Schedule 6
THIAZOPYR
Schedule 5
THIAZOSULFONE
Schedule 4
THIDIAZURON
Appendix B, Part 3
THIETHYLPERAZINE
Schedule 4
Appendix K
THIFENSULFURON
Schedule 5
THIOACETAZONE
Schedule 4
THIOBENCARB
Schedule 5
THIOCARLIDE
Schedule 4
THIODICARB
Schedule 6
Schedule 5
THIOFANOX
Schedule 7
Poisons Standard November 2016
623
INDEX
THIOFENTANYL
Schedule 9
THIOGUANINE
cross reference: TIOGUANINE
THIOMESTERONE
cross reference: TIOMESTERONE
Schedule 4
Appendix D, Item 5 (Anabolic and/or androgenic steroidal agents)
THIOMETON
Schedule 6
THIOPENTONE
Schedule 4
THIOPHANATE-METHYL
Schedule 6
Schedule 5
THIOPROPAZATE
Schedule 4
Appendix K
THIOPROPERAZINE
Schedule 4
THIORIDAZINE
Schedule 4
Appendix K
THIOSTREPTON
Schedule 4
THIOTEPA
cross reference: TRIETHYLENE THIOPHOSPHORAMIDE
Schedule 4
THIOTHIXENE
Schedule 4
Appendix K
THIOURACIL
Poisons Standard November 2016
624
INDEX
Schedule 4
THIOUREA
cross reference: ALKYL THIOUREAS
Schedule 6
Schedule 4
Appendix E, Part 2
Appendix F, Part 3
THIRAM
Schedule 6
THUJONE
Schedule 6
Appendix E, Part 2
THYME OIL
Schedule 5
Appendix E, Part 2
THYMOL
Schedule 6
THYMOXAMINE
Schedule 4
THYROID
Schedule 4
THYROTROPHIN
cross reference: TSH
Schedule 4
THYROXINE
Schedule 4
Appendix G
TIAGABINE
Schedule 4
TIAMULIN
Schedule 4
TIAPROFENIC ACID
Poisons Standard November 2016
625
INDEX
Schedule 4
TIARAMIDE
Schedule 4
TIBOLONE
Schedule 4
TICAGRELOR
Schedule 4
TICARCILLIN
Schedule 4
TICLOPIDINE
Schedule 4
TIEMONIUM
Schedule 4
TIENILIC ACID
Schedule 4
TIGECYCLINE
Schedule 4
TIGLOIDINE
Schedule 4
TILDIPIROSIN
Schedule 4
TILETAMINE
Schedule 4
TILIDINE
Schedule 8
TILMICOSIN
Schedule 4
TILUDRONIC ACID
cross reference: DISODIUM TILUDRONATE
Poisons Standard November 2016
626
INDEX
Schedule 4
TIMBER
cross reference: WALLBOARD
Appendix A
TIMOLOL
Schedule 4
TIMOTHY-GRASS POLLEN EXTRACT
cross reference: PHLEUM PRATENSE POLLEN EXTRACT
Schedule 4
TIN ORGANIC COMPOUNDS
cross reference: DIALKYL TIN COMPOUNDS, DIBUTYL TIN COMPOUNDS, DIETHYL
TIN COMPOUNDS, DIMETHYL TIN DICHLORIDE, DIMETHYL TIN COMPOUNDS,
DIPROPYL TIN COMPOUNDS, FENBUTATIN OXIDE, ORGANO TIN-COMPOUNDS,
TBTO, TRIALKYL TIN COMPOUNDS, TRIBUTYL TIN COMPOUNDS, TRIETHYL TIN
COMPOUNDS, TRIMETHYL TIN COMPOUNDS, TRIPHENYL TIN COMPOUNDS,
TRIPROPYL TIN COMPOUNDS
Schedule 7
TINIDAZOLE
Schedule 4
TINZAPARIN
Schedule 4
TIOCARBAZIL
Schedule 5
TIOCONAZOLE
Schedule 4
Schedule 3
Schedule 2
TIOGUANINE
cross reference: THIOGUANINE
Schedule 4
TIOTROPIUM
Schedule 4
TIPEPIDINE
Schedule 4
Poisons Standard November 2016
627
INDEX
TIPRANAVIR
Schedule 4
TIRILAZAD
Schedule 4
TIROFIBAN
Schedule 4
TOBRAMYCIN
Schedule 4
TOCAINIDE
Schedule 4
TOCERANIB
Schedule 4
TOCILIZUMAB
Schedule 4
TOFACITINIB
Schedule 4
TOLAZAMIDE
Schedule 4
TOLAZOLINE
Schedule 4
TOLBUTAMIDE
Schedule 4
TOLCAPONE
Schedule 4
TOLCLOFOS-METHYL
Schedule 5
TOLFENAMIC ACID
Schedule 4
Poisons Standard November 2016
628
INDEX
TOLIDINE
Schedule 4
Appendix E, Part 2
TOLMETIN
Schedule 4
TOLONIUM
Schedule 4
TOLPROPAMINE
Schedule 4
TOLRESTAT
Schedule 4
TOLTERODINE
Schedule 4
TOLTRAZURIL
Schedule 5
TOLUENE
cross reference: XYLENE
Schedule 6
Appendix E, Part 2
Appendix F, Part 3
TOLUENEDIAMINES
Schedule 10
Schedule 6
Appendix E, Part 2
Appendix F, Part 3
TOLVAPTAN
Schedule 4
TOLYLFLUANID
Schedule 6
TOPIRAMATE
Schedule 4
TOPOTECAN
Poisons Standard November 2016
629
INDEX
Schedule 4
TOPRAMEZONE
Schedule 5
TORASEMIDE
Schedule 4
TOREMIFENE
Schedule 4
TOXOIDS
Schedule 4
TRALKOXYDIM
Schedule 5
TRAMADOL
Schedule 4
Appendix K
TRAMAZOLINE
Schedule 2
Appendix F, Part 3
TRAMETINIB DIMETHYL SULFOXIDE
Schedule 4
TRANDOLAPRIL
Schedule 4
TRANEXAMIC ACID
cross reference: CETYL TRANEXAMATE
Schedule 4
TRANSFLUTHRIN
Schedule 6
TRANYLCYPROMINE
Schedule 4
Appendix K
TRASTUZUMAB
Poisons Standard November 2016
630
INDEX
Schedule 4
TRASTUZUMAB EMTANSINE
Schedule 4
TRAVOPROST
Schedule 4
TRAZODONE
Schedule 4
TRENBOLONE
cross reference: TRIENBOLONE, TRIENOLONE
Schedule 5
Schedule 4
Appendix D, Item 5 (Anabolic and/or androgenic steroidal agents)
TREOSULPHAN
Schedule 4
TREPROSTINIL
Schedule 4
TRESTOLONE
Schedule 4
Appendix D, Item 5 (androgenic steroidal agents)
TRETAMINE
Schedule 4
TRETINOIN
Schedule 4
Appendix D, Item 4
Appendix F, Part 3
Appendix L, Part 2
TRIACETYLOLEANDOMYCIN
Schedule 4
TRIADIMEFON
Schedule 6
Schedule 5
TRIADIMENOL
Poisons Standard November 2016
631
INDEX
Schedule 5
TRI-ALLATE
Schedule 5
TRIAMCINOLONE
Schedule 4
Schedule 3
Schedule 2
Appendix F, Part 3, Part 2
TRIAMIPHOS
Schedule 7
TRIAMTERENE
Schedule 4
TRIASULFURON
Appendix B, Part 3
TRIAZBUTIL
Schedule 7
TRIAZIQUONE
Schedule 4
TRIAZOLAM
Schedule 4
Appendix D, Item 5 (benzodiazepine derivatives)
TRIBENURON-METHYL
Schedule 5
TRIBUFOS
cross reference: s,s,s-TRIBUTYLPHOSPHOROTRITHIOATE
Schedule 7
TRICHLORFON
cross reference: METRIFONATE
Schedule 6
TRICHLORMETHIAZIDE
Schedule 4
Poisons Standard November 2016
632
INDEX
TRICHLOROACETIC ACID
Schedule 6
Schedule 5
Schedule 4
Appendix E, Part 2
Appendix F, Part 3
TRICHLOROACETIC ACID ALKALI SALTS
Schedule 5
Appendix E, Part 2
TRICHLOROETHYLENE
cross reference: TRICHLOROETHENE
Schedule 6
Schedule 4
Appendix E, Part 2
Appendix F, Part 3
TRICHLOROPHENOL
Schedule 6
Appendix F, Part 3
TRICHODERMA HARZIANUM
Appendix B, Part 3
TRICHODESMA AFRICANA
Schedule 10
TRICLABENDAZOLE
Schedule 6
TRICLOFOS
Schedule 4
TRICLOPYR
Schedule 6
TRICLOSAN
Schedule 6
TRICYCLAMOL
Schedule 4
TRIDEMORPH
Poisons Standard November 2016
633
INDEX
Schedule 6
TRIDIHEXETHYL
Schedule 4
TRIDIPHANE
Schedule 5
TRIETAZINE
Schedule 5
TRIETHANOLAMINE
cross reference: TROLAMINE
TRIETHYL PHOSPHATE
Schedule 6
Appendix E, Part 2
TRIETHYLENE GLYCOL
Appendix B, Part 3
TRIFLOXYSTROBIN
Schedule 5
TRIFLOXYSULFURON
Appendix B, Part 3
TRIFLUMIZOLE
Schedule 5
TRIFLUMURON
Schedule 5
TRIFLUOPERAZINE
Schedule4
Appendix K
TRIFLUOROMETHANESULFONIC ACID
Schedule 6
Appendix E, Part 2
Appendix F, Part 3
TRIFLUPERIDOL
Schedule 4
Poisons Standard November 2016
634
INDEX
TRIFLUPROMAZINE
Schedule 4
TRIFLURALIN
Appendix B, Part 3
TRIFORINE
Appendix B, Part 3
TRIHEXYPHENIDYL
cross reference: BENZHEXOL
Schedule 4
TRIISOPROPANOLAMINE LAURYL ETHER SULFATE
Schedule 5
Appendix E, Part 2
Appendix F, Part 3
TRILOSTANE
Schedule 4
TRIMEPRAZINE
cross reference: ALIMEMAZINE
TRIMETAPHAN
Schedule 4
TRIMETHOPRIM
Schedule 4
TRIMIPRAMINE
Schedule 4
Appendix K
TRIMUSTINE
Schedule 4
TRINEXAPAC-ETHYL
Schedule 5
TRINITROPHENOL
Schedule 6
Schedule 4
Poisons Standard November 2016
635
INDEX
TRIOXYSALEN
Schedule 4
TRIPARANOL
Schedule 10
TRIPELENNAMINE
Schedule 4
TRIPLE ANTIGEN VACCINE
Schedule 4
TRIPROLIDINE
Schedule 4
Schedule 3
Schedule 2
Appendix K
TRIPTORELIN
Schedule 4
TRISODIUM NITRILOTRIACETATE
Schedule 6
TRITICONAZOLE
Schedule 5
TROGLITAZONE
Schedule 4
TROLAMINE
Schedule 5
Schedule 4
Appendix E, Part 2
Appendix F, Part 3
TROMETAMOL
Schedule 4
TROPICAMIDE
Schedule 4
TROPISETRON
Poisons Standard November 2016
636
INDEX
Schedule 4
TROVAFLOXACIN
Schedule 4
TROXIDONE
Schedule 4
TRYPTOPHAN
Schedule 4
TUAMINOHEPTANE
Schedule 2
TUBERCULIN
Schedule 4
TUBOCURARINE
Schedule 4
TULATHROMYCIN
Schedule 4
TULOBUTEROL
Schedule 4
TURPENTINE OIL
cross reference: OIL OF TURPENTINE
Schedule 5
Appendix E, Part 2
TUSSILAGO FARFARA
cross reference: COLTSFOOT
Schedule 10
TYLOSIN
Schedule 4
TYMAZOLINE
Schedule 4
Appendix F, Part 3
TYPHOID VACCINE
Poisons Standard November 2016
637
INDEX
Schedule 4
U
ULIPRISTAL
Schedule 4
ULOCLADIUM OUDEMANSII
Appendix B, Part 3
UMECLIDINIUM
Schedule 4
UNOPROSTONE
Schedule 4
URACIL
Schedule 4
URAPIDIL
Schedule 4
UREA
Appendix B, Part 3
URETHANE
Schedule 4
UROFOLLITROPIN
cross reference: FOLLICLE-STIMULATING HORMONE, HUMAN
Schedule 4
Appendix D, Item 1
UROKINASE
Schedule 4
URSODEOXYCHOLIC ACID
Schedule 4
USTEKINUMAB
Schedule 4
V
Poisons Standard November 2016
638
INDEX
VACCINES
Schedule 4
VACCINIA VIRUS VACCINE
Schedule 4
VALACICLOVIR
Schedule 4
VALDECOXIB
Schedule 4
VALGANCICLOVIR
Schedule 4
VALNOCTAMIDE
Schedule 4
VALPROIC ACID
Schedule 4
VALSARTAN
Schedule 4
VAMIDOTHION
Schedule 6
VANCOMYCIN
Schedule 4
VANDETANIB
Schedule 4
VARDENAFIL
Schedule 4
VARENICLINE
Schedule 4
VARICELLA VACCINE
Schedule 4
Poisons Standard November 2016
639
INDEX
VASOPRESSIN
Schedule 4
VECURONIUM
Schedule 4
VEDAPROFEN
Schedule 4
VEDOLIZUMAB
Schedule 4
VELAGLUCERASE ALFA
Schedule 4
VELPATASVIR
Schedule 4
VEMURAFENIB
Schedule 4
VENLAFAXINE
Schedule 4
VERAPAMIL
Schedule 4
VERATRUM
Schedule 4
VERNAKALANT
Schedule 4
VERNOLATE
Schedule 5
VERTEPORFIN
Schedule 4
VETIVER OIL
Appendix B, Part 3
Poisons Standard November 2016
640
INDEX
VIDARABINE
Schedule 4
VIGABATRIN
Schedule 4
VILANTEROL
Schedule 4
VILDAGLIPTIN
Schedule 4
VILOXAZINE
Schedule 4
VINBLASTINE
Schedule 4
VINCAMINE
Schedule 4
VINCLOZOLIN
Schedule 6
Appendix F, Part 3
VINCRISTINE
Schedule 4
VINDESINE
Schedule 4
VINFLUNINE
Schedule 4
VINORELBINE
Schedule 4
VINYL CHLORIDE
Schedule 7
Appendix J, Part 2
VINYL ETHER
Poisons Standard November 2016
641
INDEX
Schedule 4
VIRGINIAMYCIN
Schedule 5
Schedule 4
VISMODEGIB
Schedule 4
VISNADINE
Schedule 4
VITAMIN A
Schedule 4
VITAMIN D
cross reference: COLECALCIFEROL, ERGOCALCIFEROL
Schedule 4
Schedule 3
VITAMIN K
cross reference: PHYTOMENADIONE
Appendix B, Part 3
VITREOUS ENAMELS
Appendix A
VORAPAXAR
Schedule 4
VORICONAZOLE
Schedule 4
VORINOSTAT
Schedule 4
VORTIOXETINE
Schedule 4
W
WALLBOARD
cross reference: TIMBER
Appendix A
Poisons Standard November 2016
642
INDEX
WARFARIN
Schedule 6
Schedule 5
Schedule 4
WRITING CORRECTION PENS
Appendix A
X
XAMOTEROL
Schedule 4
XANTHINOL NICOTINATE
Schedule 4
XANTHOPHYLL
cross reference: LUTEIN
Appendix B, Part 3
XIMELAGATRAN
Schedule 4
XIPAMIDE
Schedule 4
XYLANASE derived from Aspergillus niger
Appendix B, Part 3
XYLAZINE
Schedule 4
XYLENE
cross reference: TOLUENE
Schedule 6
Appendix E, Part 2
Appendix F, Part 3
XYLOMETAZOLINE
Schedule 2
Appendix F, Part 3
Y
YLANG YLANG OIL
Poisons Standard November 2016
643
INDEX
Appendix B, Part 3
YOHIMBINE
cross reference: ASPIDOSPERMA QUEBRACHO
Schedule 4
Z
(Z)-9-TRICOSENE
cross reference: TRICOSENE
Appendix B, Part 3
ZAFIRLUKAST
Schedule 4
ZALCITABINE
Schedule 4
ZALEPLON
Schedule 4
ZANAMIVIR
Schedule 4
ZERANOL
Schedule 6
Schedule4
ZETA-CYPERMETHRIN
Schedule 7
Schedule 6
ZIDOVUDINE
Schedule 4
ZILPATEROL
Schedule 4
ZIMELDINE
Schedule 4
ZINC BORATE
Schedule 6
Poisons Standard November 2016
644
INDEX
ZINC CHLORIDE
Schedule4
Appendix E, Part 2
ZINC COMPOUNDS
Schedule 4
ZINC LACTATE
Schedule 6
Appendix F, Part 3
ZINC NAPHTHENATE
Appendix B, Part 3
ZINC para-PHENOLSULFONATE
Schedule 6
ZINC SULFATE
Schedule 6
Appendix E, Part 2
Appendix F, Part 3
ZINEB
cross reference: DITHIOCARBAMATES, MANCOZEB, PROPINEB, THIRAM
Schedule 5
ZIPRASIDONE
Schedule 4
Appendix K
ZIRAM
Schedule 7
Schedule 6
ZOLAZEPAM
Schedule 4
ZOLEDRONIC ACID
Schedule 4
ZOLMITRIPTAN
Schedule 4
ZOLPIDEM
Poisons Standard November 2016
645
INDEX
Schedule4
Appendix K
ZONISAMIDE
Schedule 4
Appendix K
ZOPICLONE
Schedule 4
Appendix K
ZOXAZOLAMINE
Schedule 4
ZUCLOPENTHIXOL
Schedule 4
646